: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer, January 2026
Free Subscription

Abstracts
Retrieve all available abstracts of the following 2894 articles:
HTML format

Single Articles

SHI A, Yerebake M, Du Z, Li L, et al
Acupuncture as adjunctive therapy for cervical cancer pain: a systematic review and meta-analysis.
J Pain Symptom Manage. 2025 Dec 31:S0885-3924(25)01021.
Abstract

PANT S
ACS: New Cervical Cancer Screening Guidelines.
JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23004.
Abstract

WANG F, Wang L, Bai Y
Research progress of ferroptosis in cervical cancer treatment.
Ann Med. 2026;58:2611208.
Abstract

ZHANG J, Fu C, Du J
Artificial intelligence-assisted noninvasive preoperative prediction of lymph nodes metastasis in cervical cancer through a clinical-imaging feature combined strategy.
Front Oncol. 2025;15:1669396.
Abstract

BUSTOS-GUTIERREZ MT, Morales-Casetti ML, Vasquez-Palma OA, Bustos-Gutierrez LR, et al
[Social determinants of health that influence pap smear and mammography screening in Chilean women].
Rev Salud Publica (Bogota). 2025;27:114162.
Abstract

HIRAKAWA A, Iwai N, Yanai A, Matsukawa K, et al
Efficacy of Sentinel Lymph Node Sampling for Early Cervical Cancer: A Single Institute Study.
J Obstet Gynaecol Res. 2026;52:e70144.
Abstract

TANG C, Jin X
Deubiquitinating enzymes in endometrial cancer and cervical cancer.
Gene. 2025 Dec 30:149988. doi: 10.1016/j.gene.2025.149988.
Abstract

LIU T, Zhang L, Li Y, Liao W, et al
Glutamine metabolites promote the progression of cervical cancer by inducing M2 macrophage polarization.
Pathol Res Pract. 2025;278:156348.
Abstract

RAJI PS, Thomas A, Thomas DS, Thomas V, et al
Compliance to Standards of Colposcopy in an Effort to Reduce the Cervical Cancer Burden: An Audit.
J Obstet Gynaecol India. 2025;75:461-466.
Abstract

ASFAW MS, Kassahun W
The role of microRNAs on autophagy in cervical cancer: review.
Discov Oncol. 2025 Dec 31. doi: 10.1007/s12672-025-04284.
Abstract

PINGAULT O, Moskal A, Bouvard C, Payet C, et al
Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study.
BMJ Open. 2025;15:e108897.
Abstract

ASARE M, Ebu Enyan NI, Sencherey VL, Lamptey-Mills E, et al
Culturally adapting and evaluating an evidence-based communication intervention with HPV self-sampling to improve cervical cancer screening among women living with HIV in Ghana: a mixed-methods study.
BMJ Open. 2025;15:e105852.
Abstract

LU X, Feng L, Zhang L, Gu F, et al
Covalently assembled dual-functional triple-helix lentinan-Au for cervical cancer therapy.
Carbohydr Polym. 2026;375:124799.
Abstract

TUERXUN H, Li J, Liu Q, Tursun M, et al
MICA/B-Driven NK Cell Dysfunction Promotes Cervical Cancer via Toll Signaling.
Exp Cell Res. 2025 Dec 29:114876. doi: 10.1016/j.yexcr.2025.114876.
Abstract

REN Y, Li S, Xiang S, Xu J, et al
A Retrospective Study on the Clinicopathological Characteristics and Prognostic Analysis of Gynecologic Neuroendocrine Carcinoma.
Cancer Med. 2026;15:e71488.
Abstract

SHARMA H, Soni KK, Thakur N, Kumar M, et al
Intracavitary brachytherapy challenge in cervical cancer with a large cervical fibroid: A case report.
J Cancer Res Ther. 2025;21:1431-1434.
Abstract

ABRAHAM P
Human Papillomavirus Vaccination - A Moment of Prevention, a Lifetime of Protection.
Indian J Public Health. 2025;69:375-376.
Abstract

KIM CA, Shelton N, Samudrala M, Savsani K, et al
AutoEpiCollect 2.0: A Web-Based Machine Learning Tool for Personalized Peptide Cancer Vaccine Design.
Molecules. 2025;30:4702.
Abstract

KIM MH, Yang J, Song DH, Kim CH, et al
Expression of Core Hippo Pathway Proteins in Cervical Cancer and Their Association with Clinicopathologic Parameters.
Medicina (Kaunas). 2025;61:2134.
Abstract

TERKIMBI SD, Paul-Chima UO, Mujinya R, Joan C, et al
Molecular, immunological and oncogenic mechanisms of cervical cancer mediated by HPV/HIV co-infection, clinical implication and management.
Infect Agent Cancer. 2025 Dec 30. doi: 10.1186/s13027-025-00729.
Abstract

HOSHINO N, Yoshida K, Kanemitsu Y, Toyama A, et al
Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer.
Anticancer Res. 2026;46:273-281.
Abstract

OOMMEN AM, Ashfaq M, Tonsing MV, Cherian AG, et al
Protocol for a cervical screening implementation trial comparing two approaches for delivering HPV self-collection in low-resource settings in India: a type 3 hybrid cluster randomised controlled trial (SHE-CAN).
BMJ Open. 2025;15:e101599.
Abstract

ABASCAL MIGUEL L, Gaitan Barrillas R, Johnston JS, Ward V, et al
HPV vaccine awareness and uptake in rural Indigenous communities in Guatemala: a cross-sectional study.
BMJ Open. 2025;15:e107602.
Abstract

PRETI M, Lewis F, Carcopino X, Bevilacqua F, et al
Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European
Obstet Gynecol Surv. 2025;80:759-761.
Abstract

DESCAMPS P, Dixon S, Bosch Jose FX, Kyrgiou M, et al
Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened.
Obstet Gynecol Surv. 2025;80:702-704.
Abstract

MKUU RS, Tohme S, Rivero-Mendoza D, Salloum RG, et al
Improving Patient Education Materials for HPV Self-Collection: Insights from Women at High Risk of Developing Cervical Cancer.
Cancer Manag Res. 2025;17:3273-3284.
Abstract

DONG S, Feng YN, Li XY, Peng YQ, et al
An Ultrasound Radiomics Model for the Early Diagnosis of Cervical Cancer.
Ultrason Imaging. 2025 Dec 29:1617346251403960. doi: 10.1177/01617346251403960.
Abstract

YAN Q, Zhang Z, Li R, Xue J, et al
Clinical and nutritional-inflammatory biomarkers-based nomogram predicts survival in recurrent or metastatic cervical cancer treated with immune checkpoint inhibitors.
Ann Med. 2026;58:2603780.
Abstract

OOMMEN AM, Ashfaq M, Viswanathan V, Singarayar P, et al
Readiness to transition to HPV self-collection from VIA screening: a mixed methods health systems assessment from Tamil Nadu, India.
BMC Health Serv Res. 2025;25:1619.
Abstract

ISMAEL AMEEN S, Masoudi M, Azizi H, Skutella T, et al
HPV-Driven Immune Evasion in Cervical Cancer: Transcriptomic Identification of Downregulated Hub Genes and Suppressed Leukocyte Migration Pathways.
Int J Mol Sci. 2025;26:12121.
Abstract

RODRIGUEZ-NAVA C, Cortes-Sarabia K, Riano-Umbarila L, Becerril-Lujan B, et al
Generation of a scFv Derived from an IgM-Producing Hybridoma for the Detection of REST Expression in Premalignant Lesions and Invasive Squamous Cell Carcinoma.
Int J Mol Sci. 2025;26:11946.
Abstract

OPLAWSKI M, Mawlichanow K, Golec-Cera A, Jedrzejczyk A, et al
Outcomes of Cervical Cancer Treatment Using Total Mesometrial Resection (TMMR) Performed with the Robotic System-A Preliminary Report.
J Clin Med. 2025;14:8667.
Abstract

GRIECO V, Fiorito D, Giorgianni G, Irato E, et al
HPV Vaccine: An Effective but Underutilized Prevention Tool.
Int J Environ Res Public Health. 2025;22:1844.
Abstract

GISCA T, Matasariu DR, Ursache A, Socolov DG, et al
Integrating Biomarkers into Cervical Cancer Screening-Advances in Diagnosis and Risk Prediction: A Narrative Review.
Diagnostics (Basel). 2025;15:3231.
Abstract

JIANG Y, Wei Y, Li Z, Huang Z, et al
Enhancing CD8(+) T Cells Infiltration Through the Protein Arginine Methyltransferase 5 (PRMT5)/CXCL10 Axis Restricts Cervical Cancer Progression.
Biomolecules. 2025;15:1717.
Abstract

PHIANPISET R, Detwongya C, Phookiaw S, Manopunya M, et al
Long-Term Oncological Outcomes of Laparoscopic Versus Open Radical Surgery in Early-Stage Cervical Cancer: A Propensity Score-Matched Analysis.
Cancers (Basel). 2025;17:3960.
Abstract

SANTOS F, Caramelo FA, Tomaz JMP, Santana MM, et al
Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis.
Cancers (Basel). 2025;17:3945.
Abstract

SONG Y, Zou K, Zou L
Treatment of Pelvic Recurrence After Radiotherapy for Cervical Cancer.
Cancers (Basel). 2025;17:3934.
Abstract

GACUTA E, Lawicki M, Grabowska H, Lawicki P, et al
Role of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) in Diagnosing Cervical Cancer Patients.
Biomedicines. 2025;13:2910.
Abstract

RUHODE N, Madanhire C, Tumushime MK, Gudukeya S, et al
Perceptions of integrating cervical cancer screening with HIV and sexual and reproductive health services: results from serial multiple methods studies among health workers and women in Zimbabwe.
Reprod Health. 2025;22:259.
Abstract

A AMER A, Altabbaa H, Sh Ramadan M, Abdul-Hafez HA, et al
A multinational cross-sectional study on human papillomavirus and cervical cancer knowledge, vaccination attitudes, and risk factors in the Middle East.
Sci Rep. 2025 Dec 29. doi: 10.1038/s41598-025-30866.
Abstract

FANT C, Tewari K
Eradicating cervical cancer in the poorest regions of the world.
Curr Opin Obstet Gynecol. 2026;38:6-13.
Abstract

RAO S, R S, Sarma D, Nath AG, et al
HPV Screening in Women Living with HIV (WLHIV) in Karnataka, India: Can it be Integrated into ART Centres?
Asian Pac J Cancer Prev. 2025;26:4513-4523.
Abstract

BOMUANG K, Saengkhiao M, Chaimay B, Woradet S, et al
Health Literacy and Factors Associated with HPV Vaccination among Adolescent Students: A Cross-Sectional Analytic Study.
Asian Pac J Cancer Prev. 2025;26:4387-4396.
Abstract

SINGH N, Mangal S, Tanwar P, Singhal S, et al
Evaluating The Feasibility and Acceptability of Cervical Cancer Screening in an Urban Slum Community by HPV Self-Sampling With the Aid of Telecounselling: Lessons Learnt.
Asian Pac J Cancer Prev. 2025;26:4331-4338.
Abstract

LEE HY, Chipalo E, Luo Y, Chou C, et al
Determinants of Female Cancer Screening Awareness in Alabama's Black Belt Region.
Asian Pac J Cancer Prev. 2025;26:4313-4322.
Abstract

K C BHANDARI A, Htay ZW, Parvin R, Murakami M, et al
Prevalence of Cervical Cancer Screening in Asia: A Systematic Review and Meta-Analysis.
Asian Pac J Cancer Prev. 2025;26:4269-4281.
Abstract

KRYLYSHKIN M, Chernyakov A, Dil O, Truschuk J, et al
Radical Trachelectomy Using A Titanium-Nickelide Metal Tricotage Implant to Preserve Fertility in Cervical Cancer Patients.
Asian Pac J Cancer Prev. 2025;26:4265-4268.
Abstract

AZHARI HA, Chawdhury M, Islam F, Zakaria GA, et al
Visual inspection with acetic acid and colposcopy: screening of cervical cancer in resource-limited healthcare settings.
Front Glob Womens Health. 2025;6:1684205.
Abstract

WU X, Wang D, Mao X, Dong B, et al
Microbiome-Driven Resistance in Cervical Cancer Therapy: From Mechanistic Dissection to Clinical Translation.
Expert Rev Mol Med. 2025 Dec 29:1-45. doi: 10.1017/erm.2025.10029.
Abstract

BLETSAS M, Rodrigues M
[Tisotumab Vedotin - Metastatic or recurrent cervical cancer as second-line therapy].
Bull Cancer. 2025 Dec 27:S0007-4551(25)00534.
Abstract

ZHANG J, Zhao J, Cui RR, Wang TT, et al
[Clinical outcomes of people with abnormal cervical cancer screening results but normal colposcopy findings].
Zhonghua Fu Chan Ke Za Zhi. 2025;60:958-967.
Abstract

SULTANOV M, Pan F, Naheed N, Rahman A, et al
Costing of Cervical Cancer Screening and Treatment Pathways: Case Studies in Bangladesh and Uganda.
Value Health Reg Issues. 2025;54:101566.
Abstract

MANGA SM, Lee GM, Ekoue N, Simeni MH, et al
Prevalence of human papillomavirus and cervical neoplasia among women who have sex with women in Cameroon: A descriptive study.
Afr J Reprod Health. 2025;29:122-130.
Abstract

PAKDAMAN K, Esmaeilnia Shirvani A, Pakdaman K, Karim B, et al
Systematic review and meta analysis of the global incidence and clinicopathological characteristics of liver metastasis in patients with cervical cancer.
Discov Oncol. 2025 Dec 27. doi: 10.1007/s12672-025-04255.
Abstract

ADEKUNLE TE, Adekunle TB, Thomas S
Black Women's Perceptions of the Challenges Surrounding Cervical Cancer Screening in the United States.
J Racial Ethn Health Disparities. 2025 Dec 27. doi: 10.1007/s40615-025-02809.
Abstract

YIN J, Zhang S, Wang S, Li Z, et al
Age-specific clinical performance of HPV-based vs. cytology-based cervical cancer screening in China.
Nat Commun. 2025 Dec 27. doi: 10.1038/s41467-025-67215.
Abstract

MONTECILLO JAV, Yoo HJ, Lee YY, Park CM, et al
Streptococcus vaginalis affects cellular dynamics of cervical cancer cells via oxidative stress-induced activation of endoplasmic reticulum unfolded protein response.
Microbiol Res. 2025;305:128433.
Abstract

VILLARREAL XP, He R, Valle D, Kioutchoukova IP, et al
Preferences of High-Risk HPV-Based Cervical Cancer Screening among Transgender Men and Gender Diverse People Assigned Female at Birth: A Cross-Sectional Study at a Single Academic Center.
Cancer Causes Control. 2025;37:12.
Abstract

SULTANA F, Chatterjee N, Mukherjee D, Kumar Panda C, et al
Role of miRNAs, miR-135b-5p & miR-21-5p in metastasis of cervical cancer.
Indian J Med Res. 2025;162:493-503.
Abstract

CORREA CM, Zeferino LC, Juliato CT, Bahamondes L, et al
Association of cervical cancer and intrauterine device use: a narrative review.
BMC Womens Health. 2025 Dec 27. doi: 10.1186/s12905-025-04239.
Abstract

LI L, Lin D, Ao K, Zhong S, et al
YTHDF3 suppresses interferon-stimulated gene (ISG)-dependent antitumor immunity and promotes HPV carcinogenesis in cervical cancer.
Cell Death Dis. 2025 Dec 26. doi: 10.1038/s41419-025-08188.
Abstract

TODOROVA I, Panayotova Y, Kotzeva T, Greenley R, et al
Cervical cancer in Bulgaria since EU accession in 2007: a struggle in the face of political instability.
Health Policy. 2026;164:105497.
Abstract

HOLDERNESS H, Kaufmann J, Erroba J, Marino M, et al
Changes in breast and cervical cancer screening rates among Latinas after Medicaid expansion.
Am J Prev Med. 2025 Dec 24:108241. doi: 10.1016/j.amepre.2025.108241.
Abstract

FLANAGAN M, Fantasia HC
A Multicomponent, Team-Based Quality Improvement Project for Improving Cervical Cancer Screenings in Primary Care.
Nurs Womens Health. 2025 Dec 23:S1751-4851(25)00204.
Abstract

KIM SK, Fontenot HB
The Potential of Human Papillomavirus Self-Collection Testing to Improve Cervical Cancer Screening Among Women Living With HIV.
Nurs Womens Health. 2025 Dec 23:S1751-4851(25)00211.
Abstract

AKBARI P, Ali HA, Negahi M, Frimayanti N, et al
Investigation of the effect of encapsulating cisplatin with the active compound silibinin in PLGA polymeric nanoparticles on the HeLa cervical cancer cell line.
Med Oncol. 2025;43:79.
Abstract

SHAH A, Kotadia B, Padmanaban R, Patel R, et al
Assessing High-Risk HPV Infection Rates in Females Undergoing Cervical Cancer Screening in Western India Using HPV-DNA Testing.
Indian J Community Med. 2025;50:933-938.
Abstract

CHEN T, Zhen L, Su Y, Yi H, et al
Nomogram for predicting urinary retention after radical hysterectomy for cervical cancer with comparative analysis of surgical methods.
Pak J Med Sci. 2025;41:3485-3492.
Abstract

GONG P, Wang H, Wang Y
Efficacy of laparoscopic versus open abdominal radical hysterectomy on stress response and urodynamic status in patients with early cervical cancer.
Pak J Med Sci. 2025;41:3359-3364.
Abstract

PERELMUTER S, Balogun O
The global need for brachytherapy innovation in cervical cancer.
Brachytherapy. 2025 Dec 24:S1538-4721(25)00361.
Abstract

SHI Y, Zhang Z, Di X, Shen G, et al
Integrative analysis of single-cell and bulk transcriptomes reveals metabolic heterogeneity and identifies PFKP as a therapeutic target in cervical cancer.
Biochim Biophys Acta Mol Basis Dis. 2025 Dec 23:168146.
Abstract

SHEWALKAR BK, Pant P, Patel J, Patil A, et al
Neoadjuvant Chemotherapy Followed by Interdigitated Brachytherapy versus Standard Chemoradiation in Locally Advanced Cervical Cancer.
South Asian J Cancer. 2025;14:404-410.
Abstract

BABU MS, Kasting ML, Rodriguez NM
Patient attitudes toward HPV self-sampling and community health worker-delivered cervical cancer screening services in an underserved area.
J Clin Transl Sci. 2025;9:e270.
Abstract

BEN ZUR T, Gutvirtz G, Meirovitz M, Davidesko S, et al
[Cervical Conization and the Future Risk for Preterm Labor and Cesarean Delivery].
Harefuah. 2025;165:627-632.
Abstract

EMON HH, Kowbi RN, Chowdhury MN, Teep TR, et al
Assessing knowledge, attitudes, and barriers toward HPV cervical cancer and vaccination among female university students in Bangladesh.
Sci Rep. 2025;15:44529.
Abstract

CAI L, Luo X, Wu C, Deng X, et al
Prognostic value of ultrasonography findings in patients with cervical cancer.
Sci Rep. 2025;15:44471.
Abstract

STRAATHOF R, Pool LI, van Vliet-Perez SM, Kolkman-Deurloo IK, et al
Clinical factors affecting the therapeutic dose window in cervical cancer brachytherapy: A systematic review and meta-regression.
Brachytherapy. 2025 Dec 23:S1538-4721(25)00360.
Abstract

ASANO Y, Nishihara C, Kitayama T, Okawa N, et al
MRI Images of a Case of Adenocarcinoma, Human Papillomavirus-Independent, Mesonephric Type, of the Uterine Cervix.
Acta Med Okayama. 2025;79:463-468.
Abstract

BROTHERTON JML, LaMontagne DS, Bloem PJN
Global status of HPV vaccination two decades in: effective, safe and preventing cancer.
Expert Rev Vaccines. 2026;25:2609869.
Abstract

NAKASHIMA T, Matsumoto K, Yoshitake T, Kunitake N, et al
Impact of high-dose pelvic radiotherapy combined with chemotherapy on local control, symptom relief, and safety in patients with stage IVB cervical cancer (FIGO 2018): a two-center retrospective study.
Jpn J Radiol. 2025 Dec 24. doi: 10.1007/s11604-025-01923.
Abstract

ZHU M, Liu J, Wang Y, Lu H, et al
Prognostic Significance of Complete Blood Count-Derived Inflammatory Biomarkers in Patients with Small Cell Neuroendocrine Carcinoma of the Cervix.
Curr Oncol. 2025;32:654.
Abstract

PACHOLCZAK-MADEJ R, Lisik-Habib M, Madry R, Szarszewska M, et al
Real-world outcomes of immune checkpoint inhibitor monotherapy in later lines of recurrent/metastatic cervical cancer - evidence from a rescue access program in Poland.
Contemp Oncol (Pozn). 2025;29:384-392.
Abstract

LIU Z, Zhang S, Wang Y, Zong Y, et al
Development and validation of immunotherapy nomogram for predicting the efficacy and prognosis of recurrent and metastatic cervical cancer.
Front Immunol. 2025;16:1662605.
Abstract

ZHOU D, Wang R, Huang L, Yan P, et al
Real-world efficacy assessment for sintilimab in recurrent or metastatic cervical cancer.
PeerJ. 2025;13:e20477.
Abstract

HE Q, Xiao L, Lan Y, Yao D, et al
Analysis of the Development Trajectory and Influencing Factors of Depression in Patients With Cervical Cancer During Concurrent Chemoradiotherapy.
Actas Esp Psiquiatr. 2025;53:1366-1374.
Abstract

FUJISAKI M, Matsumoto K
[Latest Drug Therapies for Cervical Cancer].
Gan To Kagaku Ryoho. 2025;52:858-863.
Abstract

SHAN H, Xu Q
Prognostic significance of pretreatment systemic immune-inflammation index (SII) in patients with cervical cancer: a meta-analysis.
World J Surg Oncol. 2025 Dec 23. doi: 10.1186/s12957-025-04167.
Abstract

CHOPRA S, Samanta A, Nagar A, Mittal P, et al
Is single implant and multiple fractions radio-biologically iso-effective for cervical cancer high-dose-rate brachytherapy: Observation from patient cohorts during COVID pandemic.
Brachytherapy. 2025 Dec 22:S1538-4721(25)00365.
Abstract

YOSHIDA-COURT K, Teka B, Cisneros Napravnik T, Karpinets T, et al
Linking Microbiome Diversity and Immune Profiles in Ethiopian Patients With Cervical Cancer.
JCO Glob Oncol. 2025;11:e2500060.
Abstract

HUANG Q, Wang F, Li X, Zou W, et al
Multi-omics profiling reveals an immunosuppressive plasma cell subset within tertiary lymphoid structures in cervical cancer.
Cancer Immunol Immunother. 2025;75:26.
Abstract

KUMAR P, Ray A, Hora R, Kumari A, et al
Social Determinants of Human Papillomavirus Vaccine Uptake Among Adolescent Girls in Low-Middle-Income Countries: A Systematic Review & Meta-Analysis.
Inquiry. 2025;62:469580251399368.
Abstract

SUJAY PS, Balaji R
GC-MS and in silico analysis reveal astaxanthin, nimbin, and gamma-sitosterol from Nyctanthes arbor-tristis flowers as dual modulators of HPV E6 and p53 in cervical cancer.
In Silico Pharmacol. 2025;14:9.
Abstract

NAVA M, Earl J, Patel H, Canizares M, et al
Cancer Disparities and the Political Economy of Healthcare Access: A County-Level Analysis in a High-Disparity County.
J Prim Care Community Health. 2025;16:21501319251406402.
Abstract

PAN M, Yi T, Lei P, Mo J, et al
Identification of Glutathione Synthetase as a Therapeutic Target for Cervical Cancer via Combining Bioinformatics and Experimental Validation.
J Cell Mol Med. 2025;29:e70968.
Abstract

WU X, Wang B, Liu L, Chen Z, et al
Multi-omics analysis reveals that knockdown of IMPA2 induces apoptosis in cervical cancer cells through ROS/MYC/CDK1 signaling.
Clin Transl Oncol. 2025 Dec 22. doi: 10.1007/s12094-025-04167.
Abstract

CHEN G, Zhang W, HuYan Y, Yang Y, et al
Application value of TPAS staining technique for cervical exfoliated cells in cervical cancer screening.
Diagn Pathol. 2025 Dec 22. doi: 10.1186/s13000-025-01744.
Abstract

MIDAKSA M, Destaw A, Getachew S, Tamrat D, et al
Health system challenges in the diagnostic and treatment pathway for patients with suspected cervical cancer: a qualitative study.
BMC Health Serv Res. 2025 Dec 22. doi: 10.1186/s12913-025-13918.
Abstract

ZHANG L, Yang Q, Zhu H, Zheng Z, et al
Cadonilimab plus chemotherapy compared to chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer in China: a cost-effectiveness analysis.
BMC Health Serv Res. 2025 Dec 22. doi: 10.1186/s12913-025-13871.
Abstract

MANDIWA C, Sanna M, Gao W
Association between mass media exposure and cervical cancer screening uptake among women aged 30-49 years in four sub-Saharan African countries: a pooled analysis of demographic and health surveys.
BMC Womens Health. 2025;25:603.
Abstract

ZHANG L, Fan X, Ma J, Zhang J, et al
Distinct immune cell dynamics associated with immune-related adverse events during combined chemoradiation and immune checkpoint inhibitor therapy.
Nat Commun. 2025;16:11565.
Abstract

WANG J, Liu S, Li P, Negrin YP, et al
Unveiling the ZNF384-INTS13-hnRNPC axis as a therapeutic vulnerability in cervical cancer.
Cell Death Dis. 2025;16:920.
Abstract

WANG W, Yang G, Liu Y, Wei L, et al
Author Correction: Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center study.
NPJ Digit Med. 2025;8:774.
Abstract

KIRUBA B, Raja Karthikeyan RRR, Anilkumar SR, Sundararajan V, et al
Implications of Single-Cell RNA Sequencing in Cervical Cancer: Unravelling the Molecular Landscape.
ACS Omega. 2025;10:60080-60093.
Abstract

HUANG C, Qiu Y, Huang X, Tang H, et al
A digital health intervention: development and validation of a social media nursing program for sexual dysfunction following cervical cancer radical hysterectomy.
Front Public Health. 2025;13:1720263.
Abstract

MONDAL J, Chatterjee R, Kumar Gourisaria M, Sahni M, et al
Cervical cancer classification using a novel hybrid approach.
Front Oncol. 2025;15:1703772.
Abstract

YAN HY, Shen XP, Tao PP, Jin L, et al
Deep learning models for cervical cancer subtyping using whole slide images.
Front Oncol. 2025;15:1574639.
Abstract

Retraction: MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression.
Oncol Res. 2025;33:4157.
Abstract

HE G, Huang Y, Zhang X, Yuan L, et al
Landscape Analysis of Human Papillomavirus (HPV) Prophylactic Vaccine Clinical Trials in China Based on the NMPA Database.
Drug Des Devel Ther. 2025;19:11245-11257.
Abstract

CRABB K, Okwesa J, Yap JKW, Kwong FL, et al
Challenges in managing cervical cancer in pregnancy: Three case reports.
Case Rep Womens Health. 2025;48:e00765.
Abstract

DEWAN SMR, Proma AY, Khan SA, Meem SS, et al
Evaluation of the Association of TNF-alpha rs361525 Gene Polymorphism in Bangladeshi Patients With Breast and Cervical Cancer: A Case-Control Study and Meta-Analysis.
Health Sci Rep. 2025;8:e71653.
Abstract

BERKEL C
Radiotherapy or chemoradiotherapy might sensitize cervical cancer cells to plasma membrane rupture during necroptosis by upregulating the expression of SIGLEC12, a recently identified membrane-rupturing protein.
Hum Cell. 2025;39:24.
Abstract

OZBAS S, Gerey S, Koc SO
Attitudes Towards Early Diagnosis of Cervical Cancer Among Women Applying to a Health Institution in Turkey.
J Obstet Gynaecol Res. 2025;51:e70174.
Abstract

SORMANI J, Moukam A, Wisniak A, Yakam V, et al
Psychological and sexual impact of human papillomavirus screening in women in Cameroon: a prospective cohort study.
BMC Womens Health. 2025;25:602.
Abstract

PEREIRA D, Almeida AM, Queiroz JA, Sousa F, et al
Innovative minicircle DNA vector encoding pri-miR-375 silences E6 and E7 oncoproteins in HPV16-positive CaSki cells.
Gene. 2026;981:149964.
Abstract

DHUSIYA HR, Sethy P, Pati S, Pradhan SK, et al
How can the uptake of HPV vaccination be increased in school going girls? a qualitative study with multiple stakeholders in Ganjam, Odisha.
Int J Adolesc Med Health. 2025;37:421-430.
Abstract

PANG D, Zhang S, Yang H, Liang K, et al
(18)F-FDG PET radiomics for predicting progression-free survival in locally advanced cervical squamous cell carcinoma.
Hell J Nucl Med. 2025;28:232-245.
Abstract

PEREZ BIANCHI P, Anselmo S, Vasquez Currie M, Medel J, et al
RIVA: An Image Dataset of Conventional Pap Smear Cytology with Multiple Independent Annotations.
Sci Data. 2025;12:1991.
Abstract

CHEN X, Wang S, Ding B, Nie Y, et al
Dibutyl phthalate (DBP) induces cervical injury and promotes malignant transformation of cervical epithelial cells.
Food Chem Toxicol. 2026;208:115885.
Abstract

IKEMOTO A, Uchiyama T, Takeda M, Nakamine H, et al
Spindle-cell variant of diffuse large B-cell lymphoma in the uterine cervix: a case report and literature review.
J Clin Exp Hematop. 2025;65:312-317.
Abstract

MOHAMMADI M, Fell C, Morrison D, Bell S, et al
Cervical whole-slide images dataset for multiclass classification.
Gigascience. 2025;14:giaf144.
Abstract

ZHU L, Wu Z, Shi S, Xue H, et al
Dysbiosis of vaginal and peritoneal fluid microbiota in patients with cervical lesions.
BMC Womens Health. 2025;25:631.
Abstract

FEREDE KG, Bantie B, Abdu AM, Ferede AG, et al
Prevalence and predictors of cervical lesions among women on ART in the Awi Zone, Northwest Ethiopia: facility-based cross-sectional study.
BMC Womens Health. 2025;25:622.
Abstract

ESCOBAR V, Catalan A, Callejas V, Araya R, et al
Human papillomavirus (HPV) genotypes extended prevalence in the female population from a city in Northern Chile.
BMC Womens Health. 2025;25:617.
Abstract

CHEN M, Wu Y, Wang L, Li L, et al
A non-inferiority study of 5-aminolevulinic acid photodynamic therapy (5-ALA-PDT) for high-grade squamous intraepithelial lesions of the cervix in patients of childbearing age: A non-randomized controlled prospective study.
Photodiagnosis Photodyn Ther. 2025;56:105280.
Abstract

BANNOUR I, Mastouri S, Bannour R, Saoudi R, et al
HPV vaccination: analysis of acceptability among mothers - a study of 160 cases.
Int J Adolesc Med Health. 2025;37:389-396.
Abstract

CHEN M, Li H, Wang L, Li L, et al
Comparison of the efficacy of photodynamic therapy alone and photodynamic therapy after laser pretreatment for high-grade cervical intraepithelial lesions in women of childbearing age: a prospective study.
Photodiagnosis Photodyn Ther. 2025;56:105260.
Abstract

SUN B, Chen Y, Cao D, Xu Y, et al
Evaluation of the efficacy of carbon dioxide laser combined with 5-aminolevulinic acid photodynamic therapy in treating high-grade vaginal squamous intraepithelial lesions following hysterectomy.
Photodiagnosis Photodyn Ther. 2025;56:105256.
Abstract

WANG X, Chen Y, Xu X, Huang J, et al
Evaluation of the efficacy of topical photodynamic therapy against cervical HPV infection.
Photodiagnosis Photodyn Ther. 2025;56:105250.
Abstract

YUAN S, Zhang M, Zhang C, Su Y, et al
Effect of topical photodynamic therapy with 5-aminolevulinic acid in the treatment of high-risk cervical low-grade squamous intraepithelial lesions.
Photodiagnosis Photodyn Ther. 2025;56:105248.
Abstract

SIERRA MS, Coto C, Porras C, Herrero R, et al
Validation of TypeSeq2, a Next-Generation-Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories.
J Infect Dis. 2025;232:e906-e915.
Abstract

HETLAND FALKENTHAL TE, Nygard S, Nygard M
Beyond Women's Health: Long-Term HPV-related Cancer Trends in Norway.
J Infect Dis. 2025 Jul 9:jiaf351. doi: 10.1093.
Abstract

CHEN M, Guo J, Xu B
Targeted Fluorescent Polysaccharide Platform for Solute Carrier Protein PCNA Detection and Cervical Squamous Cell Carcinoma Inhibition.
J Fluoresc. 2025;35:11539-11552.
Abstract

CHENG E, Stubbs JM, Achat HM
Self-Collection for HPV-Based Cervical Screening: Knowledge and Attitudes of Australian Health Care Workers in an Area With Low Screening Rates, July-November 2023.
Public Health Rep. 2026;141:43-50.
Abstract

KESZTHELYI M, Sziva RE, Havran Z, Szabo V, et al
Systemic Inflammatory Indices-Systemic Immune-Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)-As Potential Rule-Out Biomarkers for Invasive Cervical Carcinoma.
Int J Mol Sci. 2025;27:435.
Abstract

ALVARADO-CAMACHO DA, Castillo-Velazquez R, Granados-Lopez AJ, Hernandez-Lopez H, et al
Differentially Expressed Genes Associated with the Development of Cervical Cancer.
Int J Mol Sci. 2025;27:258.
Abstract

WANG M, Cao Y, Zhang W, Liang Y, et al
Prediction Model of Lymph Node Metastasis in Cervical Cancer Based on MRI Habitat Radiomics.
Cancers (Basel). 2025;18:152.
Abstract

GORECKI G, Hale M, Taylor S, Garcia G, et al
Prognostic Value of Lymphoid Infiltration and Aggregation in Cervical Cancer.
Cancers (Basel). 2025;18:129.
Abstract

SEMINARIO N, Bebia V, Luzarraga Aznar A, Jose MS, et al
Postvoid Residual Volume After Radical Hysterectomy for Early-Stage Cervical Cancer: Predictive Factors and a Decision-Making Algorithm.
Cancers (Basel). 2025;18:24.
Abstract

FAN C, Fu C
Cross-country inequalities and frontier analysis in global burden of cervical cancer: cross-sectional studies.
J Gynecol Oncol. 2026 Dec 18. doi: 10.3802/jgo.2026.
Abstract

WANG S, Zhu Q, Lu Y, Yang X, et al
Update of incidence and survival in patients with cervical cancer in the United States from 2000 to 2021.
J Gynecol Oncol. 2026 Dec 18. doi: 10.3802/jgo.2026.
Abstract

LOVKIEL A, Petersen LK
Increasing cervical cancer screening participation: a cluster-randomized pilot study at a department of gynaecology.
BMC Womens Health. 2026 Jan 9. doi: 10.1186/s12905-025-04250.
Abstract

WANG L, Li X, Ren C, Liu L, et al
Site-specific HPV18 integration facilitates cervical carcinogenesis through metabolic reprogramming-induced dysfunction of the SpHK1/S1P/S1PR1 pathway.
Cell Death Dis. 2026;17:24.
Abstract

LAN C, Zhang P, Zhao J, Li Q, et al
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer.
Cancer Discov. 2026 Jan 9. doi: 10.1158/2159-8290.CD-25-0467.
Abstract

DA SILVA LOUZA LG, de Sousa Gomes ML, Oria MOB, Rafael EV, et al
Applicability of the levels of the socio-ecological model in the context of cervical cancer prevention: a scoping review.
Cancer Causes Control. 2026;37:16.
Abstract

LIU J, Lei L, Liu Y, Wu J, et al
Tanshinone I Promotes Ferroptosis of Cervical Cancer Cells by Activating the ATF3-Mediated Transcriptional Inhibition of FSP1.
Appl Biochem Biotechnol. 2026 Jan 9. doi: 10.1007/s12010-025-05535.
Abstract

WANG K, Si L, Zhao M, Guo R, et al
Preoperative assessment of tumor size by MRI and ultrasound in cervical cancer: a large-scale retrospective comparative study.
Arch Gynecol Obstet. 2026;313:23.
Abstract

ZHANG L, Mwita CJ, Soliman GA, Mushi DF, et al
Nutritional Status of Patients Diagnosed with Cervical Cancer in Tanzania.
Res Sq [Preprint]. 2025 Dec 18:rs.3.rs-7780798. doi: 10.21203/rs.3.rs-7780798.
Abstract

ZHANG LL, Ji YF, Li J, Wang WH, et al
Construction of a prognostic model based on efferocytosis for predicting survival and immunotherapy efficacy in cervical cancer.
Transl Cancer Res. 2025;14:8908-8929.
Abstract

PAI N, Rao JS
Data-based clustering in prediction of cervical cancer DNA methylation using pan-cancer genetic and clinical data.
Bioinform Adv. 2025;6:vbaf316.
Abstract

BEREZA K, Banas T, Grabarek BO, Czerw A, et al
Levels of Systemic Inflammatory Markers in Women with Cervical Cancer Undergoing Definitive Chemoradiotherapy Depend Primarily on Pre-treatment and Post-teletherapy Tumor Volume, Rather than on the Prescribed Radiation Dose.
Curr Pharm Biotechnol. 2026 Jan 6. doi: 10.2174/0113892010413911251122074226.
Abstract

XIN W, Zhang J, Wu D, Cai Y, et al
VAMP7-mediated autophagy regulates cervical cancer progression associated with persistent HPV16 infection.
Clin Transl Med. 2026;16:e70590.
Abstract

OYARO B, Wanje G, Richardson BA, Temmerman M, et al
A mixed-methods assessment of individual client-level and clinic-level factors associated with uptake of cervical cancer screening (CCS) services in family planning (FP) clinics receiving an intervention to support these services in Mombasa County, Ke
Implement Sci Commun. 2026 Jan 9. doi: 10.1186/s43058-025-00852.
Abstract

ZONG Y, Zhang D, Li Y, Wang P, et al
Rare early-onset radiation-induced lumbosacral plexopathy in cervical cancer: a case report.
BMC Neurol. 2026 Jan 8. doi: 10.1186/s12883-025-04601.
Abstract

LI F, Wei Z, Tao M, Zhao K, et al
Notch1(+) cervical cancer cells may promote perineural invasion by secreting neurotrophin-4.
Sci Rep. 2026 Jan 8. doi: 10.1038/s41598-025-34812.
Abstract

FAN QQ, Qin HF, Liu YQ
Artemisinin Inhibits Drug Resistance and Epithelial-Mesenchymal Transition in Cervical Cancer Cells via the Wnt/beta-Catenin Signaling Pathway.
Bull Exp Biol Med. 2026 Jan 8. doi: 10.1007/s10517-026-06540.
Abstract

ZHANG R, Chai S, Zhang F, Lai J, et al
Hypoxia promotes progression of cervical cancer by modulating the ATXN3-enhanced P53 stability or STAT5 phosphorylation.
Cell Death Discov. 2026;12:4.
Abstract

PEPPA V, Robitaille M, Akbari F, Enger SA, et al
Clinical test cases for commissioning, QA, and benchmarking of model-based dose calculation algorithms in (1)(9)(2)Ir HDR gynecologic tandem and ring brachytherapy.
Med Phys. 2026;53:e70260.
Abstract

OSHIKANLU BC, Sowunmi AC, Habeebu MY, Dada AO, et al
Serum Squamous Cell Carcinoma Markers: A Case-Control Study for Cervical Cancer.
Clin Med Res. 2025;23:129-136.
Abstract

FANG H, Mu J, Chow EP, Ong JJ, et al
Chinese caregivers' preferences and predicted uptake of HPV vaccination: a study protocol for two discrete choice experiments.
BMJ Open. 2026;16:e089565.
Abstract

VAN LONKHUIJZEN L, Mom CH, van der Aa M
Cervical cancer in women eligible for HPV-vaccination in the Netherlands.
J Gynecol Obstet Hum Reprod. 2026 Jan 6:103107. doi: 10.1016/j.jogoh.2026.103107
Abstract

SEEMAAB A, Colaizzi A, Matsko J, Ye Y, et al
Assessment of microorganism detection in ThinPrep Papanicolaou tests utilizing the Hologic Genius Digital Diagnostics System.
Am J Clin Pathol. 2025;164:946-952.
Abstract

GANGULY AP, Pretsch PK, Brewer NT, Spees LP, et al
Streamlined Self-Collection Screening for Sexually Transmitted Infections and Human Papillomavirus: A Single-Group Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open. 2026;9:e2551345.
Abstract

KITAMI K, Kuji S, Kamiya N, Machida H, et al
Real-world safety and efficacy of immune checkpoint inhibitors in Japanese patients with persistent, recurrent, or metastatic cervical cancer: a multicenter prospective and retrospective study.
Int J Clin Oncol. 2026 Jan 8. doi: 10.1007/s10147-025-02951.
Abstract

MURUGAIYAN K, Srivastava R, Balaraman J, Eswar K, et al
Gold-Coated Glybosomes Mimicking Physiological Micelles for ROS-Mediated Photothermal Ablation against Cervical Cancer.
ACS Appl Bio Mater. 2026 Jan 8. doi: 10.1021/acsabm.5c02289.
Abstract

OLTHOF EP, Oostveen NA, van der Aa MA, Bekkers RLM, et al
Prognostic and therapeutic implications of clinical-radiologic discrepancy in parametrial invasion prior to primary radical hysterectomy in cervical cancer.
Gynecol Oncol Rep. 2025;63:102002.
Abstract

JURJUT O, Weiss M, Daniel Y, Matovina S, et al
Detection of Cervical Intraepithelial Neoplasia Using Hyperspectral Tissue Signatures.
IEEE J Transl Eng Health Med. 2025;13:532-539.
Abstract

SINNO AK, Mustapha A, Nair N, Zaami S, et al
Circulating Tumor DNA in Cervical Cancer: Clinical Utility and Medico-Legal Perspectives.
Oncol Res. 2025;34:4.
Abstract

JIANG C, Rosenberg PS, Jemal A, Sung H, et al
Cervical cancer incidence rates by birth cohort against the backdrop of human papillomavirus vaccination in the United States.
J Natl Cancer Inst. 2026 Jan 7:djaf374. doi: 10.1093.
Abstract

LU R, Zhang J, Ma X, Feng Y, et al
Dual-dimensional profiling of host genomic variations and HPV integration in PD-L1-stratified cervical cancer via Oxford Nanopore Technology.
J Transl Med. 2026 Jan 7. doi: 10.1186/s12967-025-07674.
Abstract

PATEL MS, Patel KS, Willmann J, Feliciano EJG, et al
Cervical cancer screening beyond traditional barriers.
Lancet Public Health. 2026;11:e6.
Abstract

MEGLIC E, Ploner A, Clements M, Elfstrom M, et al
Herd effect of human papillomavirus vaccination on incidence of high-grade cervical lesions: a population-based cohort study in Sweden.
Lancet Public Health. 2026;11:e35-e43.
Abstract

LI H, Ahmad M, Zhou D
Relaxin-2 Inhibits Cervical Cancer Growth by Downregulating Kruppel-Like Factor 5 (KLF5) Through the Inhibition of Hippo-YAP and JAK2/STAT3 Signaling Pathways.
J Biochem Mol Toxicol. 2026;40:e70687.
Abstract

KABIR SF, Ashik-Ur-Rahman M, Rahman A, Hossen MA, et al
Factors Associated With Low Utilization of Cervical Cancer Screening Services in Gazipur, Bangladesh.
Obstet Gynecol Int. 2025;2025:4476955.
Abstract

ROMANOVA M, Klat J
Prognostic significance of L1CAM in cervical cancer: A narrative review.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2026.
Abstract

SOLTAU CP, Sinha D, Patil LP, Moseley PM, et al
Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.
Redox Biol. 2025;89:103989.
Abstract

YUAN K, Bai Y, Chen S, Shi Y, et al
The effects of earthworm fibrinolytic enzyme on cervical cancer Caski cells based on CiteSpace and VOSviewer visual analysis.
Medicine (Baltimore). 2026;105:e46783.
Abstract

ZHAI J, Pang T, An Y, Wang J, et al
Clinical significance of CXCL17 in cervical cancer.
Medicine (Baltimore). 2026;105:e46178.
Abstract

HERNANDEZ A, Burrowes S, Gelaw B, Abede T, et al
Is there a difference in sample adequacy when vaginal HPV DNA samples are self-collected at home, a health post, or a primary care health center in rural Ethiopia? Implications for community cervical cancer screening.
BMC Womens Health. 2026 Jan 7. doi: 10.1186/s12905-025-04226.
Abstract

ALHMEID EK, Aldohni AAA, Alghanim AI, Salha RM, et al
Sociodemographic Determinants of Cervical Cancer Screening among Ever-Married Women in Jordan: Insights from the 2023 Jordan Population and Family Health Survey.
J Epidemiol Glob Health. 2026;16:5.
Abstract

LIU R, Liang L, Wang J, Wang M, et al
Optimization of Liquid-Based Cytology Block Preparation Using Modified Adhesive Centrifugal Sedimentation for Improved Diagnostic Accuracy in Cervical Lesions.
APMIS. 2026;134:e70131.
Abstract

NANDAKUMAR V, Krishnan S, Chang CP, Yee S, et al
High-risk human papillomavirus genotype prevalence in Singapore cervical samples: Implications for clinical management.
Ann Acad Med Singap. 2025;54:758-765.
Abstract

SURMAVA S, Kvaratskhelia E, Davitashvili B, Vardiashvili N, et al
Exploratory Analysis of Candidate Gene SNPs in Relation to Cervical Cancer Susceptibility in Georgian Women.
Cancer Control. 2026;33:10732748251413338.
Abstract

MA LL, Yang SJ
[Mucosal melanoma with atypical EWSR1 break-apart signal arising in the cervix and vagina: report of a case].
Zhonghua Bing Li Xue Za Zhi. 2026;55:93-95.
Abstract

CHRISTINE B, Bush M, Thurakal A, Sheehy AM, et al
New Cervical Cancer Screening Guidelines From the US Department of Health and Human Services: Strengthening Women's Preventive Health.
JAMA. 2026 Jan 5. doi: 10.1001/jama.2025.26456.
Abstract

PENG D, Zhang A, Zhang Y
Bridging digital divides: A quantitative assessment of equity, access, and determinants of AI adoption for women's reproductive cancer care in China.
Afr J Reprod Health. 2025;29.
Abstract

YUAN H, Wang X, Liu K, Zhang J, et al
Immune Checkpoint-Related Gene Polymorphisms and High Serum Concentration of PD-L1 and CTLA4 Contribute to the Resistance to Platinum-Based Chemotherapy in Cervical Cancer.
Int J Womens Health. 2025;17:5719-5731.
Abstract

QIAN XF, Wang XW, Yi HQ, Li LF, et al
Peritoneal Post-Radiation Angiosarcoma in a Patient With a History of Radiation for Cervical Cancer.
Am J Case Rep. 2026;27:e949701.
Abstract

GONG Y, Wu J, Hu Y
m(6)A epitranscriptomic regulation of KRAS by METTL3 promotes EMT and stromal remodeling through TGF-beta/SMAD signaling in cervical cancer.
Cancer Gene Ther. 2026 Jan 3. doi: 10.1038/s41417-025-00993.
Abstract

LIU X, Guo L, Zhang H, Xue L, et al
Multi-omics profiling reveals that targeting NEK3 synergizes with cuproptosis to promote M1 macrophage polarization in cervical cancer.
Int Immunopharmacol. 2026;171:116128.
Abstract

SABEENA S, Beynon C
The Impact of the COVID-19 Pandemic on HPV Vaccination Coverage Among Adolescents From High-Income Countries and Challenges: A Scoping Review.
Rev Med Virol. 2026;36:e70102.
Abstract

WU Y, Wei B, Wei Z, Wang H, et al
Single-cell and spatial transcriptomic profiling reveals distinct tumor microenvironment dynamics in cervical adenocarcinoma and squamous cell carcinoma.
Commun Biol. 2025;9:46.
Abstract

CHATTERJEE R
Sexual assault and cancer pathways: a scoping review of biomedical and screening outcomes.
BMC Womens Health. 2025;26:16.
Abstract

ABUDUREXITI G, Muhetaer K, Yang J, Zhuo Q, et al
HPV vaccine knowledge gaps and vaccination intent: a cross-sectional study of vocational students in Southern Xinjiang of China in 2023.
BMC Public Health. 2025;26:102.
Abstract

CALFA S, de Freitas AJA, Causin RL, Hirai W, et al
Exploring shared microRNA profiles in liquid-based cytology and plasma as biomarkers of high-grade intraepithelial lesions.
Sci Rep. 2025;16:828.
Abstract

GETIE B, Wondimu E, Almaw A, Legese B, et al
Prevalence and risk factors of high-risk cervical HPV infections among women attending Debre Tabor hospital family planning and gynecology clinic, Northcentral Ethiopia.
Sci Rep. 2025;16:779.
Abstract

LAM MCY, Mbogo BW, Plaunt E, Mukankaka S, et al
Transport stipend to facilitate cancer early detection: experiences of beneficiaries and perspectives of program personnel in Rwanda.
BMC Public Health. 2025;26:13.
Abstract

ALIZADEH L, Keshavarz Z, Shalbaf A, Iranpour S, et al
Iranian women's perceptions of human papillomavirus and barriers to vaccination: a qualitative study based on the health belief model.
BMC Public Health. 2025;26:5.
Abstract

LIU Y, Han Z, Kaminski P, Tao C, et al
Topoisomerase IIalpha orchestrates secretion of IL-6 and IL-8 with human papillomavirus replication.
Virol Sin. 2025;40:946-961.
Abstract

KHASTGIR G, Saha PK, Bagga R
From hesitancy to hope: charting India's path to widespread HPV immunisation.
Eur J Contracept Reprod Health Care. 2026;31:53-58.
Abstract

BROSHKEVITCH CJ, Pretsch PK, Spees LP, Wheeler SB, et al
Underscreened Women's Reactions to At-Home Self-Collected Human Papillomavirus Test Result Delivery.
Sex Transm Dis. 2026;53:109-115.
Abstract

KOBAYASHI M, Nakagawa S, Ishii Y, Kamei Y, et al
VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix.
Cancer Sci. 2026;117:78-89.
Abstract

ICHINOHE D, Umehara Y, Fujita H, Yamauchi Y, et al
[A Case of Laparoscopic Lateral Segmentectomy for Metachronous Liver Metastasis from Cervical Cancer].
Gan To Kagaku Ryoho. 2025;52:1053-1054.
Abstract

YANG W, Liu S, Shang D, Liu P, et al
Mitochondrial HMGCS1 mediates cisplatin resistance in cervical cancer through regulation of mitochondrial transcription.
BMC Mol Cell Biol. 2026 Jan 16. doi: 10.1186/s12860-026-00566.
Abstract

LI C, Lin H, Zhang H
Transcriptomic profiling of T cell exhaustion mechanisms in cervical cancer pathogenesis.
Discov Oncol. 2026 Jan 16. doi: 10.1007/s12672-026-04423.
Abstract

HPV vaccine could help to protect the unvaccinated against cervical cancer.
Nature. 2026 Jan 16. doi: 10.1038/d41586-026-00128.
Abstract

BOSE S, Mandal R, Sengupta S, Dutta S, et al
Comparative efficacy, feasibility and acceptability of HPV DNA testing on first-void urine versus self-collected vaginal samples: a real-world study in a resource-limited setting.
BMJ Glob Health. 2026;11:e021707.
Abstract

ULMER KK, Soltani LF, Addis I, Young AP, et al
Major changes in cervical cancer screening in the US.
Prev Med. 2026 Jan 14:108512. doi: 10.1016/j.ypmed.2026.108512.
Abstract

TOES-ZOUTENDIJK E, Arbyn M, Auvinen A, Baldwin D, et al
European Code Against Cancer, 5th edition - organised cancer screening programmes.
Mol Oncol. 2026;20:134-153.
Abstract

OKUNADE KS, Soibi-Harry A, Fayinto AI, Adelabu H, et al
Effect of Socioeconomic Status on Cervical Cancer Screening Behaviour Among Mothers of Adolescent Girls in Lagos, Nigeria: A Secondary Analysis of the mHealth-HPVac Study.
Res Sq [Preprint]. 2026 Jan 9:rs.3.rs-8126074. doi: 10.21203/rs.3.rs-8126074.
Abstract

PAKDEL T, Kargar M, Farhadi A, Aghdaei MH, et al
MCPyV small T antigen enhances HPV16 oncogene expression, promotes Ca Ski cell proliferation, and reduces 5-fluorouracil-induced apoptosis in cervical cancer cells.
Infect Med (Beijing). 2025;4:100222.
Abstract

JIA Y, Zhang F, Zou K, Zou L, et al
Corrigendum to "A Clinical Study on the Efficacy of Concurrent Chemoradiotherapy Combined with Targeted Therapy and Hyperthermia in Patients with Locally Advanced Cervical Cancer" [Translational Oncology,Volume61, November 2025, 102516].
Transl Oncol. 2026;64:102656.
Abstract

ESTUPINAN RUIZ CA, Morales Doncel RD, Hincapie-Carvajal JA
[Public health and cervical cancer in Latin America: the impact of health spending and legislation on prevention in three countries].
Aten Primaria. 2026;58:103427.
Abstract

ZAHIROVA N, Tillyashaykhov M, Egamberdiev D, Lucas E, et al
Lessons Learned From Evaluation of a Human Papillomavirus Screening Pilot in Uzbekistan.
JCO Glob Oncol. 2026;12:e2500250.
Abstract

ZHANG J, Feng J, Yin C, Dong Z, et al
The Impact of Anesthesia and Surgical Intervention on Liver and Kidney Function in Patients With Gynecological Malignancies.
Ann Ital Chir. 2026;97:175-184.
Abstract

VAN NOORTWIJK R, Kroon PS, van Vliet-van den Ende KM, Brondijk EH, et al
Dosimetric comparison between brachytherapy and MR-Linac as a boost modality for locally advanced cervical cancer.
Clin Transl Radiat Oncol. 2025;57:101098.
Abstract

MISZCZYK M, Wu T, Kuna K, Stankiewicz M, et al
Corrigendum to "Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials". [Clin. Translat. Radiat. Oncol. 47 (2024) 100801].
Clin Transl Radiat Oncol. 2025;56:101057.
Abstract

LAN T, Yao X, Zhou X, Shi L, et al
[Clinicopathological Characteristics of Cervical Neuroendocrine Carcinoma and Their Relationship With Prognosis].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56:1633-1640.
Abstract

ZHENG Z, Sun S, Zhu J, Jiang Q, et al
Relationship Between Intestinal Flora and Acute Radiation Enteritis in Patients With Advanced Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
Adv Radiat Oncol. 2025;11:101968.
Abstract

YING Z, Shi M, Gong W, Chen Y, et al
g(E)-pHLIP promote virus immunity to destroy cervical cancer cell.
Eur J Med Res. 2026 Jan 14. doi: 10.1186/s40001-025-03787.
Abstract

AMANKWAH I, Gone M, Jaliu A, Morand M, et al
Breast and cervical cancer care in Ghana: a qualitative exploratory study of stakeholder perspectives on National Health Insurance Scheme coverage.
BMJ Open. 2026;16:e098784.
Abstract

PILLAY J, Gates A, Guitard S, Zakher B, et al
Correction: Screening for the prevention and early detection of cervical cancer: systematic reviews to inform an update to recommendations by the Canadian Task Force on Preventive Health Care.
Syst Rev. 2026;15:9.
Abstract

SU X, Wu H, Chen X, Ouyang Y, et al
Comparison of efficacy and safety of definitive chemoradiotherapy for cervical cancer patients of different age groups using propensity score matching.
Discov Oncol. 2026 Jan 13. doi: 10.1007/s12672-026-04392.
Abstract

WUBINEH BZ, Rusiecki A, Halawa K
Deep learning-based automatic segmentation and classification for cervical cancer detection using an improved U-Net and ensemble methods.
Sci Rep. 2026 Jan 13. doi: 10.1038/s41598-026-35299.
Abstract

BHENGU P, Wiysonge CS, Magasana V, Cooper S, et al
Healthcare workers' and caregivers' knowledge, perceptions and experiences of the school-based human papillomavirus (HPV) immunization program: A qualitative study in eThekwini District of the KwaZulu-Natal Province, South Africa.
Hum Vaccin Immunother. 2026;22:2613571.
Abstract

RAECK J, da Silva JB, Carvalho L, Salgado L, et al
Endothelial dysfunction markers in cervical cancer and their influence on patient outcome.
Mol Biol Rep. 2026;53:283.
Abstract

XUE L, Zhou S, Tang L, Li G, et al
EM2, a Novel Elephantopus mollis H.B.K. Monomer, Enhances Radiosensitivity in Cervical Cancer Through Dual Inhibition of AKT and Autophagy.
FASEB J. 2026;40:e71454.
Abstract

CHENG L, Guo C, Yang Y
Correlation and combined predictive value analysis of serum IL-6 and IL-10 levels with tumor progression in patients with cervical cancer.
Eur J Med Res. 2026 Jan 12. doi: 10.1186/s40001-025-03791.
Abstract

CAO Z, Yang S, Zou J, Jin Y, et al
CSN5 overexpression promotes the integral progression of cervical cancer by enhancing ENO3-mediated glycolysis.
Apoptosis. 2026;31:41.
Abstract

YUAN L, Wen B, Li X, Liu F, et al
Development and validation of a risk prediction model for overall survival in cervical cancer patients under 50: a prospective cohort study in southwest China.
PeerJ. 2026;14:e20509.
Abstract

ZHOU Y, Cheng S, Shu L, He W, et al
Quercetin-Fe nanodots inhibit cervical cancer cell proliferation by targeting PCNA.
Cancer Nanotechnol. 2026;17:2.
Abstract

FENG H, Yoshida E, Sheng K
Multimodality and temporal analysis of cervical cancer treatment response.
Quant Imaging Med Surg. 2026;16:78.
Abstract

RAMOS-PIBERNUS A, Bermonti-Perez M, Mejias-Serrano D, Moreta-Avila F, et al
Development of a Culturally Sensitive Intervention for Cervical Cancer Screening Promotion for Latinx Transgender Individuals.
Cancer Med. 2026;15:e71494.
Abstract

BECK JB, Morenz AM
Updates in Cervical Cancer Screening: A Practical Guide for the Internist.
Am J Med. 2026 Jan 9:S0002-9343(26)00014-8. doi: 10.1016/j.amjmed.2025.
Abstract

BLAZEJCZYK I, Daniluk T, Toczylowski K, Gorbacz-Kononczuk J, et al
Antimicrobial peptides in cervical carcinogenesis: Dual roles in tumor progression and emerging therapeutic strategies.
Biomed Pharmacother. 2026;194:118928.
Abstract

NONBOE MH, Napolitano G, Schroll JB, Andersen B, et al
Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2+ from childhood vaccinated women: The Trial23 cohort study.
Vaccine. 2025;73:128142.
Abstract

GUO S, Lin H, Chen Y, Hu Q, et al
A study on strategies to optimize bladder volume consistency in radiotherapy patients.
Eur J Med Res. 2025;31:81.
Abstract

LI Y, Zhao J, Li M, Cheng Y, et al
Xiaoyou decoction suppresses cervical precancerous lesions through the activation of cellular autophagy and the upregulation of p53 expression.
Int J Biochem Cell Biol. 2026;191:106894.
Abstract

ZHANG Y, Yan L, An N, Geng J, et al
TFF3 sensitizes cervical carcinoma cells to cisplatin toxicity by binding to IGF2R.
Cancer Gene Ther. 2026;33:155-168.
Abstract

DUSHKIN A, Maxim A, Oxana S, Stanislav A, et al
Effect of photodynamic therapy on the expression of toll-like receptor 2, -3, -4, and -8 in the cervical lesions.
Photochem Photobiol. 2026;102:141-153.
Abstract

KWEK ME, Ang JX, Mathur M, Kho LCL, et al
Comparison of awareness, attitudes and knowledge on human papilloma virus vaccination in Singapore: 2019 versus 2013.
Singapore Med J. 2025;66:596-600.
Abstract

MADHAVAN Y, Muthukumar V, Ramasubramanian S, Ramshankar V, et al
High throughput HPV genotyping by next generation sequencing for detection of 28 HPV types and 13 sexually transmitted infections: A first community-based cervical cancer screening study from India.
Diagn Microbiol Infect Dis. 2026;114:117278.
Abstract

NGUANBOONMAK A, Pakkaranang B, Yanaranop M, Tantiyavarong P, et al
Incidence trends and survival of cervical cancer: A population-based study on Thai Cancer registry database.
Cancer Epidemiol. 2026;101:102992.
Abstract

GROVER S, Chambers A, Azoba C, Bhatia RK, et al
Overcoming Logistical Barriers to Conducting Collaborative Clinical Research Between a High-Income Country and a Low- and Middle-Income Country.
JCO Glob Oncol. 2026;12:e2400534.
Abstract

AHMED B, Sayeed S, Rhodes C, Shahab G, et al
The Virginia Commonwealth University Cervical Cytology Biorepository: A Protocol for Advancing Translational Cervical Cancer Research through Biobanking.
Cancer Epidemiol Biomarkers Prev. 2026.
Abstract

KIM U, Bae J, Paik ES, Lim MC, et al
Prognostic value and adjuvant treatment outcomes for the use of the JGOG prognostic model in early-stage intermediate-risk cervical cancer: a Korean Gynecologic Oncology Group study (KGOG 1028).
J Gynecol Oncol. 2026 Jan 8. doi: 10.3802/jgo.2026.
Abstract

KIM J, Jang J, Kang S
Patient-centered valuation of minimally invasive surgery in cervical cancer: a discrete choice experiment.
J Gynecol Oncol. 2025 Dec 29. doi: 10.3802/jgo.2026.
Abstract

BABATUNDE AO, Kokelu E, Olusanya OA, Kalulu P, et al
Creative Arts to Enhance Cervical Cancer Awareness Using Art-Based Messages From a Nigerian Crowdsourcing Open Call: Qualitative Thematic Analysis.
JMIR Form Res. 2026;10:e76240.
Abstract

YI K, Zhang J, Wang H, Chen P, et al
Utility of extended HPV genotyping in cervical cancer screening: a prospective population-based cohort study in China.
Front Oncol. 2026;15:1754438.
Abstract

YANG H, Xu F, Liu Y, Chen Q, et al
Pelvic artery embolization versus vaginal packing for controlling vaginal bleeding in locally advanced cervical cancer: a retrospective cohort study from a tertiary cancer center in Xinjiang, China.
Front Oncol. 2026;15:1711701.
Abstract

MUTUA F, Dube S, Shrivastav A, Kakumanu S, et al
Cervical Cancer Outcomes and Toxicity in HIV-Positive Women Treated With Radiation or Chemoradiation: A Systematic Review.
Cureus. 2025;17:e99855.
Abstract

SHAN X, Si J, Qian M, Chen X, et al
Revealing relationships: The role of self-disclosure and marital intimacy in the post-traumatic growth of cervical cancer patients-A qualitative study.
Support Care Cancer. 2026;34:121.
Abstract

LIN X, Piao Z, Huang X, Huang H, et al
Inter-fraction target and OARs reproducibility in cervical cancer: Influence of immobilization systems and patient positioning verified by daily fan beam CT.
Radiography (Lond). 2026;32:103328.
Abstract

SATO S, Kagabu M, Jo A, Otsuka H, et al
Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancer.
Int J Clin Oncol. 2026 Jan 22. doi: 10.1007/s10147-026-02960.
Abstract

CIHAN E, Pirincci CS
The efficacy of complex decongestive therapy in the treatment of lymphedema associated with endometrial and cervical cancer: evaluation of sensation and balance.
Support Care Cancer. 2026;34:113.
Abstract

HARADA I, Ito Y, Morita K, Kawahara M, et al
Associations Between Regional Factors and Cervical Cancer Screening Coverage in Tokyo.
Asian Pac J Cancer Prev. 2026;27:281-285.
Abstract

HANGA AH, Amin S, Iqbal A, Shah A, et al
Between Belief and Biology: Cervical Cancer's Occurrence and Health Literacy among India's Muslim Women.
Asian Pac J Cancer Prev. 2026;27:219-226.
Abstract

MOHD NAFIS NS, Mat Zin AA, Ab Hamid SA
Assessment of Pathtezt(R) Infinity Processor and Autoloader Efficiency in Cervical Smear Analysis.
Asian Pac J Cancer Prev. 2026;27:193-199.
Abstract

LATTASAKSIRI P, Prasongvej P, Chanthasenanont A, Boriboonhirunsarn D, et al
Knowledge and Attitudes of Pregnant Women toward Cervical Cancer Screening during Pregnancy.
Asian Pac J Cancer Prev. 2026;27:117-121.
Abstract

GEORGA D, Saridi M, Rouka E, Fradelos EE, et al
Exploring Women's Attitudes Towards Cervical Cancer Screening and Their Association with Life Satisfaction and General Life Attitudes: A Systematic Review.
Asian Pac J Cancer Prev. 2026;27:37-46.
Abstract

JIANG R, Zheng J, Lin X, Wang S, et al
EGF Family-Based Prognostic Model Reveals AREG as a Key Regulator in Cervical Cancer Progression.
Curr Med Chem. 2026 Jan 9. doi: 10.2174/0109298673397451251105070115.
Abstract

DING L, Li S, Jin Z, Yao C, et al
The impact of body composition and systemic inflammatory markers on postoperative complications in early-stage cervical cancer.
Front Oncol. 2026;15:1696383.
Abstract

YAMAZAWA Y, Iijima T, Shigenaga D, Cho T, et al
Rapid enlargement of a tubo-ovarian abscess in a patient with cervical cancer and multiple uterine fibroids: A case report.
Case Rep Womens Health. 2026;49:e00784.
Abstract

ZOU D, Wu X, Xin X, Xu T, et al
Correction to: Construction and Validation of a Novel Prognostic Model Based on Cervical Cancer-Related Genes.
Reprod Sci. 2026 Jan 21. doi: 10.1007/s43032-026-02053.
Abstract

ZHANG YJ, Yan L, Chen YY, Jiang X, et al
A nomogram-based prediction model for assessing the risk of vain and stump cancer recurrence following radical surgery for cervical cancer.
Discov Oncol. 2026 Jan 21. doi: 10.1007/s12672-026-04462.
Abstract

ZHANG Y, Zhang Y, Wang K
EP300 promotes cervical cancer progression through a Wnt/beta-catenin-dependent HIF-1alpha signaling axis.
Toxicol Appl Pharmacol. 2026 Jan 19:117718. doi: 10.1016/j.taap.2026.117718.
Abstract

JIANG H, Cai J, Shen Z, Xu M, et al
UniCAS: A foundation model for cervical cytology screening.
Cell Rep Med. 2026;7:102570.
Abstract

SPARKES NK, Adcock A, Slater T, MacDonald EJ, et al
'Point-of-Care-Testing is definitely the way to go': primary healthcare professionals in rural Aotearoa New Zealand talk about point-of-care testing for cervical cancer prevention.
J Prim Health Care. 2026 Jan 22. doi: 10.1071/HC25164.
Abstract

KOIVISTO T, Eriksson T, Hokkanen M, Apter D, et al
Human papillomavirus vaccinations' association to childbirth rates.
Hum Vaccin Immunother. 2026;22:2598691.
Abstract

WANG W, Zhang J, Mei C, Dai Q, et al
Prevalence and genotype distribution of human papillomavirus infection among women in Chengdu, China between 2020 and 2024.
Front Public Health. 2026;13:1740177.
Abstract

BAO T, Li X, Li W, Yang R, et al
Integrated multi-omics profiling of plasma extracellular vesicles reveals the hsa-miR-1-3p-LRP1 axis as a potential biomarker in cervical cancer.
Mol Clin Oncol. 2025;24:13.
Abstract

GROSS M, Wang JY, Goff BA, Ma TM, et al
Treatment delay and prolongation in locally advanced cervical cancer.
Gynecol Oncol Rep. 2025;63:102004.
Abstract

WEBB S, Mat Ali N, Augustin Y, Hayward SE, et al
Understanding knowledge, beliefs, values and barriers towards cervical cancer screening and self-sampling amongst migrant Muslim women in Southwest London: an in-depth qualitative interview study.
BMJ Public Health. 2026;4:e003254.
Abstract

AKISEKU AK, Adenuga TO, Jagun OE, Popoola MA, et al
Individual-level determinants of late-stage cervical cancer diagnosis and their implications for prevention and control.
Ecancermedicalscience. 2025;19:2008.
Abstract

OLAYIWOLA AA, Oshodi YA, Akinola OI, Banjo AA, et al
High-risk HPV serotype distribution in cervical cancer: comparative analysis of detection in cervicovaginal secretions and tissue DNA extraction.
Ecancermedicalscience. 2025;19:1992.
Abstract

ADENEKAN MA, Minari JB, Adefemi A, Olorunfemi G, et al
Comparison analysis of serum interleukin-6 levels and cervical cancer.
Ecancermedicalscience. 2025;19:2009.
Abstract

CHHABRA M, Meet S, Tendulkar G, Oswal K, et al
Barriers to screening of breast and cervical cancer among women in remote villages of Karnataka: an analysis using the Health Belief Model.
Ecancermedicalscience. 2025;19:1980.
Abstract

SAMIA K, Yassine B, Mehdi SE, Wissal H, et al
Psychosocial impact of cervical cancer diagnosis: a study conducted in the Radiotherapy Department at CHU Hassan II, Fez, Morocco.
Ecancermedicalscience. 2025;19:1976.
Abstract

KIBUDDE S, Kavuma A, Abal B, Katumba MF, et al
Radiation therapy for cervical cancer in Uganda: a practice guideline.
Ecancermedicalscience. 2025;19:1999.
Abstract

WANG L, Zhu J, Ding Z, Xie Z, et al
Immune Predictors of Radiotherapy Outcomes in Cervical Cancer.
Adv Sci (Weinh). 2026 Jan 21:e09784. doi: 10.1002/advs.202509784.
Abstract

ZHANG Y, Meng Y, Shi H, Li L, et al
Prevalence and influencing factors of depressive and anxiety symptoms in cervical cancer patients during the peri-chemoradiotherapy period: A systematic review meta-analysis.
Medicine (Baltimore). 2026;105:e47023.
Abstract

JIA H, Arifu A, Wang J, Fan P, et al
SPP1 enhances radiotherapy resistance through CCL2-mediated M2-like polarization of macrophages in cervical Cancer.
Int Immunopharmacol. 2026;172:116119.
Abstract

CHANG Y, Li T, Zhou Q, Kang D, et al
Effectiveness of Artificial Intelligence-Assisted Colposcopy in a Resource-Limited Population.
Obstet Gynecol Surv. 2026;81:24-25.
Abstract

SAPKOTA A, Adhikari C, Kaphle HP, Bist BB, et al
Effectiveness of health education interventions for cervical cancer screening: A quasi-experimental study in Pokhara Metropolitan Slum, Nepal.
PLOS Glob Public Health. 2026;6:e0005853.
Abstract

HUANG Z, Luo Y, Gao Q, Wang L, et al
Novel N(6)-methyladenosine (m(6)A) writer METTL16 promotes the cervical cancer tumorigenesis by targeting FTH1-dependent ferroptosis.
Discov Oncol. 2026 Jan 20. doi: 10.1007/s12672-026-04403.
Abstract

INOUE T, Iijima K, Takatsu J, Murakami N, et al
Impact of the locking function of hybrid inverse planning optimization on the treatment plan quality of intracavitary/interstitial brachytherapy for locally advanced cervical cancer.
Radiol Phys Technol. 2026 Jan 20. doi: 10.1007/s12194-026-01007.
Abstract

ZHANG J, Wei W
Re-examining the lymph node surgical strategies for small-cell cervical cancer: shifting from local intervention to a systemic paradigm.
Int J Surg. 2026 Jan 20. doi: 10.1097/JS9.0000000000004649.
Abstract

AHMED AE, Hatan WM, Alrehaili SE, Alghamdi WR, et al
Interventions in Primary Care to Improve Cervical Cancer Screening: A Systematic Review.
Cureus. 2025;17:e99604.
Abstract

XIE H, Li J, Huang H, Emmanuel A, et al
SOX1/PAX1 Methylation for Triage of HPV-Positive Women in Cervical Cancer Screening: A Cohort Study.
BJOG. 2026 Jan 19. doi: 10.1111/1471-0528.70162.
Abstract

LI Y, Xin R, Chai P, Liu B, et al
Economic evidence for expansion of HPV vaccination for the prevention of cervical cancer in LMICs: BIA framework construction and empirical analysis in China.
BMC Public Health. 2026 Jan 19. doi: 10.1186/s12889-026-26216.
Abstract

GAO M, Cui Z, Song H, Li Y, et al
IRF4 Enhances Radiosensitivity of Cervical Cancer by Inhibiting the PI3K/Akt/mTOR Pathway to Regulate Autophagy.
Cancer Sci. 2026 Jan 19. doi: 10.1111/cas.70305.
Abstract

WONG SIAW LIN C, Ghosh A, Bhardwaj N, Zouridis A, et al
Concomitant low-grade B-cell lymphoma and cervical intraepithelial neoplasia.
BMJ Case Rep. 2026;19:e270886.
Abstract

FOKOM DEFO V, Fokom Domgue J
Understanding the WHO global strategy to accelerate cervical cancer elimination.
Lancet Glob Health. 2026 Jan 16:S2214-109X(26)00004.
Abstract

AMANI A, Bloem P, Kobayashi E, Atuhaire B, et al
Understanding the WHO global strategy to accelerate cervical cancer elimination - Authors' reply.
Lancet Glob Health. 2026 Jan 16:S2214-109X(26)00011.
Abstract

PEI Y, Zhong Z, Li H, Tan Y, et al
Targeting thymidylate synthase enhances CD8 + T-cell infiltration and inhibits tumor growth in cervical cancer.
Med Oncol. 2026;43:120.
Abstract

NAMUTUNDU J, Nakku-Joloba E, Kiguli J, Makumbi F, et al
"Correcting Misinformation is Challenging": Exploring Barriers and Facilitators of Health Care Providers' Responsiveness to Cervical Cancer Screening Literacy Needs of Rural Women Living With HIV in Eastern Uganda.
Cancer Control. 2026;33:10732748261419591.
Abstract

CAI X, Lu X, Yang J, Wei X, et al
Diagnostic value of magnetic resonance imaging in preoperative evaluation of cervical cancer and analysis of pathological features.
Oncol Lett. 2026;31:96.
Abstract

ENYAN NIE, Zhang M, Ken-Amoah S, King-Okoye M, et al
Acceptance of HPV Vaccination: A Systematic Review of Knowledge, Attitudes and Barriers Among Healthcare Practitioners in Low- and Middle-Income Countries.
Biomed Res Int. 2026;2026:9294978.
Abstract

BASERA A, Alaouna M, Duvenhage J, Bates DO, et al
HPV-driven transcriptome and splicing rewiring under SRPK1 inhibition in cervical cancer.
Front Oncol. 2026;15:1712170.
Abstract

FOKOM DOMGUE J, Al-Antary N, Gerend MA, Nair M, et al
Awareness of the link between HPV and cancer according to cancer type and gender in the US from 2014-2020.
Hum Vaccin Immunother. 2026;22:2610894.
Abstract

TIMALSINA G, Parida BP, Radhakrishnan M, Khoiyang T, et al
Falcarindiol induces apoptosis, ROS accumulation, and cell cycle arrest via EGFR/mTOR pathway modulation: an integrated in silico and in vitro study in cervical cancer.
Daru. 2026;34:7.
Abstract

AL-MUTAIRI SH, Akhtar S
Age at first marriage, menopause status and cervical cancer risk in a middle eastern country: a national cancer registry-based case-control study.
Cancer Causes Control. 2026;37:18.
Abstract

OOMMEN AM, Ashfaq M, Ranjani DP, Suresh D, et al
Leveraging the role of families in decision-making to inform a program of HPV-based self-collection for cervical screening in Tamil Nadu, India: a qualitative study.
Cancer Causes Control. 2026;37:25.
Abstract

SU Q, Duan H, Li Q, Zhang M, et al
Galectin-1-Targeted Type-I/II Photosensitizers Activate the NF-kappaB Pathway to Enhance Immunity and Treat High-Risk HPV-Associated Cervical Lesions.
ACS Appl Mater Interfaces. 2026;18:3599-3614.
Abstract

RAY-COQUARD I, Kaminsky-Forrett MC, Ohkuma R, de Montfort A, et al
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial.
Nat Commun. 2026;17:922.
Abstract

LU Q, Li J, Gao X, Wu B, et al
Folic acid inhibits the Wnt/beta-catenin pathway by upregulating DKK3 to exert anti-tumor effects in cervical squamous cell carcinoma.
Sci Rep. 2025;16:2930.
Abstract

LI J, Huang CB, Zhao F, Zhao DD, et al
Factors related to cervicogenital high-risk human papillomavirus persistence among Chinese women: a nationwide multi-center cohort study.
Virol J. 2025;23:13.
Abstract

MWAENI V, Nyamai D, Khamadi S, Musenjeri S, et al
Multimodal detection of high-risk HPV oncogenic transcripts using a branched hybridization chain reaction amplification method.
Anal Methods. 2026;18:293-305.
Abstract

IZQUIERDO-CONDOY JS, Torres PL, Galarza MO, Salinas KA, et al
Prevalence and age-related trends of high-risk Human Papillomavirus genomes in Ecuadorian women: a comprehensive cross-sectional study.
BMC Infect Dis. 2025;26:83.
Abstract

AKALIN K, Cicek Gumus E, Dolu I
Cancer screening knowledge and health literacy among rural women Aged 30-69.
Cancer Epidemiol. 2026;100:102971.
Abstract

CHIN T, Ostrbenk A, Verhavert N, Poljak M, et al
Multi-centre clinical validation of the NeuMoDx HPV assay for ASC-US / LSIL triage.
Diagn Microbiol Infect Dis. 2026;114:117208.
Abstract

STOLNICU S
Role of human papillomavirus status in the classification, diagnosis, and prognosis of malignant cervical epithelial tumors and precursor lesions.
Pathologie (Heidelb). 2026;47.
Abstract

CHARBEL A, Akiki G, Diwan SS, Leung SOA, et al
Small cell neuroendocrine carcinoma of the cervix: diagnostic challenges and emerging molecular insights(dagger).
J Pathol. 2026;268:123-126.
Abstract

YANG XL, Zhu JW, Zhou YC, You Y, et al
Appraisal the significance of completion hysterectomy after definitive concurrent chemoradiotherapy for patients with locally advanced cervical adenocarcinoma: the ATTRACT study.
Int J Surg. 2026;112:1274-1283.
Abstract

SAHOO GR, Sah AN, Srivastava M, Panigrahi PK, et al
In Vivo Cervical Precancer Classification Through Multifractal Analysis of Spectral Fluctuations in Intrinsic Fluorescence Spectra.
J Biophotonics. 2026;19:e202500282.
Abstract

KIRKPATRICK CE, Lawrie LL
"This is What a Speculum Looks Like!" Effects of Medical Instrument Demonstration and Message Framing in Pap Test Videos on Social Media.
Health Commun. 2026;41:278-289.
Abstract

Retraction: miR-126-5p Restoration Promotes Cell Apoptosis in Cervical Cancer by Targeting Bcl2l2.
Oncol Res. 2026;34:30.
Abstract

PANDIT SK, Sen B, Kumar P, Tripathi A, et al
Anti-cervical cancer potential of apigenin, daidzein, and isokaempferide of Glycyrrhiza glabra Linn. Methanolic extract via network pharmacological analysis.
In Silico Pharmacol. 2026;14:44.
Abstract

ANUPAMA CV, Devarapalli D, Ahammad SH, Eid MMA, et al
Cervical cancer cell prediction and detection with high test accuracy based on a reliable automated system.
3 Biotech. 2026;16:83.
Abstract

KHORRAMABADI SM, Ebrahimi N, Aghbash PS, Ravanlo ZZ, et al
Silencing HPV: the rise of RNA therapeutics in cervical cancer.
Infect Agent Cancer. 2026 Jan 29. doi: 10.1186/s13027-026-00733.
Abstract

UMEMIYA M, Kou K, Inayama Y, Kamei J, et al
Comparison of nedaplatin and cisplatin in concurrent chemoradiotherapy for cervical cancer: a systematic review and meta-analysis.
Int J Clin Oncol. 2026 Jan 29. doi: 10.1007/s10147-026-02968.
Abstract

ZENG L, Chen Z, Wang K, Yi C, et al
Epidemiology and prevention of HPV-driven cervical cancer in urban-rural China: a population-based study of 60,280 women.
Sci Rep. 2026;16:3937.
Abstract

ELFSTROM KM, Dillner J
Towards faster, better, and cheaper cervical cancer screening.
Lancet Public Health. 2026;11:e72-e73.
Abstract

SULTANA F, Smith M, Saville M, Bateson D, et al
Uptake and performance of self-collection offered through primary care to all eligible participants in a national cervical screening programme in Australia: a retrospective cohort study.
Lancet Public Health. 2026;11:e101-e110.
Abstract

XIAO FY, Ma RC, Wang YX, Zhou JW, et al
[Value of self-sampling cervical exfoliated cells of HPV E6/E7 mRNA detection in cervical cancer screening: a multicenter clinical study].
Zhonghua Fu Chan Ke Za Zhi. 2026;61:60-66.
Abstract

YUAN M, Hong Y, Feng Y, Sun J, et al
Cervical Cancer Incidence and Mortality Trends in China: The role of Screening.
Cancer Lett. 2026 Jan 27:218286. doi: 10.1016/j.canlet.2026.218286.
Abstract

BALE CA, Pearce JV, Deng X, Bandyopadhyay D, et al
Prognostic value of FDG-PET SUV changes in cervical cancer following radiation therapy: a retrospective cohort study.
Arch Gynecol Obstet. 2026;313:66.
Abstract

GU X, Yang Y, Zhang Z, Ouyang Y, et al
Long Non-Coding RNA RAB11B-AS1 Suppresses Cervical Cancer Progression by Upregulating RPL26 Expression.
Front Biosci (Landmark Ed). 2026;31:47597.
Abstract

WU Z, Huang C, Li R, Li H, et al
Correction: PRKCI mediates radiosensitivity via the Hedgehog/GLI1 pathway in cervical cancer.
Front Oncol. 2026;16:1765010.
Abstract

WANG Z, Zhang H, Zhu Y, Jiang Y, et al
Comprehensive evaluation of prophylactic HPV vaccines: a systematic review and meta-analysis of efficacy, safety, and immunogenicity in males and females.
Front Immunol. 2026;16:1747082.
Abstract

NGUYEN AT, Duckworth ED, Li RA, Adam TH, et al
Cervical Cancer Prevention and Treatment Disparities Among Native Hawaiian and Pacific Islanders: A Systematic Review and Meta-Analysis.
J Surg Oncol. 2026 Jan 28. doi: 10.1002/jso.70200.
Abstract

GENNARI P, Luft D, Meszaros J, Ignatov A, et al
Incidence, risk factors, and outcomes of ovarian metastasis in early-stage cervical cancer: a population-based analysis of 983 patients.
Arch Gynecol Obstet. 2026;313:65.
Abstract

ASEFA T, Endale HT, Mengstie TA, Getnet M, et al
Determinants of cervical cancer screening among women living with HIV in Lesotho using nationally representative 2023/24 DHS data.
Sci Rep. 2026 Jan 28. doi: 10.1038/s41598-026-37180.
Abstract

KULJARUSNONT S, Karnchanabanyong W, Ruengkhachorn I, Ularnwong M, et al
Comparative Performance of Visual Inspection with Acetic Acid and Colposcopy for Detection of Cervical Precancer in Women with High-Risk Human Papillomavirus Infection: A Cross-Sectional Study.
Cancer Control. 2026;33:10732748261422014.
Abstract

Correction to "Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline".
CA Cancer J Clin. 2026;76:e70066.
Abstract

JIA X, Da X, Shi J, Wang Y, et al
Digital health interventions for cervical cancer screening among hard-to-reach women in health-resource-limited areas: Protocol for a controlled trial with historical controls and two randomised intervention arms.
Digit Health. 2026;12:20552076261416317.
Abstract

ZHUANG Q, Liu Y
Efficacy and safety of Cadonilimab in the treatment of recurrent/metastatic and advanced cervical cancer: a systematic review and meta-analysis.
Front Immunol. 2026;16:1729380.
Abstract

KONDLO S, Giyose N, Businge CB, Mbulawa ZZA, et al
Human Papillomavirus Genotype Landscape Across Cervical Cytology Grades and Impact of HIV Among Women of Eastern Cape Province, South Africa.
Viruses. 2025;18:65.
Abstract

CINTONI M, Autorino R, Rinaldi RM, Leonardi E, et al
Clinical Tolerability and Safety of Ketogenic Diet in Patients with Gynecological Malignancies Undergoing Radiotherapy: Preliminary Results of a Prospective, Randomized, Open-Label Trial (KOMPARC).
Nutrients. 2026;18:312.
Abstract

DAVID LL, Singh M
Functionalized Core/Shell Gold-Palladium Bimetallic Nanoparticles in Transferrin-Targeted Dual-Drug Delivery in a Cervical Cancer Cell Model.
Pharmaceuticals (Basel). 2025;19:74.
Abstract

HUSSAIN SS, Maisam M, Younas S, Wang F, et al
From Functional Food to Therapeutic Prospect: Mechanistic Study of Gypenoside XVII in HeLa Cells.
Molecules. 2026;31:214.
Abstract

PATINO-MORALES CC, Jaime-Cruz R, Gonzalez-Perez R, Villavicencio-Guzman L, et al
The Chick Embryo Chorioallantoic Membrane Assay as a Short-Term Exploratory Model for Cervical Cancer Research.
Life (Basel). 2026;16:135.
Abstract

TOROMANI G, Saglimbeni GS, Upadhyayula BS, Manu E, et al
Comprehensive Genomic Characterization of 102 Cervical Adenocarcinoma Tumors.
Medicina (Kaunas). 2026;62:123.
Abstract

GORGULU G, Sanci M
Perspectives from Hysterectomy Specimens on the Hidden Malignancy Risk in HSIL Patients with Surgical Margin Continuity.
Medicina (Kaunas). 2025;62:77.
Abstract

IBIS K, Aydin MH, Kokce K, Suncak L, et al
The "Undefined and Ignored Normal Tissue" Bulboclitoral Complex in Locally Advanced Cervical Cancer Treated with Definitive Radiochemotherapy: Is It Not the Organ at Risk?
Medicina (Kaunas). 2025;62:14.
Abstract

SEMENOV DV, Tatarnikova IS, Chesnokova AS, Talyshev VA, et al
Single-Cell Transcriptomic Landscape of Cervical Cancer Cell Lines Before and After Chemoradiotherapy.
Cells. 2026;15:115.
Abstract

LEGAKI E, Lappa T, Prasoula KL, Kardasi Z, et al
HPV-Driven Cervical Carcinogenesis: Genetic and Epigenetic Mechanisms and Diagnostic Approaches.
Int J Mol Sci. 2026;27:803.
Abstract

LAGUNAS-CRUZ MDC, Valle-Mendiola A, Soto-Cruz I
The Vaginal Microbiome and Host Health: Implications for Cervical Cancer Progression.
Int J Mol Sci. 2026;27:640.
Abstract

MARTINEZ-RAMIREZ I, Munoz-Bello JO, Contreras-Paredes A, Parra-Hernandez E, et al
Cholesterol Metabolism: An Ally in the Development and Progression of Cervical Cancer.
Int J Mol Sci. 2026;27:591.
Abstract

KIM J, Jang J, Tewari KS, Kim KS, et al
Nationwide Survival Impact of Bevacizumab Under National Reimbursement for Advanced Cervical Cancer in South Korea.
Cancers (Basel). 2026;18:346.
Abstract

DU M, Zheng Z, Lu P, Wang W, et al
Oncological Outcomes and Genomic Features of Gastric-Type Endocervical Adenocarcinoma, the Most Aggressive and Common HPV-Independent Cervical Cancer.
Cancers (Basel). 2026;18:320.
Abstract

KARNIK M, Tulimilli SV, Anantharaju PG, Bettadapura ADS, et al
An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance.
Cancers (Basel). 2026;18:318.
Abstract

MAREMA TP, Laka K, Mbita Z
Medicinal Plants for Overcoming Drug Resistance in Cervical Cancer.
Biology (Basel). 2026;15:191.
Abstract

EMADI SH, Ahmad S, Rahmanian M, Baharlou R, et al
Design and computational evaluation of a prophylactic and therapeutic multi-epitope vaccine candidate against cervical cancer.
Virol J. 2026 Jan 27. doi: 10.1186/s12985-026-03072.
Abstract

WAN Y, He Y, Chen X, Wang S, et al
Effective delivery of genome editor to cervical cancer targeting Mcl1 for cancer therapy.
Cancer Gene Ther. 2026 Jan 27. doi: 10.1038/s41417-025-00958.
Abstract

VENGHATERI JB, Nathani P, Kaur J, Gadgil A, et al
India's Path to Cervical Cancer Control: From Obstacles to Opportunities in HPV Vaccine Uptake.
Public Health Res Pract. 2026 Jan 20:PU25036. doi: 10.1071/PU25036.
Abstract

WILKINSON AN, Wright K, Savage C, Pearl D, et al
Towards Cervical Cancer Elimination: Insights from an In-Depth Regional Review of Patients with Cervical Cancer.
Curr Oncol. 2026;33:52.
Abstract

NAGDEV P, Chittilla M
Advances in Screening, Immunotherapy, Targeted Agents, and Precision Surgery in Cervical Cancer: A Comprehensive Clinical Review (2018-2025).
Curr Oncol. 2026;33:48.
Abstract

XIAO H, Guo F, Wang Z, Pei K, et al
Is Moderately Hypofractionated Radiotherapy a Safe and Effective Strategy for Cervical Cancer?-A Review of Current Evidence.
Curr Oncol. 2026;33:24.
Abstract

ZAMUDIO CANAS R, Vallejo Ruiz V, Jaramillo Flores ME, Delgado Macuil RJ, et al
Detection of Premalignant Cervical Lesions via Maackia amurensis Lectin-Based Biosensors.
Biosensors (Basel). 2025;16:24.
Abstract

LEONI F, Giorgi Rossi P, Morana C, Marchione R, et al
Conservative Management of CIN2 Within Primary HPV Cervical Cancer Screening Programme: A Cohort Study.
J Low Genit Tract Dis. 2026 Jan 26. doi: 10.1097/LGT.0000000000000930.
Abstract

SELVAJOTHI J, Hewitt M, de Haan A, Ting S, et al
Managing women with cervical cancer symptoms: Cervical One-Stop Assessment Clinic.
Ir Med J. 2026;119:9.
Abstract

OMI M, Saito M, Nishino S, Fusegi A, et al
Case report on critical well-leg compartment syndrome: early diagnosis and treatment after cervical cancer surgery.
Int Cancer Conf J. 2025;15:25-29.
Abstract

BONLOKKE S, Blaakaer J, Steiniche T, Iachina M, et al
Increased Risk of Second Squamous Cell Carcinomas Following Cervical Cancer: A Nationwide Danish Case-Control Study.
Cancer Med. 2026;15:e71559.
Abstract

HUANG C, Pang G, Lang X, Zhang J, et al
Single-Cell RNA Sequencing Analysis Reveals Correlation Between Immune Cell Composition and Gene Expression in Cervical Cancer.
J Cell Mol Med. 2026;30:e70998.
Abstract

CHEN L, Liu L, Lin F, Fu Y, et al
Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population-Based Cohort Study.
Cancer Med. 2026;15:e71585.
Abstract

XIAO Y, Zhao Y, Wang Z, Peng C, et al
Ferroptosis Targeting by beta-Sitosterol in Cervical Cancer Radiotherapy.
Curr Med Chem. 2026 Jan 19. doi: 10.2174/0109298673409273251103055503.
Abstract

LI W, Yan Q, Zhou D, Yin X, et al
Disparities in early-stage cervical cancer detection: the critical role of educational attainment in 75,268 women in Hubei Province.
BMC Public Health. 2026 Jan 26. doi: 10.1186/s12889-025-26056.
Abstract

SIFERIH M, Gedif G, Lamesgen A, Alamneh AA, et al
Point-of-care HPV testing for cervical cancer screening in Sub-Saharan Africa: platform diversity, diagnostic performance, implementation feasibility, and determinants-a scoping review with contextual considerations for Ethiopia.
BMC Public Health. 2026 Jan 26. doi: 10.1186/s12889-026-26382.
Abstract

SAMBATH J, George IA, Manda SS, Ariyannur P, et al
Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer.
Mol Oncol. 2026 Jan 26. doi: 10.1002/1878-0261.70108.
Abstract

DE LA CRUZ-HERNANDEZ E, Morales-Sandoval GC, Lizano M, Aviles-Salas A, et al
Prognostic value of glioma-associated oncogene homolog 1 and SET domain-containing protein 2 immunohistochemical scores in locally advanced cervical cancer.
Oncol Lett. 2026;31:105.
Abstract

LIU Y, Wu R, Zhang L
A cross-sectional study on the quality of cervical cancer health information across multiple short video platforms: Analysis of content, quality, and dissemination characteristics.
Digit Health. 2026;12:20552076261415927.
Abstract

GOVENDER S, Phillips TK, Walter FM, Day S, et al
Cervical cancer awareness among women recently diagnosed with cervical cancer in South Africa and Zimbabwe.
Ecancermedicalscience. 2025;19:2018.
Abstract

NARTEY Y, Osae-Larbi J, Daniels J
Cervical cancer screening in women with disabilities in Ghana: bridging the gap in access and equity.
AJOG Glob Rep. 2025;6:100597.
Abstract

JI R, Geng R, Zhang Z, Gao F, et al
Exploring the Dynamic Changes of Intercellular Connections in Cervical Cancer: Insights From Transcriptomic Data Combined With Single-Cell Sequencing.
Hum Mutat. 2026;2026:8140041.
Abstract

GO AE, Feliciano EJG, Martinez J, Ho FDV, et al
Global determinants of cervical cancer outcomes: a health systems analysis.
BMJ Oncol. 2026;5:e000975.
Abstract

SUN Y, Zhang J, Guo L, Zhang J, et al
Discovering the abnormalities and functional importance of ferroptosis-related molecules in cervical cancer.
Int J Med Sci. 2026;23:443-460.
Abstract

YU H, Chen J, Lin J, Chen L, et al
Cadonilimab rechallenge in patients with recurrent or metastatic cervical cancer following prior PD-1/PD-L1 inhibitor failure: a retrospective multicenter study.
Front Immunol. 2026;16:1701319.
Abstract

AMBOREE TL, Dorali P, Damgacioglu H, Montealegre JR, et al
The cervical cancer divide: State variation in incidence, mortality, and progress toward elimination in the US.
JNCI Cancer Spectr. 2026 Jan 25:pkag005. doi: 10.1093.
Abstract

DANIELS-DONKOR SS, Marryat L
Health system barriers and facilitators influencing the uptake of cervical cancer screening among women in sub-Saharan Africa: systematic review and meta-synthesis.
BMC Health Serv Res. 2026 Jan 24. doi: 10.1186/s12913-026-14003.
Abstract

POLEBOYINA PK, Pawar SC
Elucidation of MMP-9 expression and association of MMP-9 rs3918242-1562 C/T promoter polymorphism in the progression of cervical cancer.
Cancer Genet. 2026;302-303:79-92.
Abstract

ABAR B, Wood N, Merriman J, Adler D, et al
Test results and follow-up care stemming from an ED-based cervical cancer intervention.
Am J Emerg Med. 2026;102:78-80.
Abstract

LI J, Zhong X, Mou Y, Tao X, et al
Identification of dephosphorylation related genes prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Medicine (Baltimore). 2026;105:e47292.
Abstract

ZHENG H, Gao M, Xu H, Cai J, et al
Initial different human papillomavirus infection statuses and subsequent infection risk: a decade-long longitudinal study.
J Health Popul Nutr. 2025;45:32.
Abstract

MABIKA-OBANDA AKF, Ambounda Ledaga N, Ngou Milama K, Zang Obame V, et al
Vaccine-preventable HPV burden and cervical abnormalities in women during 2022-2024 Octobre Rose campaigns in Libreville.
Nat Commun. 2025;17:1032.
Abstract

HAHN E, Zakaras JM, Balasubramanian A, Russo A, et al
Identifying gaps in women's preventive health services for women living with HIV in Vermont.
Reprod Health. 2025;23:15.
Abstract

PITAKKARNKUL S, Tangjitgamol S, Sangariyavanich E, Buasom R, et al
The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data.
J Gynecol Oncol. 2026;37:e56.
Abstract

BRENNAN LP, Hamacher F, Claure LA, Claure Dips AL, et al
Development of an HPV 16 rapid test founded in user-centered design with primary care clinicians.
Anal Methods. 2026;18:786-799.
Abstract

TONG Y, Xu L, Sun Y, Lan Y, et al
Construction of a nomogram model for predicting residual or recurrent cervical intraepithelial neoplasia after the loop electrosurgical excision procedure.
Am J Clin Pathol. 2026;165:aqaf125.
Abstract

SHARMA S, Verma M, Rautela I, Khan F, et al
Tumor Microenvironment: From Cervical Carcinogenesis to Therapeutic Advancements.
Curr Pharm Biotechnol. 2025;26:2065-2081.
Abstract

CHEN J, Wu M, Zhang R, Cao Y, et al
Luteolin, a Bioactive Compound from Celastrus orbiculatus Stem, Inhibits Cervical Cancer via CA2 Suppression: A Translational Study Bridging Basic Research and Clinical Application.
J Ethnopharmacol. 2026 Feb 4:121326. doi: 10.1016/j.jep.2026.121326.
Abstract

SMITH MA, Killen J, Jamieson L, O'Farrell X, et al
Accelerating cervical cancer elimination in Aboriginal and Torres Strait Islander women: a modelling study.
Lancet Public Health. 2026 Feb 3:S2468-2667(26)00005.
Abstract

ZHANG L, Zhang S, Liu S, Jian W, et al
Human Papillomavirus Vaccination Policies and Discourse on Social Media.
JAMA Health Forum. 2026;7:e256425.
Abstract

FOKOM DOMGUE J, Chandra M, Oladoyin O, Desai M, et al
Women's Preferences for Home-Based Self-Sampling or Clinic-Based Testing for Cervical Cancer Screening.
JAMA Netw Open. 2026;9:e2558841.
Abstract

LOOS G, Duclos M, Ennequin G
Physical activity and exercise in cervical cancer: a state-of-the-art review.
Cancer Causes Control. 2026;37:41.
Abstract

AGYEMAN AA, Bader G, Opoku NKO
The impact of human papillomavirus vaccination implementation in reducing cervical cancer in a heterosexual population.
Cancer Causes Control. 2026;37:42.
Abstract

PANG S, Jian X, Wei W, Chen Y, et al
Phosphoproteins Identification on Stretchable Photonic Crystal for Cervical Cancer Assessment.
Anal Chem. 2026 Feb 6. doi: 10.1021/acs.analchem.5c05791.
Abstract

JOSTEN K, Rose Dhar R, Reshmi B, Natti Krishna V, et al
Barriers to HPV vaccination among adolescent girls in India: A scoping review.
Indian J Med Res. 2026;162:743-753.
Abstract

CHEPKORIR J, Kivuti-Bitok L, Perrin N, Gross D, et al
Cervical cancer information access and dissemination strategies among rural Kenyan women: A mixed methods study.
J Public Health Afr. 2026;17:1457.
Abstract

OZGURLUK I, Erdem HB, Alay MT, Oktar O, et al
Unveiling mitochondrial DNA copy number alterations: Insights into progression from cervical intraepithelial neoplasia to cervical cancer.
Oncol Lett. 2026;31:117.
Abstract

LOU H, Langan D, Syracuse N, Murphy EA, et al
A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy.
medRxiv [Preprint]. 2026 Jan 23:2026.01.21.26344562.
Abstract

RODRIGUEZ NM, Case X, Balian L, Ziolkowski R, et al
Cervical Cancer Screening Rates and Associated Sociodemographic and Behavioral Factors among People Experiencing Homelessness in Indiana.
Res Sq [Preprint]. 2026 Jan 30:rs.3.rs-8524257. doi: 10.21203/rs.3.rs-8524257.
Abstract

WANG Q, Su M, Zheng Y
The Application of Tumor-Free Technique in Robotic Single-Site Radical Hysterectomy for Early Stage Cervical Cancer.
Ann Surg Oncol. 2026 Feb 5. doi: 10.1245/s10434-025-19026.
Abstract

YANG J, Shi Z, Song T, Shao Y, et al
LncRNA TMPO-AS1 aggravates the cisplatin resistance in cervical cancer via miR-140-5p/DNMT1 axis-mediated DNA methylation of KLK10.
Med Oncol. 2026;43:136.
Abstract

PENG L, Yu S, Dong Y, Gu H, et al
A potential association between the characteristics of the multi-organ microbiota and lymph node metastasis in cervical cancer.
Front Cell Infect Microbiol. 2026;15:1639811.
Abstract

ZHANG J, Shen J, Yuan L
Effect of HOXB7 in promoting proliferation, invasion and migration of cervical cancer cells.
Cytotechnology. 2026;78:38.
Abstract

ZHANG Y, Yuan J, Chen L
Transforming cervical cancer pathological diagnosis through artificial intelligence: progress, performance, and barriers to clinical implementation.
Front Oncol. 2026;15:1716018.
Abstract

NEWHOUSE R, McWilliams L, Baker-Rand H, Cullimore V, et al
Investigating the Acceptability of Cervical Screening and Self-Sampling in Postnatal Women at the 6-Week Postnatal Check-Up: A Qualitative Study.
Health Expect. 2026;29:e70582.
Abstract

ALLIN T, Taunton C, Ketchell F, Hempenstall A, et al
High Cervical Cancer Screening Rates and Low Human Papillomavirus Detection in the Remote Torres Strait, Far North Queensland.
Aust N Z J Obstet Gynaecol. 2026;66:e70060.
Abstract

TATARNIKOVA I, Talyshev V, Sen'kova A, Markov O, et al
Two paired HPV-59 cervical cancer cell lines with distinct chemoradioresistant phenotypes.
Sci Rep. 2026 Feb 4. doi: 10.1038/s41598-026-36260.
Abstract

LEINO A, Numminen E, Kares S, Merio M, et al
Clinical relevance of partial HPV genotyping in cervical cancer screening.
Sci Rep. 2026 Feb 4. doi: 10.1038/s41598-026-36594.
Abstract

TIAN X, Cao C, Wang L, Zhang J, et al
Testing menstrual blood for human papillomavirus during cervical cancer screening in China: cross sectional population based study.
BMJ. 2026;392:e084831.
Abstract

DOU J, Liu Z
Mapping interventions to increase uptake of breast and cervical cancer screening along the Intervention Ladder: a systematic review.
Health Psychol Rev. 2026 Feb 4:1-30. doi: 10.1080/17437199.2026.2623887.
Abstract

SCHWAB R, Emrich K, Heimes AS, Schwarzer K, et al
Combined Cervical Cancer Screening and the Incidence of Adenocarcinoma: An Analysis of Data From the German Cancer Registries.
Dtsch Arztebl Int. 2026;.
Abstract

MILERAD H, Bonander C, Nordqvist Kleppe S, Dillner J, et al
[Geomapping of 10-year coverage rate of cervical cancer screening in Sweden - a basis for targeting population-level interventions to improve screening].
Lakartidningen. 2026;123:25052.
Abstract

RAJAIE S, Emamgholipour S, Azari S, Karimi Z, et al
Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A systematic review.
Hum Vaccin Immunother. 2026;22:2609345.
Abstract

SHEN Y, Kang M
Retrospective analysis of preoperative serum tumor marker levels and their correlation with pathological characteristics and prognosis in cervical cancer patients.
Front Genet. 2026;17:1724789.
Abstract

BAHARDOUST M, Ghalavand N, Shamohammadi M, Asl MS, et al
Pretreatment CRP-Albumin-Lymphocyte (CALLY) Index as a Prognostic Biomarker of Survival and Recurrence-Free Survival in Patients With Early-Stage Cervical Cancer After Radical Hysterectomy: A Multicenter Retrospective Cohort Study.
Obstet Gynecol Int. 2026;2026:6137796.
Abstract

WISE J
Cervical cancer: Fewer screening tests needed, study suggests.
BMJ. 2026;392:s224.
Abstract

LU X, Yao L, Xu X, Rexiti MG, et al
m5c-modified LINC01094 participates in epithelial-mesenchymal transition and metastasis of cervical cancer cells via the ZNF582-SIRT1/p53 axis.
Mamm Genome. 2026;37:32.
Abstract

NING B, Li Z, Yu D, Li C, et al
Deep learning and dual-radiomics model incorporating brachytherapy applicator type to predict radiation-induced acute rectal injury in cervical cancer patients.
Phys Imaging Radiat Oncol. 2026;37:100908.
Abstract

POLANE MG, Dlamini SB
A qualitative study exploring the primary health care nurses' lived experiences of cervical cancer screening.
Afr J Prim Health Care Fam Med. 2026;18:e1-e9.
Abstract

KAYA M, Kara Y, Sanli-Mohamed G
Anticancer Properties of Newly Synthesized Pyrrole Derivatives as Potential Tyrosine Kinase Inhibitors.
J Biochem Mol Toxicol. 2026;40:e70665.
Abstract

JAHANSHAHI S, Soleimani-Jelodar R, Jalilvand S, Shoja Z, et al
Investigation of the expression level of human endogenous retrovirus E env transcript in cervical cancer.
Retrovirology. 2026 Feb 2. doi: 10.1186/s12977-025-00672.
Abstract

AYSI?N N, Kurt Can E, Koltas S, Yilmaz M, et al
A qualitative study on the experiences of stigmatisation and spiritual coping among women diagnosed with cervical cancer in Turkey.
BMC Womens Health. 2026 Feb 2. doi: 10.1186/s12905-026-04318.
Abstract

HARIPRASAD R, Bhatnagar T
A Systematic Framework for Evaluating Cervical Cancer Screening Programs: Innovative Approaches and Best Practices.
Indian J Public Health. 2026;70.
Abstract

MABROUK NOUH F, Abualruz H, Al-Zoubi M, Al-Mugheed K, et al
Nursing students' knowledge and attitudes toward human papillomavirus vaccination and infection.
Hum Vaccin Immunother. 2026;22:2609329.
Abstract

XIA W, Wang J, Yang X, Sha Y, et al
DNA methylation triage of human papillomavirus-positive atypical squamous cells of undetermined significance in cervical cancer screening.
J Obstet Gynaecol. 2026;46:2623828.
Abstract

PEDERSEN K, Di Silvestre J, Sy S, Portnoy A, et al
Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus: Health and Resource Implications.
Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
Abstract

Summary for Patients: Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus.
Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
Abstract

WENTZENSEN N, Egemen D
Adapting Cervical Cancer Screening in Vaccinated Populations: Individualized Versus Population-Based Approaches.
Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05559.
Abstract

HULLON D, Kara Damor D, Singh T, ALKhatib M, et al
The Overlay of Cervical Cancer with Cardiac Metastasis.
Cardiology. 2026 Feb 2:1-22. doi: 10.1159/000550823.
Abstract

TJALMA WA
Rare Today, Common Tomorrow: Strengthening Cervical Cancer Prevention in Low-Incidence Countries is Urgently Needed.
Int J Prev Med. 2025;16:85.
Abstract

ZRAIDI M, Kamel N, El Belloute G, Abidi K, et al
[Obstetrical characteristics related to cervical cancer in the Northern Territory of the Rabat-Sale-Kenitra Region, Morocco].
Pan Afr Med J. 2025;52:102.
Abstract

ZHANG F, Hu J, Bian J, Lan Y, et al
Mullerian adenosarcoma mimicking cervical carcinoma in a 79-year-old woman: diagnostic challenges and laparoscopic treatment: a case report.
Pan Afr Med J. 2025;52:110.
Abstract

WANG R, Liu S, Wang R, Guo Q, et al
Different Expressions and Methylation Patterns of cGAS and STING in Cervical Cancer.
Obstet Gynecol Int. 2026;2026:2210380.
Abstract

SHEN X, Guo W, Yao C, Wu H, et al
Epidemiological analysis of human papillomavirus and its subtype infections in 36,248 women in Wuhan, China.
Front Public Health. 2026;14:1745604.
Abstract

WANG X, Wang Q, Ding G, Wang J, et al
Artificial intelligence for colposcopic and cytological image analysis in early cervical cancer detection.
iScience. 2026;29:114627.
Abstract

ROTHSCHILD H, Keverline K, McKinney S, Farrell M, et al
From #cervicalcancerscreening to #LEEP - Quality and accuracy of cervical cancer content on TikTok.
Gynecol Oncol Rep. 2025;63:102018.
Abstract

ADANKWAH E, Mensah ABB, Konney T, Nones M, et al
A pilot study on the acceptability and feasibility of HPV self-sampling for cervical cancer screening among women attending urban hospitals in Kumasi, Ghana.
J Cancer Policy. 2026 Jan 30:100710. doi: 10.1016/j.jcpo.2026.100710.
Abstract

GUIDOBALDI L, Cafiero C, Stillitano G, Ricciardi E, et al
Cervical Cancer Complexity: Exploring the Coexistence of CIN3 and Glandular Lesions.
Infect Disord Drug Targets. 2026.
Abstract

SHAHRY P, Mohammadi Khoshoei Z, Cheraghi M, Talaiezadeh A, et al
Population-based epidemiological study of cervical cancer in Khuzestan province, Iran (2014-2019).
BMC Public Health. 2026 Jan 31. doi: 10.1186/s12889-026-26428.
Abstract

SABATIER R, Hennequin C, Martin-Babau J, Follana P, et al
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of advanced cervical cancer].
Bull Cancer. 2026 Jan 30:S0007-4551(26)00022.
Abstract

PARIDA P, Mehta A, Raj EA, Guruvare S, et al
Diagnostic and prognostic significance of circulating HPV cfDNA in cervical cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol. 2026;220:105161.
Abstract

JIANG N, Xin Z, Zhang Y, Liu Y, et al
Clinical translation of a DWI-radiomics nomogram integrating serum biomarkers for pretreatment staging of cervical cancer.
BMC Med Imaging. 2026 Jan 30. doi: 10.1186/s12880-026-02175.
Abstract

KAIDO Y, Kagabu M, Chiba Y, Sato S, et al
Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.
Int J Clin Oncol. 2026 Jan 30. doi: 10.1007/s10147-026-02971.
Abstract

CHARGARI C, Martinez A, Michels J, Lecuru F, et al
[French recommendations for clinical practice, Nice-Saint-Paul-de-Vence 2024-2025: Management of localized cervical cancer].
Bull Cancer. 2026 Jan 29:S0007-4551(26)00025.
Abstract

SAGER G, Livik M, Hellevik T, Orbo A, et al
Extracellular cGMP Levels Predict the Response of C4-1 Cervical Cancer Cells to Ionizing Radiation.
Anticancer Res. 2026;46:611-618.
Abstract

YANG ST, Chang CW, Wang PH
Clinical impact of glandular involvement in high-grade squamous intraepithelial lesions of the cervix.
Taiwan J Obstet Gynecol. 2026;65:64-69.
Abstract

IMATAKE H, Taki M, Yamanoi K, Murakami R, et al
Healthcare provider bias in cancer treatment decisions for elderly patients.
Taiwan J Obstet Gynecol. 2026;65:29-33.
Abstract

NIRMALKAR AP, Mamulwar M, Godbole S, Shahabuddin SM, et al
Cost-effectiveness of cervical cancer screening among women living with HIV in India: study protocol.
BMJ Open. 2026;16:e108752.
Abstract

PENG Z, Liu C, Tang D, Li S, et al
Slice-prompted HR-CTV interactive segmentation for cervical cancer brachytherapy: A multi-center study.
Med Phys. 2026;53:e70305.
Abstract

ZHOU Z, Li J, Zhao X, Xu H, et al
Gramine Suppresses Cervical Cancer by Targeting CDK2: Integrated Omics-Pharmacology and In Vitro Evidence.
Curr Issues Mol Biol. 2026;48:64.
Abstract

LEI X, Yang W, Xu S, Wu H, et al
Regulation of Energy Metabolism and Lipid Metabolites by IMP3 in Cervical Cancer.
Curr Issues Mol Biol. 2025;47:1014.
Abstract

VIDALINA D, Ghali L, Kassouf N, Li S, et al
The Therapeutic Effect of EZH2 Inhibitors in Targeting Human Papillomavirus Associated Cervical Cancer.
Curr Issues Mol Biol. 2025;47:990.
Abstract

GHOLAMI S, Aghbash PS, Ravanlo ZZ, Rahimi SB, et al
Therapeutic targeting of the HPV E7 oncoprotein: Current advances and emerging strategies.
Int Immunopharmacol. 2026;172:116193.
Abstract

COBLENTZ EG, Packee CR, Ky SL, Brubaker AG, et al
Prioritization of HPV vaccine preventable diseases among emerging adults - Implications for health education and communication.
Vaccine. 2026;74:128223.
Abstract

XIE X, Liu C, Liu X, Hou L, et al
Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
Sci Rep. 2026;16:5155.
Abstract

YI H, Huang J, Zhang N, Sundquist J, et al
The association of post-conization pregnancy with subsequent cervical lesions: evidence from a nationwide cohort in Sweden.
BMC Med. 2025;24:61.
Abstract

WANG Z, Hu T, Liu W, Zhou H, et al
Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid detection of 14 high-risk HPV types.
Microbiol Spectr. 2026;14:e0303625.
Abstract

SHI L, Gao X, Huang L, Gao Z, et al
Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18-30-year-old Chinese women: a phase III, double-blind, randomized, controlled trial.
BMC Infect Dis. 2025;26:248.
Abstract

CONTRERAS GARDUNO S, Saraiba-Rabanales V, Chavarri-Guerra Y, Soto-Perez-de-Celis E, et al
Trends in Cervical Cytology Test Reports and Cervical Dysplasia Severity according to Social Deprivation in Mexico (2013-2019): An Analysis of a National Database.
Cancer Epidemiol Biomarkers Prev. 2026;35:341-347.
Abstract

AHADI L, Zarei F, Kazemnejad A
From screen to screening: a randomized controlled trial on mHealth vs. traditional training on knowledge, attitudes, practice, self-efficacy, and adherence intention to pap smear.
BMC Womens Health. 2025;26:61.
Abstract

DALAL S, Sundstrom K, Silva R, Taghavi K, et al
Age-specific distribution of cervical precancer and cancer among women living with HIV across seven countries: a systematic review and an individual patient data meta-analysis.
Lancet HIV. 2026;13:e126-e137.
Abstract

TRAN CT, Wang M, Plymoth M, Chen J, et al
Accuracy of Self-Reported Cervical Screening Status Among Pregnant Women.
Aust N Z J Obstet Gynaecol. 2025 Nov 26. doi: 10.1111/ajo.70057.
Abstract

RUAN J, Gao C, Wang R, Hu B, et al
A novel dual-effect bimodal chip cancer research platform: Chips system interconnected vascularized tumor organoids culture with real-time exploration and detection from bench to bedside.
Cancer Lett. 2026;640:218110.
Abstract

ZHANG Z, Kong D, Ding Y, Lu M, et al
Laser ablation combined with photodynamic therapy for complex vaginal HSIL after repeat cervical conizations: a case report.
Photodiagnosis Photodyn Ther. 2026;57:105267.
Abstract

WANG Z, Luo H
Diagnostic Value of Ultrasound in Primary Cervical Ewing's Sarcoma: Two Case Reports and Literature Review.
J Clin Ultrasound. 2026;54:490-498.
Abstract

YANG L, Zou Y, Tian R
Cervical Paraganglioma Negative on Both 68Ga-DOTATATE and 18F-FDG PET/CT Studies.
Clin Nucl Med. 2025 Apr 24. doi: 10.1097/RLU.0000000000005895.
Abstract

FENG H, Zhao J, Zhang J, Jia P, et al
The role of E7 oncoprotein self-sampling and self-testing in cervical cancer screening.
BMC Womens Health. 2026 Feb 16. doi: 10.1186/s12905-026-04336.
Abstract

DISILVESTRO JB, Scott A, Novetsky AP, Perkins RB, et al
A Lens into the Quality Standards of Modern-Day Colposcopy.
Obstet Gynecol Clin North Am. 2026;53:121-138.
Abstract

ANDERSSON H, Dillner J
Population-based cervical screening with Human Papillomavirus self-sampling at home and incidence of cervical cancer in Sweden.
Prev Med. 2026 Feb 13:108540. doi: 10.1016/j.ypmed.2026.108540.
Abstract

ANDERSON EM, Saah AJ, Tota JE
HPV Type Replacement After HPV Vaccination.
Curr Top Microbiol Immunol. 2026;448:113-127.
Abstract

GRIFFIOEN MS, Runello F, Steenbergen RDM
DNA Methylation in Cervical Intraepithelial Neoplasia and Cervical Cancer: Triage and Management.
Curr Top Microbiol Immunol. 2026;448:93-112.
Abstract

DILLNER J
Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus Genotypes.
Curr Top Microbiol Immunol. 2026;448:81-92.
Abstract

ELLIS LB, Kyrgiou M, Moscicki AB
Microbiome, Human Papillomavirus and Cervical Carcinogenesis.
Curr Top Microbiol Immunol. 2026;448:59-80.
Abstract

DEL PINO M
Cofactors in Human Papillomavirus Carcinogenesis.
Curr Top Microbiol Immunol. 2026;448:39-58.
Abstract

POKA R
[New data to the evolution of the surgical treatment of early-stage cervical cancer].
Orv Hetil. 2026;167:251-256.
Abstract

SHI Y, Yao Y, He F, Chen X, et al
Association of EGFR and EGF gene polymorphisms with cervical cancer in a case-control study and cross-cancer meta-analysis.
Sci Rep. 2026 Feb 14. doi: 10.1038/s41598-026-38712.
Abstract

HE G, Qu X, Ding Z, Liang J, et al
IGSF3 binds to TNFR2 on Treg to facilitate immunosuppression in cervical cancer.
Cancer Lett. 2026 Feb 12:218307. doi: 10.1016/j.canlet.2026.218307.
Abstract

MEI J, Yang Z, Li M, Xiong C, et al
The impact of illness perception on marital quality among patients with cervical cancer and their husbands: based on actor-partner interdependence mediation model.
Eur J Oncol Nurs. 2026;81:103143.
Abstract

JIANG H, Zhu P, Chen Y, Xiong J, et al
The Dual Role of DNA Methylation Test Can Optimize the Clinical Application of High-Risk Human Papillomavirus Testing in Detecting Cervical Intraepithelial Neoplasia Grade 3 or Worse.
J Med Virol. 2026;98:e70836.
Abstract

SWANSON M, El Ayadi A, Nakalembe M, Namugga J, et al
Predictors of delay in the cervical cancer care cascade in Kampala, Uganda.
BMC Womens Health. 2026 Feb 13. doi: 10.1186/s12905-026-04292.
Abstract

COLE G, Ali AA, McCrudden CM, McBride JW, et al
Corrigendum to "DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system" [Eur. J. Pharm. Biopharm. 127 (2018) 288-297].
Eur J Pharm Biopharm. 2026 Feb 12:115018. doi: 10.1016/j.ejpb.2026.115018.
Abstract

LIU X, Wang A, Su M, Liang Z, et al
ADARB1 inhibits glycolysis and progression of cervical cancer through the HMGB1/PFKFB3 axis.
Biochim Biophys Acta Mol Basis Dis. 2026 Feb 11:168191.
Abstract

VINCZE A, Marai D, Frivaldszky L, Rancz A, et al
Neoadjuvant chemotherapy enables fertility preservation without compromising oncologic outcomes in early cervical cancer >/=2 cm: A systematic review and meta-analysis.
Eur J Surg Oncol. 2026;52:111461.
Abstract

GUO Q, Wang H, Diao X, Liu Y, et al
Utility of PAX1/JAM3 methylation analysis for triage of high-risk HPV-positive individuals.
Lab Med. 2026;57:lmaf096.
Abstract

SNIADECKI M, Jaworek P, Regent B, Biernat W, et al
Challenges in examining mentally Ill virgo intacta: a case of non-HPV cervical cancer and potential ovarian metastasis.
Ginekol Pol. 2026 Feb 13. doi: 10.5603/gpl.106395.
Abstract

ZHANG G, Wang L, Chen J, Wang J, et al
LAG-3-associated CD8(+) T-cell dysfunction in the cervical cancer tumor microenvironment.
Front Immunol. 2026;17:1750726.
Abstract

WANG Y, Xie Y, Fang Y, Sui B, et al
Acupuncture combined with immunotherapy for recurrent and metastatic cervical cancer: a pilot RCT protocol.
Front Oncol. 2026;16:1718170.
Abstract

MISHRA V, Pandey L, Pandey A, Chatterjee R, et al
Evaluation of Interfraction Dose Discrepancies in Organs at Risk, Clinical Target Volume, and Points A and B in Computed Tomography-based High-dose-rate Intracavitary Brachytherapy for Cervical Cancer Patients.
J Med Phys. 2025;50:709-713.
Abstract

DETWONGYA C, Tantipalakorn C, Charoenkwan K
External validation of the SUCCOR Risk score for predicting recurrence in early-stage cervical cancer patients treated with radical hysterectomy.
J Gynecol Oncol. 2026 Jan 27. doi: 10.3802/jgo.2026.
Abstract

MOLIKA P, Nittayaboon K, Kerdkumthong K, Navakanitworakul R, et al
Mesenchymal Stem Cell-Derived Exosomes Reprogram Chemosensitivity Pathways in Cervical Cancer Spheroids.
Int J Mol Sci. 2026;27:1575.
Abstract

SZTUKA M, Jelen A, Krygier A, Szmajda-Krygier D, et al
The Epidemiology of Human Papillomavirus (HPV) Infections in Poland in the Light of the Nationwide HPV Vaccination Program for Children Aged 12-13 and Updated HPV DNA Detection Guidelines.
Int J Mol Sci. 2026;27:1434.
Abstract

OLIVEIRA MHR, Aparicio SL, Silva JACD, Neto DAL, et al
Barriers to Accessing Cervical Cancer Screening and Treatment in the Amazon Region-A Systematic Review.
J Clin Med. 2026;15:1206.
Abstract

JOUYA S, Shahabinia Z, Mazidimoradi A, Allahqoli L, et al
Cervical Cancer Epidemiology: Global Incidence, Mortality, Survival, Risk Factors, and Equity in HPV Screening and Vaccination.
J Clin Med. 2026;15:1079.
Abstract

CHODICK G, Strassberg M
Association Between Human Papillomavirus Vaccination and the Risk of Cervical Cancer and Precancerous Lesions in Israel: A Retrospective Cohort Study.
J Clin Med. 2026;15:995.
Abstract

CHANUDOM I, Tharavichitkul E, Laosiritaworn W
Survival Period Prediction in Cervical Cancer Patients Using the Selective Stacking Technique.
Healthc Inform Res. 2026;32:38-49.
Abstract

ZHAO Q, Yang W, Cao L, Chen Y, et al
Magnesium Ions Promote the Apoptosis of Cervical Cancer Cells through the PI3K/AKT/FoxO1 Pathway.
Biol Trace Elem Res. 2026 Feb 13. doi: 10.1007/s12011-026-05014.
Abstract

BONALA SR, Raja SA, Subramanian BV, Balaraju S, et al
Randomized comparison of tandem-ring versus tandem-ovoid applicators in volume-based brachytherapy for cervical cancer: Dosimetric analysis and early clinical outcomes.
Brachytherapy. 2026 Feb 11:S1538-4721(25)00373.
Abstract

JACQUES LJ, Clarkson M, Humphrey PM
Patient experiences of radiation-induced menopause in cervical cancer: A scoping review.
Radiography (Lond). 2026;32:103345.
Abstract

CHEN J, Gu Y, Zheng Y, Gu M, et al
FTO promotes the cervical cancer progression via regulation of FGF2 expression.
Ann Med Surg (Lond). 2026;88:1359-1368.
Abstract

CHENG C, Yang Y, Qu Y
Investigation of the impact of image-guided radiotherapy selection on image registration results and non-coding RNAs for cervical cancer patients.
Noncoding RNA Res. 2025;18:87-91.
Abstract

QIU H, Shi Q, Tang T, Shen K, et al
Feasibility study of U-Net-based automatic segmentation of pelvic bone marrow for postoperative radiotherapy in cervical cancer.
Front Oncol. 2026;15:1612984.
Abstract

BALAMOU C, Zysman K, Rodrigue CM, Seigneurin A, et al
Impact of commune level social inequalities on time to diagnosis and follow-up in women with high-grade cervical lesions in Isere, France: Evidence from the French cervical cancer screening program.
Prev Med Rep. 2026;62:103396.
Abstract

YANG C, Li M, Yang C, Jiang P, et al
Radiomics based on habitat analysis in predicting parametrial invasion of early stage cervical cancer.
Front Oncol. 2026;16:1694347.
Abstract

CORBEAU A, Welters MJP, Boekestijn S, Mens JWM, et al
Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy.
Clin Transl Radiat Oncol. 2026;58:101107.
Abstract

LU Y, Zhao J, Jia Z, Zhang C, et al
Efficacy and safety of neoadjuvant chemotherapy combined with concurrent chemoradiotherapy and concurrent chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis.
Transl Cancer Res. 2026;15:17.
Abstract

WANG C, Zhu K, Bai L, Zhu X, et al
Sodium selenite promotes apoptosis and augments autophagic flux in cervical cancer cells by activating the YAP-Hippo signaling pathway.
Transl Cancer Res. 2026;15:36.
Abstract

MORADPANAH S, Rahimi S, Nayebzadeh M, Doosty F, et al
Hydrogel-enhanced brachytherapy in cervical cancer: redefining precision, efficacy, and safety.
Eur J Med Res. 2026 Feb 11. doi: 10.1186/s40001-026-03876.
Abstract

LIU J, Zhou L, Yao P, Zhang N, et al
M(5)C-driven stabilization of SERPINB5 promotes cervical cancer progression and chemotherapy resistance.
Cell Death Dis. 2026 Feb 11. doi: 10.1038/s41419-026-08453.
Abstract

MOODLEY J, Scott SE, Day S, Guzha BT, et al
Time to diagnosis for breast, cervical and colorectal cancer in Zimbabwe and South Africa: a cross-sectional study.
BMJ Glob Health. 2026;11:e021889.
Abstract

CHAE YK, Othus M, Patel SP, Backes FJ, et al
DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix.
J Immunother Cancer. 2026;14:e012805.
Abstract

FLINT ML, Byrne ME, Friedman CF
Locally Advanced Cervical Cancer: What is the Preferred Systemic Treatment?
J Natl Compr Canc Netw. 2025;23:e257123.
Abstract

ABU-RUSTUM NR, Campos SM, Amarnath S, Arend R, et al
Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.
J Natl Compr Canc Netw. 2025;23:549-573.
Abstract

AKERELE OE, Olanrewaju AK
Social Media Peer-Driven Communication on Cervical Cancer and HPV Vaccine Among Female Youth in Nigeria.
J Cancer Educ. 2026 Feb 11. doi: 10.1007/s13187-025-02817.
Abstract

SUN P, Fan Z, Li L
Comment on "Analysis of Quality, Reliability, and Content of Cervical Cancer-Related Chinese Videos on TikTok".
J Cancer Educ. 2026 Feb 11. doi: 10.1007/s13187-026-02834.
Abstract

SHAO D, Wu P, Jiang H, Wang Z, et al
Global trends and future projections of cervical cancer burden: an integrated analysis of GBD 2021, UN population and WHO HPV vaccination data.
Front Public Health. 2026;14:1702186.
Abstract

WANG F, Pang R, Zhang Y
Efficacy and safety of neoadjuvant chemotherapy followed by radical surgery vs. radical surgery alone in locally advanced cervical cancer: A systematic review and meta-analysis.
Biomed Rep. 2026;24:40.
Abstract

SHI H, Huang X, Yu J, Shan W, et al
Precision management of cervical cancer emphasizes immunotherapy combination regimens and translational advances.
Discov Oncol. 2026 Feb 11. doi: 10.1007/s12672-026-04588.
Abstract

SILVA LGSD, Silva PVS, Chaves MFD, Oliveira NPD, et al
Spatial distribution of timely treatment for cervical cancer: Socioeconomic inequalities and disparities in healthcare service availability in Brazil.
Cancer Epidemiol. 2026;101:103010.
Abstract

QUINTERO-URIBE MP, Benavides-Lozano N, Campino-Alvarado T, Aguirre-Martinez MA, et al
Role of Self-Sampling Devices for HPV Detection in Cervical Cancer Screening: A Systematic Review.
J Low Genit Tract Dis. 2026 Feb 10. doi: 10.1097/LGT.0000000000000935.
Abstract

TIAN X, Li M, Wang Z, Fang T, et al
Proteogenomic characterization of cervical cancer identifies molecular subtypes predictive of clinical outcomes and subtype-specific targets.
J Clin Invest. 2026 Feb 10:e199497. doi: 10.1172/JCI199497.
Abstract

BAVOR C, Jennett C, Phillips E, Mitchell L, et al
How would Australian women and people with a cervix like to access self-collection for cervical screening? Screening preferences from a national survey.
Cancer Causes Control. 2026;37:47.
Abstract

PASSARELLI GV, Whang SN, Gilbert NM, Hu J, et al
The vaginal microbiome, papillomavirus infection, and cervical cancer: established associations in search of model systems and mechanistic answers.
mBio. 2026 Feb 10:e0267725. doi: 10.1128/mbio.02677.
Abstract

WANG X, Zheng X, Fang Y, Zheng T, et al
The promoting role of protein arginine methyltransferase 1 in cervical cancer: Mechanisms of angiogenesis and immune evasion.
Cytojournal. 2025;22:104.
Abstract

NAMUTUNDU J, Nakalembe M, Nakku-Joloba E, Kiguli J, et al
Integrating the behavior change wheel and co-design approach in selecting strategies for improving cervical cancer screening literacy among rural women living with HIV in Eastern Uganda.
BMC Health Serv Res. 2026 Feb 9. doi: 10.1186/s12913-026-14152.
Abstract

MIN S, Xie L, Wu Y, Bo L, et al
Efficacy of FOXP3+Treg cells combined with platelet in predicting recurrence of cervical cancer: a retrospective study.
BMC Womens Health. 2026 Feb 9. doi: 10.1186/s12905-026-04274.
Abstract

WU H, He C, Liu M, Zhao X, et al
Impact of rectal gas evacuation on dosimetry and applicator displacement in cervical cancer brachytherapy.
J Appl Clin Med Phys. 2026;27:e70490.
Abstract

GGINGO S, Obore S, Musaba M, Wandabwa J, et al
Factors Associated with Human Papillomavirus Vaccination Uptake Among Adolescent Girls in Uganda.
Am J Trop Med Hyg. 2025;114:355-359.
Abstract

GUAN J, Liu H, Li J, Chang Z, et al
Cervical HPV in central China: regional prevalence, subtypes and pathology.
J Infect Dev Ctries. 2026;20:129-133.
Abstract

BAO YH, Chen Y, Xiao ML, Li YA, et al
Primary tumor-derived, multiparametric MRI-based deep learning-radiomics-clinical model for predicting lymph node metastasis in early-stage cervical cancer.
Insights Imaging. 2026;17:38.
Abstract

WINARTO H, Glenardi G, Habiburrahman M, Kusuma F, et al
Exploring Knowledge, Attitudes, Practices, and Information-Seeking on HPV Infection and Cervical Cancer Prevention in Rural Indonesia.
Asian Pac J Cancer Prev. 2026;27:693-704.
Abstract

DAS D, Sepai HM, Pal SK, Chakraborty BC, et al
An Altered Ratio of CD4+ and CD8+ T Lymphocytes in Cervical Cancer Tissue and Peripheral Blood as a Predictor of Prognostic Outcome: A Clinicopathological Study.
Asian Pac J Cancer Prev. 2026;27:643-649.
Abstract

RAY A, Karmakar A, Maiti M, Banerjee S, et al
Evaluation of the Diagnostic Accuracy of Cervical Cell Morphologies from Android Device-Captured Cytopathological Microscopic Images through Artificial Intelligence in Mainly Rural or Resource-Constraint Areas of India.
Asian Pac J Cancer Prev. 2026;27:601-612.
Abstract

DARTIBALE CB, De Souza MVF, Prado GC, Sant'Ana DMG, et al
Performance of a New Brazilian Self-Sampling Device for High-Risk Human Papillomavirus Screening.
Asian Pac J Cancer Prev. 2026;27:405-409.
Abstract

WANG X, Pan X, Li X, Ding B, et al
Epithelial Cell-Specific Prognostic Signature (FTH1, RIT1, WASL, NDRG2, KIFC3) Stratifies Cervical Cancer Patients and Correlates With Immune Infiltration.
Hum Mutat. 2026;2026:4109928.
Abstract

ALGHANMI R, Alkhalawi E, Albeladi R, Albeladi S, et al
Parental Knowledge and Acceptance of HPV Vaccine in Rabigh's School, Saudi Arabia.
Ann Glob Health. 2026;92:13.
Abstract

JOHNSON M, Joy TM, Rasheed A, Rose BM, et al
Cervical Cancer Screening Among Rural Women in Ernakulam District, Kerala: A Cross-Sectional Study.
Cureus. 2026;18:e100961.
Abstract

WANG Z, Liu H, Chen X, Zhang F, et al
Comparative predictive performance of three machine learning algorithms for acute radiation enteritis risk among patients with cervical cancer undergoing radiotherapy: A prospective cohort study.
Asia Pac J Oncol Nurs. 2026;13:100853.
Abstract

JIANG K, Shao Y, Wang H, Zhao F, et al
HPV vaccination willingness and behavior among patients with cervical intraepithelial neoplasia in low-resource areas of Western China: a cross-sectional study.
Front Public Health. 2026;13:1708917.
Abstract

JOSEPH EA, Mula M, Mehdi Khan MM, Allen CJ, et al
Assessing long-term quality of life and survivorship priorities in cervical cancer patients: a social media survey-based study.
Gynecol Oncol Rep. 2026;63:102031.
Abstract

WANG H, Xu S, Li S, Lin M, et al
TMEM121 suppresses cervical cancer cell proliferation and migration via interaction with the ERK pathway.
Am J Cancer Res. 2026;16:70-87.
Abstract

NISHIZAWA N, Ishikawa M, Maskey MR, Esumi A, et al
Circularly polarized light scattering imaging of a cancerous layer creeping under a healthy layer for the diagnosis of early-stage cervical cancer.
J Biomed Opt. 2026;31:027002.
Abstract

BEREZOWITZ JD, Fish MC, Mehanna LE, Knicely B, et al
Tiny plastic, big trouble: how polystyrene nanoparticles impact DNA-damage repair deficient cervical cancer cells.
Soft Matter. 2026 Feb 9. doi: 10.1039/d5sm01095.
Abstract

VANAN AG, Hassanzadeh F, Ghorbaninezhad F, Taheri F, et al
LncRNA CCAT2 role in female-related cancer progression and diagnosis: a comprehensive review.
Clin Exp Med. 2026;26:130.
Abstract

JIT M
Human papillomavirus, human immunodeficiency virus, and the shared road to cervical cancer elimination.
J Natl Cancer Inst. 2026 Feb 6:djag017. doi: 10.1093.
Abstract

WIWEKANANDA IGNA, Malek NANN, Endharti AT, Permatasari HK, et al
Nab-paclitaxel for the treatment of cervical cancer: a systematic review of clinical safety and effectiveness.
J Chemother. 2026 Feb 8:1-13. doi: 10.1080/1120009X.2026.2625548.
Abstract

RETRACTION: Epigallocatechin Gallate in Combination With Eugenol or Amarogentin Shows Synergistic Chemotherapeutic Potential in Cervical Cancer Cell Line.
J Cell Physiol. 2026;241:e70143.
Abstract

ZHANG Y, Shao Y, Li X, Zhou D, et al
SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2.
Commun Biol. 2026 Feb 7. doi: 10.1038/s42003-026-09678.
Abstract

XIAO C, Wang L, Xia C, Chan PKS, et al
HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
Tumour Virus Res. 2026;21:200339.
Abstract

WU X, Li Y, Zheng Z, Hu J, et al
Site-specific propynylation modification of apigeninidin enhances anti-cervical cancer activity by targeting PARP-1.
Bioorg Chem. 2026;172:109600.
Abstract

HUANG J, Wu S, Wang X, Lin H, et al
NIR Triggered Fluorescence Imaging and Synergistic Ablation of Cervical Cancer Using ICG-Loaded CuO Nanoleaves via Photothermal-Augmented ROS Amplification.
ACS Appl Bio Mater. 2026 Feb 7. doi: 10.1021/acsabm.5c02472.
Abstract

LIU J, Wang A, Wang G, Jiang S, et al
Gallium-enriched bimetallic nanomedicine for cervical tumour suppression via bioimaging-guided surgery and highly synergistic reactive oxygen species burst.
J Colloid Interface Sci. 2026;709:139952.
Abstract

ZHAO C, Li M, Chen R, Zhao Y, et al
Comparison of different mRNA testing technologies with HPV DNA testing for predicting ASCUS triage and post-cone excision outcomes: a systematic review and meta-analysis.
Syst Rev. 2026;15:53.
Abstract

TAN Y, Huang Q, Zeng J, Wang Y, et al
Transient receptor potential canonical 3 is required for HPV-induced malignant transformation of cervical epithelial cells.
Commun Biol. 2026;9:204.
Abstract

MANJESHWAR S, Kojima N, Tsang E, Pereira D, et al
Performance of a novel, urine-based test for the detection of cervical human papillomavirus infection.
J Clin Microbiol. 2026;64:e0131825.
Abstract

MA M, Luo F, Ma B, Liu S, et al
A Multi-instance Learning Network with Prototype-instance Adversarial Contrastive for Cervix Pathology Grading.
Med Image Anal. 2026;109:103880.
Abstract

RAKE C, Davidson EJ, Young A, Maskell A, et al
The Use of First-Void Urine to Screen Women Aged 60-79 for HPV in the UK: The Catch-Up Screen Study.
BJOG. 2026;133:814-822.
Abstract

LUAN Y, Zhu Y, Sun L, Qin F, et al
MRI quantitative parameters combined with pathological microvascular characteristics predict lymph node metastasis of cervical squamous cell carcinoma.
Acta Radiol. 2026;67:188-198.
Abstract

JIN Q, Zhang X, Yuan J, Fang Q, et al
Breaking New Ground in Cervical Metastatic Carcinoma of Unknown Primary: Neoadjuvant Immunochemotherapy's Pathologic Regression and Survival Advantage.
Ann Surg Oncol. 2026;33:2493-2502.
Abstract

LA FRINERE-SANDOVAL NQNB, Cubbin C, DiNitto DM
The Association between Binge Drinking and Mammography and Pap Test Screening by Women's Race and Ethnicity.
J Womens Health (Larchmt). 2026;35:306-317.
Abstract

XU R, Liu H, Zhu T, Tang H, et al
An immunosuppressive tertiary lymphoid structure is associated with adverse prognosis in gastric-type endocervical adenocarcinoma.
J Natl Cancer Inst. 2026;118:276-288.
Abstract

HOWARD MF, Fyffe-Freil RC, Pierre CC, Maku HO, et al
Self-collection for primary HPV screening using dry swabs: a review of clinical performance, laboratory considerations, and patient preferences.
J Clin Microbiol. 2025 Oct 21:e0076724. doi: 10.1128/jcm.00767.
Abstract

ZHANG X, Wang J, Ke G, Zhang Y, et al
Self-management experiences of vaginal toxicities among patients undergoing radical radiotherapy for cervical cancer: a qualitative study.
BMC Womens Health. 2026 Feb 21. doi: 10.1186/s12905-026-04343.
Abstract

LAMICHHANE A, Kaphle HP, Neupane N, Baral S, et al
Factors associated with cervical cancer screening uptake among women aged 30-49 years of Bhanu Municipality, Tanahun, Nepal: a cross-sectional study.
BMC Womens Health. 2026 Feb 21. doi: 10.1186/s12905-026-04360.
Abstract

LAAS E, Gaillard T, Fourchotte V, Hotton J, et al
[Cervical cancer with SHAPE criteria: Conisation before simple hysterectomy].
Bull Cancer. 2026 Feb 19:S0007-4551(26)00101.
Abstract

YOUNG AP, O'Dwyer MC, Smith R, Saunders N, et al
Kennedy v Braidwood Ruling Affects Women and Cervical Cancer Screening.
J Am Board Fam Med. 2025;38:1113-1116.
Abstract

LEJEUNE CL, Van Calsteren K, Baert T, Vandecaveye V, et al
A multidisciplinary management approach to cervical cancer during pregnancy.
Lancet. 2026 Feb 17:S0140-6736(26)00190-X. doi: 10.1016/S0140-6736(26)00190.
Abstract

VIDAURRE MENDES S, Kischinhevsky DG, Lopes da Silva J, Dos Santos ALS, et al
Epidemiology of Cervical Cancer in Brazil: Age-Specific Trends From 2000 to 2018.
JCO Glob Oncol. 2026;12:e2500416.
Abstract

VEERAVAGU T, Hamdiui N, Stein ML, Al-Rubaie N, et al
Supporting Informed Decision-Making Regarding Participation in Cervical Cancer Prevention Programs: A Qualitative Study Among Turkish-, Moroccan-, and Syrian-Dutch Women.
Community Health Equity Res Policy. 2026 Feb 20:2752535X261427045.
Abstract

ZHONG M, Peitz J, Newman M, Yussuf S, et al
Novel circRNA signatures in cervical cancer: implications for early detection and screening.
Biomark Med. 2026 Feb 19:1-10. doi: 10.1080/17520363.2026.2631965.
Abstract

CHIGBU CO, Dim CC, Eneh SC, Olakunde BO, et al
Cervical cancer screen-and-treat services at HIV treatment sites in Nigeria: findings from the ICON-3 Practice Based Research Network.
BMC Health Serv Res. 2026 Feb 20. doi: 10.1186/s12913-026-14167.
Abstract

ZHAO X, Huang Y, Lv Q, Wang L, et al
Awareness of cervical cancer and its correlates among junior high school students in Eastern China: a cross sectional study.
BMC Public Health. 2026 Feb 20. doi: 10.1186/s12889-026-26748.
Abstract

ANAND KV, Mishra GA, Suryawanshi VB, Pimple SA, et al
Experiences with HPV self-sampling in India: advancing cervical cancer prevention and screening.
BMC Public Health. 2026 Feb 19. doi: 10.1186/s12889-026-26212.
Abstract

LIN J, Lin M, Lin L, Chen Q, et al
Single-Cell Sequencing Combined with RNA Sequencing Reveals the Role of Natural Killer Cells in Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma.
Crit Rev Immunol. 2026;46:27-43.
Abstract

ROWLINSON E, Snih SA
Factors associated with mammogram and Papanicolaou testing among Mexican American older women.
Womens Health (Lond). 2026;22:17455057261421727.
Abstract

CHEN J, Mo Z, Pan J, Jia L, et al
Automated gross tumour volume delineation on T2-weighted magnetic resonance imaging coupled with radiomics for predicting cervical cancer recurrence.
Eur J Med Res. 2026 Feb 18. doi: 10.1186/s40001-025-03777.
Abstract

AMUBUOMOMBE PP, Itsura P, Tonui PK, Orang'o EO, et al
Pregnancy outcomes among women with and without HIV infections who underwent excisional treatment for high-grade cervical intraepithelial neoplasia: a retrospective cohort study in low-resource settings.
BMJ Open. 2026;16:e105559.
Abstract

AGUSTI N, Viveros-Carreno D, Wu CF, Iniesta MD, et al
Survival Outcomes After Inadvertent Surgery in Low-Risk Early-Stage Cervical Cancer.
Am J Obstet Gynecol. 2026 Feb 16:S0002-9378(26)00081.
Abstract

RICARDO MG, Alberto MG, Maria HA, Ramos, et al
PD-L1 expression in cervical cancer tissue is strongly associated with the expression of CD73/TGF-beta1, the percentage of CD8+/PD-1+ T cells and disease progression.
Immunol Lett. 2026 Feb 16:107150. doi: 10.1016/j.imlet.2026.107150.
Abstract

ZHANG X, Tao X, Bao K
Comparative analysis of trends and projections of cervical cancer burden among women aged 20-64 years in China, Japan, and South Korea, 1990-2050.
Discov Oncol. 2026 Feb 18. doi: 10.1007/s12672-026-04688.
Abstract

CHENG X, Wang J, Wang H, Song H, et al
Case Report: A rare case of external iliac artery rupture and sigmoid fistula following multimodal treatment for cervical cancer.
Front Oncol. 2026;16:1708443.
Abstract

GOMES P, de Abreu WC, Dos Reis RG, Guerra ENS, et al
Photobiomodulation therapy approach to a rare phenomenon of radiation recall reaction triggered by cisplatin in a cervical cancer patient: a case report and scoping review.
Front Oncol. 2026;15:1700942.
Abstract

THARAVICHITKUL E, Chitapanarux I, Sripan P, Tovanabutra C, et al
Unlocking economic gains: the impact of image-guided brachytherapy on cervical cancer treatment in Thailand.
Front Public Health. 2026;13:1725415.
Abstract

MENG X, Wang Z, Zhang Y, Wang X, et al
RapidArc Dynamic (RAD) multi-mechanical axis optimization achieves enhanced OAR sparing in cervical cancer: A dosimetric comparison study.
J Appl Clin Med Phys. 2026;27:e70506.
Abstract

WENTZENSEN N, Egemen D, Clarke MA, Poitras N, et al
Long-Term Prospective Cohort Study of Cervical Cancer Screening Using Triage of Women who Are Human Papillomavirus-Positive With Dual Stain and Human Papillomavirus Genotyping.
J Clin Oncol. 2026 Feb 17:JCO2500689. doi: 10.1200/JCO-25-00689.
Abstract

OGUNDARE OC, Adeyemo GO, Folorunsho S
Determinants of cervical cancer screening among African and African American women: a qualitative systematic review.
Ethn Health. 2026 Feb 17:1-16. doi: 10.1080/13557858.2026.2630820.
Abstract

LIU Y, Wang S, Gao S
Human Papillomavirus (HPV) Type Distribution in Cervical Carcinoma, Low-Grade, and High-Grade Squamous Intraepithelial Lesions in Women Under 25 Years Old From the Largest Women Hospital in China.
J Med Virol. 2026;98:e70846.
Abstract

WANG Z, Wang Z, Jiang J, Yang L, et al
Reprogramming the tumor immune microenvironment in cervical cancer: synergy between radiotherapy and immunotherapy.
Mol Cancer. 2026 Feb 17. doi: 10.1186/s12943-026-02600.
Abstract

SOLTANI LF, Addis I, Lin P, Kamdar N, et al
Characterizing Cervical Cancer Screening in the US: Preparing for the Era of Self-Collection.
J Am Board Fam Med. 2026 Feb 16. doi: 10.3122/jabfm.2025.250040.
Abstract

YANG Q, Zhao J, Liu X, Liu J, et al
Identification and mechanistic exploration of VEGFA and CALML3 as calcium channel-related prognostic genes in cervical cancer.
Discov Oncol. 2026 Feb 16. doi: 10.1007/s12672-026-04683.
Abstract

LI Y, Wang F, Fang Z, Sun H, et al
MUL1 suppresses cervical cancer progression by targeting FUNDC1 for ubiquitination and inhibiting DRP1-dependent mitophagy.
J Mol Histol. 2026;57:79.
Abstract

ALMASABI SHA, Almasoudi HH, Albargy H, Alabbas MMA, et al
Retraction Note: Alternative use of Droxidopa for treating cervical cancer: inhibiting transferase, cell cycle signalling, and transport proteins via multitarget docking, DFT, MD simulations, and binding free energy studies.
Med Oncol. 2026;43:150.
Abstract

SINGH A, Sahani P, Singh S, Ojha A, et al
Role of human papillomavirus (HPV) variants and host genetic susceptibility in cervical carcinogenesis.
Arch Microbiol. 2026;208:198.
Abstract

WANG B, Xiao J, Ding Y, Yu J, et al
Preoperative prediction of parametrial invasion in early-stage cervical cancer: a radiomics nomogram fusing multi-parametric MRI and clinical biomarkers.
Abdom Radiol (NY). 2026 Feb 16. doi: 10.1007/s00261-025-05353.
Abstract

KIBONIRE RA, Mphuthi DD
Understanding the determinants of cervical cancer screening uptake in Hoima District, Uganda.
Afr J Reprod Health. 2026;30:104-113.
Abstract

LI D
Influence of gemcitabine combined with lobaplatin interventional embolization on vaginal flora and biofilm formation in patients with advanced cervical cancer.
Afr J Reprod Health. 2026;30:38-50.
Abstract

WANG Z, Zhang Y, Xiu Y, Chen Z, et al
Au-PtNPs@Mn(3)O(4) Nanozymes Enhance the Antitumor Effect of Photodynamic Therapy and Radiotherapy in Cervical Cancer by Modulating Tumor Hypoxia.
ACS Omega. 2026;11:8183-8196.
Abstract

YORKE AA, Muramuzi A, Lin LL, Awusa K, et al
Quantifying cervical cancer radiotherapy care gap: Baseline assessment prior to implementation of a digital Health App.
Tech Innov Patient Support Radiat Oncol. 2026;37:100381.
Abstract

RAY S, Nagar A
Educational intervention and its effect on medical students' knowledge and readiness for cervical cancer screening and human papillomavirus vaccination.
J Family Community Med. 2026;33:53-54.
Abstract

WANG X, Xiong D, Duan B, Huang Y, et al
Mechanistic pathways predictive modeling and translational interventions for radiation enteritis in cervical cancer radiotherapy.
Front Cell Infect Microbiol. 2026;15:1729528.
Abstract

MUNE G, Asefa A, Chillo SL, Woldesemayat EM, et al
Cervical Cancer Screening and Associated Factors Among Women of Reproductive Age in Sidama Regional State of Ethiopia: A Cross-Sectional Survey.
Cancer Rep (Hoboken). 2026;9:e70498.
Abstract

ZHANG T, Choon Park D, Jeong Jeong Y, Geun Yeo S, et al
Screening of cervical intraepithelial neoplasia based on multiple features extracted from multi-electrode bioimpedance spectroscopy.
Physiol Meas. 2026;47.
Abstract

POPOVIC J, Hahut A, Torres GE, Vincent A, et al
Changes in EGFR activity following CRISPR/Cas9-editing of the EGF binding domain.
Sci Rep. 2026;16:6797.
Abstract

LI X, Sun L, Qiu M, Wu X, et al
Investigation of thoracico-abdominal infrared thermal imaging characteristics in patients with cervical HR-HPV infection.
Sci Rep. 2026;16:6500.
Abstract

STUART R, Theopold N, Miall N, Kobayashi E, et al
The role of HPV single-dose vaccination in expanding access in GAVI-supported countries during a period of supply constraints.
Vaccine. 2026;75:128187.
Abstract

ZOU R, Xu J, Fang Q, Guan R, et al
A novel cervical image recognition framework based on feature cognitive enhancement for improved performance.
Proc Inst Mech Eng H. 2026;240:192-205.
Abstract

CHEN Q, Quan J, Zhu K, Lan L, et al
Variations in the Natural History of High-Risk HPV Types Following HPV-16/18 Bivalent Vaccination in Females Aged 18-45 Years.
Nat Commun. 2026;17:1677.
Abstract

XIA D, Gao Z, Li J, Chen C, et al
pH-Responsive Biomineralized Probiotic for Self-Amplifying Mucosal Vaccination: Gut-Engineered Antigen Factories Drive Targeted Cervical Tumor Regression.
Adv Mater. 2026;38:e10404.
Abstract

KOIVISTO T, Kalliala I, Eriksson T, Nieminen P, et al
Human papillomavirus vaccinations' impact on preterm birth rates.
Eur J Public Health. 2026;36:214-219.
Abstract

MUKEREBE C, Cordeiro AA, Aristide C, Colombe S, et al
Schistosome Infection is Associated with High-Risk Human Papillomavirus Persistence, Together with Altered Cervicovaginal Microbiota.
J Infect Dis. 2025 Aug 22:jiaf447. doi: 10.1093.
Abstract

CULLIMORE V, Newhouse R, Baker-Rand H, Chu K, et al
Investigating the acceptability of cervical screening, using conventional clinician-taken cervical samples or urine self-sampling, at 6 weeks postnatal: A cross-sectional questionnaire.
J Med Screen. 2026;33:48-58.
Abstract

FITZPATRICK P, O'Flynn A, Jalal R, Frazer K, et al
Identifying barriers and facilitators to participation in cancer screening among Irish travellers, a minority ethnic group in Ireland, using a codesigned approach.
J Med Screen. 2026;33:9-14.
Abstract

FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
Ripple effect of temporary self-sampling HPV test on screening uptake in the next round: A secondary analysis of the ACCESS randomized controlled trial.
J Med Screen. 2026;33:62-65.
Abstract

GAO J, Yang R, Lu R, Ma X, et al
Current status and influencing factors of different dimensions of HPV knowledge among HPV-infected women.
J Health Psychol. 2026;31:536-549.
Abstract

KANG M, Jiang S, Chen H, Xu Y, et al
Prediction of the Prognosis and Treatment Responses Based on the Characteristics of Disulfidptosis-Related Genes in Patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Endocr Metab Immune Disord Drug Targets. 2026;26:e18715303374396.
Abstract

FU F, Wang T, Wu Z, Feng Y, et al
Retraction Note: HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
Cell Death Dis. 2026;17:232.
Abstract

TONOMURA N, Yoshida K, Morita H, Nakai M, et al
Diuretic Administration for Vomiting During Concurrent Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study.
Anticancer Res. 2026;46:1497-1506.
Abstract

GE Z, Zhang C, Zhang Z, Li J, et al
The causal effect of cytokine cycling levels on the risk of cervical cancer: A bidirectional 2-sample Mendelian randomization study.
Medicine (Baltimore). 2026;105:e47782.
Abstract

LI W, Liang X, Wu X, Zheng B, et al
RHBDD1 promotes cervical cancer progression by activating the EGFR/PI3K/AKT signaling pathway.
Arch Biochem Biophys. 2026 Feb 25:110777. doi: 10.1016/j.abb.2026.110777.
Abstract

BERTOLAZZI M, Genta ML, Lopes A, Fernandes R, et al
Randomized trial of autologous ovarian graft to preserve ovarian function in young women undergoing pelvic radiotherapy for cervical cancer.
Eur J Surg Oncol. 2026;52:111496.
Abstract

PECK LC, Petty MC, Walker AR, Huepenbecker SP, et al
Adherence to 2019 ASCCP Cervical Cancer Screening Guidelines at a Community Health Network.
J Low Genit Tract Dis. 2026 Feb 27. doi: 10.1097/LGT.0000000000000938.
Abstract

MENG N, Pan J, Wei W, Sun J, et al
Lymph Node Metastases Prediction in Cervical Cancer Using Time-Dependent Diffusion MRI and Macromolecular Proton Fraction Imaging.
Radiol Imaging Cancer. 2026;8:e250452.
Abstract

KUSAKABE H, Fukutome T, Suzuki H, Teramoto Y, et al
Single-organ vasculitis of the uterine cervix mimicking cervical cancer: A case report.
Case Rep Womens Health. 2026;49:e00787.
Abstract

XIONG J, Qian Y, Wang M, Sun X, et al
Factors associated with cervical cancer screening participation in Southwest China: a retrospective database-based cross-sectional study.
Front Med (Lausanne). 2026;13:1740068.
Abstract

SCHULTE-FROHLINDE R, Georges D, Clifford G, Baussano I, et al
Correction to "Predicting cohort-specific cervical cancer incidence from population-based surveys of human papilloma virus prevalence: a worldwide study".
Am J Epidemiol. 2026 Feb 27:kwae310. doi: 10.1093.
Abstract

KUMAR V, Bharti N, Ranjan R, Pal RR, et al
CRISPR-Cas9 Gene Editing: Promising Therapeutics for HPV-driven Cervical Cancer.
Curr Drug Targets. 2026 Feb 23. doi: 10.2174/0113894501437052251204164311.
Abstract

ILIA G, Thomopoulos A, Chronas D
Preserved Menstruation After Chemoradiotherapy in Stage IIIC1 Cervical Cancer: A Unique Case.
J Clin Med. 2026;15:1550.
Abstract

PRASERTPAKDI S, Suprasert P, Salakphet T, Khunamornpong S, et al
Cervical Cancer Screening: Histologic Outcomes of HPV-Negative HSIL/ASC-H Cytology in a Tertiary Referral Cohort in Northern Thailand.
Medicina (Kaunas). 2026;62:371.
Abstract

JULIANTI RA, Putra AD, Fuady A, Nuranna L, et al
Expression of miR-92a and miR-125b and Their Association with Chemoradiotherapy Response in Locally Advanced Cervical Cancer.
Int J Mol Sci. 2026;27:1723.
Abstract

REZENDE B, Wolf B, Colman V, Oliveira R, et al
FIGO 2018 Versus Ontogenetic Staging for Locally Advanced Cervical Cancer: An International Multicenter Cohort Study Comparing the Two Classifications and Their Prognostic Implications.
Cancers (Basel). 2026;18:689.
Abstract

MULUGETA-GORDON L, Jang M, Dagher C, Nasioudis D, et al
Advances in the Surgical Management of Cervical Cancer.
Cancers (Basel). 2026;18:628.
Abstract

YOUSSEF J, El Masri A, Atwi M, Ibrahim E, et al
Molecular Targets of Cervical Cancer and Its Microenvironment: Advances in Treatment.
Cancers (Basel). 2026;18:563.
Abstract

KARAMI P, Yahya SI, Roshani S, Parandin F, et al
Enhanced design of a photonic crystal biosensor for early cervical cancer detection using refractive index variation and neural network classification.
Sci Rep. 2026 Feb 26. doi: 10.1038/s41598-026-41676.
Abstract

ZHAO X, Yang L, Pan J, Zeng Z, et al
Correction: CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer.
Sci Rep. 2026;16:7718.
Abstract

MITTAL P, Kamalnath J, Charnalia M, Anjana AK, et al
Point S (sigmoid) doses and correlation with late recto-sigmoid adverse events in patients undergoing image-based brachytherapy for cervical cancer: clinical outcomes.
Brachytherapy. 2026 Feb 25:S1538-4721(25)00394.
Abstract

BOUGHRIOU M, Zendehdel K, Lotfi F, Gorgati E, et al
Cervical cancer in foreign-born women living in Italy: A systematic review of population-based studies.
Cancer Epidemiol. 2026;102:103029.
Abstract

MALIKOVA H, Graffneter K, Kremenova K, Burgetova R, et al
Pretreatment computed tomography L1 attenuation values: Easy reaching predicting factor for radiation-related bone insufficiency fractures in females treated for advanced cervical cancer (prospective study).
Womens Health (Lond). 2026;22:17455057261426799.
Abstract

ZHANG Y, Zhang J, Zhong M, Yu L, et al
A Novel Three-Dimension Printed Individualized Curved-Needle-Based Interstitial Brachytherapy for Re-Irradiation in Uterine Fundus-Involving Recurrent Cervical Cancer: A Case Report.
Curr Oncol. 2026;33:108.
Abstract

MERCIER NB, Khudina Y, Roberts L, Feely A, et al
Surgically Treated Cervical Cancer in Manitoba: A Retrospective Study of the Impact of Geography on Care.
Curr Oncol. 2026;33:70.
Abstract

GU H, Hu B, Jiang Y
The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons.
Immunotargets Ther. 2026;15:572970.
Abstract

SUN F, Ge X, Deng L, Wang Y, et al
Research on a method for early diagnosis and progression prediction of cervical cancer based on imaging omics and molecular omics.
Front Oncol. 2026;15:1670852.
Abstract

WANG R, Ning L, Li X, Xu Y, et al
Lactylation-based machine algorithm combined with multi-omics analysis to predict prognosis in cervical cancer.
Oncol Lett. 2026;31:133.
Abstract

BABATUNDE AN, Aroba OJ, Adeniyi AE, Isiaka SO, et al
Joint segmentation and classification of cervical cells using U-Net and CNN ensemble for early detection of cervical cancer.
Cancer Cell Int. 2026 Feb 25. doi: 10.1186/s12935-026-04234.
Abstract

DIRIE NI, Hassan MM, Ahmed MM, Hassan J, et al
Current Cervical Cancer Status in Resource-Limited Somalia: a Systematic Review of Burden, Screening Findings, and Knowledge Gaps.
J Epidemiol Glob Health. 2026;16:22.
Abstract

WU S, Deng Y, Lepp T, Ask LS, et al
Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based study.
BMJ. 2026;392:e087326.
Abstract

LI J, Chu C, Zhu L, Du Z, et al
NIR-activated dual-mode oxygen-generating and -delivering nanoplatform for enhanced photodynamic therapy of cervical cancer.
J Mater Chem B. 2026 Feb 25. doi: 10.1039/d5tb02652.
Abstract

ZHAO X, Zhang X, Xu Y, Huang Y, et al
Awareness of HPV, HPV vaccine and associated factors among male junior high school students in Zhejiang Province, China.
Front Public Health. 2026;14:1727798.
Abstract

MAHE L, Cagetti LV, Myxa J, Gonzague-Casabianca L, et al
Dosimetric comparison between manual and inverse optimization methods in high-dose-rate intracavitary/ interstitial cervical cancer brachytherapy for two treatment planning systems.
J Contemp Brachytherapy. 2025;17:400-406.
Abstract

KILAR CR, Bajwa HK, Pifer PM, Beriwal S, et al
Selection of hybrid applicators for adaptive cervical cancer brachytherapy: A practical guide.
J Contemp Brachytherapy. 2025;17:390-399.
Abstract

Erratum to the article: Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer. Authors: Pittaya Dankulchai, Natthakorn Thanamits
J Contemp Brachytherapy. 2025;17:421.
Abstract

YIHEYIS MM, Yeheyis MM, Dessie MG, Anagaw YK, et al
Exploring knowledge, attitudes, and practices on cervical cancer screening and their associated factors among female university students at Debre Markos University, Ethiopia.
Cancer Treat Res Commun. 2026;47:101147.
Abstract

SULEMAN DB, Folorunsho S
Cervical cancer research disparities among African immigrant women in the United States: A systematic review.
Palliat Support Care. 2026;24:e68.
Abstract

FOUCAULT E, Macioce V, Soler M, Pers YM, et al
Adherence to breast and cervical cancer screening guidelines according to obesity status: a French cross-sectional multicenter survey.
Prev Med Rep. 2026;63:103405.
Abstract

LI F, Ding S, Chen Z, Chen K, et al
Potential of margin reduction for cervical cancer radiotherapy in an online adaptive image-guided workflow.
Phys Imaging Radiat Oncol. 2026;37:100923.
Abstract

DASGUPTA S
Efficiency of Human Papillomavirus (HPV) Testing in Cervical Cancer Screening and Vaccination: A Review.
Cureus. 2026;18:e102126.
Abstract

SUN M, Zhou H, Chen J
Reappraising the clinical value of adjuvant chemoradiotherapy in intermediate-risk cervical cancer: beyond statistical significance.
Int J Surg. 2026;112:5267-5268.
Abstract

CHEN C, Wang S, Liu J, Liao J, et al
Bone marrow function in cervical cancer patients after concurrent chemoradiotherapy using 99mTc-SC SPECT/CT: A cross-sectional retrospective study.
Medicine (Baltimore). 2026;105:e47766.
Abstract

JOSHI M, Rajbanshi M, Rana A, Thapa S, et al
Awareness of cervical cancer, practice of cervical cancer screening and its associated factors among reproductive-aged women in Shankharapur Municipality of Kathmandu district, Nepal: A cross-sectional study.
Medicine (Baltimore). 2026;105:e47729.
Abstract

ADHIAMBO HF, Thomas K, Coe MM, Oluoch L, et al
Applying FRAME-IS to characterize provider-led adaptations to a cervical cancer prevention intervention in Kenya.
Implement Sci Commun. 2026 Feb 24. doi: 10.1186/s43058-026-00883.
Abstract

MOUSAVI-NEJAD S, Rezaei E, Nourizadeh R, Mohammadzadeh Z, et al
The effect of Fogg model-based virtual education on health literacy and stages of behavior change in cervical cancer screening: study protocol for a randomized controlled trial.
Trials. 2026 Feb 24. doi: 10.1186/s13063-026-09574.
Abstract

SHEN T, Ma Y, Wu T, Cao Z, et al
Human papillomavirus16 E7 enhances cell stemness by regulating the APC2/SPIN4/beta-catenin axis in cervical cancer.
Oncogenesis. 2026 Feb 24. doi: 10.1038/s41389-026-00602.
Abstract

SINGH S, Batra N, Mittal S
Emerging nanocarrier platforms in cervical cancer therapy: From molecular targeting to precision nanomedicine.
Nanomedicine. 2026 Feb 21:102913. doi: 10.1016/j.nano.2026.102913.
Abstract

LIU X, Xu T, Wu J, Zhou B, et al
RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by inducing DNA damage and mitotic catastrophe and enhances cisplatin sensitivity.
Biochem Pharmacol. 2026;248:117828.
Abstract

JIANG C, Rosenberg PS, Star J, Bandi P, et al
State-level progress in reducing cervical cancer incidence among US young women between the pre- and post-human papillomavirus vaccination eras.
J Natl Cancer Inst. 2026 Feb 24:djag051. doi: 10.1093.
Abstract

SINGH N, Raj Jalagam V, Somagattu S, Kunwar S, et al
Role of Training Paramedical Staff for Cervical Cancer Screening via Human Papillomavirus Self-Sampling in Remote Mountainous Regions: A Pilot Feasibility Study.
Cureus. 2026;18:e102046.
Abstract

SHARMA V, Gupta N, Leger PD, Ryan WT, et al
Asymptomatic Cervical Cancer Recurrence Presenting As Gastric Metastasis: A Report of a Rare Case.
Cureus. 2026;18:e102001.
Abstract

FRANCIS DL
Maternal Cancer Mortality and Orphanhood: A Neglected Global Health and Equity Challenge.
Ann Glob Health. 2026;92:18.
Abstract

ZORRILLA CD, Olmo-Lopez CV, Hernandez Garayua AM, Ibarra J, et al
Associations of HIV RNA Viral Load, CD4 Counts, HPV Detection, and Cytology Support Co-Testing for Cervical Cancer Screening Among Women Living with HIV.
HIV AIDS (Auckl). 2026;18:553851.
Abstract

XIAMUXI H, Deng X, Ablise M, Yan T, et al
A novel pyrrolidine-chalcone derivative exhibits synergistic anti-cervical cancer activity by dual-targeting MDM2-p53 axis and ferroptosis pathway.
Front Pharmacol. 2026;17:1715712.
Abstract

PANDEY P, Hussain A, Khan F
Editorial: Plant bioactive compounds as modulators of oncogenic signalling pathways in cervical cancer.
Front Pharmacol. 2026;17:1788689.
Abstract

ZIDI S, Yacoubi-Loueslati B, Ben Abdelmoumen Mardassi B, Almawi WY, et al
A machine learning approach to a nine-SNP immunogenetic score for prognostic stratification in cervical cancer.
Front Immunol. 2026;17:1759674.
Abstract

LEE SS, Boitano TKL, Hutchcraft ML, Modesitt SC, et al
#DidYouKnow: Physician engagement online and offline is mission critical to promote accurate and impactful cervical cancer information dissemination.
Gynecol Oncol Rep. 2026;63:102042.
Abstract

TIAN X, Yang H
Development of bioengineered SPIONs using Carica monoica extract: evaluation of antioxidant and anticancer activity of human cervical cancer cells (SiHa).
Open Life Sci. 2026;21:20251258.
Abstract

XUE J, Xiao H, Ren X, Yang Q, et al
Low-molecular-weight metabolites from lactic acid bacteria suppress cervical cancer progression by inhibiting EMT via the Wnt/beta-catenin pathway.
Open Life Sci. 2026;21:20251264.
Abstract

ABUBAKARI AK, Gross J, Adusei-Poku E
Understanding Cervical Cancer Screening Intentions Through the Lens of Care-Seeking Behavior: A Cross-Sectional Study Among Islamic Women in Ghana.
Health Sci Rep. 2026;9:e71827.
Abstract

RIPON RK, Hossain MJ, Prasad NG, Thakkar N, et al
Cervical Cancer, HPV, and HPV Vaccine Knowledge and Willingness to be Vaccinated Among Adolescent Girls in Dhaka, Bangladesh: A Cross-Sectional Study.
Health Sci Rep. 2026;9:e71843.
Abstract

SHI R, Hou W, Gao Y, Sun S, et al
Meta-analysis of risk factors for recurrence in cervical cancer patients following fertility-sparing treatment.
Front Surg. 2026;12:1625067.
Abstract

BERMUDEZ Y, Miller J, Kenney K, Schlueter D, et al
Predictors of Breast Cancer Screening Variability Among National Breast and Cervical Cancer Early Detection Program Awardees: Provider Shortages and Nurse Practitioner Autonomy.
Public Health Rep. 2026 Feb 22:333549261421878. doi: 10.1177/00333549261421878.
Abstract

ALREDHA RDA, Hussein TN, Alzerfi HSR, Haddawi KH, et al
Evaluation of serum Cytokeratin 5 and p63 as non-invasive biomarkers for the diagnosis and staging of cervical cancer: a case-control study.
Clin Transl Oncol. 2026 Feb 21. doi: 10.1007/s12094-026-04238.
Abstract

ANDERER S
At-Home Cervical Cancer Screening Favored by Certain Groups.
JAMA. 2026 Feb 20. doi: 10.1001/jama.2025.26399.
Abstract

ZHAO Y, Sha Z, An T, Wang W, et al
TMEM130 promoter hypermethylation predicts tumor cell migration in cervical cancer.
J Mol Histol. 2026;57:83.
Abstract

JIAO Y, He Y, Zhao B, Sha L, et al
The correlation between the systemic immune-inflammation index and relapse and metastasis in cervical squamous cell carcinoma patients over 50 years and older.
BMC Immunol. 2026;27:20.
Abstract

FU X, Zhang Q, Wagner AL, Yao Y, et al
Public Health Impact and Cost-Effectiveness of Routine and Catch-Up Human Papillomavirus Vaccination in Girls and Women in Selected Regions of China: A Model-Based Study.
Pharmacoeconomics. 2026;44:343-357.
Abstract

OLIVA PJ, Ghosh S, Huang F, Wiebe E, et al
Towards robust deep learning-based autosegmentation in MRI-planned gynecological brachytherapy: Importance of scalable development and comprehensive evaluation.
Brachytherapy. 2026;25:361-372.
Abstract

BOGANI G, Sopracordevole F, Corso G, Vizza E, et al
Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: Analysis of 5-year outcomes.
Tumori. 2026;112:75-82.
Abstract

NISHIOKA K, Sekiyama K, Shiro R, Tsunoda I, et al
Lack of molecular mimicry between HPV vaccine L1 antigen and human proteins by a computational analysis.
Int J Clin Oncol. 2026;31:494-503.
Abstract

HUYNH GT, Li A, Nims L, Seiler J, et al
Intimate Partner Violence and Cervical, Breast, and Colorectal Cancer Screening: Findings from the Washington State Behavioral Risk Factor Surveillance System.
J Womens Health (Larchmt). 2026;35:413-420.
Abstract

GOYAL A, Davey DD, Souers RJ, Roberson J, et al
Practice Patterns Regarding Quality Assurance Measures in Gynecologic Cytology: Survey Results of Laboratories Participating in the 2022 College of American Pathologists PAP Education Program.
Arch Pathol Lab Med. 2025;150:194-201.
Abstract

MILLS AM
Biomarkers in Cervical Squamous Neoplasia: Diagnostic, Prognostic, and Predictive.
Arch Pathol Lab Med. 2025;150:e46-e55.
Abstract

THIEU HH, Le TAH, Lao TD
Meta-analytic and systematic review of the diagnostic value of DNA methylation-based biomarkers in cervical cancer.
Int J Biol Markers. 2026 Mar 5:3936155261419529. doi: 10.1177/03936155261419529.
Abstract

CAO Y, Peng Y, Shen J
ANO6 Confers Paclitaxel Resistance by Targeting Ferroptosis in Cervical Cancer.
Biofactors. 2026;52:e70070.
Abstract

IFEZUOKE TD, Ajah MI, Ajah LO, Ezegwui HU, et al
Chlamydia trachomatis infection seroprevalence among women with normal and abnormal cervical smears and its implication for Nigerian cervical cancer screening.
BMC Infect Dis. 2026 Mar 4. doi: 10.1186/s12879-026-12994.
Abstract

REDDY Y, Pai P, Das I, Nayak S, et al
Topoisomerase inhibitors in cervical cancer: mechanistic insights and therapeutic strategies.
Mol Med. 2026 Mar 4. doi: 10.1186/s10020-026-01446.
Abstract

THASANTHAN L, Hilmi AJ, Rosairo S, Abeysundara HTK, et al
Impact of treatment duration on cervical cancer outcomes with concomitant chemoradiation.
Radiography (Lond). 2026;32:103375.
Abstract

YAMAMURA A, Ukita M, Takemura H, Ishibashi T, et al
Evaluation of neoadjuvant chemotherapy followed by radical hysterectomy in cervical cancer: a single-center study.
Int J Clin Oncol. 2026 Mar 4. doi: 10.1007/s10147-026-02998.
Abstract

EKER K, Sabour Takanlou M, Sabour Takanlou L, Rostamlou A, et al
BET inhibition enhances temozolomide sensitivity in cervical cancer cells through ALDH suppression and epigenetic reprogramming.
Mol Biol Rep. 2026;53:457.
Abstract

SHANG Y, Li K, Liu W, Wang Y, et al
New Sinomenine Derivative as a Potential Drug for Cervical Cancer via Inducing Ferroptosis.
Arch Pharm (Weinheim). 2026;359:e70218.
Abstract

ATTIQUE KHAN M, Rauf F, Abbas MJ, Hussain A, et al
A Novel Network-Level Fused Self-Attention Deep Neural Network for Cervical Cancer Classification from Cervicography Images.
Technol Cancer Res Treat. 2026;25:15330338261426741.
Abstract

DIEDRICH D, Silva EF, Willig JB, Ruaro TC, et al
The Privileged Scaffold Quinoline in Derivatives With Anticancer Potential Mediated by Late Apoptosis.
Anticancer Res. 2026;46:1475-1487.
Abstract

AL-SHIBLI K, Nguyen DT, Mohammed HAL, Sorbye SW, et al
Genotype-Specific HPV E6/E7 mRNA Triage Improves Risk Stratification and Reduces Referrals in DNA-Positive ASC-US/LSIL: A Real-World Cohort from Nordland, Norway.
Pathogens. 2026;15:178.
Abstract

STRNADOVA I, Refalo JL, Power R, Basckin C, et al
'Give People More Time and Take the Time to Explain Things Properly': Cervical Screening Experiences of People With Intellectual Disability.
J Appl Res Intellect Disabil. 2026;39:e70206.
Abstract

MARTINEZ B, Jennings P, Strik M, Simon K, et al
Cancer Screening and Barriers to Screening Among Unhoused Individuals in Rhode Island.
R I Med J (2013). 2026;109:41-47.
Abstract

LI L, Wang Y, Liu L, Lou Y, et al
Miniaturized Single-Step Duplex CRISPR Diagnostic Platform for At-Home Molecular Testing of HPV16 and HPV18.
ACS Sens. 2026;11:1117-1128.
Abstract

RINDAL DB, Asche S, Kharbanda E, Michalowicz B, et al
Increasing HPV vaccine promotion by dental providers: A clinical trial protocol.
Contemp Clin Trials. 2026;162:108222.
Abstract

GODDARD Q, Coward S, Seow CH, Bertazzon S, et al
Association of Geography With Screening and Development of Cervical Neoplasia in Those With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Nov 20:izaf249. doi: 10.1093.
Abstract

KIM A, Kim J, Kwak W, Mo K, et al
Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer.
Int J Oncol. 2026;68:57.
Abstract

ZHOU J, Ye W, Ranarisoa SN, Tian L, et al
Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis.
Front Immunol. 2026;17:1775409.
Abstract

JI LY, Wang X, Jiao RX, Yang J, et al
Application of Cytokines in Cervical Secretion for High-grade Squamous Intraepithelial Lesion Caused by High-risk Human Papillomavirus Infection.
Biomed Environ Sci. 2026;39:215-222.
Abstract

WILLIAMS DM, Reilly S, Lord T, Ayers K, et al
"Give me the sense that I matter:" Queer women's recommendations for an ideal cervical cancer screening exam and pathways to screening equity.
Womens Health (Lond). 2026;22:17455057261428108.
Abstract

VAN KEER S, van den Helder R, Teblick L, De Smet A, et al
Clinical performance of ASCL1/LHX8 DNA methylation on first-void urine to screen for cervical cancer.
Commun Med (Lond). 2026 Mar 12. doi: 10.1038/s43856-026-01512.
Abstract

LIU X, Vidrine DJ, Sutton SK, Wetter DW, et al
Cost-Effectiveness of Smoking Cessation Among Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer.
JAMA Netw Open. 2026;9:e261543.
Abstract

ZHANG L, Quan R, Huang H, Wu M, et al
Boronophenylalanine-Mediated Boron Neutron Capture Therapy Confers Selective Killing of Cervical Cancer by Exploiting DNA Repair Deficiency.
Cancer Biother Radiopharm. 2026 Mar 12:10849785261426657.
Abstract

TAWE L
Mapping the HPV Detection Landscape in Botswana: A Narrative Review of Diagnostic Platforms and Their Impact on Cervical Cancer Control.
Health Sci Rep. 2026;9:e72038.
Abstract

CHENG Y, Wang J, Wang L, Yan D, et al
Systemic immune-inflammatory index for the prediction of the survival in patients with cervical cancer: A meta-analysis.
iScience. 2026;29:114862.
Abstract

LIANG H, Li Q, Liao Y, Huang H, et al
Rosa roxburghii Tratt fruit polysaccharides inhibit proliferation and induce apoptosis in human cervical cancer cell line.
Transl Cancer Res. 2026;15:121.
Abstract

KIVUTI-BITOK LW, Mugo CW, Mituki D, Marete C, et al
The effect of school-based educational session on knowledge, attitudes, and beliefs of cervical cancer among adolescents in mixed day high schools in Embu County: a quasi-experimental study.
BMC Public Health. 2026 Mar 11. doi: 10.1186/s12889-026-26675.
Abstract

TANG X, Peng X, Zhang W, Li Z, et al
Ultrasensitive Electrochemiluminescence Nanoprobe for Early Screening and Early Diagnosis of Cervical Cancer.
Anal Chem. 2026 Mar 11. doi: 10.1021/acs.analchem.5c08162.
Abstract

CLAIRE LIN CC, Tai CC, Hung P, Tung YC, et al
Corrigendum to "Community mobile health clinics' availability is associated with cervical cancer screening in rural and urban areas: A national cohort study in Taiwan" [Taiwan J Obstet Gynecol 64 (2025) 1024-1029].
Taiwan J Obstet Gynecol. 2026;65:399.
Abstract

ZHENG J
Comment on "Recent advances in cervical cancer treatment: Innovations from early-stage to advanced disease".
Taiwan J Obstet Gynecol. 2026;65:393.
Abstract

WENG CS, Chen RC, Chen HJ, Tsay JY, et al
Genotype-specific prevalence of high-risk human papillomavirus among cytologically normal women in Taiwan.
Taiwan J Obstet Gynecol. 2026;65:292-298.
Abstract

WANG CC, Liu SH, Wu MH, Chen JR, et al
Increased risk of ischemic stroke in cervical cancer patients received radiotherapy: A nationwide population-based study.
Taiwan J Obstet Gynecol. 2026;65:247-255.
Abstract

RYU SY, Nam BH, Kim MH, Jang WI, et al
A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study.
ESMO Open. 2026;11:106102.
Abstract

LIN S, Ouyang Y, Gu H, Chen K, et al
Toward fully automated pre-implantation planning for cervical cancer brachytherapy: a template-guided multi-criteria optimization framework for catheter placement and dose distribution.
Phys Med Biol. 2026 Mar 11. doi: 10.1088/1361-6560.
Abstract

HUA Y, Li Y, Qin H, Huo M, et al
Association Between Folate Status and Risk of Cervical Cancer: A Systematic Review, Dose-Response Meta-analysis, and Mendelian Randomization Study.
Nutr Rev. 2026 Mar 11:nuag016. doi: 10.1093.
Abstract

CAKIR Z, Gok Ugur H
The Effect of Motivational Interviewing Based on the COM-B Model on Women's Cervical Cancer Health Beliefs and Participation in Screening: A Single-Blind Randomized Controlled Trial.
Cancer Nurs. 2026 Mar 10. doi: 10.1097/NCC.0000000000001553.
Abstract

GOTTSCHLICH A, Smith LW, Hong Q, Dabee S, et al
HPV, Cytology, and Cotest Cervical Cancer Screening and the Risk of Precancer.
JAMA Netw Open. 2026;9:e261304.
Abstract

HUANG J, Li X, Zhuang Y, Zhang Z, et al
Nomogram Prediction Model and Prognostic Comparison of Cervical Clear Cell Carcinoma and Cervical Endometrioid Adenocarcinoma: A SEER Database Study.
Cancer Med. 2026;15:e71699.
Abstract

LI G, Lu Z, Yin F, Lu H, et al
High-risk HPV and bacterial STIs in a primary screening population in rural Hainan, China: prevalence, co-infection, and association with cervical abnormalities.
Front Public Health. 2026;14:1773020.
Abstract

GONZALEZ GMN, Inam ME, Msadabwe S, Lee KL, et al
Social Determinants of Health Impact Cervical Cancer Stage at Presentation among Women in Zambia.
Res Sq [Preprint]. 2026 Feb 23:rs.3.rs-8522732. doi: 10.21203/rs.3.rs-8522732.
Abstract

BODHARE T, Bele S, V S, Sheela Kumari K S, et al
An Intervention Study Assessing the Effects of a Breast and Cervical Cancer Health Education Program on Knowledge, Attitudes, and Practices Among Adolescent Female Students in Madurai, South India.
Cureus. 2026;18:e103131.
Abstract

MAYUMI WADA C, Ferrari G, Silveira da Silva L, Pitton M, et al
Intrauterine devices incorporating nanocarriers for targeted cervical cancer therapy.
Nanomedicine (Lond). 2026 Mar 11:1-13. doi: 10.1080/17435889.2026.2641148.
Abstract

TRYBUS W, Trybus E, Krol T
Alizarin induces a multidirectional mechanism of anti-cancer action in cervical cancer and prostate cancer cells.
Sci Rep. 2026 Mar 10. doi: 10.1038/s41598-026-43011.
Abstract

ALSULAYS BB, Anwer MK, Hatata MN, Raish M, et al
Development of beta-CD metal organic frameworks loaded with olaparib: a novel approach for the treatment of cervical cancer.
Sci Rep. 2026 Mar 10. doi: 10.1038/s41598-026-43779.
Abstract

SUROV A, Hohn AK, Hinnerichs M, Meyer HJ, et al
Associations Between Body Composition and Intratumoural Immune Cells in Patients With Uterine Cervical Cancer.
J Cachexia Sarcopenia Muscle. 2026;17:e70241.
Abstract

IWAHASHI N, Noguchi T, Sakai K, Yahata T, et al
Comprehensive circulating tumor DNA mutation profiling via CAPP-Seq liquid biopsy for cervical cancer.
Int J Clin Oncol. 2026 Mar 10. doi: 10.1007/s10147-026-03006.
Abstract

ZHANG X, Yin Y, Yang T, Cong Y, et al
HALP outperforms systemic inflammatory biomarkers for prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Biomol Biomed. 2026 Mar 10. doi: 10.17305/bb.2026.13993.
Abstract

TUSAR MTT, Ara R, Farazi R, Roy CR, et al
Complete genome sequence of human papillomavirus type 45 identified from a cervical cancer patient in Bangladesh.
Microbiol Resour Announc. 2026 Mar 10:e0138225. doi: 10.1128/mra.01382.
Abstract

XIAO G, Quan K, Zeng M, Ye Y, et al
Region-specific Multi-Omics Modeling for Predicting Acute Radiation-Induced Proctitis in Cervical Cancer Radiotherapy: A Retrospective Analysis.
Technol Cancer Res Treat. 2026;25:15330338261424144.
Abstract

WU H, Yu Y, Wang W, Xu Q, et al
SMC4/SMAD3/NF-kappaB axis drives cervical cancer progression and radioresistance via DNA damage repair and immune modulation.
J Transl Med. 2026 Mar 9. doi: 10.1186/s12967-026-07979.
Abstract

ZOU Z, Huang L, Yin K, Li Y, et al
Effect of immune-related lncRNA BZRAP1-AS1/miR-541-3p and its molecular mechanism in cervical cancer.
World J Surg Oncol. 2026 Mar 9. doi: 10.1186/s12957-026-04270.
Abstract

HU D, Zhao Y, Han M, Qian W, et al
Analysis of factors associated with cervical cancer and precancerous lesions.
Sci Rep. 2026 Mar 9. doi: 10.1038/s41598-025-32215.
Abstract

KONG W, Liu P, Zhang J, Liu Q, et al
Chemoradiotherapy facilitates siglec-10(+)/siglec-9(+) macrophage-mediated impairment of CD24(+)/MUC16(+) tumor cell elimination and enhances PD-L2 dependent immunosuppression in cervical cancer.
Cancer Immunol Immunother. 2026;75:97.
Abstract

PAIVA SANTOS J, Prata R, Serrado MA, Cunha TM, et al
Evaluating lymph node metastases in cervical cancer: the added value of T2/DWI MRI fusion compared to standard MRI alone and 18 F-FDG PET/CT.
Abdom Radiol (NY). 2026 Mar 9. doi: 10.1007/s00261-026-05415.
Abstract

GUO Y, Li S, Liu T, Chang X, et al
Gene Mutations and Related Molecular Events in Distant Metastasis of Cervical Cancer: A Review.
Int J Med Sci. 2026;23:1015-1032.
Abstract

PAN G, Wang W, Sun Z, Chu R, et al
High-Risk Clinical Characteristics and Risk Model for Unexpected Cervical Cancer Diagnosed After Surgery in Patients with LSIL/HSIL Biopsy.
Int J Womens Health. 2026;18:584455.
Abstract

CUI Y, Li Y, Na J, Lu J, et al
Investigating the causal association between plasma lipids and the risk of squamous cervical cancer: A two-sample mendelian randomization study.
J Med Biochem. 2025;44:1843-1849.
Abstract

SANCHEZ DIAZ E, Levin G, Fernandes A, Fletcher A, et al
Clinical evidence on a Coriolus versicolor-based vaginal gel for HPV-related cervical disease: a narrative review.
Chin Clin Oncol. 2026;15:9.
Abstract

WANG J, Zhang Y, Wang H, Zhang J, et al
Cystathionine-gamma-Lyase/Hydrogen Sulfide Axis Plays a Crucial Role in Promoting the Progression of Cervical Cancer.
J Biochem Mol Toxicol. 2026;40:e70765.
Abstract

KONGWATTANAKUL S, Petroch P, Nimjaroen K, Bawornpatarapakorn S, et al
The effectiveness of a 3-dimensional printed vaginal dilator in mitigating radiation-induced vaginal stenosis for patients with cervical cancer.
J Gynecol Oncol. 2026 Feb 24. doi: 10.3802/jgo.2026.
Abstract

ZHANG G, Zhang X, Li H, Du X, et al
Multi-omic and immune landscapes of HPV-negative versus HPV-positive cervical cancer reveal implications for immunotherapy.
Eur J Surg Oncol. 2026;52:111425.
Abstract

SUSHMA N, C R TP, Y S N, Kaginelli S, et al
Analysis of In-Vivo Dose Measurement of Urethra Using Array MOSFET Detectors and TPS-Calculated Dose in High-Dose-Rate Interstitial Brachytherapy in Gynaecological Malignancies.
Asian Pac J Cancer Prev. 2026;27:1091-1098.
Abstract

SRIVASTAVA H, Raghuvanshi S, Bhalla S, Raghuvanshi S, et al
PIK3CA Polymorphisms in Cervical Cancer: Differential Impact of rs6443624 and rs141178472.
Asian Pac J Cancer Prev. 2026;27:1061-1068.
Abstract

FATIHA RA, Ngabdi CK, Azizah JS, Putri BSN, et al
Disruption of EMT Signaling and Migration by Moringa oleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells.
Asian Pac J Cancer Prev. 2026;27:981-988.
Abstract

MOSAVI JARRAHI A, Rajaie S, Azari S, Karimi F, et al
Standardizing Cost-Effectiveness Evidence for Cancer Prevention: A Case Study Analysis of HPV Vaccination.
Asian Pac J Cancer Prev. 2026;27:789-792.
Abstract

ZHENG L, Zhao G, Zheng L, Zou Y, et al
Insights Into Highly Associated Co-Factors on HPV-Related Cervical Cancer.
Rev Med Virol. 2026;36:e70131.
Abstract

Prophylactic para-aortic irradiation vs pelvic radiotherapy in pelvic node-positive carcinoma cervix in the setting of concurrent chemoradiation: a phase II open-label multi centric randomized controlled trial (PRO-PARA).
Trials. 2026;27:195.
Abstract

JIA M, Zeng S, Zou J, Chen H, et al
Predicting Risk of Lymph Node Metastasis in Neuroendocrine Carcinoma of Cervix: A Validated Nomogram Incorporating Neuroendocrine Markers and Clinical Parameters.
Cancer Med. 2026;15:e71686.
Abstract

MATOBA Y, Oomori Y, Nishibuchi I, Uegami S, et al
Reirradiation for Recurrent Cervical Cancer Within the Previous Radiation Field Using a Bioabsorbable Spacer: A Case Report.
J Obstet Gynaecol Res. 2026;52:e70225.
Abstract

CHEN X, Zheng X, Yang Z, Sui F, et al
Clinicopathologic characteristics and survival outcomes of patients with high-grade neuroendocrine cervical cancer.
Medicine (Baltimore). 2026;105:e47961.
Abstract

LI Y, Zhang W, Tang L, Zhu Y, et al
Core targets of bisphenol A in cervical cancer revealed by network toxicology and molecular docking.
Medicine (Baltimore). 2026;105:e47993.
Abstract

LI C, Zhao H, Wang J, Liu C, et al
A tumor-resident bacterium promotes cervical cancer progression through lysoPC-mediated c-Jun/c-Fos activation.
Cell Rep. 2026;45:117079.
Abstract

ZHANG J, Zhang Y, Zhang J
BATF Drives Cervical Cancer Progression and Immune Evasion by Regulating the STAT1-PD-L1 Axis.
Iran J Immunol. 2026;23.
Abstract

POY M, Jacquot K, Gross S, Lepiller Q, et al
[Development and distribution of an inter-laboratory comparison test for HPV testing].
Virologie (Montrouge). 2026;30:63-69.
Abstract

CHARPENTIER C, Brousseau J, Jary A, Ferre VM, et al
[Cervical cancer screening: what role for methylation tests?].
Virologie (Montrouge). 2026;30:19-32.
Abstract

DOGHMAN I, Malassigne V, Roucaute L, Azais H, et al
[Advances in screening and follow-up of HPV-related cervical cancer].
Virologie (Montrouge). 2026;30:7-18.
Abstract

ZHAO J, Wang L, Shao N, Qu Y, et al
RRM2/GCH1 signaling decreased cisplatin sensitivity in cervical cancer by modulating the ferroptosis process.
Histol Histopathol. 2026 Mar 6:25056. doi: 10.14670.
Abstract

Corrigendum to "Prevalence of Human Papillomavirus Subtypes and Related Cytology in Estonian Cervical Cancer Screening Population in 2021".
Cancer Control. 2026;33:10732748261431083.
Abstract

SVINTSITSKY V, Yegorov M, Stakhovsky E, Vitruk Y, et al
NON-STANDARD STRATEGIES IN THE TREATMENT OF ADVANCED CERVICAL CANCER: A CASE SERIES.
Exp Oncol. 2026;47:467-477.
Abstract

FASZHOLZ AM, Lozano V, Garda J
Structure, utilization, and screening adherence of a student-run women's health clinic for uninsured Spanish-speaking women: A descriptive analysis.
Womens Health (Lond). 2026;22:17455057261424823.
Abstract

KIRUTHIGA N, Krishnan S, Arulsamy S, Natarajan A, et al
Design and Synthesis of Piperidine Hydroxamate Scaffolds as Novel HDAC Inhibitors with Apoptotic Potential in Human Cervical Cancer Cells.
Med Chem. 2026 Mar 2. doi: 10.2174/0115734064378681251128061500.
Abstract

SHADANG M, Arumugam A, Singh DK, Keshari P, et al
The R2TP complex stabilises E7 to drive human papillomavirus-mediated pathogenesis in cellular models of cervical cancer.
Virol J. 2026;23:66.
Abstract

ZHU Y, Liu K, Yang Z, Peng Z, et al
Machine-learning with multiomics for radiotherapy-induced acute rectal toxicities and survival outcome in patients with cervical cancer.
Radiat Oncol. 2026 Mar 5. doi: 10.1186/s13014-026-02814.
Abstract

BENCHEIKH S, Lemriss H, Souiri A, Akachar J, et al
Human papillomavirus-encoded microRNAs: key regulators in cervical cancer development.
RNA Biol. 2026;23:1-14.
Abstract

NGHIEM VTH, Smith S, Shi J, McBrayer A, et al
Acceptability and Feasibility of Home-Based Human Papillomavirus Self-Testing as Primary Screening for Cervical Cancer Detection in the State of Alabama.
J Community Health. 2026 Mar 6. doi: 10.1007/s10900-026-01554.
Abstract

ISLAM O, Assaduzzaman M, Akter S, Fahad N, et al
Enhanced cervical cancer diagnosis using a novel Bayesian fusion ensemble method with explainable AI.
Sci Rep. 2026 Mar 5. doi: 10.1038/s41598-026-35334.
Abstract

MIAO Z, Yang XL, Zhu JW, Zhou YC, et al
The differences of pelvic lymph node metastasis between squamous cell carcinoma and adenocarcinoma in early-stage cervical cancer patients undergoing radical surgery and adjuvant radiotherapy: a large cohort study.
Ther Adv Med Oncol. 2026;18:17588359261425694.
Abstract

KYEI-ARTHUR F, Agyekum MW, Afrifa-Anane GF, Alhassan N, et al
Cervical Cancer Screening Prevalence and Predictors Among Women Aged 25-49 Years in Ghana: A Cross-Sectional Study.
Health Sci Rep. 2026;9:e71971.
Abstract

ANSARI SN, Kunwar R, Vaidya SA
Immunohistochemical Expression of P16 in Cervical Lesions: An Observational Study.
JNMA J Nepal Med Assoc. 2025;63:823-827.
Abstract

ULMER KK, Sargent MD, Cina KR, Vinson AH, et al
Native American Women's Willingness to Screen for Both Cervical and Colorectal Cancer at Home.
Cancer Med. 2026;15:e71654.
Abstract

BERHANU W, Yigremachew S, Hanson C, Avermark H, et al
A missed opportunity: faith leaders and the HPV vaccination effort in Addis Ababa, Ethiopia.
Glob Health Action. 2026;19:2635822.
Abstract

EL-MOGASSABI A, Baiu HS, Hassan NO, Salem EM, et al
Translation, adaptation and validation of the AWACAN tool for breast and cervical cancer awareness among Arabic-speaking women: a study from Libya.
Ecancermedicalscience. 2025;19:2047.
Abstract

PUENTE-VALLEJO R, Garcia-Gutierrez A, Jara-Jimenez S, Mosquera-Ruiz MN, et al
Impact of treatment delay on survival in women diagnosed with cervical cancer in Quito, Ecuador: a retrospective cohort study.
Ecancermedicalscience. 2025;19:2039.
Abstract

DAS NEVES MAB, Galvao ND, de Lima FCDS, Oliveria JFP, et al
Factors associated with advanced diagnosis of cervical cancer: a hospital-based retrospective study in a state of the Brazilian Legal Amazon.
Ecancermedicalscience. 2025;19:2045.
Abstract

MATHOBELA MN, Chuang TW, Chen PC, Motsa MPS, et al
Prevalence and factors associated with urinary schistosomiasis in women attending cervical cancer screening in Sithobela, Eswatini: A facility-based cross-sectional study.
Helminthologia. 2025;62:296-303.
Abstract

KIM JH, Shim SH, Min KJ, Lee JK, et al
Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk HPV testing in cervical cancer screening.
Obstet Gynecol Sci. 2026 Mar 4. doi: 10.5468/ogs.26066.
Abstract

MURAHWA AT, Dzobo M, Mahenge A, Rantshabeng P, et al
The Burden of HPV35 in African Cervical Pathologies: Prevalence, Contributing Factors, and Vaccine Prospects.
Rev Med Virol. 2026;36:e70129.
Abstract

MA X, Xu Z, Chen Y, Jiang F, et al
KIF20A promotes cervical cancer progression by interacting with CLIP1.
Sci Rep. 2026 Mar 3. doi: 10.1038/s41598-026-42883.
Abstract

ZHANG H, Luo X, Jiang J, Zhang C, et al
The clinical application value of dynamic monitoring of HPV ctDNA in concurrent chemoradiotherapy for locally advanced cervical cancer.
NPJ Precis Oncol. 2026 Mar 3. doi: 10.1038/s41698-026-01348.
Abstract

KOVACEVIC IN, Jovanovic A, Ristic J, Milic N, et al
Effect of Organized Cervical Cancer Screening Programs on Incidence and Mortality: A Systematic Review and Meta-analysis.
J Prev (2022). 2026 Mar 4. doi: 10.1007/s10935-026-00908.
Abstract

ZHANG Y, Gao Y, Guan X, Wang E, et al
LILRB4 shapes an immunosuppressive microenvironment to drive cervical cancer progression through tumor-infiltrating myeloid cell expansion and CD8(+) T-cell suppression.
Cell Mol Life Sci. 2026;83:146.
Abstract

GAO H, Gao Q, Xue L, Lin H, et al
Risk Stratification for Underlying Cervical Intraepithelial Neoplasia Grade (CIN)3+ in Reproductive-Age Women With Biopsy-Confirmed CIN2: Implications for Fertility-Preserving Management.
Cancer Control. 2026;33:10732748261427836.
Abstract

REN W, Cui Z, Wu S, Shen F, et al
A Clinical-DKI Fusion Model for Objective Pretreatment Prediction of Parametrial Invasion in Cervical Cancer.
Acad Radiol. 2026 Mar 2:S1076-6332(26)00108-X. doi: 10.1016/j.acra.2026.
Abstract

LIN J, Wu Q, Liu B, He H, et al
Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial.
J Gynecol Oncol. 2026 Feb 9. doi: 10.3802/jgo.2026.
Abstract

SSETAALA A, Muwonge I, Namulwa D, Kyakuwa N, et al
Cervical Cancer Screening in Uganda: Determinants of Past Screening and Post-Education Uptake; A Cross-Sectional Survey.
Cancer Control. 2026;33:10732748261427062.
Abstract

JIANG L, Ma S, Du Q, Lv J, et al
Prognostic value of Node-RADS scoring in stage IIICr cervical cancer: development and validation of novel nomograms.
Insights Imaging. 2026;17:64.
Abstract

PENG Y, Wang L, Jin F, Su Z, et al
Application of Manual Lymph Drainage Combined With Complex Decongestive Therapy in Lower Limb Lymphedema After Cervical Cancer Surgery and Its Impact on Quality of Life.
J Obstet Gynaecol Res. 2026;52:e70217.
Abstract

YANG T, Tang M, Xu L, Jiang L, et al
A tailored phosphorothioate coordinator enables CRISPR/Cas in-situ amplification.
Nucleic Acids Res. 2026;54:gkag187.
Abstract

BI Y, Ye Y, Wu X, Cao H, et al
Mechanism of isoleucyl-tRNA synthetase 2 regulating proliferation and apoptosis of cervical cancer cells.
Sci Rep. 2026 Mar 2. doi: 10.1038/s41598-026-41218.
Abstract

HASSINE A, Tisler A, Martel M, Bardou M, et al
Risk of cervical cancer and high-grade lesions in vulnerable women a systematic review and meta-analysis.
Nat Commun. 2026 Mar 2. doi: 10.1038/s41467-026-70050.
Abstract

ZI XJ, Li YL, Chu ZY
Mechanisms of bisphenols-induced cervical cancer: A multidimensional bioinformatics analysis.
Reprod Toxicol. 2026;141:109209.
Abstract

MASSAD LS
Incremental Progress in the Cervical Cancer Screening Revolution.
J Clin Oncol. 2026 Mar 2:JCO2503021. doi: 10.1200/JCO-25-03021.
Abstract

ISAACSON S, Spees LP, Hudgens MG, Pence BW, et al
Racial differences in expected versus actual costs of cervical cancer screening among low-income, under-screened women in North Carolina.
Cancer Epidemiol Biomarkers Prev. 2026 Mar 2. doi: 10.1158/1055-9965.EPI-25-0885
Abstract

ACHARYA GC, Das S, Jasuja A, Debata I, et al
Perception, Practices, and Barriers to Cervical Cancer Screening Among Women in Rural and Urban Slums of Eastern India: A Community-Based Cross-Sectional Study.
Cureus. 2026;18:e102449.
Abstract

ZHOU G, Chen W, Dong X, Guo Q, et al
Nocardia rubra cell wall skeleton-induced MARCO expression: implications for improved phagocytosis and cytokine secretion in tumor-associated macrophages.
Front Immunol. 2026;17:1611476.
Abstract

ZELINI P, Zavaglio F, Dominioni M, Valsecchi M, et al
Detection of human papillomavirus (HPV)-specific T cell response in women with low-grade cervical intraepithelial lesion and HPV vaccinated subjects.
Front Immunol. 2026;16:1733404.
Abstract

KOTIAN N, Reddy Y, Pai P, Sundara BK, et al
A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review.
Cancer Med. 2026;15:e71482.
Abstract

ALI AA, McCrudden CM, McCaffrey J, McBride JW, et al
DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles.
Nanomedicine. 2026 Feb 27:102923. doi: 10.1016/j.nano.2026.102923.
Abstract

MENGISTIE MB, Ayalew WL, Mengistie SK, Gebeyehu AS, et al
Prevalence of cervical cancer and its associated factors among women living with HIV attending public referral hospitals in Amhara Region, Ethiopia, 2025, a cross-sectional study.
BMC Infect Dis. 2026 Feb 28. doi: 10.1186/s12879-026-12976.
Abstract

FREIJOMIL-VAZQUEZ C, Gastaldo D
The Intersecting Effects of Biomedicine and Patriarchy on the Social Lives of Women Undergoing Cervical Cancer Prevention.
Semin Oncol Nurs. 2026 Feb 27:152173. doi: 10.1016/j.soncn.2026.152173.
Abstract

WILLIAMS HR, Kelly D
Prevention and Diagnosis of Cervical Cancers in the UK and Europe: What Have We Learned in the Last 10 Years and What Is Next?
Br J Hosp Med (Lond). 2026;87:50727.
Abstract

MASUMOTO S, Tanaka M, Yamamoto K, Hori Y, et al
HPV18-positive Small Cell Neuroendocrine Carcinoma of the Uterine Cervix Treated With Immunotherapy: A Case Report.
Anticancer Res. 2026;46:1733-1739.
Abstract

VEGA C, Leon R, Medina N, Fabelo H, et al
Design and Characterization of a Hyperspectral Colposcope Based on Dual-LCTF VNIR Narrow-Band Illumination.
Sensors (Basel). 2026;26:1255.
Abstract

AZIZAH JS, Ngabdi CK, Fatiha RA, To SW, et al
Physicochemical characterization and anticancer potential of Ficus deltoidea-silver nanoparticles (FD-AgNPs) on HeLa cells: Evidence from apoptosis and proliferation assays.
Biochem Biophys Res Commun. 2026;808:153407.
Abstract

ZHANG J, Wang H, Liu Y, Li Z, et al
HPV testing with 16/18 genotyping for risk stratification among women with normal cytology: a multicenter prospective cohort study from China.
J Clin Microbiol. 2026 Feb 19:e0128925. doi: 10.1128/jcm.01289.
Abstract

NITTA N, Sugiyama Y, Sugimura T, Ito T, et al
Clinical-grade autonomous cytopathology through whole-slide edge tomography.
Nature. 2026;651:472-481.
Abstract

JUNIOR DST
Incorporation of HPV-DNA molecular test into the Brazilian healthcare system.
J Cancer Policy. 2026;47:100713.
Abstract

XUE L, Hao S, Sun H, Du L, et al
Spatial clustering of gynecological cancers in China: A countrywide migration-adjusted analysis at the district level.
Cancer Epidemiol. 2026;101:103023.
Abstract

YAN M, Yang Y, Zhao Y, Ma L, et al
Prevalence and genotype distribution of high-risk human papillomavirus infection among Chinese women aged 35-64: A national screening population-based study.
J Infect. 2026;92:106697.
Abstract

LEONARDSEN AL, Englund E, Trope A, Stensrud M, et al
The effect of a cervical testing campaign on incarcerated females- a repeated cross-sectional study in Norwegian prisons.
BMC Womens Health. 2026;26:141.
Abstract

LI P, Wang H
The diagnostic value of colposcopy in postmenopausal women: a retrospective study.
BMC Womens Health. 2026;26:140.
Abstract

NAVARRO-TORNE A, Aris E, Callegaro A, Benninghoff B, et al
Maximizing impact: the power of early HPV vaccination for long-term protection-lessons from a systematic review and meta-regression analysis.
J Public Health (Oxf). 2026;48:216-227.
Abstract

YIN L, Zhang J, Pang Y, Mou Y, et al
Predictive value of R2 * values derived from blood oxygen level-dependent magnetic resonance imaging for lymph node metastasis after neoadjuvant chemotherapy for cervical squamous cell carcinoma.
Clin Radiol. 2026;94:107149.
Abstract

RASHEED A, Shirazi SH, Khan P, Aseere AM, et al
cervical nuclei segmentation through synergic conditional generative adversarial network in cervical smear images.
Comput Biol Chem. 2026;122:108918.
Abstract

HE J, Cheng C, Ding Y, Li N, et al
Design of Therapeutic Vaccines Based on Antigen Epitopes of alpha-9 HPV E6 in Sichuan.
J Immunother. 2026;49:87-97.
Abstract

LEE YS, Yim K, Kim CJ, Kim JH, et al
Tumour budding in pretreatment cervical biopsies: a prognosticator for personalised therapy in the era of precision oncology.
Histopathology. 2026;88:970-984.
Abstract

YASUTAKE N, Yokawa Y, Tanaka T, Mishima R, et al
Claudin-18 expression in gastric type adenocarcinoma and HPV-associated adenocarcinoma of the uterine cervix.
Histopathology. 2026;88:1003-1015.
Abstract

AZIM MR, Sakib QN, Rahman MM, Islam MS, et al
Economic burden of breast, cervical, and oral cancer in Bangladesh: a cost-of-illness study.
J Cancer Policy. 2026;47:100694.
Abstract

WANG Z, Zhuang L, Liu S, Cao C, et al
Single-Cell and Multiomic Analysis Reveals Neutrophil Heterogeneity and Prognostic Value in Cervical Lesions.
Cancer Sci. 2026;117:597-612.
Abstract

GAO T, Farag M, Agha S, Mobula L, et al
Economic evaluation of the one-dose HPV vaccination program in Nigeria.
J Cancer Policy. 2026;47:100675.
Abstract

DORJI N, Dorji T, Dorjey Y, Yangdon Y, et al
Quality improvement initiatives on colposcopy and treatment of cervical pre-cancer services in Bhutan: Experiences, challenges, and way forward.
J Cancer Policy. 2026;47:100676.
Abstract

NGUYEN-THANH H, Marshall L, Wilson H, Stewart K, et al
Awareness of HPV-related cancers and the HPV vaccination programme in Scotland: a cross-sectional study of gender, deprivation and knowledge gaps.
J Public Health (Oxf). 2026;48:239-248.
Abstract

KAYALI E, Comert GK, Yildirim HT, Toptas T, et al
Nicotinamide Phosphoribosyltransferase (NAMPT) as a New Marker in Cervical Preinvasive Lesions.
Int J Surg Pathol. 2026;34:385-391.
Abstract

STOUT CE, Poiani LTH, Mcglynn A, Enujioke CDRSC, et al
Recommendation for Human Papillomavirus Vaccine after Abnormal Pap Smear in Unvaccinated Active Duty Women.
Mil Med. 2026;191.
Abstract

SAILLANT A, Rasclard M, Gaume JB, Souchaud O, et al
A Case of Anti-3-hydroxy-3-methylglutaryl-coenzyme A Reductase Myopathy Associated With Advanced Cervical Carcinoma.
Anticancer Res. 2023;43:4723-4727.
Abstract

LINDWALL G, Gerlee P
Bayesian inference on the Allee effect in cancer cell line populations using time-lapse microscopy images.
J Theor Biol. 2023;574:111624.
Abstract

SAITO M, Rajesh A, Innes C, van der Griend R, et al
The High-Risk Human Papillomavirus Type Influences the Tissue Microenvironment in Cervical Intraepithelial Neoplasia Grade 2.
Viruses. 2023;15:1953.
Abstract

CHAIWONGKOT A, Buranapraditkun S, Oranratanaphan S, Chuen-Im T, et al
Efficiency of CIN2+ Detection by Thyrotropin-Releasing Hormone (TRH) Site-Specific Methylation.
Viruses. 2023;15:1802.
Abstract

BOUBLENZA L, Nahet A, Masdoua N, Sadouki N, et al
Prevalence of human papillomavirus infection among women at a gynaecological clinic in Tlemcen, Algeria.
Afr J Reprod Health. 2023;27:56-63.
Abstract

ZHANG H, Liu C, Zhai X, Zhang Q, et al
Disfunction of communication among immune cells in minimal-deviation adenocarcinoma of the cervix as an immunotherapeutic opportunity.
Int Immunopharmacol. 2023;124.
Abstract

HUANG B, Lou Y, Zeng Z, Kan X, et al
A Cas12a-based fluorescent microfluidic system for rapid on-site human papillomavirus diagnostics.
Appl Microbiol Biotechnol. 2023;107:6287-6297.
Abstract

KIHARA K, Kajiyama Y, Kimura Y, Okazaki S, et al
Adult-onset botulism in a Japanese woman with prolonged spore excretion.
J Infect Chemother. 2023;29:1172-1176.
Abstract

ZHANG C, Li X, Zhong L, Wang Y, et al
Assessment of the relationships between invasive endocervical adenocarcinoma and human papillomavirus infection and distribution characteristics in China: According to the new WHO classification criteria in 2020.
Cancer Epidemiol. 2023;86:102442.
Abstract

PAUTIER P, Genestie C, Gladieff L, Kurtz JE, et al
[Not Available].
Bull Cancer. 2023;110.
Abstract

WANG X, Shi W, Pu X, Hu Y, et al
Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma.
J Cancer Res Clin Oncol. 2023;149:13727-13739.
Abstract

MADZARAC V, Culej D, Muzinic D, Zovko G, et al
Small-cell neuroendocrine carcinoma of the cervix associated with adenocarcinoma in situ: A case report with analysis of molecular abnormalities.
Neuro Endocrinol Lett. 2023;44:332-335.
Abstract

VILLANUEVA-AGUILAR ME, Rizo-de la Torre LC, Bencomo-Alvarez AE, Gallegos-Arreola MP, et al
Sequence analysis of exons 30 and 31 of LAMA3 gene variants and its association with human papillomavirus infection predisposition: no evidence was found.
Eur Rev Med Pharmacol Sci. 2023;27:6860-6866.
Abstract

ALHARBI SA, Alshammari FD, Humaida MI, Abdalhabib EK, et al
The cytological pattern of cervical smears of a series of Saudi women in one gynecologic center.
Eur Rev Med Pharmacol Sci. 2023;27:6785-6791.
Abstract

THANGARAJAH F, Busshoff J, Salamon J, Pruss MS, et al
Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer.
J Cancer Res Clin Oncol. 2023;149:12597-12604.
Abstract

ZHAO J, Liu X, Gao J, Xiao H, et al
Factors Associated with Lesion Recurrence Following Cervical Conization.
Altern Ther Health Med. 2023;29:50-55.
Abstract

VALENZA C, Spada F, Multinu F, Benini L, et al
Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.
Endocr Relat Cancer. 2023;30:e230112.
Abstract

BAHARVAND S, Asghari-Jafarabadi M, Nourizadeh R, Sattarzadeh Jahdi N, et al
The Effect of Decision Aid on Satisfaction With Decision and Anxiety Among Women With Abnormal Cervical Screening Results.
Cancer Nurs. 2023;46:E405-E411.
Abstract

WANG Y, Qiao H, Yu P, Gao W, et al
IKBIP as a prognostic biomarker and immunotherapeutic target regulates the JAK-STAT3 signaling pathway to promote cervical cancer.
J Transl Med. 2026 Mar 20. doi: 10.1186/s12967-026-08015.
Abstract

RADHAKRISHNAN M, Parida BP, Shekhar H, Singh P, et al
Anticancer potential of Curcuma caesia: induction of DNA damage and apoptosis in cervical cancer.
BMC Complement Med Ther. 2026 Mar 21. doi: 10.1186/s12906-026-05351.
Abstract

ZHU Y, Wang H, Zhang B, Chen M, et al
Trends in over- and under-screening for cervical cancer after EMR implementation in rural China.
NPJ Digit Med. 2026 Mar 20. doi: 10.1038/s41746-026-02504.
Abstract

WILLIAMS KP, Todem D, Roman LA, Meghea CI, et al
Kin Keeper(SM) Breast and Cervical Cancer Prevention: An Educational Intervention: A Community-Based Randomized Controlled Trial in Black, Latina, and Arab Women.
J Cancer Educ. 2026 Mar 20. doi: 10.1007/s13187-026-02851.
Abstract

SHEN P, Ye J, Yee HN, Zhang L, et al
Prognostic significance of tumor budding and residual viable tumor volume in post-neoadjuvant resection specimens of locally advanced cervical cancer.
Virchows Arch. 2026 Mar 20. doi: 10.1007/s00428-026-04477.
Abstract

PARELLADA CI, Bierrenbach AL, Bittencourt Campaner A, Goncalves Queijo R, et al
Assessing the burden of HPV-associated cancers in Brazil: Hospitalization and mortality trends from 2011 to 2019.
Hum Vaccin Immunother. 2026;22:2640760.
Abstract

TOLOSKO J, Beauchesne M
A comparison of the knowledge and practices of cervical cancer prevention between United States and international female college students.
J Am Assoc Nurse Pract. 2026 Mar 20. doi: 10.1097/JXX.0000000000001272.
Abstract

WATANABE K, Di Carlo V, Sugiyama H, Nakamura S, et al
Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000-14 (CONCORD-3).
Jpn J Clin Oncol. 2026;56.
Abstract

XIAO C, Zeng S, Li L, Wang R, et al
Efficacy and safety of immune checkpoint inhibitors combined with chemoradiotherapy in locally advanced cervical cancer: a systematic review and meta-analysis.
Front Pharmacol. 2026;17:1766157.
Abstract

LIU W, Niu Z, Yan Z, Shi L, et al
The Association of EGFL7 Polymorphism and Expression with Cervical Cancer Susceptibility and Pathogenesis.
Int J Gen Med. 2026;19:563592.
Abstract

LUO J, Li G, Ye M, Xu X, et al
RNA methyltransferase NSUN2 enhances vasculogenic mimicry and malignant progression of cervical cancer through upregulation of MMP-9.
Oncol Lett. 2026;31:165.
Abstract

XIAO C, Zeng S, Li L, Wang R, et al
Sentinel lymph node biopsy versus lymphadenectomy in early-stage cervical cancer: a meta-analysis of oncologic outcomes and surgical morbidity.
Front Oncol. 2026;16:1765529.
Abstract

YANG W, Lu J, Wang L, Wang H, et al
Dosimetric comparison of MRI-guided and CT-guided intracavitary and interstitial brachytherapy for locally advanced cervical cancer.
Front Oncol. 2026;16:1765505.
Abstract

NAVAKANITWORAKUL R, Choochuen P, Hanprasertpong J, Liangpunsakul S, et al
Plasma proteomic biomarkers for predicting chemoradiation response in locally advanced cervical cancer.
BMC Womens Health. 2026 Mar 19. doi: 10.1186/s12905-026-04410.
Abstract

GUILLAUME D, Perrin N, Alcaide ML, Amedee LM, et al
Development and Psychometric Testing of a Scale Evaluating Traditional Health Practices for Cervical Cancer Prevention Among Haitian Migrant Women.
Psychooncology. 2026;35:e70433.
Abstract

XIONG H, Shi X, Li L, Yang Q, et al
Emodin exerts antitumor effects in cervical cancer cells by reprogramming phospholipid metabolism through modulation of H3K27ac and H3K27me3.
Int J Biol Macromol. 2026 Mar 17:151454. doi: 10.1016/j.ijbiomac.2026.151454.
Abstract

JACOBS C, DeMoulin D, Kayamba V, Sudenga S, et al
Stigma and Its Association With Social Support and Quality of Life Among Patients With Cervical Cancer in Zambia.
JCO Glob Oncol. 2026;12:e2500593.
Abstract

NDLELA MG, Vilakati LN, Williams V, Ginindza NM, et al
Cervical cancer screening adherence following initial HIV testing in Eswatini.
HIV Med. 2026 Mar 19. doi: 10.1111/hiv.70227.
Abstract

CHAN HCC, Bhoora S, Zhou E, Marais S, et al
Analysis of Reactive Oxygen Species-Induced Cellular Damage in Cervical Cancer.
Curr Protoc. 2026;6:e70328.
Abstract

HOMENTA C, Kurniadi A, Winarno GNA, Santiana L, et al
Neoadjuvant Paclitaxel-Carboplatin Followed by Concurrent Chemoradiotherapy versus Concurrent Chemoradiotherapy Alone in Locally Advanced Cervical Cancer.
Int J Womens Health. 2026;18:580324.
Abstract

PUROBI SM, Ashrafunnesa, Begum SA, Mahmud T, et al
HPV DNA Test Alone and HPV DNA Test Combined with VIA as Screening Test for Cervical Cancer.
J Pharm Bioallied Sci. 2026;18.
Abstract

OGUNLAJA AO, Adeleke OT, Ughonu PC, Oyelami MO, et al
A multi-magnification digital colposcopy image datasets for cervical cancer screening in Nigeria.
Data Brief. 2026;65:112633.
Abstract

NEZAMABADI FARAHANI L, Kazemnejad A, Afrasiabi M, Tapak L, et al
In Silico Transcriptomic Analysis for Identification of Potential Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Cervical Cancer using a Hybrid Genetic Algorithm-Support Vector Machine Approach.
Arch Iran Med. 2025;28:677-686.
Abstract

BOLTEN K, Burns H, Scott C, Smart K, et al
Cytology and High-Risk Human Papillomavirus Testing Performance for Cervical Cancer Screening in Transmasculine Patients.
J Womens Health (Larchmt). 2026 Mar 18:15409996261433761.
Abstract

EL-ZEIN M, Kassam P, Alhamlan F, Zafar N, et al
Toward cervical cancer prevention and elimination in the Eastern Mediterranean Region: Current landscape and opportunities for evidence-based action.
Prev Med. 2026 Mar 16:108549. doi: 10.1016/j.ypmed.2026.108549.
Abstract

ABREU M, Mota ME, Oliveira DMA, Medeiros YL, et al
Inequalities in time to cancer treatment initiation over a decade in Brazil.
Rev Saude Publica. 2026;60:e12.
Abstract

KURBAN R, Pan J, Amar T, Bo X, et al
The eIF3a/m6A/ENO1 axis orchestrates glycolytic reprogramming and cell growth in cervical cancer.
J Bioenerg Biomembr. 2026 Mar 18. doi: 10.1007/s10863-026-10096.
Abstract

BAUTISTA J, Cortinas Sardi P, Paguay-Caisabanda I, Gancino-Guevara K, et al
Integrating microbiome insights into cervical cancer.
Front Med (Lausanne). 2026;13:1766052.
Abstract

AMATULLAH M, Begum SA, Mahmud T, Nahar K, et al
Association of Preoperative Controlling Nutritional Status (CONUT) Score with the Staging of Cervical Cancer.
J Pharm Bioallied Sci. 2025;17.
Abstract

KUMAR N, Dash M, Lal P, Kotian T, et al
Incidence and Impact of HPV Vaccination on Cervical Cancer: A Data Base Research.
J Pharm Bioallied Sci. 2025;17.
Abstract

WANGSATIDTONGBAI P, Buhachat R, Thiangphak E
Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer.
Obstet Gynecol Sci. 2026 Mar 17. doi: 10.5468/ogs.26032.
Abstract

BARAL S, Silwal SR, Bhattarai N, Lamichhane D, et al
Evaluation of Quality Indicators for Radiation Therapy of Cervical Cancer: Experience From a Tertiary Cancer Center in Nepal.
JCO Glob Oncol. 2026;12:e2500435.
Abstract

CILLA S, Medici F, Ferioli M, Arcelli A, et al
Unsupervised clustering analysis unravels the role of systemic inflammatory indices in the prognosis of patients with locally advanced cervical cancer treated with chemoradiation.
Strahlenther Onkol. 2026 Mar 17. doi: 10.1007/s00066-026-02513.
Abstract

CHANDA S, Kumar N, Agarwal A, Pradhan A, et al
Fluorescence Mueller matrix imaging of the stromal region in unstained cervical tissue sections: quantitative categorization of CIN grades.
Appl Opt. 2025;64:8840-8848.
Abstract

JANOVSKA N, Rob L, Pichlik T, Sehnal B, et al
Cervical cancer screening in the European context - from cytology to primary HPV testing.
Ceska Gynekol. 2026;91:69-76.
Abstract

ROBOVA K, Pichlik T, Rob L, Robova H, et al
Age-specific incidence and mortality of cervical cancer in the Czech Republic - analysis of nationwide data and data from a gynecologic oncology center.
Ceska Gynekol. 2026;91:61-68.
Abstract

ROKOS T, Kudela E, Pribulova T, Holubekova V, et al
Cytological versus histological results in ASCUS cervical dysplasia - a retrospective study.
Ceska Gynekol. 2026;91:11-15.
Abstract

KOZACHEK CC, Btoush R
Cervical Cancer Risk: Sexual and Screening Behaviors Among Middle Eastern College Women in the United States.
J Transcult Nurs. 2026 Mar 17:10436596261430095. doi: 10.1177/10436596261430095.
Abstract

DELGADO LOPEZ D, Pozo-Palacios J, Vergara Quezada J, Caulier-Cisterna R, et al
Factors Associated with Under- and Over-Screening for Cervical Cancer in Rural Areas of Cuenca, Ecuador.
J Prim Care Community Health. 2026;17:21501319251414282.
Abstract

WEI X, Su L, Chen R, He T, et al
Unveiling TNFRSF19: a novel tumor suppressor targeting endoplasmic reticulum stress and LGR5/Wnt/beta-catenin in cervical cancer.
Hum Cell. 2026;39:53.
Abstract

GAO W, Wang C, Jia J, Li Y, et al
Evaluation and comparison of TCR repertoire differences between patients with cervical cancer and healthy individuals.
Sci China Life Sci. 2026 Mar 10. doi: 10.1007/s11427-025-3221.
Abstract

Self-Collected Samples for Cervical Cancer Screening: What You Need to Know.
Am Fam Physician. 2026;113:online.
Abstract

WISER A MD, Quinlan JD MD
Cervical Cancer Screening.
Am Fam Physician. 2026;113:137-144.
Abstract

CAI C, Richards-McDonald L, Trimble CL
Barriers to Cervical Cancer Screening Follow-up: A Study of an Inpatient Screening Program.
J Low Genit Tract Dis. 2026 Mar 16. doi: 10.1097/LGT.0000000000000943.
Abstract

JI L, Zhou X, Yao L
Factors Influencing Universal Coverage of AI-Assisted Cervical Cancer Screening: A Qualitative Study Based the Macro Model of Health System.
J Med Internet Res. 2026 Feb 23. doi: 10.2196/75372.
Abstract

HE C, Li F, He M, Li J, et al
The false-negative rate of sentinel lymph node biopsy and its related factors in early-stage cervical cancer: a systematic review and meta-analysis.
Acta Oncol. 2026;65:213-227.
Abstract

DANIELS K, Khan MJ, Gaffikin L, Gonzalez Montoya RA, et al
Integrating Cervical Cancer Screening Into Pre-existing, Low-resource Mexican-US Border Clinics.
J Low Genit Tract Dis. 2026 Mar 16. doi: 10.1097/LGT.0000000000000940.
Abstract

KETCH PW, Boitano TKL, Longinos NA, Swann SA, et al
Physician Perspectives on the Transition to Primary Human Papillomavirus Testing for Cervical Cancer Screening.
J Low Genit Tract Dis. 2026 Mar 16. doi: 10.1097/LGT.0000000000000942.
Abstract

MANJESHWAR S, Kojima N, Tsang E, Pereira D, et al
Reply to "Urine-based detection of HPV for cervical cancer screening: towards clinical implementation".
J Clin Microbiol. 2026 Mar 16:e0016226. doi: 10.1128/jcm.00162.
Abstract

LI G, Lamsisi M, Chenafi S, Moniod L, et al
Urine-based detection of HPV for cervical cancer screening: towards clinical implementation.
J Clin Microbiol. 2026 Mar 16:e0013326. doi: 10.1128/jcm.00133.
Abstract

DORJI C, Dorji N, Dechen S, Pradhan G, et al
Incidental finding of a sewing needle in the buttock of a woman with cervical cancer: how did we manage it?
Int J Surg Case Rep. 2026;138:808-813.
Abstract

YANG X, Zhao B, Yu G, He Z, et al
Dosimetric Comparison of Intracavitary Versus Combined Intracavitary-Interstitial Image-Guided Brachytherapy in Locally Advanced Cervical Cancer.
Dose Response. 2026;24:15593258261430575.
Abstract

BELCHER NL
Clinician Education and Workflow Tools to Improve Access to Recurrent and Metastatic Cervical Cancer Treatment.
Cureus. 2026;18:e103426.
Abstract

KIM JH, Shim SH, Min KJ, Lee JK, et al
Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology.
J Gynecol Oncol. 2026 Mar 1. doi: 10.3802/jgo.2026.
Abstract

HALDER S, Singh S, Sood R, Mathur S, et al
Synchronous Presentation of Gastric-Type Adenocarcinoma In Situ of Cervix and Vagina in a Young Adult Female: A Precursor Seldom Seen.
J Obstet Gynaecol Res. 2026;52:e70249.
Abstract

MUTISYA R, Gitonga E, Maundu MM, Iseme-Ondiek R, et al
Implementation and acceptability of a community based intervention for cervical cancer screening amongst women of reproductive age in Kiambu County, Kenya.
BMC Res Notes. 2026 Mar 15. doi: 10.1186/s13104-026-07710.
Abstract

LU Z, Li Y, Luo D, Chen C, et al
Impact of bladder volume precision control on setup errors and dosimetry in intensity-modulated radiation therapy for cervical cancer.
J Egypt Natl Canc Inst. 2026;38:9.
Abstract

QI M, Tian C, Di X, Ma J, et al
Trends and regional patterns of cervical cancer incidence by histological subtypes: A Chinese population-based analysis from cancer registry data.
Cancer Epidemiol. 2026;102:103047.
Abstract

BELHADJ A, Boumeddane YK, Meddah D, Sahraoui T, et al
Exploring risk factors and survival rates in invasive cervical carcinoma: New perspectives.
Tunis Med. 2025;103:1098-1103.
Abstract

LAGU IJL, Letoluo R, Kamau SW, Kuria JM, et al
Antiproliferative activity, phytochemistry, network pharmacology, molecular docking and gene expression analysis of Maerua edulis extracts against human cervical cancer cell line.
BMC Complement Med Ther. 2026 Mar 14. doi: 10.1186/s12906-026-05321.
Abstract

SUN R, Gong H, Zhao R, Lv H, et al
SOX4 induces cisplatin resistance in cervical cancer cells by inhibiting aerobic glycolysis.
Cell Death Discov. 2026 Mar 14. doi: 10.1038/s41420-026-02954.
Abstract

CHEN Y, Zhong L, Chen J, Li X, et al
Corrigendum to "Glutamine modified lipid nanoparticles loaded with GPX4 siRNA for cervical cancer targeting" [Int. J. Biol. Macromol. 336 (2026) 149419].
Int J Biol Macromol. 2026 Mar 13:151353. doi: 10.1016/j.ijbiomac.2026.151353.
Abstract

OSORNO-VALENCIA D, Montoya-Gomez A, Sevilla-Sanchez MJ, Burbano-Guerrero N, et al
Lansbermin-I, a disintegrin from Porthidium lansbergii lansbergii venom as a potential anticancer prototype: In vitro and in silico effects on cervical cancer cells.
Toxicon. 2026;276:109063.
Abstract

SCHNALL R, Ozoria Ramirez S, Halpern M, Kuhn L, et al
Factors Related To Improving the Quality of Cervical Cancer Screening for Women Living with HIV in La Romana, Dominican Republic: A Qualitative Descriptive Study.
AIDS Behav. 2026 Mar 14. doi: 10.1007/s10461-026-05074.
Abstract

JIA X, Da X, Shi J, Duan R, et al
HPV vaccine awareness and uptake among women attending cervical screening in health-resource-limited areas of China: A multicenter cross-sectional study.
Hum Vaccin Immunother. 2026;22:2644020.
Abstract

OZDEMIR S, Caglayan R
Health education on HPV vaccination and cervical cancer prevention: A randomised controlled trial on knowledge, attitudes, beliefs, and behaviours.
J Pak Med Assoc. 2026;76:140-150.
Abstract

MARTIN RJ, Arya M, Ramakrishnan J, Menachery SJ, et al
Machine Vision Approaches for Cervical Cancer Screening Using Pap-Smear Images: A Systematic Review.
Curr Cancer Drug Targets. 2026 Mar 11. doi: 10.2174/0115680096398033251128082310
Abstract

SOHEL HI, Zahan UF, Ishikawa M, Kanno K, et al
Integrated Molecular and Functional Characterization of Cervical Small-Cell Neuroendocrine Carcinoma Using a 3D Organoid Model.
Int J Mol Sci. 2026;27:2393.
Abstract

CHANG Y, Kay N, Chiu LC, Huang CI, et al
Incidence Trends and Geographic Variations of Corpus Uteri and Cervical Cancer in Taiwan, 1995-2022: A Population-Based Study.
Cancers (Basel). 2026;18:881.
Abstract

LIU J, Zhu Y, Liu K, Deng D, et al
Comprehensive Comparison of Surgery Followed by Radiotherapy and Radical Radiotherapy for Cervical Cancer: A Multicenter Retrospective Propensity-Score-Matched Analysis.
Cancers (Basel). 2026;18:865.
Abstract

SHENG Y, Wujcik HE, Wakefield MR, Fang Y, et al
Poseidon's Trident: "Divine" Intervention in Cervical Cancer Through Chemoradiation, Immunotherapy, and Antibody-Drug Conjugates.
Cancers (Basel). 2026;18:774.
Abstract

ASAKITOGUM DA, Ohene LA, Aziato L
Women's experiences with traditional medicine for the treatment of cervical cancer: a qualitative study.
BMC Complement Med Ther. 2026 Mar 13. doi: 10.1186/s12906-026-05344.
Abstract

OSAFO KS, Zhang Y, Obiri-Yeboah D, Sun B, et al
Advancing the elimination of cervical cancer across Africa.
Nat Commun. 2026 Mar 13. doi: 10.1038/s41467-026-70450.
Abstract

SUN Y, Yang H, Wang J, Lou H, et al
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial.
Nat Commun. 2026 Mar 14. doi: 10.1038/s41467-026-69965.
Abstract

DUN C, Su Y, Basu P, Zhao X, et al
Temporal trends in cervical cancer incidence and mortality in economically emerging countries, 1992-2021: an age-period-cohort analysis.
BMJ Glob Health. 2026;11:e018569.
Abstract

YANG D, Liu J, Gao Y, Guan X, et al
RNF125 promotes CD8 T cell-mediated anticancer immunity and suppresses the malignant phenotype of cervical cancer.
Mol Cell Biochem. 2026 Mar 13. doi: 10.1007/s11010-026-05507.
Abstract

LIXIA H, Liangcheng X, Tian T, Dongmei Z, et al
Prevalence of high-risk human papillomavirus among women with different HPV-vaccination status in Sichuan, China.
Vaccine. 2026;77:128387.
Abstract

CHEN CC, Hsiao KY, Lu SC, Bai CH, et al
Accuracy of HPV Testing Using Self-collected Urine Compared With Physician-collected Cervical Specimen for HSIL or Worse.
J Low Genit Tract Dis. 2026;30:100-109.
Abstract

LU Y, Tang C, Xu S, Hussain I, et al
Understanding parental HPV vaccination decision in China through the lens of vaccine hesitancy and preference heterogeneity: a discrete choice experiment.
Vaccine. 2026;76:128307.
Abstract

UYSAL O, Yalcin Y, Cakar MK, Ozerkan K, et al
The Effect of Cervical Blockade in LEEP Procedures Performed Under General Anesthesia: A Randomized Controlled Trial.
J Low Genit Tract Dis. 2026;30:132-139.
Abstract

BOOTH BB, Khare SK, Blanes-Vidal V, Bor P, et al
Higher Diagnostic Accuracy of an AI Model for Colposcopy Compared With Conventional and Digital Colposcopic Evaluation.
J Low Genit Tract Dis. 2026;30:118-123.
Abstract

ROTH MT, Torous VF
Cytomorphologic alterations, histologic correlates, and clinical importance of pap test evaluation in intrauterine device users.
J Am Soc Cytopathol. 2026;15:133-143.
Abstract

MAINA J, Benseler A, Dzyubak O, Bouchard-Fortier G, et al
Retained Surgical Sponge in the Pelvis From Magnetic Resonance Imaging-Guided Cervix Brachytherapy.
Pract Radiat Oncol. 2026;16:103-106.
Abstract

GE Y, Wang X, Zhang Y, Ma L, et al
Comparative Survival Outcomes of Total Hysterectomy Versus Radical Hysterectomy in Gastric-Type Endocervical Adenocarcinoma: A SEER Database Analysis.
J Obstet Gynaecol Can. 2026;48:103156.
Abstract

QIU Y, Hu C, Zhao S, Chen D, et al
ROS-Responsive Nano-Encapsulated Selenium Targeting Cervical Cancer Cell via PI3K/AKT Signaling Pathway.
Int J Nanomedicine. 2026;21:558115.
Abstract

WANG M, Cao Y, Zhu M, Zhao P, et al
An auxiliary diagnosis model for the pathological classification of cervical cancer based on radiomics biomarkers.
Front Genet. 2026;17:1685927.
Abstract

PIERSON RN, Gupta SA, Zhang M, Kaiser LC, et al
QUANTIFYING GLYCOGEN AND LIPID DROPLET SYNTHESIS IN OVARIAN AND CERVICAL CANCER CELLS USING DEUTERATED RAMAN PROBES WITH STIMULATED RAMAN SCATTERING MICROSCOPY.
bioRxiv [Preprint]. 2026 Mar 18:2026.03.16.712189.
Abstract

SAVAS LS, Heredia NI, Huyan Y, Coan S, et al
A randomized controlled trial to evaluate an adapted community health worker-delivered breast and cervical cancer screening education and navigation intervention for underserved Latina adults.
Front Oncol. 2026;16:1687113.
Abstract

PAUDEL YR, Xu L, Onobrakpor SI, Dampf H, et al
Reduced age-wise disparity in estimated cervical cancer screening participation rates after applying hysterectomy correction: a population-based cross-sectional study.
BMC Womens Health. 2026 Mar 26. doi: 10.1186/s12905-026-04414.
Abstract

ASARE M, Sam-Agudu NA, Cudjoe O, Frueh E, et al
HOme-based self-sampling for cervical cancer prevention education among women living with HIV in Ghana (HOPE-inG): study protocol for a cluster-randomized type 2 hybrid effectiveness implementation trial.
BMC Public Health. 2026 Mar 27. doi: 10.1186/s12889-026-26505.
Abstract

SAKTHIVEL M, Ramalingam A, Chadwick J, Kriina M, et al
Cervical cancer screening coverage and care cascade in Tamil Nadu, India, based on a community-based cross-sectional survey.
Sci Rep. 2026 Mar 26. doi: 10.1038/s41598-026-45005.
Abstract

ALI AA, McCrudden CM, McCaffrey J, McBride JW, et al
Corrigendum to "DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles" [Nanomed Nanotechnol Biol Med 10.1016/j.nano.2016.11.019 [pubmed: 27979747 issn: 1549-9634]].
Nanomedicine. 2026 Mar 25:102932. doi: 10.1016/j.nano.2026.102932.
Abstract

LIM JH, Yeap LL, Saw PS, Ng KY, et al
Determinants of cervical cancer screening in Southeast Asia: A systematic review using the COM-B model and the theoretical domains framework.
Prev Med. 2026 Mar 24:108564. doi: 10.1016/j.ypmed.2026.108564.
Abstract

SAPKOTA S, Pandit S, Bhandari J, Adhikari A, et al
Stage Migration and Validity of the International Federation of Gynecology and Obstetrics (FIGO) 2018 Staging System for Cervical Cancer: A Retrospective Cohort Study From a Tertiary Cancer Center in Nepal.
Clin Med Insights Oncol. 2026;20:11795549261434986.
Abstract

JI L, Wu J, Zhou Y, Pu X, et al
A prospective cohort study on the association between cervical microenvironmental factors and the efficacy of treating high-risk human papillomavirus infection comorbid with cervical diseases.
Front Cell Infect Microbiol. 2026;16:1734088.
Abstract

WANG L, Zhang M, Li Y, Lei R, et al
Serum PLAC1 levels for differential diagnosis between cervical intraepithelial neoplasia and invasive cervical cancer: a prospective observational study.
Cytotechnology. 2026;78:70.
Abstract

GOPALANI SV, Qin J, Wu M, Senkomago V, et al
Declines in cervical cancer incidence among young women in the United States.
J Natl Cancer Inst. 2026 Mar 25:djaf375. doi: 10.1093.
Abstract

LI J, Li F, Meng X, Yang Z, et al
FAM83D facilitates EMT and metastasis of cervical cancer via interaction with GSK3beta and inactivation of GSK3beta/stabilization of Snail signaling.
Biol Direct. 2026 Mar 25. doi: 10.1186/s13062-026-00761.
Abstract

ROSENBERG K
One dose of HPV vaccine is noninferior to two doses.
Am J Nurs. 2026;126:62.
Abstract

LI T, Ma J, Pang C, Wang Y, et al
Head-to-head Comparison of Fibroblast Activation Protein Inhibitors and (18)F-fluorodeoxyglucose in Cervical Cancer: A Systematic Review and Meta-analysis.
Acad Radiol. 2026 Mar 24:S1076-6332(26)00170-4. doi: 10.1016/j.acra.2026.
Abstract

SIGOVANA K, Nomatshila SC, Chitha W, Mabunda SA, et al
Protocol for exploring health promoter-led mental wellness initiatives for early prevention, screening and quality of life in patients with cervical cancer of rural Eastern Cape, South Africa: a mixed-methods study.
BMJ Open. 2026;16:e104827.
Abstract

WENG Z, Huang W, Wu Y, Xiu X, et al
Machine learning-directed massively parallel programmable nucleic acid amplification.
Sci Adv. 2026;12:eaec9175.
Abstract

HAN C, Zhao Y, Yang X, Sun F, et al
Integrated analysis and functional validation of PEG3, SYNPO2, and DCN as regulators of tumor suppression and cellular stress in cervical cancer.
Immunol Res. 2026;74:31.
Abstract

PUNZIANO C, Minopoli G, Romano S, Marrone L, et al
Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation.
Mol Oncol. 2026 Mar 25. doi: 10.1002/1878-0261.70216.
Abstract

LI W, Ran R, Li J
Single-cell and multi-omics analyses identify CAMP-associated neutrophil remodeling during radiochemotherapy in cervical cancer.
Front Cell Dev Biol. 2026;14:1773562.
Abstract

LU C, Chen N, Sun H, Wang C, et al
Effect of Electroacupuncture on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Randomized Controlled Trial.
J Pain Res. 2026;19:598960.
Abstract

MOHAMAD B, Saifo M
Real-world evaluation of bevacizumab plus platinum and paclitaxel for advanced cervical cancer: a single-arm study from Syria.
Ecancermedicalscience. 2026;20:2066.
Abstract

CHEN C, Guo L, Li S, Sun J, et al
Predicting complete response to concurrent chemoradiotherapy in locally advanced cervical squamous cell carcinoma using multi-sequence MRI data and a 2.5D deep learning algorithm integrated with crossformer model.
Sci Prog. 2026;109:368504261437172.
Abstract

SONODA K, Chrusciel T, Gebauer SC, Bello JK, et al
Cervical Cancer and Sexually Transmitted Infections Screening Among Individuals with a Substance Use Disorder: A Retrospective Cohort Study.
Popul Health Manag. 2026 Mar 24:19427891261434371.
Abstract

BILGAIYAN S, Swain A, Das S, Medha, et al
Advanced analysis and detection of cervical cancer using NASNetLarge.
Sci Rep. 2026 Mar 24. doi: 10.1038/s41598-026-38341.
Abstract

SU Y, Zhang J, Wu H, Zhang Y, et al
NCBP2 Regulates PGAM5-Mediated Mitophagy Via KIF23 Alternative Splicing To Promote Cervical Cancer ProgressionRun Title: NCBP2 Promotes Cervical Cancer Via Mitophagy.
Appl Biochem Biotechnol. 2026 Mar 24. doi: 10.1007/s12010-026-05607.
Abstract

ANTONY EDWIN RODRIGUES F, Krishnan D, Abbas HH, Raj MJM, et al
Transcriptome sequencing (RNA-Seq) reveals non-coding pseudogene CDC27P9 role in cervical cancer.
Apoptosis. 2026;31:111.
Abstract

ANDRADE MB, Pilger TL, Candido Dos Reis FJ
Prevalence of Pelvic Floor Dysfunction in Women with Cervical Cancer: A Cross-Sectional Study.
Int Urogynecol J. 2026 Mar 24. doi: 10.1007/s00192-026-06582.
Abstract

WU R, Kalima M, Msadabwe S, Mwaba C, et al
Changes in cervical cancer stage at diagnosis in Zambia over 15 years.
Cancer Causes Control. 2026;37:65.
Abstract

YANG H, Li Y, Xiao Z, Kuang M, et al
Mechanism of HAND2 Regulating Glycolytic Metabolism and Metastasis Through TLR4/NOX2/DUOX2 Signaling Axis in Cervical Cancer.
Mol Carcinog. 2026 Mar 23. doi: 10.1002/mc.70082.
Abstract

MALFATTI MC, Gualandi N, Tell G, Antoniali G, et al
The cooperative regulation of miR-221 by APE1 and AUF1 impacts p27(Kip1) defining a miR signature relevant for cervical cancer.
FEBS Open Bio. 2026 Mar 23. doi: 10.1002/2211-5463.70190.
Abstract

ABUDOUKADE A, Hong S, Jiang M, Yin D, et al
Predictive value of the systemic immune-inflammation index combined with the prognostic nutritional index for postoperative recurrence in early-stage cervical cancer: evidence from a multicenter cohort study.
Front Oncol. 2026;16:1792373.
Abstract

YANG Q, Bai D, Bao L, Liang L, et al
Case Report: A case of right ventricular metastasis from cervical cancer presenting with thrombocytopenia: the role of echocardiography and myocardial contrast echocardiography.
Front Oncol. 2026;16:1774949.
Abstract

LI Y, Liu Z, Jin H
Mechanism of N6-methyladenosine (m6A)-mediated upregulation of LINC00958 in the growth of cervical cancer.
Front Oncol. 2026;16:1663904.
Abstract

ZHOU L, Sun C, Diao P, Wang J, et al
Efficacy and safety of adding immune checkpoint inhibitors to standard chemotherapy or chemoradiotherapy for advanced or recurrent cervical cancer: a meta-analysis.
Front Immunol. 2026;17:1780791.
Abstract

HE Z, Lai J, Lin W, Lu K, et al
Prognostic value of the lactate dehydrogenase-to-albumin ratio (LAR) combined with clinicopathological indicators for predicting outcomes in locally advanced cervical cancer undergoing concurrent chemoradiotherapy: a retrospective cohort study and nom
Am J Cancer Res. 2026;16:470-495.
Abstract

XU B, Liu J, Li H, Zhang T, et al
Concordance and acceptability of a novel human papillomavirus self-collection tool for cervical cancer screening in economically developed regions: a prospective cohort study in Shanghai, China.
Front Med (Lausanne). 2026;13:1760186.
Abstract

BENITEZ MAJANO S, Katz N, Urrutia S, Caixeta R, et al
Accelerating the elimination of cervical cancer: cross-sectional examination of cancer prevention and control in Latin America and the Caribbean.
Lancet Reg Health Am. 2026;55:101398.
Abstract

SHAMSUNDER S, Digumarti L, Nayak B, Dasari V, et al
Bringing Cervical Cancer Screening Closer to Women: Feasibility of Artificial Intelligence and Remote Assessment in Primary Health Care.
Int J Public Health. 2026;71:1609094.
Abstract

MAO Y, Xing N, Sun W, Bao X, et al
Development of a novel immune infiltration-based gene signature to predict prognosis and immunotherapy response of a novel anti-PD-L1/TGF-beta bifunctional fusion protein in recurrent cervical cancer.
Hum Vaccin Immunother. 2026;22:2647560.
Abstract

A clinical review of cervical cancer.
Nursing. 2026;56:27-28.
Abstract

PULLEN RL JR, Ritchie S
A clinical review of cervical cancer.
Nursing. 2026;56:17-27.
Abstract

HAGOS MT, Suutala A, Bychkov D, Kucukel H, et al
Validation of conformal prediction in cervical atypia classification.
Sci Rep. 2026;16:9649.
Abstract

XIAO JJ, Cong Q, Sui L
[Correlation study of blood lipid indexes and body mass index with clinical characteristics of cervical squamous cell carcinoma].
Zhonghua Fu Chan Ke Za Zhi. 2026;61:236-245.
Abstract

MA X, Jiang F, Chen Y, Cao Y, et al
RNF2 facilitates the progression of cervical cancer through the degradation of LATS1.
Life Sci. 2026 Mar 20:124340. doi: 10.1016/j.lfs.2026.124340.
Abstract

HASE EA, Ferreira HB, Peres SV, Sadalla JC, et al
Cervical cancer during pregnancy: Management and maternal and perinatal outcomes.
Cancer Treat Res Commun. 2026;47:101185.
Abstract

WANG J, Li Z, He Y, Chu Y, et al
Corrigendum to "Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical cancer development" [Tissue Cell 93 (2025) 102713].
Tissue Cell. 2026 Mar 20:103478. doi: 10.1016/j.tice.2026.103478.
Abstract

PILLAI S, Wynter K, Galbally M
A Systematic Review of Women's Cancer Screening and Mortality in Women with Severe Mental Illness.
Schizophr Bull. 2026;52:sbaf254.
Abstract

MECOLI CA, Viswanathan AN, Rosen A, Casciola-Rosen L, et al
Parallel course of calcinosis and cancer in a patient with anti-NXP2-positive dermatomyositis: A case report.
Mod Rheumatol Case Rep. 2026;10:rxag016.
Abstract

LIM H, Kim SI, Min KJ, Lee JK, et al
Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations.
J Gynecol Oncol. 2026;37:e71.
Abstract

HERRERA DJ, Huber L, Ferrari A, Van Hal G, et al
Barriers to and facilitators of cancer prevention services for transgender and gender-diverse people: A systematic review.
Prev Med. 2026;206:108544.
Abstract

KAMOLRATANAKUL S, Niyom SL, Isarankura N, Ruengprasertkit C, et al
Long-term effectiveness of at least one dose of human papillomavirus vaccine in adolescents: A test-negative case-control study.
Int J Infect Dis. 2026;165:108489.
Abstract

LIU Y, Dai W, Du H, Jiang X, et al
Evidence for triaging HPV-positive women using viral load: data from two large cohort-screening projects in different regions of China.
Int J Infect Dis. 2026;165:108462.
Abstract

GOMEZ CHEREY JF, Noemi Payalef S, Chen X, Paula Reyes A, et al
Prevalence of hr-HPV types and their association with bacterial vaginosis, yeasts and trichomoniasis in Argentine women.
Rev Argent Microbiol. 2026;58:206-217.
Abstract

TANTITAMIT T, Vasuratna A, Khemapech N, Havanond P, et al
Cost-effectiveness of HPV catch-up vaccination program in women aged 13-24 years in a middle income country.
J Gynecol Oncol. 2026;37:e27.
Abstract

LIN CC, Chuang CC, Wang CY, Cheng SH, et al
The Cancer Screening Disparity among Women With Schizophrenia by Co-occurring Chronic Physical Illness Status: A Nationwide Cohort Study in Taiwan.
Schizophr Bull. 2026;52:sbaf206.
Abstract

KANAO H, Tamate M, Matsuura M, Nagao S, et al
Relationship between the lateral dissection lines of various radical hysterectomies and anatomical structures in the female pelvis: an educational video from the Sapporo Cadaver Surgical Workshop.
J Gynecol Oncol. 2026;37:e21.
Abstract

CHAULEUR C, Bourrely T
Robotic Single Port Retroperitoneal Para-aortic Lymphadenectomy, Staging for Advanced Squamous Cell Carcinoma of the Cervix.
J Minim Invasive Gynecol. 2026;33:374.
Abstract

MAHDAVI SABET F, Forghani S, Shahsavand A, Kharaghani M, et al
Diagnostic and clinical utility of ultrasound elastography for uterine cervical neoplasms-a comprehensive systematic review and meta-analysis.
Abdom Radiol (NY). 2026;51:2030-2043.
Abstract

CAIA C, De Maria F, Sopracordevole F, Ciavattini A, et al
Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia.
Eur J Cancer Prev. 2026;35:243-249.
Abstract

SAMAILA A, Isah A, Biambo AA, Usman N, et al
Development and reliability testing of a cervical cancer patients knowledge and practice of self-care management of treatment-related adverse events questionnaire.
J Oncol Pharm Pract. 2026;32:238-243.
Abstract

ZHANG Y, Li C, Xiang Y
Tumor immune microenvironment in cervical cancer: Histological subtype-specific immune landscapes and therapeutic implications.
Biochim Biophys Acta Rev Cancer. 2026 Apr 1:189581.
Abstract

SAINI K, Saini A, Yadav N, Kumar V, et al
Emerging frontiers in cervical cancer diagnostics: Recent innovations in biosensors for HPV detection.
Talanta. 2026;306:129750.
Abstract

YI J, Xu C, Huo Z, Zhou H, et al
MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells.
Recent Pat Anticancer Drug Discov. 2026.
Abstract

JIN W, Wang X, Fan Y, Huang C, et al
A preference study for applying mHealth to improve the quality of cervical cancer screening management from a supply and demand perspective: a discrete choice experiment.
Cancer Causes Control. 2026;37:70.
Abstract

BAO YH, Xiao ML, Li YA, Ma FH, et al
Multiparametric MRI-based Deep Learning and Radiomics for Evaluating Lymph Node Metastasis in Early-Stage Cervical Cancer.
Radiol Imaging Cancer. 2026;8:e250345.
Abstract

DU Q, Liu Q, Zhou Y, Kong Y, et al
Primary prophylaxis with pegylated G-CSF is associated with improved treatment completion and progression-free survival in locally advanced cervical cancer undergoing concurrent chemoradiotherapy: a retrospective cohort study.
Future Oncol. 2026 Apr 3:1-10. doi: 10.1080/14796694.2026.2654729.
Abstract

MATSUKAWA H, Yugawa K, Hosokawa C, Furuichi K, et al
Hyperspectral Imaging of Whole-Cell Region for Differentiating Cervical Squamous Intraepithelial Lesion Cytology.
Cancer Med. 2026;15:e71746.
Abstract

CHU C, Du Z, Wang J, Aili M, et al
Targetable Biomimetic NIR-II Theranostic Nanoplatform for Highly Efficient Multimodal Imaging-Guided Photothermal Therapy of Cervical Cancer.
Int J Nanomedicine. 2026;21:576589.
Abstract

KITONSA J, Kafeero P, Ankunda V, Muhumuza R, et al
Knowledge, perceptions, uptake, and determinants of HPV vaccination, and preferred delivery strategies among out-of-school girls in Masaka, Uganda.
Hum Vaccin Immunother. 2026;22:2654928.
Abstract

ABUZOOR A, Jabin MSR, Jonker C
Health Beliefs and Perspectives of Parents Regarding Human Papillomavirus Vaccination in Kuwait: Qualitative Study.
JMIR Form Res. 2026;10:e85438.
Abstract

NAZAROVA V, Kamzayeva N, Ukybassova T, Kozhakhmetov S, et al
Systems analysis of the HPV-microbiome-biofilm triad.
Front Cell Infect Microbiol. 2026;16:1767224.
Abstract

FANG Y, Bai J, Bo S, Cui X, et al
Targeting the AKT/mTOR axis: pectolinarigenin induces autophagy and apoptosis in human cervical cancer cells.
Front Pharmacol. 2026;17:1544170.
Abstract

MANICKAM R, Karnik M, Madhunapantula SV, Mohideen HS, et al
Human CLIC5 as a Recurrent Hotspot of HPV 16 Integration in Cervical Cancer.
J Med Virol. 2026;98:e70897.
Abstract

NAKAJIMA K, Otsuka Y, Ikejiri T, Hakariya H, et al
Evaluating the "Praise Movement" on Social Media: Perceptions of the Human Papillomavirus Vaccine in Japan.
Yakugaku Zasshi. 2026;146:339-343.
Abstract

JI L, Zhou X, Yao L
Factors Influencing Universal Coverage of AI-Assisted Cervical Cancer Screening: Qualitative Study Based on the Macro Model of Health System.
J Med Internet Res. 2026;28:e75372.
Abstract

ABE K, Ito K, Watanabe M, Tsuneda M, et al
Feasibility of online adaptive SBRT boost with 1.5-T MR-Linac for cervical cancer patients unsuitable for brachytherapy: a planning study.
J Radiat Res. 2026 Apr 1:rrag013. doi: 10.1093.
Abstract

ZHANG M, Gao L, Bai X
Health-related hardiness and influencing factors among cervical cancer radiotherapy patients: A cross-sectional study.
Support Care Cancer. 2026;34:394.
Abstract

SINGH P, Sharma K, Tamrakar VK, Khare R, et al
CRISPR-Cas system: recent advancements in prompt diagnosis of high-risk HPV genotypes in cervical cancer.
Expert Rev Mol Diagn. 2026 Apr 1. doi: 10.1080/14737159.2026.2654503.
Abstract

XIAOYAN Z, Xiaojuan L, Shijiao M, Xiaofan Z, et al
Baseline inflammatory and metabolic indicators associated with early PD-1 inhibitor resistance in advanced cervical cancer: a retrospective cohort study.
Front Med (Lausanne). 2026;13:1779898.
Abstract

LU X, Su Y, Xu W, Tang T, et al
Efficacy of induction chemotherapy combined with standard chemoradiotherapy vs. standard chemoradiotherapy monotherapy in locally advanced cervical cancer: A systematic review and meta-analysis.
Oncol Lett. 2026;31:183.
Abstract

EMAGNENEH T, Mulugeta C, Ejigu B, Alamrew A, et al
Burden and predictors of cervical cancer mortality in Sub-Saharan Africa: a systematic review and meta-analysis.
Infect Agent Cancer. 2026 Mar 31. doi: 10.1186/s13027-026-00749.
Abstract

FEROZ B, Ebner C, Skvortsov S, Purtscheller R, et al
Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer.
Radiat Oncol. 2026 Mar 31. doi: 10.1186/s13014-026-02834.
Abstract

MOHAN N
HPV Vaccination: A Transformative Step Towards Eliminating Cervical Cancer in India.
Indian Pediatr. 2026 Mar 31. doi: 10.1007/s13312-026-00326.
Abstract

WANG D, He J, Wu S, Liu S, et al
UM-6 remodels the tumor immune microenvironment by blocking PD-L1 N-glycosylation and promoting ERAD-mediated degradation in cervical cancer.
Bioorg Chem. 2026;175:109788.
Abstract

GARG S, Udayashankara AH, S N, F HNA, et al
Pain management and analgesic strategies in patients with carcinoma uterine cervix undergoing intracavitary or interstitial brachytherapy.
Support Care Cancer. 2026;34:391.
Abstract

YUILL S, Naidu C, Smith M, Bateson D, et al
Cervical Cancer Elimination in Australia and the Asia Pacific: Progress and Barriers.
Med J Aust. 2026;224:e70164.
Abstract

ABBAS G, Bokhari TH, Iqbal MA, Rehman S, et al
Mechanosynthesis and computational studies of new imidazole-based selenium adducts as potential anticancer agents against human prostate and cervical cancer.
Future Med Chem. 2026 Mar 31:1-11. doi: 10.1080/17568919.2026.2648984.
Abstract

SATO K, Oshima N, Onuki M, Matsumoto K, et al
Psychosocial Burden of Women With Cervical Intraepithelial Neoplasia in Japan: Results of A Web-Based Survey.
J Obstet Gynaecol Res. 2026;52:e70258.
Abstract

YAO Q, Wang K, Liu B, Jiang P, et al
Integrated optimization of needle paths and dwell time for individualized template-guided interstitial brachytherapy.
Med Phys. 2026;53:e70411.
Abstract

SU R, Wang Y
CLO26-078: Impact of Laparoscopic Surgical Proficiency on Survival Outcomes in Laparoscopic Radical Hysterectomy for Cervical Cancer.
J Natl Compr Canc Netw. 2026;24.
Abstract

CALDERON AM, Goyal S, Peddinani B, Lopez M, et al
EPR26-154: Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data.
J Natl Compr Canc Netw. 2026;24.
Abstract

GANDHI AK, Rastogi M, Sharma V, Bhutia TD, et al
Doses to pelvic bone marrow from intracavitary brachytherapy in carcinoma cervix: A dosimetric study.
J Cancer Res Ther. 2026;22:84-89.
Abstract

SINDHU KR, Pranitha SL, Arpitha S, Narayanan GS, et al
Impact of the revised FIGO 2018 staging system on survival outcomes with respect to prognostic factors in cervical cancer patients treated in a tertiary care cancer center in South Karnataka.
J Cancer Res Ther. 2026;22:27-35.
Abstract

ZHAO Z, Sun C, Liu X, Yu P, et al
GSTO1 Promotes Cell Proliferation and Stemness of Cervical Cancer via Activating PI3K/AKT/mTOR Pathway.
FASEB J. 2026;40:e71702.
Abstract

MEIRELLES I, Pinto M, Russomano F
Cost-utility of screening with liquid cytology or p16/Ki67 dual-stain in women identified in cervical cancer screening with non 16/18 HR-HPV.
Int J Technol Assess Health Care. 2026.
Abstract

TANG J, Oska C, Xie X, Small I, et al
Impact of BMI on Organs at Risk Dose for Cervical Cancer Treated With Definitive Radiation Therapy Followed by Brachytherapy Boost.
Cureus. 2026;18:e104301.
Abstract

O'NEILL H, Bruegl A
Immunotherapy induced sarcoidosis in a 47-year-old female with stage IIIC cervical cancer on pembrolizumab: A case report.
Gynecol Oncol Rep. 2026;64:102062.
Abstract

LI G, Chen N, Li X, Deng D, et al
Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Pilot Randomized Controlled Trial.
Int J Womens Health. 2026;18:595680.
Abstract

HUANG X, Zhou C, Ou Y
Case Report: Fully transvaginal extraperitoneal pelvic lymphadenectomy via retropubic access combined with radical vaginal hysterectomy or trachelectomy for early-stage cervical cancer.
Front Surg. 2026;13:1775199.
Abstract

LIU J, Ren WJ
Durable progression-free survival with first-line sintilimab plus chemotherapy followed by sintilimab maintenance in PD-L1-high recurrent cervical cancer: a case report.
Front Oncol. 2026;16:1736364.
Abstract

LI S, Wang N
The correlation between the triglyceride-glucose index and the odds of cervical cancer.
Front Oncol. 2026;16:1766167.
Abstract

DUSHKIN A, Grishacheva T, Afanasiev S, Dushkina I, et al
One more opportunity in early-stage cervical cancer: the role of photodynamic therapy in managing positive surgical margins.
J Gynecol Oncol. 2026 Mar 18. doi: 10.3802/jgo.2026.
Abstract

HAN KH, Yang E, Kim N, Son JH, et al
Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002).
J Gynecol Oncol. 2026 Mar 12. doi: 10.3802/jgo.2026.
Abstract

GOTLIB-MALKOWSKA J, Debska M
Effectiveness of ChatGPT in simplifying information for Polish patients on cervical cancer screening using advanced prompting.
Ann Agric Environ Med. 2026;33:46-52.
Abstract

RAKHMANOVA M, Sakko Y, Suleimenova A, Sakhipova G, et al
Patient acceptance of HPV self-sampling approach for cervical cancer screening: evidence from a pilot study in Kazakhstan.
Ann Med. 2026;58:2645175.
Abstract

CASTLE PE
Declining cervical cancer incidence in young women living in the United States: is it time to stop screening them?
J Natl Cancer Inst. 2026 Mar 29:djag041. doi: 10.1093.
Abstract

TANG W, Ma H, Li J, Kuang Y, et al
Targeting cell membrane sphingolipids: a novel ceramide analog CeY-B1 inhibits migration and invasion in cervical cancer cells.
J Transl Med. 2026 Mar 28. doi: 10.1186/s12967-026-08031.
Abstract

HALLSSON LR, Hoflacher AM, Stratil J, Muehler M, et al
Cost-effectiveness studies evaluating HPV self-sampling for cervical cancer screening - a systematic review.
BMC Health Serv Res. 2026 Mar 28. doi: 10.1186/s12913-026-14409.
Abstract

ENDALEW A, Kassahun M, Habtegiorgis SD, Tsega TD, et al
Determinants of precancerous cervical lesion among HIV positive women on ART in Awi zone public health facilities, Northwest Ethiopia, 2024.
Sci Rep. 2026;16:10729.
Abstract

LUO J, Lin Y, Yi Q, Long Y, et al
Efficacy of focused ultrasound for HPV clearance and cervical LSIL treatment: a meta-analysis.
Sci Rep. 2026;16:10747.
Abstract

WU X, Zhang H, Yang X, Li Z, et al
Rechallenging Immunotherapy With Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Achieved Partial Response in a Heavily Treated Patient With Metastatic Cervical Cancer: Case Report.
Clin Ther. 2026 Mar 27:S0149-2918(26)00069.
Abstract

MALISZEWSKI B, Ignaczak A, Skonieczna B, Pastuszynski A, et al
Targeted delivery of doxorubicin via cholesteryl-modified cyclodextrin: Antitumor activity in breast, ovarian, and cervical cancer cell lines.
Chem Biol Interact. 2026;432:112062.
Abstract

SHEN J, Miao Z, Wang L, Huo Z, et al
Deep Learning Can Predict the Overall Survival of Cervical Cancer Based on Histopathological Image, Gene Mutation and Clinical Information.
IET Syst Biol. 2026;20:e70060.
Abstract

CSIKOS C, Ngo MT, Vagner A, Nagy G, et al
Enhanced Tumor-to-Background Contrast with [(52)Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer.
Pharmaceuticals (Basel). 2026;19:517.
Abstract

LI J, Parhat P, Ma Y, Peng L, et al
Exploring the Anti-Cervical Cancer Effect and Hepatotoxicity Risk of Gossypol Based on Untargeted Metabolomics and Network Toxicology.
Pharmaceuticals (Basel). 2026;19:377.
Abstract

GIORGIO V, Del Dotto V, Grandi M, Grillini S, et al
Pathogenic Mechanisms in Cervical Cancer: Energy Metabolism, Hypoxia and Therapy.
Life (Basel). 2026;16:450.
Abstract

ZHAO S, Yang X, Zhang L, Yang D, et al
Correlation Between Dosimetric Parameters and Hematologic Toxicity in Cervical Cancer Patients Undergoing Intensity-Modulated Pelvic Radiotherapy.
Cancers (Basel). 2026;18:992.
Abstract

ELSAYIM R, Alhamdi HW, Almuraikhi N, Alkhateeb MA, et al
Multi-Omics Analysis of CDKN2A (p16INK4a) in Cervical Carcinoma in the Context of Human Papillomavirus and in Endometrial Carcinoma.
Genes (Basel). 2026;17:281.
Abstract

MOLNAR O, Mihutiu S, Straciuc OM, Vesa A, et al
Correction: Molnar et al. PET CT Imaging with FDG in the Therapeutical Management of Locally Advanced Cervical Cancer Diagnosed in a 43-Year-Old Patient: Case Report and Review of the Literature. Biomedicines 2025, 13, 83.
Biomedicines. 2026;14:676.
Abstract

TAN L, Li H, Liu T, Mao W, et al
Perineural Invasion in Early-Stage Cervical Cancer: Marker of Aggressive Pathology and Increased Recurrence Risk.
Biomedicines. 2026;14:591.
Abstract

PRETI M, Gallio N, Costa S, Borella F, et al
Opportunistic and Organized Cervical Cancer Screening: Impact on Lesion Severity and Surgical Outcomes in 9830 Cervical Conizations.
Diagnostics (Basel). 2026;16:839.
Abstract

YANG T, Guo L, Liu D, Hua K, et al
Proteome-based molecular subtyping and therapeutic target prediction in cervical cancer.
Biomark Res. 2026;14:35.
Abstract

SITTIWONG W, Prasartseree T, Tuntapakul P, Thaweerat W, et al
Correction: Re-irradiation in oligorecurrence and oligometastatic cervical cancer in modern radiotherapy era.
Radiat Oncol. 2026;21:42.
Abstract

BRIN M, Caraballo PB, Ramirez SO, Guzman L, et al
Evaluation of a patient educational brochure to increase knowledge of cervical cancer screening among women living with HIV in La Romana.
BMC Public Health. 2026 Mar 28. doi: 10.1186/s12889-026-27029.
Abstract

HACHIMI SE, Essayagh F, Essayagh M, Kazadi GB, et al
Assessing the prevalence of non-use of cervical cancer screening in Khouribga, Morocco.
Sci Rep. 2026;16:10858.
Abstract

SARKAR S, Saha A, DAS B, DAS D, et al
Phosphodiesterase 5 Inhibitor Sildenafil Inhibits HPV(+) Cervical Cancer Cells and Cervical Cancer Stem Cells by Apoptotic Induction and Telomerase Activity Modulation.
Anticancer Res. 2026;46:2007-2024.
Abstract

PARKER JM, Williams LR, Haines NA, Mayberry TG, et al
Unveiling the Molecular Blueprint of Spinach Induced Anti-proliferation and Pro-apoptosis in Cervical Cancer.
Anticancer Res. 2026;46:1833-1841.
Abstract

WANG H, Luo C, Chen W, Wang Y, et al
Folic acid-decorated chitosan nanoparticles co-delivering silymarin and docetaxel induce CDK-mediated cell cycle arrest and apoptosis in cervical cancer cell.
Int J Biol Macromol. 2026 Mar 25:151668. doi: 10.1016/j.ijbiomac.2026.151668.
Abstract

NARESH KUMAR A, Sageengran S, Mahalle PN, Guganathan L, et al
Cervical cancer image analysis: Detection and segmentation using self-guided quantum GANs and musical chairs optimization.
Comput Biol Med. 2026;208:111633.
Abstract

YANG T, Zhang T, Yan W, Chen X, et al
DWI-derived intratumoral, peritumoral, and habitat features for preoperative prediction of lymph node metastasis in early-stage cervical cancer using machine learning method.
Abdom Radiol (NY). 2026 Mar 27. doi: 10.1007/s00261-026-05463.
Abstract

BIEDERMAN EB, Champion VL, Head KJ, Imburgia TM, et al
Correlates of Integrated Human Papillomavirus Vaccination and Cervical Cancer Screening Protection in U.S. Low-Income Women.
Vaccines (Basel). 2026;14:251.
Abstract

PANCZEL I, Herold M, Borbenyi E, Horanyi D, et al
Survival Difference in Advanced-Stage Cervical and Ovarian Cancer Patients Treated with Concomitant Modulated Electro-Hyperthermia in Comparison to Classic Treatment Modalities: Results of a Pilot Study and Meta-Analysis.
Med Sci (Basel). 2026;14:105.
Abstract

TANAKA YO
A Novel, Promising Technique for Metastatic Lymph Node Detection in Uterine Cervical Cancer.
Radiol Imaging Cancer. 2026;8:e260111.
Abstract

BROOK E, Patterson K, Wijenayake N, Madin-Warburton M, et al
The broad societal value of pembrolizumab for women's cancer in Canada.
Future Oncol. 2026;22:939-952.
Abstract

SATAKE M, Ito S, Sawano C, Scuffham P, et al
Benefit-risk assessment of HPV vaccination programs in Australia, the United States, and Japan.
Vaccine. 2026;78:128407.
Abstract

TAN LT, Gregory DL, Prewett S, Duke SL, et al
Long-term Clinical Outcomes of a Resource-conserving Accelerated Magnetic Resonance Imaging-guided Brachytherapy Schedule for Cervix Cancer.
Clin Oncol (R Coll Radiol). 2026;52:104057.
Abstract

GUPTA K, Mandal S, Singh M, Mala YM, et al
The expression of p16 , epidermal growth factor receptor and CD44 in squamous cell carcinoma uterine cervix.
Indian J Pathol Microbiol. 2026;69:48-53.
Abstract

CHU K, Vidali S, Parberry A, Saull M, et al
Evaluation of the Quality and Suitability of Self-Collected Vaginal and Urine Samples for Human Papillomavirus Testing: A Prospective Matched Study.
BJOG. 2026;133:1262-1270.
Abstract

JIA X, Da X, Shi J, Chen M, et al
Real-World Performance of HPV DNA-Based Screening in Health Resource-Limited Areas of China: A Multicenter Implementation Study.
Cancer Epidemiol Biomarkers Prev. 2026;35:528-539.
Abstract

VIEIRA-BAPTISTA P, Lima-Silva J, Freitas G, Goncalves M, et al
Impact of HPV vaccination after a diagnosis of cervical HSIL - a case-control study.
Expert Rev Anticancer Ther. 2026;26:519-527.
Abstract

FENG X, Ginjupalli R, Lukhorito J, Karanja D, et al
Cervical Cancer Screening with Visual Inspection with Acetic Acid (VIA) among Women Living with HIV in Nairobi, Kenya: Results and Transformation Zone.
medRxiv [Preprint]. 2026 Mar 30:2026.03.27.26349550.
Abstract

ZHU F, Xie X, Wang C, Liu J, et al
PIK3CA mutation-induced immune microenvironment remodeling sensitizes cervical cancer to immunotherapy.
Front Immunol. 2026;17:1780752.
Abstract

YARZA R, Farinas-Madrid L, Garcia-Duran C, Garcia-Illescas D, et al
The game changer in the cervical cancer therapeutic landscape: immunotherapy.
Immunotherapy. 2026 Apr 10:1-17. doi: 10.1080/1750743X.2026.2647581.
Abstract

LEE SM, Seo H, Kim S, Cho HW, et al
Prognostic significance of psoas muscle index at diagnosis in cervical cancer progression.
J Gynecol Oncol. 2026 Mar 30. doi: 10.3802/jgo.2026.
Abstract

WANG S, Ma GF, Xiao C, Liu J, et al
Adjuvant concurrent chemoradiotherapy for early-stage cervical cancer patients with intermediate-risk factors in the era of intensity-modulated radiation therapy.
J Gynecol Oncol. 2026 Mar 19. doi: 10.3802/jgo.2026.
Abstract

PALAIA I, Perniola G, Tonti N, Tomao F, et al
Outcomes of node-positive cervical cancer treated with neoadjuvant chemotherapy followed by radical surgery: a single-center approach to a challenging disease.
J Gynecol Oncol. 2026 Mar 30. doi: 10.3802/jgo.2026.
Abstract

TAKAHASHI K, Takeda K, Takagi H, Niiyama A, et al
Deep learning-based auto-contouring for organs at risk in three-dimensional image-guided brachytherapy for cervical cancer and endometrial cancer.
J Appl Clin Med Phys. 2026;27:e70570.
Abstract

BUSARI DA, Ntekim A, John-Akinola YO, Adejumo PO, et al
Financial toxicity and psychosocial distress of breast and cervical cancer patients at a tertiary healthcare facility in south-western Nigeria.
BMC Womens Health. 2026 Apr 9. doi: 10.1186/s12905-026-04436.
Abstract

INFANTE V, Miyaji KT, Martini CCR, Picone C, et al
Human papillomavirus (HPV) seroprevalence, cervical HPV prevalence and cervical lesions in systemic lupus erythematosus (SLE) and immunocompetent women.
Lupus Sci Med. 2026;13:e001812.
Abstract

AUDIGER C, Chatignoux E, Rasia I, Serra-Jezewski D, et al
Area-based socioeconomic inequalities in cervical cancer screening coverage in France.
J Epidemiol Popul Health. 2026;74:203350.
Abstract

LIU X, Lei J
PET-CT radiomics and artificial intelligence for predicting lymph node metastasis in cervical cancer: a systematic review and meta-analysis.
Clin Transl Oncol. 2026 Apr 9. doi: 10.1007/s12094-026-04346.
Abstract

JIANG Y, Ren J, Tao J
Ultrasound-Assisted Radiopharmaceutical Investigation of GNL1-Mediated AKT-P53-P21 Axis Activation in Cervical Cancer Progression.
Cancer Biother Radiopharm. 2026 Apr 9:10849785261438424.
Abstract

MIAO JJ, Zhang XY, Zhang YX, Gao L, et al
Comparison of long-term prognoses between 3D-printed template-guided and conventional freehand interstitial brachytherapy for locally advanced cervical cancer: a single-center retrospective study.
Front Oncol. 2026;16:1766456.
Abstract

FRANKLIN G, Henry C, Larsen P, Johnson C, et al
"It Feels Like Another Thing Cancer Took From Me"- Exploring Cervical Cancer Patients' Experience of Financial Toxicity in Aotearoa, New Zealand.
J Med Imaging Radiat Oncol. 2026 Apr 8. doi: 10.1111/1754-9485.70096.
Abstract

LENCHA B, Geda B, Ahmed K, Spigt M, et al
Barriers and facilitators of adherence to cervical cancer screening follow-up among women living with HIV in South Ethiopia: a qualitative study.
BMC Prim Care. 2026 Apr 8. doi: 10.1186/s12875-026-03303.
Abstract

CHEISHVILI D, El-Zein M, Franco EL, Szyf M, et al
Correction: ??Enhancing the sensitivity of non-invasive cervical cancer detection using CpG methylation haplotype profiling.
Sci Rep. 2026;16:11751.
Abstract

RICHARDS-MCDONALD L, Baptiste DL, Nettles B
Addressing Inequalities in Cervical Cancer Screening: Nursing Strategies to Overcome Barriers and Improve Health Outcomes.
Clin J Oncol Nurs. 2026;30:161-167.
Abstract

CHEN Y, Xie H, Wang S, Chen Y, et al
Generation of deep learning based virtual contrast-enhanced CT images from noncontrast CT images for target volume delineation in cervical cancer radiotherapy.
Front Oncol. 2026;16:1764560.
Abstract

NAMUTUNDU J, Nakalembe M, Kiguli J, Wanyenze RK, et al
User-Centered Design of Strategies for Improving Cervical Cancer Screening Literacy Among Rural Women Living with HIV in Eastern Uganda.
Patient Prefer Adherence. 2026;20:572018.
Abstract

PALMER C, Ovcinnikova-Hutchings O, Engelbrecht K, Favato G, et al
Modelling the time to cervical cancer elimination in England: strategies for achieving elimination by 2040.
BMJ Public Health. 2026;4:e004290.
Abstract

AZUBUIKE S, Adamu M
Cervical cancer screening uptake and its determinants among rural women in North Central Nigeria: a cross-sectional study.
Rural Remote Health. 2026;26:10433.
Abstract

HOSSEINI K, Alizadeh M, Jalilian A, Hoseini S, et al
Silver nanoparticles combine with Nigella sativa oil to potentiate apoptosis in cervical cancer.
Sci Rep. 2026;16:11446.
Abstract

PAPAGIANNAKOU V, Fradelos EC, Dimitriadou I, Saridi M, et al
Missed Opportunities in Cervical Cancer Prevention: Knowledge and Screening Practices Among Women with Hemoglobinopathies in Greece.
Asian Pac J Cancer Prev. 2026;27:1535-1542.
Abstract

YUTYUENYONG S, Punyashthira A, Poomtavorn Y, Suwannarurk K, et al
Prediction Score of Cervical Intraepithelial Neoplasia Grade II or Higher (CIN2+) in Patients with Low-Grade Cytology (ASC-US, LSIL) and HPV- Negative or Non-type 16/18 High-Risk HPV-Positive Results.
Asian Pac J Cancer Prev. 2026;27:1515-1522.
Abstract

WINATA IGS, Syofyan SD, Syofyan JF, Santoso RC, et al
Bioinformatics Analysis Reveals Distinct Oncogenic Profiles of HPV-16 and HPT-18 to Other Subtypes in Cervical Cancer.
Asian Pac J Cancer Prev. 2026;27:1505-1513.
Abstract

CHELLAT FZ, Bahra N, Chami Khazraji Y, Bekkali R, et al
HPV Self-Sampling for Cervical Cancer Screening in Morocco: A Cross-Sectional Study.
Asian Pac J Cancer Prev. 2026;27:1249-1256.
Abstract

DANKAI W, Thangvorathum P, Pukdee K, Aithin P, et al
Enhancing Cervical Cancer Screening Among Northern Thai Women: Satisfaction with Self-Collected HPV DNA Testing under the National Program.
Asian Pac J Cancer Prev. 2026;27:1211-1217.
Abstract

A AM, M ZT, Tesfey T, Mulaw G, et al
Phytochemical Analysis and Apoptosis-Inducing Anticancer Activity of Buddleja polystachia Leaf Extract against HeLa Cell Lines.
Asian Pac J Cancer Prev. 2026;27:1201-1210.
Abstract

GABDULLINA M, Ainakulova A, Elboga U, Karibayeva I, et al
Performance of [68Ga]Ga-FAPI PET in Breast, Ovarian, and Cervical Cancers: A Systematic Review and Meta-Analysis.
Asian Pac J Cancer Prev. 2026;27:1161-1170.
Abstract

BUTLER S, Niedermayr T, Kidd E
Lateral needle placement using 3D-printed ovoid-based needle guides mitigates the negative impact of high T-score cervical cancer.
Brachytherapy. 2026 Apr 6:S1538-4721(26)00023.
Abstract

FAN X, Guo H, Wang S, Peng X, et al
HPV16/18 Genotyping Combined With PAX1 Methylation Triage Reduces Immediate Colposcopy While Improving CIN3+ Detection: A Real-World Study of 3,233 Chinese Women.
Cancer Control. 2026;33:10732748261442617.
Abstract

SHIRANE T, Kurahashi T, Takatsuji N, Nagai S, et al
An In-Field Recurrent Cervical Cancer Case After Chemoradiotherapy With a Marked Response to Pembrolizumab Combined With TC (Paclitaxel-Carboplatin) Therapy: A Case Report.
Cureus. 2026;18:e106460.
Abstract

SAVCI G, Sahin EA, Sahin H, Olcenoglu MF, et al
Laparoscopic type 3 radical hysterectomy with enclosed colpotomy using the Bakay technique for early-stage cervical cancer: a retrospective case series.
BMC Womens Health. 2026 Apr 6. doi: 10.1186/s12905-026-04442.
Abstract

LIU Y, You J, Liu D, Wen L, et al
Development, validation, and visualization of a novel nomogram for predicting clinical outcomes of postoperative cervical cancer patients.
Sci Rep. 2026 Apr 6. doi: 10.1038/s41598-026-42652.
Abstract

ALLON H
The HPV vaccination programme and cervical cancer elimination.
Br J Nurs. 2026;35:366-369.
Abstract

ZHU Y, Wang Q, Zhang Y, Liu Y, et al
Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway.
Clin Transl Med. 2026;16:e70652.
Abstract

TOBON-OSORNIO F, Arellano-Llamas AA, Perales-Flores PM, Torrecilla-Toledo CA, et al
Change of Cervical Cancer Stage at Diagnosis After the COVID-19 Pandemic.
Cureus. 2026;18:e104659.
Abstract

ATIBIOKE OP, Oyasope BT, Ojomo OA, Jima BW, et al
A cross-sectional assessment of cervical cancer vaccination and screening among women of reproductive age living with HIV in North Central States, Nigeria.
Pan Afr Med J. 2025;52:175.
Abstract

WU Y, Xue X, Su L, Liu Y, et al
Effect of bladder volume on dose of exposure to dangerous organs and incidence of cystitis and enteritis in patients with cervical cancer after external radiotherapy.
Front Oncol. 2026;16:1760076.
Abstract

ZHAO M, He W, Dai J, Xie Y, et al
C2FAU-Net: A Deep Learning Approach with Multi-scale Strategy for Automated Delineation of Organs-at-risk in Cervical Cancer High-dose Rate Brachytherapy.
J Med Phys. 2025;50:217-226.
Abstract

VASQUEZ GUZMAN CE, Hodes T, Lucas J, Marino M, et al
Cervical Cancer Screening among Older Latina Migrant and Seasonal Farmworkers in a Network of Community Health Centers.
Ethn Dis. 2026;35:165-172.
Abstract

TANG X, Zheng Q, Li X, Wang K, et al
Integrated Multi-Omics Analysis Constructs an Intratumoral Heterogeneity-Corrected Prognostic Signature for Cervical Cancer.
Int J Gen Med. 2026;19:593477.
Abstract

RADOJEVIC MZ, Jankovic K, Folic M, Spasic M, et al
Nodal status in predicting the outcome of treatment with definitive chemoradiation in patients with cervical cancer in FIGO IIIC1 and IIIC2 stages.
Rep Pract Oncol Radiother. 2026;31:96-106.
Abstract

AMADI A, Lawal M, Khan H, Japhet S, et al
Bridging the gap: exploring healthcare professionals' perceptions and barriers towards cervical cancer screening services uptake amongst women in rural communities.
J Egypt Natl Canc Inst. 2026;38:10.
Abstract

MENG N, Wei W, Huang Z, Feng P, et al
The Value of Time-dependent Diffusion MRI and Macromolecular Proton Fraction Imaging in Assessing Pathological Grade in Cervical Cancer.
Acad Radiol. 2026 Apr 4:S1076-6332(26)00186-8. doi: 10.1016/j.acra.2026.
Abstract

JOHN G, Ghanekar S, Dominic D, Gawde JR, et al
Dynamic gamma-H2AX response in blood lymphocytes for prediction of radiotherapy induced bladder toxicity in cervical cancer patients.
Indian J Med Res. 2026;163:11-18.
Abstract

YU Q, Wang M, Li Z, Yu X, et al
Baicalein induces cervical cancer apoptosis via PTEN/PI3K/AKT pathway modulation.
Pak J Pharm Sci. 2026;39:1759-1770.
Abstract

JIN P, Cheng Q, Hong X, Jia Q, et al
Development of Covalent Small-Molecule Fluorescent Probes for DNA Methyltransferase 1 Detection in Cancer Cells and Cervical Exfoliated Cells.
J Med Chem. 2026;69:8130-8147.
Abstract

TADELE S, Yilema A, Woldesemayat B, Zealiyas K, et al
High-risk human papillomavirus genotype distribution, cytological abnormalities, and associated factors among Ethiopian women: a multicenter study.
Microbiol Spectr. 2026;14:e0315425.
Abstract

HUANG X, Gao H, Xue H, Chen Y, et al
Efficacy and influencing factors of photodynamic therapy in treating cervical low-grade squamous intraepithelial lesion.
Photodiagnosis Photodyn Ther. 2026;58:105426.
Abstract

HUSSAIN N, Haddad AHIA
Immune-priming mechanisms of photodynamic therapy in cervical high-grade squamous intraepithelial lesions and translational implications for ovarian near-infrared photoimmunotherapy.
Photodiagnosis Photodyn Ther. 2026;58:105406.
Abstract

STOLNICU S, Hoang L, Rakislova N, Horn LC, et al
Cervical intraepithelial neoplasia: the expanding spectrum of cervical squamous intraepithelial lesions with focus on morphologic and molecular nuances.
Virchows Arch. 2026;488:707-720.
Abstract

MA R, Jin Y, Lei Z, Sun P, et al
Exploring adenoid basal carcinoma to squamous cell carcinoma of the uterine cervix transformation using spatial transcriptomics.
J Pathol. 2026;269:86-99.
Abstract

CHEN M, Li L, Wang L, Zhu X, et al
Efficacy and safety of photodynamic therapy mediatied by 5-aminolevulinic acid for the treatment of cervical in low-grade squamous intraepithelial lesions combined with high-risk human papillomavirus in patients of childbearing age: A retrospective an
Photodiagnosis Photodyn Ther. 2026;58:105380.
Abstract

SAKAMOTO M, Takeda S, Fujiwara A, Hirata M, et al
Phase I/II clinical study of next-generation photodynamic therapy (L-PDT) using talaporfin sodium (Laserphyrin(R)) for cervical intraepithelial neoplasia: Efficacy, safety, and fertility preservation.
Photodiagnosis Photodyn Ther. 2026;58:105372.
Abstract

GENG L, Mo W, Gao G, Liu Z, et al
Comparative efficacy of topical 5-aminolevulinic acid versus Hiporfin photodynamic therapy in HPV-positive cervical intraepithelial neoplasia grade II.
Photodiagnosis Photodyn Ther. 2026;58:105329.
Abstract

GRIMES DR, Brennan A, Walsh C
A method of estimating cervical cancers prevented by the introduction of national screening in Ireland.
Eur J Public Health. 2026;36:ckaf225.
Abstract

GONG N, Takeyama S, Yamaguchi M, Urata T, et al
Papanicolaou stain unmixing for RGB image using weighted nucleus sparsity and total variation regularization.
Med Biol Eng Comput. 2026;64:911-929.
Abstract

LI J, Ye Z, Gan Y, Li D, et al
Expression of TCEAL2 is a Novel Prognostic Biomarker and Potential Therapeutic Target in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Curr Med Chem. 2026;33:1635-1650.
Abstract

ZHANG L, Yang J, Zhang P, Shang Y, et al
Association between log odds of positive lymph nodes and survival in surgically treated cervical cancer patients: a SEER database-based cohort study.
World J Surg Oncol. 2026 Apr 18. doi: 10.1186/s12957-026-04353.
Abstract

WALLE M, Mulatie Z, Cherie N, Ibrahim AM, et al
Hematological parameters as predictive indicators of disease stage in patients with cervical cancer.
Sci Rep. 2026 Apr 17. doi: 10.1038/s41598-026-47004.
Abstract

HE G, Liang J, Ding Z, Qu X, et al
KDM5B recruits FOXG1 to suppress the IFN response, leading to malignant progression and immune evasion in cervical cancer.
Front Med (Lausanne). 2026;13:1749536.
Abstract

LI J, Su Y, Chen L, An Y, et al
Association of CDK15 and L1CAM Expression in Cervical Cancer Tissues with Clinicopathological Characteristics and Recurrence/Metastasis After Radical Hysterectomy.
Pak J Med Sci. 2026;42:621-628.
Abstract

IFEBI CO, Chigbu CO, Ajah LO, Aniebue UU, et al
Cervical Cancer Screening among Human Immunodeficiency Virus-positive Women: A Comparison of Outcome between Visual Inspection with Acetic Acid and Papanicolaou Smear Cytology.
Ann Afr Med. 2026 Apr 17. doi: 10.4103.
Abstract

SEMPRINI J
RE: State-level progress in reducing cervical cancer incidence among US young women between the pre- and post-human papillomavirus vaccination eras.
J Natl Cancer Inst. 2026 Apr 15:djag116. doi: 10.1093.
Abstract

WU Y, Zhang Y, Qian X, Li Y, et al
The association of fungal infection in cervical cancer: a systematic review and meta-analysis.
BMC Womens Health. 2026 Apr 17. doi: 10.1186/s12905-026-04451.
Abstract

JIA M, Wapmuk A, Gbaja-Biamila T, Abudulrasheed OA, et al
Knowledge, attitudes, and practices of cervical cancer preventive services among mothers living with HIV in Lagos, Nigeria: a cross-sectional study.
BMC Public Health. 2026 Apr 16. doi: 10.1186/s12889-026-27320.
Abstract

ZHONG P, Li W, Feng M, Guo A, et al
METTL3-mediated m(6)A modification stabilizes circCDK6 to promote cervical cancer tumorigenesis via the miR-449a/CDK6 axis.
Sci Rep. 2026 Apr 16. doi: 10.1038/s41598-026-47660.
Abstract

TIAN D, Deng L, Lu E, Li H, et al
Lactobacillus crispatus attenuates Escherichia coli-induced inflammation and migration of cervical cancer cells.
AMB Express. 2026 Apr 16. doi: 10.1186/s13568-026-02055.
Abstract

MSIBI SS, Lopez C, Khumalo FN, Su LJ, et al
Predictors of survival among cervical cancer patients in Swaziland (Eswatini): A population-based analysis in a resource-limited setting (2016-2024).
PLOS Glob Public Health. 2026;6:e0006309.
Abstract

CHERAGHI P, Khalaj-Kondori M, Moqadami A
Epithelial-mesenchymal transition and its role in drug resistance of cervical cancer.
Mol Biol Rep. 2026;53:618.
Abstract

NOVAK EN, Ma A, Hansen CJ, Wazir Z, et al
Mock Samples That Mimic Human Cervicovaginal Samples to Accelerate the Development and Evaluation of Assays for High-Risk HPV for Cervical Cancer Screening.
J Med Virol. 2026;98:e70931.
Abstract

YAN Y DAGGER, Bai D dagger, Li L, Xu L, et al
Distinct miR319a identified from Persicaria chinensis mediates cross-kingdom suppression of cervical cancer by targeting ITGA3.
Acta Biochim Biophys Sin (Shanghai). 2026 Apr 13. doi: 10.3724/abbs.2026010.
Abstract

DA ROCHA KC, Castanha EB, Elias MEM, da Silva CML, et al
Human papillomavirus-based vs. cytology for cervical cancer screening: a systematic review with meta-analysis.
Rev Bras Ginecol Obstet. 2026;48:e-rbgo130.
Abstract

LI Q, Zeng J, Li X, Huang M, et al
Case Report: Two cases of primary malignant melanoma of the female genital tract and literature review.
Front Immunol. 2026;17:1797752.
Abstract

XIONG HY, Li R, Hu XM, Zhang Y, et al
P2X7 receptor mediates the anti-tumor effect of running on cervical cancer in mice.
Purinergic Signal. 2026;22:39.
Abstract

MCCORMICK LJ, Gillot M, Ussery F, Bihini C, et al
Cervical cancer screening coverage increased in Malawi, Tanzania, Zambia, and Zimbabwe: Findings from sequential Population-based HIV Impact Assessment Surveys 2015-2017 and 2020-2023.
J Acquir Immune Defic Syndr. 2026 Apr 15. doi: 10.1097/QAI.0000000000003880.
Abstract

WOITTIEZ L, Soekdew A, Dams E, Brinkman K, et al
Cervical Cancer Screening in Women Living With HIV in Suriname.
Cureus. 2026;18:e105234.
Abstract

LEMOINE V, Legros R, Rosec S, Salaun C, et al
Negative Xpert HPV Test (Cepheid) With Late Amplification Signals: Is There a Clinical Significance? (the PaPCR Study).
J Med Virol. 2026;98:e70915.
Abstract

OLVERA-VALENCIA M, Grijalva-Perez A, Millan-Catalan O, Albino-Sanchez ME, et al
Cellular plasticity and heterogeneity underlying therapy resistance in 3D cervical cancer models.
Hereditas. 2026 Apr 14. doi: 10.1186/s41065-026-00668.
Abstract

NING B, Liang X, Cui Z, Li Y, et al
A deep learning-driven automated treatment planning framework for cervical cancer patients treated with volumetric modulated arc therapy.
Radiat Oncol. 2026 Apr 14. doi: 10.1186/s13014-026-02842.
Abstract

AHMADI M, Yoosefian M
Integrated computational screening of FDA-approved anticancer drugs as novel HPV-16 E6 inhibitors in cervical cancer.
Sci Rep. 2026 Apr 14. doi: 10.1038/s41598-026-42656.
Abstract

CHEN C, Zhang F, Shen J, Zheng Q, et al
Correction: CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells.
Cell Death Discov. 2026;12:184.
Abstract

LOU H, Langan D, Syracuse N, Murphy EA, et al
PIK3CA mutant cervical cancer is selectively suppressed by PI3Kalpha inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy.
Neoplasia. 2026;76:101305.
Abstract

VILAKATI LN, Ndlela MG, Hlophe NP, Liu JJ, et al
Comparison of early-onset and later-onset cervical cancer clinical characteristics and trends in Eswatini.
Cancer Epidemiol. 2026;102:103071.
Abstract

LEVY MS, Huang M, Dietrich CS, Fabian D, et al
Oncology Clinicians' Attitudes on Hormonal Therapy After Chemoradiotherapy for Cervical Cancer.
JAMA Netw Open. 2026;9:e266862.
Abstract

GUO L, Yuan X, Zhou Y, Zhang D, et al
Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study.
Clin Lab. 2026;72.
Abstract

Correction to: "Impact of rectal gas evacuation on dosimetry and applicator displacement in cervical cancer brachytherapy".
J Appl Clin Med Phys. 2026;27:e70549.
Abstract

PHIANPISET R, Detwongya C, Manopunya M, Cheewakriangkrai C, et al
Prognostic Survival Model Following Primary Radical Surgery for Early-Stage Cervical Cancer.
Cancers (Basel). 2026;18:1134.
Abstract

LANCELLOTTA V, La Milia MC, Autorino R, Rosa E, et al
Development of an Enomogram to Predict the Rate of Loco-Regional Control After Radio-Chemotherapy and Interventional Radiotherapy in Cervical Cancer.
Cancers (Basel). 2026;18:1096.
Abstract

TRZESZCZ M, Mazurec K, Mazurec M, Kobierzycki C, et al
Informative High-Risk HPV Genotyping in Cervical Cancer Screening: Integrated Analysis of Cytology and p16/Ki67 Dual Staining.
Cancers (Basel). 2026;18:1056.
Abstract

KAMASHIDZE K, Beruchashvili T, Peshkova T, Nakashidze I, et al
Physician-Level Determinants of Cervical Cancer Screening Practices: A Socio-Ecological Model-Based Study from Adjara, Georgia.
Healthcare (Basel). 2026;14:961.
Abstract

GU Z, Liu Y, Liang Y, Lian X, et al
Enhancing the precision and uniformity of clinical target volume delineation for cervical cancer through a structured educational program.
BMC Med Educ. 2026 Apr 13. doi: 10.1186/s12909-026-09203.
Abstract

CHOKWASSANASAKULKIT T, Ranasinghe V, Woods E, Nguyen LQ, et al
What If Trojan Horse Nanoparticles Could Change the Game for HPV Gene-Targeted Therapies?
J Med Virol. 2026;98:e70916.
Abstract

YANG Y, Zhang G, Shang H, Fu X, et al
Tumor apparent diffusion coefficient as a predictive marker for PD-1 inhibitor outcome in advanced cervical cancer: a retrospective study.
Front Oncol. 2026;16:1769071.
Abstract

CHUGH M, Goel B, Sehgal A, Dubey S, et al
Revolutionizing Community-Based Cervical Cancer Screening: Evaluating an Indigenous Artificial Intelligence-Enabled Portable Colposcope.
J Obstet Gynaecol India. 2026;76:42-48.
Abstract

DONG S, Liu W, Yu D, Zhang X, et al
Co-assembled structures of Fe(3)O(4) nanoparticles for therapy of cervical cancer by inducing apoptosis and autophagy.
Transl Cancer Res. 2026;15:150.
Abstract

WANG ZX, Chang LL, Liu J, Wu DM, et al
A retrospective cohort study comparing long-term clinical outcomes between patients with and without neoadjuvant therapy in stage IB-IIB cervical cancer: a propensity score-matched study.
Transl Cancer Res. 2026;15:201.
Abstract

ABUZEYAD RN, Ali NA, Twalbeh DA
Effect of a culturally tailored educational intervention on women's knowledge and attitudes toward cervical cancer screening: a single-group pre-post study.
Womens Health Nurs. 2026;32:52-63.
Abstract

JIAN W, Zhu L, Zhang B, He Q, et al
Megavoltage CT enhancement for cervical cancer tomotherapy using a generative adversarial network with deformable convolution and self-attention.
Med Phys. 2026;53:e70416.
Abstract

QI W, Liao F, Luo Z, Shao M, et al
Clinical and 18F-FDG PET/CT Imaging Characteristics of Post-radiotherapy Sacral Insufficiency Fractures in Cervical Cancer Patients.
Curr Med Imaging. 2026 Apr 8. doi: 10.2174/0115734056428627260223054010.
Abstract

ZHAN F, Zhong Y, Qin Y, Li L, et al
Retraction notice to "SND1 facilitates the invasion and migration of cervical cancer cells by Smurf1-mediated degradation of FOXA2" [Exp. Cell Res. 388 (2020) 111809].
Exp Cell Res. 2026 Apr 10:115008. doi: 10.1016/j.yexcr.2026.115008.
Abstract

BHETWAL B, Sharma V, Abbott A, Schafer EJ, et al
Cervical cancer prevention behaviors and determinants among Indigenous women in rural Nepal.
Health Promot Int. 2026;41:daag042.
Abstract

DONG X, Corbin H, Zhang X, Bai X, et al
Comprehensive Assessment of Artificial Intelligence as a Stand-alone tool for Cervical Cancer Screening Using a 50% Negative Cutoff Value.
Lab Invest. 2026 Apr 9:106126. doi: 10.1016/j.labinv.2026.106126.
Abstract

RAHMAN MT, Mahmood S, Attwell K
Religion, Politics, and Vaccines: Elaborating the Integrative Public Policy Acceptance (IPAC) Framework Through HPV Vaccine Program Acceptance Among Religious Leaders in Bangladesh.
Int J Health Policy Manag. 2026;15:9179.
Abstract

JIBA DF, Turay P, Baldeh M, Kamara MN, et al
Human Papillomavirus Vaccine Hesitancy and Uptake Among Adolescent Girls Living with HIV in Sierra Leone: A Call for Integration of Cervical Cancer Services.
AIDS Behav. 2026 Apr 11. doi: 10.1007/s10461-026-05065.
Abstract

LEI T, Wang F, Zhang S, Zhang L, et al
Tumor Core-Edge Divergence in T-Cell Exhaustion and Clonal Expansion in HPV-Related Cervical Squamous Cell Carcinoma Unveiled by Simultaneous Single-Cell RNA and TCR Sequencing.
J Med Virol. 2026;98:e70912.
Abstract

KOLIGUDDE V, Agarwal M, Marbaniang E, Shinde P, et al
Beyond HPV-16 and 18: Clinical Significance of HPV-58 and 59 in Cervical Abnormalities in Northeast India.
J Med Virol. 2026;98:e70924.
Abstract

ATTALLAH O
Light-XAI: a CADx for explainable cervical cancer detection via attention-based lightweight convolutional neural networks and layer-wise feature fusion.
BioData Min. 2026;19:26.
Abstract

LI Z, Zhao Z, Zhang Y, Xie Z, et al
A nanoplatform for hypoxia-responsive co-delivery of an NQO1 enzyme-responsive pterostilbene prodrug and phenanthriplatin for multi-mechanistic cervical cancer therapy.
Biochim Biophys Acta Mol Cell Res. 2026 Apr 8:120145.
Abstract

MONTIEL S, Pasaca C, Lopepe M, Gorosito F, et al
[Post-hysterectomy chyloascites: A rare complication].
Medicina (B Aires). 2026;86:526-528.
Abstract

DAI Y, Huang F, Li X, Wu W, et al
Development and preclinical evaluation of KDTV001, an adenovirus 5-vectored trivalent HPV therapeutic vaccine targeting HPV16/18/52.
EBioMedicine. 2026;126:106230.
Abstract

HUANG CY, Chang CY, You SL, Tsai HT, et al
Recurrent cytologic inflammation on cervical smear and risk of low-grade cervical abnormalities in cytology-based screening: A 25-year multicenter cohort study from HPV-resource-limited settings.
J Infect Public Health. 2026;19:103192.
Abstract

GE Z, Wang X, Zhang Z, Li J, et al
Synchronous atypical lobular endocervical glandular hyperplasia of the cervix and endometrium: a clinicopathologic case report and review of literature.
J Med Case Rep. 2026;20:191.
Abstract

JAHAN N, Hossain MS, Ariful Kabir KM
Analyzing the impact of gender-specific vaccination strategies and behavioral dynamics on HPV transmission.
Sci Rep. 2026;16:12115.
Abstract

CHIBWESHA CJ, Mollan KR, Teodoro NS, Keys JR, et al
Randomized clinical trial protocol: Acceptability and feasibility of combination treatment for cervical precancer among South African women living with HIV (ACT 2).
Contemp Clin Trials. 2026;164:108272.
Abstract

MARTIN-NOGUEROL T, Lopez-Ubeda P, Barrientos-Manrique EA, Garcia-Ferrer M, et al
Towards Automated FIGO Staging in Radiology: The Role of LLMs in Cervical and Endometrial Cancer.
Acad Radiol. 2026;33:1545-1555.
Abstract

BOCHNIAK K, Nitsch-Osuch A, Zamudio Padilla JD, Prusaczyk A, et al
Systemic recommendations on the promotion of HPV vaccinations based on international social marketing campaigns.
Ginekol Pol. 2026;97:233-238.
Abstract

PAVONE M, Teodorico E, Bizzarri N, Innocenzi C, et al
From Avoiding Empty Packets to Real-Time Diagnosis: The Value of Robotic Ultrasound-Guided Surgery in Sentinel Lymph Node Dissection.
Ann Surg Oncol. 2026;33:4763-4764.
Abstract

RYAN M, Riain CO, Thodi G, Finn S, et al
Dedifferentiated Cervical Mesonephric Adenocarcinoma: Report of 2 Cases of a Previously Undescribed Phenomenon.
Int J Gynecol Pathol. 2026;45:210-216.
Abstract

KABARAMBI A, Kizito S, Girma AZ, Nartey P, et al
Preliminary Impact of Public Health Messaging on HPV Vaccine Uptake Among Adolescent Girls and Young Women Living with HIV in Central Uganda.
AIDS Behav. 2026;30:1202-1210.
Abstract

BONAR G, Cameron S
Human papillomavirus vaccination and cervical screening uptake among women presenting for abortion: exploring opportunities for health care interventions.
BMJ Sex Reprod Health. 2026;52:95-100.
Abstract

ABBAS S, Teague K, Lakin K, Bari K, et al
Cervical Screening Experiences among Culturally and Linguistically Diverse Muslim Women in Australia: A Scoping Review.
J Immigr Minor Health. 2026;28:489-504.
Abstract

XU J, Li Q, Weisman PS
HPV-associated Endocervical Adenocarcinoma In Situ (AIS) With an ER+/Vimentin+/CEA- immunophenotype Mimicking Tubo-endometrioid Metaplasia.
Int J Gynecol Pathol. 2026;45:246-248.
Abstract

SHUQIAN Z, Zhi C, Ain Q, Yan L, et al
LncRNA-LINC01281 exerts anti-cancer functions via the MYC/VEGF pathway in the progression of cervical cancer.
J Cancer Res Clin Oncol. 2026;152:93.
Abstract

DARVISHIAN M, Moustaqim-Barrette A, Awadalla P, Bhatti P, et al
Provincial variation and associated factors in adherence to cervical cancer screening in Canada: Evidence from the Canadian Partnership for Tomorrow's Health.
J Med Screen. 2026 Apr 24:9691413261445025. doi: 10.1177/09691413261445025.
Abstract

GINGLES J, Zou Y, Chinula L, Tang JH, et al
Persistent human papillomavirus after thermal ablation in Malawian women with and without HIV: Implications for risk-based cervical cancer prevention in low- and middle-income countries.
Womens Health (Lond). 2026;22:17455057261428547.
Abstract

WEI W, Liu C
[Retracted] Prognostic and predictive roles of microRNA?411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer.
Mol Med Rep. 2026;33:176.
Abstract

SUN ZY, Xu J, Wei W
Optimized ultrasound extraction and cytotoxic activity against HeLa cervical cancer cells of total flavonoids of Physochlaina physaloides (L.) G. Don.
Front Pharmacol. 2026;17:1800105.
Abstract

LI X, Wang D
Role of mesenchymal stem cells and their derived exosomes in cervical cancer: Bidirectional mechanisms and research progress (Review).
Oncol Lett. 2026;31:225.
Abstract

HE Z, Hao H, Li X, Ji Y, et al
The role of long non-coding RNAs in therapy resistance of cervical cancer and therapeutic potential.
Front Cell Dev Biol. 2026;14:1746979.
Abstract

CHEN C, Zhao W, Guo M, Wang W, et al
Comprehensive analysis of mutational signatures and corresponding driver genes in cervical cancer from Xinjiang.
Biochem Biophys Rep. 2026;46:102591.
Abstract

NOBLE E, Webb L, Abdalla E
Evaluation of the Impact of Cervical Cancer and HPV Educational Awareness Program in Macon County, Alabama from 2018 to 2023.
J Healthc Sci Humanit. 2025;15:120-145.
Abstract

JANOUSKOVA K, Frei J, Mainz D, Papezova K, et al
The role of the health belief model and HPV self-testing in cervical cancer screening participation in the Czech Republic.
BMC Womens Health. 2026 Apr 23. doi: 10.1186/s12905-026-04467.
Abstract

BENARBIA M, Boukerche A
Comparative Outcomes of Survival and Relapse After High-Dose-Rate Brachytherapy Versus External-Beam Radiotherapy Boost Following Concurrent Chemoradiation in Locally Advanced Cervical Cancer in Algeria.
JCO Glob Oncol. 2026;12:e2500664.
Abstract

LAVANDEROS S, Valenzuela-Rocuant A, Moraga-Arias B, Ramirez-Faure L, et al
[Trends in Cervical Cancer Screening Coverage Through Papanicolaou Smear. Chile, 2002-2023].
Rev Med Chil. 2026;154:171-182.
Abstract

KARATAEV CAPITAL EM, CYRILLICC, Zhumabaev AR, Azhimamatova ZT, Ryspekova CD, et al
[THE INDICATORS OF MORBIDITY, MORTALITY, ONE-YEAR LETHALITY AND DESOLATION OF PATIENTS WITH CERVICAL CANCER IN THE OSH OBLAST OF THE KYRGYZ REPUBLIC].
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2026;34:318-321.
Abstract

RODRIGUEZ D, Fonseca T, King TS, Moreno M, et al
Cervical Cancer Screening Patterns and Outcomes in Women Over 65 Years Old: A Retrospective Study of Medicare Patients.
J Low Genit Tract Dis. 2026 Apr 23. doi: 10.1097/LGT.0000000000000958.
Abstract

LU Y, Yuan Y, Liang S
miR-1307-3p promotes the progression of cervical cancer by targeting FOXO3.
Ir J Med Sci. 2026 Apr 23. doi: 10.1007/s11845-026-04372.
Abstract

LOHNER A, Muller V, Baehr A, Krug D, et al
INTERLACE Study: Real-world Data for Germany Based on a Case Series of Patients with Locally Advanced Cervical Cancer.
Geburtshilfe Frauenheilkd. 2026;86:376-381.
Abstract

HENES M, Mann E, Hirchenhain C, Kentner A, et al
Registry Study of the Working Group on Cervical Pathology and Colposcopy (AGCPC) on the Diagnostic Algorithm for the New Cervical Cancer Screening - Persistent HPV Infections and Squamous Cell Lesions: Evaluation of over 10000 Patients.
Geburtshilfe Frauenheilkd. 2026;86:382-394.
Abstract

ALDEYAIN SJ, Alkhulaifi NS, Almutairi FM, Alenezi RS, et al
Knowledge, attitudes and practice toward cervical cancer and its screening among women in Kuwait: A cross-sectional study.
J Family Med Prim Care. 2026;15:750-755.
Abstract

ZHAO L, Zhai Q, Zhang W, Wen L, et al
Favorable short-term survival in locally advanced cervical cancer with optimal pathological response after neoadjuvant chemoimmunotherapy: a real-world analysis.
Front Immunol. 2026;17:1737081.
Abstract

DARVISHALI MH, Nikkhah H, Rahavi H, Jalali H, et al
HPV Genotypes and Survival Outcomes in Invasive Cervical Cancer: A Retrospective Molecular Analysis of FFPE Clinical Samples in an Iranian Cohort.
Int J Womens Health. 2026;18:589530.
Abstract

KHAN SU, Halawi MH, Almehmadi M, Taha R, et al
Innate immune recognition and microenvironmental reprogramming in HPV-induced cervical cancer: from pattern recognition receptor activation to immune tolerance disruption.
Front Cell Infect Microbiol. 2026;16:1758873.
Abstract

HE Y, Lu Y, Hu L
Radiomics and artificial intelligence in precision radiotherapy for cervical cancer: a narrative review.
Front Oncol. 2026;16:1781422.
Abstract

DE BONDT DD, Simms KT, Naslazi E, Killen J, et al
Optimal cervical cancer screening strategies for unvaccinated and HPV-vaccinated cohorts in the United States: a comprehensive comparative modeling analysis.
Lancet Reg Health Am. 2026;58:101474.
Abstract

OUYANG S, Xiong K, Chen P, Liu X, et al
Correction: Mechanism of interaction between ANXA6 and cGAS to regulate STING signaling pathway and promote ferroptosis in cervical cancer.
Cancer Cell Int. 2026;26:176.
Abstract

DELISLE V, Rochaix L, Bardou M, Uuskula A, et al
Women's preferences for cervical cancer screening methods: a discrete choice experiment in Estonia and France.
BMC Womens Health. 2026 Apr 22. doi: 10.1186/s12905-026-04478.
Abstract

LI Y, Lin YF, Cai B, Chen F, et al
Modelling the epidemic dynamics of HPV among women in China and optimization of ongoing cervical cancer elimination strategies.
BMC Med. 2026 Apr 22. doi: 10.1186/s12916-026-04881.
Abstract

ZHANG C, Zhao Z, Shi D
LncRNA CXCL8-203 down-regulates IL-8 and enhance the radiosensitivity of Siha cells in cervical cancer.
Sci Rep. 2026 Apr 22. doi: 10.1038/s41598-026-49502.
Abstract

TRISHA S, Balaji R
GC-MS guided phytochemical profiling of Bauhinia tomentosa flowers: molecular docking against HPV-E6 and p53 in cervical cancer.
Sci Rep. 2026 Apr 22. doi: 10.1038/s41598-026-40361.
Abstract

LEE-FOON NK, Lofters A, Dias K, Ogilvie GS, et al
EMPOWHPVR: exploring the factors that impact HPV self-sampling uptake amongst Black women and people with a cervix in Peel region, Ontario - a qualitative study protocol.
BMJ Open. 2026;16:e110930.
Abstract

QI M, Liu J, Li S, Chang Y, et al
A fast dosimetric optimization method of intensity modulated brachytherapy(IMBT) treatment plans for cervical cancer.
Phys Med Biol. 2026 Apr 22. doi: 10.1088/1361-6560.
Abstract

OZBEY G, Aytac S
A multimodal scanning electron microscopy-atomic force microscopy images for early cervical cancer detection using discrete wavelet transform-derived features and divergence-based classification.
Rev Assoc Med Bras (1992). 2026;72:e20251173.
Abstract

BAO Q, Wang Z, Gu G, Wang W, et al
CD8(+) T Cells in Association with SCD1 Regulate Cervical Cancer and Tumour Microenvironment Correlation Research.
Reprod Sci. 2026 Apr 22. doi: 10.1007/s43032-026-02070.
Abstract

VASQUEZ GUZMAN CE, Hodes T, Lucas JA, Leslie V, et al
Cervical Cancer Screening and Prevention among Latinas in the U.S. among a Network of Community Health Centers.
Cancer Epidemiol Biomarkers Prev. 2026.
Abstract

SABALE U, Cherif A, Valente S, Cook J, et al
Estimating the age distribution of disease-causal HPV infection in women with high-grade cervical intraepithelial neoplasia in Denmark, Estonia, Norway, Slovenia, and Sweden: A modeling study.
Hum Vaccin Immunother. 2026;22:2651503.
Abstract

LUVIAN-MORALES J, Galvan-Cota LD, Galvan-Cota LD, Castro-Eguiluz D, et al
Comparison of Two Instruments to Assess the Impact of Cachexia on Quality of Life in Women with Cervical Cancer.
Nutr Cancer. 2026 Apr 22:1-13. doi: 10.1080/01635581.2026.2658765.
Abstract

ZENG Z, Yang X, Wang W, Liu X, et al
Effect of Cisplatin Cycles on Prognosis for Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy: A Retrospective Cohort Study.
Technol Cancer Res Treat. 2026;25:15330338261446498.
Abstract

LI Y, Han J, Xiao S, Zhong S, et al
Prognostic Utility of Systemic Immune-Inflammation Markers in Locally Advanced Cervical Cancer Undergoing Radical Radiotherapy.
Oncologist. 2026 Apr 21:oyag139. doi: 10.1093.
Abstract

NKADI EH, Schaal DL, Scott RS
Epstein-Barr Virus and Human Papillomavirus Co-Infections in Epithelial Carcinomas.
J Med Virol. 2026;98:e70935.
Abstract

LAN D, Sun X, Yao L, Cao B, et al
miR-1229-3p promotes epithelial-mesenchymal transition and metastasis of cervical cancer cells by targeting FBXL5.
Hereditas. 2026 Apr 22. doi: 10.1186/s41065-026-00679.
Abstract

LI H, Wu M, Xing Y, Li J, et al
Sacituzumab govitecan combined with tislelizumab as second-line therapy for recurrent or metastatic cervical cancer: a case report and literature review.
BMC Womens Health. 2026 Apr 22. doi: 10.1186/s12905-026-04481.
Abstract

DANGE HB, Kana IY, Suleiman HC, Akyala AI, et al
Cultural and traditional influences on cervical cancer screening uptake in Nigeria and other West African countries.
BMC Public Health. 2026 Apr 21. doi: 10.1186/s12889-026-27347.
Abstract

WU X, Wang D, Wang J, Huang Y, et al
Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study.
Commun Med (Lond). 2026 Apr 21. doi: 10.1038/s43856-026-01572.
Abstract

ZHAO M, Liu P, Sun C, Luo F, et al
Dysregulation of cholesterol metabolism decreases cervical cancer cells' migratory ability caused by propofol in vitro.
Sci Rep. 2026 Apr 21. doi: 10.1038/s41598-026-49591.
Abstract

ZHU Y, Xu C, Gu X, Tian Y, et al
Reprogramming NF-kappaB signaling in cervical cancer: Implications for immune microenvironment and therapeutic resistance.
Biochem Biophys Res Commun. 2026;818:153746.
Abstract

CHARGARI C, Ducassou A, Laville A, Lucia F, et al
Corrigendum to 'Radiotherapy and brachytherapy for cervical cancer : Recommendations of the Societe francaise de radiotherapie oncologique' [Cancer Radiother 29 (2025) 104753].
Cancer Radiother. 2026;30:104799.
Abstract

YOKOI A, Machida H, Okazawa-Sakai M, Nishino K, et al
Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis.
Int J Clin Oncol. 2026 Apr 21. doi: 10.1007/s10147-026-03028.
Abstract

XU M, Qiu S, Zhou J, Zhang Y, et al
Ivonescimab combined with chemotherapy for the treatment of metastatic cervical cancer: A case report and literature review.
Hum Vaccin Immunother. 2026;22:2632451.
Abstract

ZENG H, Qiu B, Yang J, Xie Y, et al
Design, Synthesis and Biological Evaluation of 6H-Benzimidazo[1',2':1,2]pyrido[3,4-b]indole Derivatives as TDP1 Inhibitors: Potent Synergistic Agents with Topotecan against Cervical Cancer.
J Med Chem. 2026 Apr 21. doi: 10.1021/acs.jmedchem.6c00016.
Abstract

NIU E, Nicolau IA, Olthof E, de Kok IMCM, et al
Trends in the Incidence of Human Papillomavirus-Related Cancers in Canada and the Netherlands.
Cancer Control. 2026;33:10732748261445046.
Abstract

HUANG CB, Liao GD, Zhang SK, Zeng X, et al
Risk of 3-Year Cytological Progression by Baseline HPV Status Among Women With Normal Cytology: A Multicenter Cohort Study.
Cancer Med. 2026;15:e71855.
Abstract

SHI G, Xiao Y, Han L, Zhao W, et al
Impact of Prior Conization on Oncological Outcomes of Laparoscopic versus Open Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity Score-Weighted Retrospective Observational Study.
J Minim Invasive Gynecol. 2026 Apr 18:S1553-4650(26)00240.
Abstract

VANG AP, Quino JE, Rolon AM, Morales Arana A, et al
Capturing Latino Health Disparities: Lessons from Mail- and Community-Based Population Health Surveys in California.
Cancer Res Commun. 2026;6:873-883.
Abstract

CHANDRAN A, Togawa K, Mosquera I, Selmouni F, et al
From evidence to action: the IARC's role in strengthening cancer prevention and early detection.
J Natl Cancer Inst Monogr. 2026;2026:69-77.
Abstract

ABUDUXIKUER G, Abulimiti T, Abudurexiti G, Zhuo Q, et al
Population-Based Evaluation of a Novel E6/E7 Immunocytochemistry Assay for Cervical Cancer Screening and Triage of HPV-Positive Women.
J Med Virol. 2026;98:e70922.
Abstract

HAKIM PK, Zeinalkhani F, Alaeddini S, Mohammadzadeh S, et al
Diagnostic utility of apparent diffusion coefficient values in cervical cancer staging: A retrospective study.
Eur J Radiol Open. 2026;16:100744.
Abstract

YANG H, Li W, Zhang H, Liu Y, et al
pH-responsive Folate-PEG modified ZIF-8 Nanoparticles deliver fisetin to Aquaporin-3 for cervical cancer therapy.
iScience. 2026;29:115521.
Abstract

HARISHKUMAR SD, Pasha S, Harendra B, Dharmashekar C, et al
Piceid as a promising candidate for multi-target adjunctive therapeutic for inflammation-associated cervical cancer progression: an in silico approach.
In Silico Pharmacol. 2026;14:117.
Abstract

TOSCANO FP, Cipullo LMA, Rispoli AI, Curcio B, et al
Low-volume nodal disease in early-stage cervical cancer: a case report of favorable outcome without adjuvant therapy.
Gynecol Oncol Rep. 2026;64:102077.
Abstract

ZIDANE P, Berger T, Boros A, Caraivan I, et al
Early tumor shrinkage correlates with final EBRT response in cervical cancer patients treated with MRI-guided radiotherapy.
Clin Transl Radiat Oncol. 2026;59:101158.
Abstract

RAMIDI GR, Yadav R, Sunny G, Patnaik A, et al
Low-Dose Metronomic Chemotherapy With Fixed Low-Dose Nivolumab for Recurrent Cervical Cancer After Radiotherapy: Experience From Routine Clinical Practice.
Cureus. 2026;18:e105439.
Abstract

KOLAHDOOZ F, Jang SL, Yi KJ, Deck S, et al
Barriers and facilitators to the utilization of cancer screening services in two Arctic Indigenous communities in Canada.
Glob Health Action. 2026;19:2657081.
Abstract

RASPAGLIESI F, Bogani G, Ditto A, Maggiore ULR, et al
Revisiting the Concept of Nerve-Sparing Radical Hysterectomy: A Proof-of-Concept Prospective Study From a Cervical Cancer Cohort.
Ann Surg Oncol. 2026 Apr 19. doi: 10.1245/s10434-026-19671.
Abstract

ELI AV, Kasten BB, Hartman Y, Wodeyar AM, et al
Harnessing Id1 as a biomarker in a plasmid reporter system for cervical cancer.
Sci Rep. 2026 Apr 19. doi: 10.1038/s41598-026-49073.
Abstract

HALL KC, Stewart MW, Risley C, Reaves S, et al
Individual and Geographical Factors Associated With Follow-Up Care After an Abnormal Cervical Cancer Screening Result.
Womens Health Issues. 2026 Apr 18:S1049-3867(26)00043.
Abstract

YIN Y, Song Z, Wang L, Karam S, et al
Discovery of novel 1,2,4-triazoles derivatives acting as NF1 activators against cervical cancer.
Bioorg Med Chem. 2026;138:118661.
Abstract

RODRIGUEZ-SOTO AE, Conlin C, Zuo J, Ebrahimi S, et al
Development and evaluation of a cervical cancer-specific restriction spectrum imaging (RSI) model.
Magn Reson Imaging. 2026 Apr 16:110692. doi: 10.1016/j.mri.2026.110692.
Abstract

GRACE M, Beeravolu H, Alhamshari A, Skelin J, et al
Characterization of patient-derived HPV16 E6 and E7 variant alleles.
J Virol. 2026;100:e0023626.
Abstract

COORAY U, Singh A, Peres MA
Long-term impacts of HPV vaccination strategies on HPV related Cancer burden among Singaporean female population: A prospective simulation using proportional multistate lifetables.
Vaccine. 2026;80:128513.
Abstract

FAN G, Xiaolu Y, Keremu Y, Weina K, et al
Effectiveness analysis and clinical application potential exploration of combined detection of PAX1/JAM3 gene methylation in early diagnosis of cervical precancerous lesions.
Clin Epigenetics. 2026;18:73.
Abstract

LU Y, Qin H, Zhang W, Shi Q, et al
An integrated microfluidic system for automatic and self-validated analysis of cervical extracellular vesicle markers PD-L1 and ERBB3.
Anal Sci. 2026;42:299-312.
Abstract

CECEN S, Ozkan E
G8 score predicts survival in elderly women undergoing vaginal brachytherapy: A retrospective cohort study.
Brachytherapy. 2026;25:438-444.
Abstract

GROSS A, Wu X, Wang M, Podder T, et al
Improving complex brachytherapy efficiency: Multidisciplinary quality assurance and workflow optimization.
Brachytherapy. 2026;25:445-454.
Abstract

FALLONE CJ, Frick MJ, Golestani A, Cho D, et al
Assessment of geometric distortions and dosimetric impact from implementing 2D-T2-PROPELLER and 3D-T1-LAVA-FLEX in an MRI-only gynecological brachytherapy workflow.
Brachytherapy. 2026;25:486-500.
Abstract

SHEN X, Li SB, Gao MJ, Cao JJ, et al
Relationship Between Fecal Bile Acid Profile and Intestinal Microbiota in Patients With Chronic Radiation Enteritis.
J Dig Dis. 2026;27.
Abstract

SALAZAR-ZUNIGA B, Thurner L, Mohr T, Staber P, et al
Hemophagocytic lymphohistiocytosis induced by radio-chemo-immunotherapy: a case report.
Strahlenther Onkol. 2026;202:539-543.
Abstract

DOUBOVA SV, Contreras-Sanchez SE, McClellan SP, Pina-Sanchez P, et al
Evaluation of the Pilot Human Papillomavirus Self-Sampling Program in Workplaces in Ciudad Juarez, Mexico.
Arch Med Res. 2026;57:103316.
Abstract

KAWIA H, Mgaya J, Paul L
Linamarin and its analogues as targeted therapeutic agents in cervical cancer: insights from atomistic molecular docking, dynamics and MMPBSA calculations.
In Silico Pharmacol. 2026;14:132.
Abstract

ABDULLAH H, Mamat N, Sazeli S, Hapidin H, et al
Upregulation of Apoptotic Protein and Migration-Inhibitory Effects of Gallic Acid and Methyl Gallate Combined with Cisplatin in HeLa Cervical Cancer Cells.
Trop Life Sci Res. 2026;37:109-131.
Abstract

PHISALMONHKHON T, Kantathavorn N, Wetcho T, Samrarn J, et al
Long-Term Survival Outcomes of HPV DNA-Negative Cervical Cancer Compared with HPV DNA-Positive Disease in a Thai Tertiary Cohort.
Int J Womens Health. 2026;18:601452.
Abstract

BADWAN SN, McKinnish TR, Massad LS, Markovina S, et al
Correlation of patient reported outcomes and physical exam screening for pelvic floor dysfunction: An opportunity for improved quality of life during chemoradiotherapy for cervical cancer.
Gynecol Oncol Rep. 2026;65:102083.
Abstract

WANG Y, Tang N, Zhang W, Zeng Y, et al
An interpretable machine learning model for predicting symptomatic pelvic lymphocele after pelvic lymphadenectomy in cervical cancer.
Front Oncol. 2026;16:1754363.
Abstract

AGU PU, Dim CC, Nnagbo JE, Odoh GU, et al
Awareness of cervical cancer prevention among rural dwellers in Enugu State, Nigeria: findings from Ituku outreach.
Rural Remote Health. 2026;26:10083.
Abstract

ZHANG T, Yu Y, Zhang C, Zhang M, et al
Multi-omics analysis reveals the alterations in the tumor microbiome and metabolome associated with cervical cancer lymph node metastasis.
Microbiol Spectr. 2026 Apr 30:e0224725. doi: 10.1128/spectrum.02247.
Abstract

LEE CY, Wang PH, Hsieh YH, Hsiao YH, et al
GO-Y078 Triggers Program Cell Death in Human Cervical Cancer Cells Via MAPK Activation-Dependent Apoptotic Caspases Signaling.
Integr Cancer Ther. 2026;25:15347354251411859.
Abstract

HERNANDEZ S, Ahuja A, Kakkad N, Nignang CT, et al
"My Wife's Healthcare Is my Healthcare": A Qualitative Study Exploring Family-Centered Strategies to Enhance Cervical Cancer Prevention in Northern Ghana.
Cancer Control. 2026;33:10732748261448259.
Abstract

SLESNICK LD, Gordy E, Class QA, Gokhale P, et al
Follow-Up Cervical Cancer Screening After Benign and Low-Grade Colposcopy.
AJPM Focus. 2025;5:100425.
Abstract

JIANG Y, Cui Y, Su D, Yang H, et al
Immune checkpoint inhibitor-associated diabetic ketoacidosis induced by cadonilimab: a case report and literature review.
Front Endocrinol (Lausanne). 2026;17:1819809.
Abstract

XU Z, Zhang L, Wang H, Li X, et al
Combined neutrophil-to-lymphocyte ratio and nomogram for predicting progression-free survival in recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors.
Front Immunol. 2026;17:1811428.
Abstract

WANG S, Xiao H, Gao H
A novel methylation marker on the CLEC14A gene for cervical cancer screening.
Front Oncol. 2026;16:1730952.
Abstract

MATHIBELA SP, Lebelo MT, Steenkamp V
Antiproliferative Effects of Cannabinoids and Cisplatin in Cervical Cancer Cells.
Cancer Rep (Hoboken). 2026;9:e70561.
Abstract

BONI S, Goore D, Adie M, Gnahatin F, et al
Cervical Cancer Screening Cascade in Cote d'Ivoire: A Decade of Real-World Program Evaluation According to HIV Status.
JCO Glob Oncol. 2026;12:e2500164.
Abstract

GUPTA RD, Sarker P, Haider SS, Mazumder A, et al
Determinants and Socioeconomic Inequalities in Breast and Cervical Cancer Screening in Tajikistan: Evidence From the 2023 Demographic and Health Survey.
JCO Glob Oncol. 2026;12:e2500582.
Abstract

ORTIZ AP, Ramos-Cartagena JM, Torres-Cintron CR, Santiago-Rodriguez EJ, et al
Age Differences in Hysterectomy-Corrected Cervical Cancer Incidence Trends in Puerto Rico, 2001-2023.
JAMA Netw Open. 2026;9:e269681.
Abstract

SHEN F, Chen J, Gu Y, Li Y, et al
Cervical cancer derived extracellular vesicles expressed higher level of CD24 and suppressed the phagocytosis of macrophages.
Discov Oncol. 2026 Apr 29. doi: 10.1007/s12672-026-05124.
Abstract

HUANG M, Gong C, Liu B, Wang Y, et al
Exploration of overlap volumes-based IMRT Rapidplan for cervical cancer patients with the aim of OARs sparing.
Phys Eng Sci Med. 2026 Apr 29. doi: 10.1007/s13246-026-01732.
Abstract

DERIBE KS, Shewaye S, Wondimagegnehu A, Azmera YM, et al
Unmet palliative care needs and determinants among women with breast and cervical cancer and their caregivers in Ethiopia.
Front Oncol. 2026;16:1788481.
Abstract

MUTYABA I, Akurut H, Nabaasa R, Limo J, et al
Facilitators and Barriers to Cervical Cancer Screening Among Women in a Rural District of Northeastern Uganda, a Qualitative Study.
Cancer Manag Res. 2026;18:598738.
Abstract

NEMETH BLAZIC T, Zhu Q, Cahun E, Nola IA, et al
Developing a digital interactive tool to enhance cervical cancer awareness and health literacy in Croatia: a community case study.
Front Public Health. 2026;14:1767197.
Abstract

DING N, Chen Y, Zhou X, Wang G, et al
Women's preferences for HPV self-sampling in cervical cancer screening: a discrete choice experiment.
Front Public Health. 2026;14:1779443.
Abstract

ZHANG Y, Zhuo Q, Abuduwufu S, Wushouer A, et al
Dual-specificity phosphatase 14 inhibits the growth of cervical cancer cells by regulating the transforming growth factor-beta-activated kinase 1 and NOD-like receptor pyrin domain containing 3 inflammatory pathways.
J Int Med Res. 2026;54:3000605261441200.
Abstract

WANG D, Wu S, Wang H, Yan B, et al
FAT4 restrains epithelial-mesenchymal transition and metastasis in cervical cancer and shapes the tumor immune microenvironment.
J Transl Med. 2026 Apr 28. doi: 10.1186/s12967-026-08177.
Abstract

ZHU Q, Xu G, Wang T, Ding Z, et al
Downregulation of LRRC59 suppresses cervical cancer progression likely by inhibiting YBX1-mediated Wnt/beta-catenin signaling.
Sci Rep. 2026 Apr 28. doi: 10.1038/s41598-026-50275.
Abstract

ZHAO ZY, Zheng QJ, Zhao XL, Zhao FH, et al
[Current status of artificial intelligence applications in cervical cancer screening: a systematic review].
Zhonghua Yi Xue Za Zhi. 2026;106:1630-1638.
Abstract

GARCIA-MONTOYA IA, Picazo-Perez L, Arellano-Ortiz AL, Salcedo-Vargas M, et al
Obesity and Pro-Inflammatory Cytokines: Gene Expression Patterns Within Cervical Cancer Progression.
In Vivo. 2026;40:1463-1472.
Abstract

KOVALYOV O, Kovalyov K, Deinichenko O, Dillner J, et al
HPV self-sampling for cervical cancer screening during wartime: a pilot implementation study from a conflict-affected region of Ukraine.
BMJ Glob Health. 2026;11:e023478.
Abstract

KOKSAL OK, Baydemir SK, Oncu HN, Bakan FE, et al
The Association Between the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score and Lymph Node Metastasis in Early and Locally Advanced Cervical Cancer.
J Obstet Gynaecol Res. 2026;52:e70290.
Abstract

ALVAREZ A, Diaz S, Nino RA, Medina YA, et al
Cost-effectiveness of Including p16/Ki-67 Dual Staining in the Detection of Cervical Lesions in Colombia, 2024.
Rev Colomb Obstet Ginecol. 2026;77.
Abstract

SATOH M, Sato N
Participation in Cervical and Breast Cancer Screening Among Working Women in Japan: Panel Survey Study.
JMIR Cancer. 2026;12:e86885.
Abstract

WANG M, Zuo C, Wang K, Li F, et al
BA-UNet: A Boundary Augmented Segmentation Network for Cervical Cancer Radiotherapy.
J Imaging Inform Med. 2026 Apr 28. doi: 10.1007/s10278-026-01953.
Abstract

GORGATI E, Lotfi F, Boughriou M, Zendehdel K, et al
Cervical cancer prevention in migrant women: Overcoming barriers.
Health Care Women Int. 2026 Apr 28:1-7. doi: 10.1080/07399332.2026.2660648.
Abstract

ATAYA J, Alotaki B, Alhammadi K, Homsi TA, et al
Knowledge, attitudes, and practices regarding cervical cancer screening among women in Damascus, Syria: A cross-sectional study.
Womens Health (Lond). 2026;22:17455057261443140.
Abstract

YANG Y, Zhou H, Wang Y, Zhang H, et al
A Triage Model for HR-HPV Positive Women Based on Methylation of Human and HPV Genes.
J Med Virol. 2026;98:e70930.
Abstract

PRUSKI D, Millert-Kalinska S, Zurawski J, Jach R, et al
The use of the HPV vaccine in a group of primarily unvaccinated HPV-positive patients.
Hum Vaccin Immunother. 2026;22:2664310.
Abstract

FRANKLIN G, Larsen P, Henry C, Johnson C, et al
Financial Toxicity in Cervical Cancer Patients Undergoing Radical Treatment With External Beam Radiation and Brachytherapy at a Tertiary New Zealand Radiation Oncology Centre.
J Med Imaging Radiat Oncol. 2026 Apr 28. doi: 10.1111/1754-9485.70112.
Abstract

AN JE, Kim NK, Lee SH, Kim KH, et al
Factors affecting health-related quality of life in cervical cancer survivors: a multicenter cross-sectional study in Korea.
BMC Womens Health. 2026 Apr 27. doi: 10.1186/s12905-026-04459.
Abstract

WU SY, Wang DY, He JX, Wang HX, et al
[Experimental study on the inhibitory effects of recombinant bee venom peptide on the malignant biological behavior of cervical cancer].
Zhonghua Fu Chan Ke Za Zhi. 2026;61:316-327.
Abstract

DENG ZP, Wu D, Lai WX, Geng LN, et al
[Evaluating the efficiency of 24 secondary triage strategies for detecting cervical lesions of self-collected high-risk HPV-positive women].
Zhonghua Fu Chan Ke Za Zhi. 2026;61:289-304.
Abstract

CHO AR, Park SY, Sim DY, Ahn CH, et al
Targeting the CNOT2/VEGF pathway by Cornin attenuates angiogenesis and invasion in cervical cancer cells.
Sci Rep. 2026 Apr 27. doi: 10.1038/s41598-026-50829.
Abstract

ANDREW-BASSEY UI, Bello YO, Okunlola MA, Morhason-Bello IO, et al
Women's preferences and concerns on HPV screening sampling methods for cervical cancer in Ibadan, Nigeria: a cross-sectional study.
BMJ Open. 2026;16:e110692.
Abstract

TAGUE C, Junaid A, Anwar Y, Asad S, et al
Human papillomavirus: role of HPV2 and HPV9 in reducing the burden of cervical cancer in sub-Saharan Africa.
Int J Infect Dis. 2026 Apr 25:108733. doi: 10.1016/j.ijid.2026.108733.
Abstract

WENDEL SO, Brooke GM, Hu C, Sandoval AR, et al
Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer.
Cancer Res Commun. 2026 Apr 27. doi: 10.1158/2767-9764.CRC-25-0648.
Abstract

YANG N, Liu L, Ding L, Chen Z, et al
GE11/RGD Dual-Ligand Copper Nanoassemblies Synchronize Cuproptosis and Photothermal Therapy for Targeted Cervical Cancer Ablation.
Mol Pharm. 2026 Apr 27. doi: 10.1021/acs.molpharmaceut.6c00002.
Abstract

MAO F, Cook RJ, Lorey T, Wentzensen N, et al
Two-phase designs for cost-effective evaluation of cancer screening tests.
Biometrics. 2026;82:ujag058.
Abstract

GUNGOR SERIN B, Temiz BE, Tuncer H, Atakul MO, et al
Association of Oral Papivir/Pavirona((R)) Supplementation with HPV DNA Clearance.
Viruses. 2026;18:455.
Abstract

KNAP-WIELGUS W, Knap A, Pietrzak B, Suchonska B, et al
A Role of the Lower Genital Tract Microbiome in Promoting Cervical Intraepithelial Neoplasia: A Premalignant Precursor of Cervical Cancer-A Literature Review.
Viruses. 2026;18:403.
Abstract

WANG F, Zhan Q, Dai Z, Zhang H, et al
Lattice Radiation Therapy Plays a Synergistic Role in the Radical Treatment of Bulky Cervical Cancer: A Case Report and Literature Review.
Curr Oncol. 2026;33:196.
Abstract

LU L, Chen X, Liu J, Chen G, et al
A Lightweight Skeletal Muscle Intelligent Segmentation Network Based on Planning CT for Cervical Cancer Radiotherapy.
Technol Cancer Res Treat. 2026;25:15330338261446535.
Abstract

HULIKAL N, Panneerselvam V, Banoth M, Singaram NK, et al
Open Versus Laparoscopic Radical Hysterectomy Using Myoma Screw for Early-Stage Cervical Cancer- A Retrospective Analysis from Pre-LACC Era.
Indian J Surg Oncol. 2026;17:670-675.
Abstract

SHU H, Wang M, Zhang L, Jiang X, et al
Application of omental flap in total vaginectomy for post-radiotherapy recurrent cervical cancer: a case report.
Front Surg. 2026;13:1779661.
Abstract

LU S, Liu K, Luo W, Zheng S, et al
PD-L1 expression patterns in stage IB1 cervical squamous cell carcinoma: a retrospective study on implications for tumor budding and immune microenvironment.
PeerJ. 2026;14:e21052.
Abstract

JIANG CQ, Song Z, Yan ZC, Liu Y, et al
MXene-based CRISPR/Cas9 nanoplatform targeting FABP5 for ROS amplification and synergistic photothermal/photodynamic therapy of cervical cancer.
J Nanobiotechnology. 2026 Apr 27. doi: 10.1186/s12951-026-04480.
Abstract

SK ABD RAZAK R, Amsah N, Heng PP, Jane Ling MY, et al
Barriers and facilitators of cervical cancer screening among female healthcare professionals: a systematic review.
BMC Public Health. 2026 Apr 27. doi: 10.1186/s12889-026-27501.
Abstract

DELATTRE C, Uthuriague M, Barnetche T, Lambert M, et al
Cervical cancer screening practices among patients with autoimmune and inflammatory rheumatic diseases: a descriptive cross-sectional observational study.
BMC Womens Health. 2026 Apr 25. doi: 10.1186/s12905-026-04475.
Abstract

TANAKA YK, Yamazaki K, Yomogita N, Yamazaki S, et al
Evaluation of Platinum Transfer to Breast Milk in Cervical Cancer Patient Undergoing Cisplatin-Based Chemotherapy.
Biol Trace Elem Res. 2026 Apr 25. doi: 10.1007/s12011-026-05114.
Abstract

HE L, Liang W, Zheng Y, Wu Q, et al
A GPU-accelerated brachytherapy planning framework for template-based applications: Evaluated on three-dimensional printed individual templates in cervical cancer.
Brachytherapy. 2026 Apr 24:S1538-4721(26)00025.
Abstract

DIAZ-PALOMERA CD, Gonzalez-Lucano LR, Garcia-Bernal JR, de Arellano-Sanchez JAR, et al
Modulatory effects of Pioglitazone on the CAF-driven malignant phenotype in cervical cancer: an in vitro bidirectional study.
Discov Oncol. 2026 Apr 25. doi: 10.1007/s12672-026-04898.
Abstract

YAN Y, Li J, Zhang C, Yang R, et al
miR-1247-5p is correlated with cervical cancer and regulates cervical cancer cell functions by targeting DVL1.
Nucleosides Nucleotides Nucleic Acids. 2026.
Abstract

YILMAZ E, Murray GL, Balgovind P, Garland SM, et al
International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening.
J Med Virol. 2026;98:e70936.
Abstract

TAO H, Tong Z, Li H, Mao S, et al
Paired box 1 gene methylation as a promising triage strategy for atypical squamous cells: a retrospective comparison with high-risk HPV testing in cervical cancer screening.
Infect Agent Cancer. 2026 Apr 24. doi: 10.1186/s13027-026-00763.
Abstract

MENGISTIE MB, Mengstie SK, Teferi GH, Shume AW, et al
Predicting cervical cancer among women living with HIV/AIDS at public health facilities in a resource-limited setting in Ethiopia using machine learning analysis.
Discov Oncol. 2026 Apr 24. doi: 10.1007/s12672-026-05043.
Abstract

BAHRA N, Chami Y, Bekkali R, Bennani M, et al
Feasibility and acceptability of HPV testing using GeneXpert for cervical cancer screening in Morocco.
Sci Rep. 2026 Apr 24. doi: 10.1038/s41598-026-46200.
Abstract

MENICAGLI D, Casigliani V, Panizza F, Gandolfi S, et al
HPVoice: a single-blind three-arm RCT on social media communication strategies among adolescents in Tuscany, Italy.
Vaccine. 2026;79:128466.
Abstract

WEI T, Li Y, Zhang Z, Xu Y, et al
Global burden, trends, and attributable risk factors of women's cancers with projection to 2050: Results from the GLOBOCAN 2022 and global burden of disease study 2021.
Eur J Surg Oncol. 2026;52:111742.
Abstract

AJROUDI OE, Razzok EM, Khadija Z, Safae H, et al
Adherence to Human Papillomavirus Vaccination in the Province of Oujda-Angad, Morocco.
Public Health Nurs. 2026;43:595-605.
Abstract

KLEIN KV, Srivastava PV, Sauer JM, Trivedi N, et al
The Impact of a Student-Led Initiative to Improve Cancer Screenings in Primary Care.
Am J Prev Med. 2026;70:108262.
Abstract

RYSER MD, Bravo IG, Campos NG, Hammer A, et al
IPVS Consensus Statement on the Natural History of Cervical HPV Infection.
J Infect Dis. 2025 Nov 14:jiaf574. doi: 10.1093.
Abstract

GIGI AL, Vanslembrouck R, Bonne L, Timmerman D, et al
Technical results and clinical outcome of transcatheter embolization for severe post-hysterectomy intra-abdominal hemorrhage.
Rofo. 2026;198:635-643.
Abstract

YANG J, Song L, Yin R, Zhong L, et al
Cervical cancer with BRCA1 gene mutations: case reports and literature review.
Front Oncol. 2026;16:1742990.
Abstract

AKINTOLA A, Dareng EO, Adebamowo SN, Adebamowo CA, et al
Impact of educational intervention on the uptake of self-sampling for HPV test-based cervical cancer screening.
Front Oncol. 2026;16:1810950.
Abstract

ALANAZI AM, Dardouri S
CERV-Score: A Hybrid Machine Learning Framework for Cervical Cancer Risk Prediction Using Integrated Clinical and Genomic Data.
Int J Telemed Appl. 2026;2026:9913421.
Abstract

WENANG S, Sugiyo D, Sutantri S, Febrianti L, et al
Population-based self-sampling under primary care conditions - a possible approach for cervical cancer screening in Indonesia (IndoCerCa study).
Reprod Health. 2026 May 8. doi: 10.1186/s12978-026-02350.
Abstract

KEBEDE HK, Gesesew HA, Mwanri L, Ward P, et al
HIV care continuity for women in postconflict Tigray: assessing mother-to-child transmission rates, infant health and cervical cancer screening.
BMJ Glob Health. 2026;11:e023272.
Abstract

WANG JN, Liao LL, Yang F, Wang R, et al
TSPAN8-mediated Epithelial-mesenchymal Transition Drives Acquired Radioresistance in Cervical Cancer.
Radiat Res. 2026;205:513-527.
Abstract

DUSKA LR
Update on immune checkpoint inhibition for cervical cancer.
Clin Adv Hematol Oncol. 2026;24:167-169.
Abstract

CV S, Prakash GH, B Darukaradhya T
Cervical cancer and human papillomavirus (HPV) vaccination awareness Among university students: A global scoping review of knowledge, attitudes, and barriers.
J Oncol Pharm Pract. 2026 May 7:10781552261446556.
Abstract

GORAL S, Liljander A, Kai M, Cavalar M, et al
High-risk and low-risk human papillomavirus detection in self-collected samples compared to clinician-collected samples in a Polish population.
Front Public Health. 2026;14:1804719.
Abstract

JI X, Ji X, Chen S, Wang X, et al
Diagnostic accuracy of self-collected menstrual blood for high-risk human papillomavirus testing for cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis.
Front Microbiol. 2026;17:1782917.
Abstract

LAN J, Lu J, Dina T, Li Y, et al
Akiferidin suppresses cervical cancer growth and angiogenesis via the VEGF/DLL4-Notch pathway.
Front Pharmacol. 2026;17:1803135.
Abstract

LUMIA C, Fumagalli S, Martinelli M, Ausili D, et al
Adherence to HPV-Based Cervical Cancer Screening: A Concept Analysis for Nursing and Midwifery Practice.
J Multidiscip Healthc. 2026;19:601358.
Abstract

VAHEDPOOR Z, Matini A, Rahimi H, Lotfinia M, et al
Expression of Programmed Death-Ligand 1 in Cervical Cancer: Correlation With Histologic Subtypes and Clinicopathological Features.
Immun Inflamm Dis. 2026;14:e70464.
Abstract

ODEI-MENSAH B, Adeyemi SA, Ngema LM, Mndlovu H, et al
Nano-enabled targeted transdermal therapy for pain management in cervical cancer.
J Pharm Sci. 2026 May 4:104313. doi: 10.1016/j.xphs.2026.104313.
Abstract

DEBANTH A, Achary T, Halder P, Dasgupta A, et al
Time to treatment initiation delays in cervical cancer worldwide: A systematic review and meta-analysis.
Cancer Epidemiol. 2026;103:103095.
Abstract

CHAUHAN NK, Kumar A, Jain A, Singh K, et al
Optimizing cervical cancer diagnosis with a hybrid deep neural network and progressive resizing on pap smear WSIs.
Sci Rep. 2026 May 6. doi: 10.1038/s41598-026-49654.
Abstract

PEREZ-SANTOME I, Morales-Bravo SJ, Dominguez-Canto T
[Risk factors for cervical intraepithelial lesions among beneficiaries of second-level care].
Rev Med Inst Mex Seguro Soc. 2026;64:e6792.
Abstract

MCNICHOLAS C, Memmel L, Kaplan C, Hwang Y, et al
Addressing Cervical Cancer Screening Disparities: At-Home Self-Collection Among LGBQ+ Populations.
Cancer Control. 2026;33:10732748261448263.
Abstract

HARPER DM, Young AP
Cervical cancer screening intervals extendable to ten years for 9v HPV vaccinated persons.
Lancet Reg Health Am. 2026;58:101486.
Abstract

MOHAMED YB, Karimi SM
A comprehensive review of HPV vaccination policies in the United States.
Front Public Health. 2026;14:1810845.
Abstract

ZHOU Y, Liu H, Pan S, Ruan L, et al
Simvastatin Restores Cisplatin Sensitivity by Suppressing the Caveolin-1-Mediated PI3K/AKT Signaling Pathway in Cisplatin-Resistant Cervical Cancer Cells.
FASEB J. 2026;40:e71873.
Abstract

THAYER-FREEMAN C, Washington B, Cheek D, Luo W, et al
Impact of variation in the alpha/beta of cervical cancer on predicted clinical outcomes.
J Appl Clin Med Phys. 2026;27:e70608.
Abstract

CHEPKORIR J, Kim T, Zamora M, Han HR, et al
Patient portal notifications for breast and cervical cancer screening results: Perspectives of women with limited english proficiency.
Patient Educ Couns. 2026;149:109651.
Abstract

SHARMA J, Yennapu M, Kumar V
Implementation Barriers to Cervical Cancer Screening Program in Primary Health Facilities of South Delhi: A Qualitative Inquiry.
Indian J Public Health. 2026 Apr 18. doi: 10.4103.
Abstract

TODSAPORN D, Sanachai K, Suddee N, Kanjanapanyakom C, et al
Integrating QSAR-Machine Learning, Biochemical Assays, and Molecular Dynamics for the Discovery of JAK2 Inhibitors in Cervical Cancer.
J Chem Inf Model. 2026 May 5. doi: 10.1021/acs.jcim.6c00414.
Abstract

PAOLINO M, Basu P, Lucas E, Cucchiaro M, et al
Barriers and Facilitators of Programmatic HPV Testing: Lessons Learnt From Two In-Depth Provincial Case Studies Ten Years After the Jujuy Demonstration Project in Argentina.
Cancer Control. 2026;33:10732748261446046.
Abstract

B VS, Prabhu A, Koumar RC
Splicing: A New Dimension in Decoding the Complex Traits for Cervical Cancer.
Curr Cancer Drug Targets. 2026 Apr 27. doi: 10.2174/0115680096409242251125093718
Abstract

USSO AA, Mohammed H, Ahmed M
Cervical Cancer Screening Utilization Among Female Health Workers in Ethiopia: A Systematic Review and Meta-Analysis.
J Obstet Gynaecol Res. 2026;52:e70313.
Abstract

PRABHAKARAN A, Mathias EG, Sathiyamoorthy R, Bebarta NK, et al
Caring for the caregivers: breast and cervical cancer screening among informal caregivers of cancer patients - a scoping review.
BMC Prim Care. 2026 May 4. doi: 10.1186/s12875-026-03333.
Abstract

SHI Y, Zhang Z, Liu J, Zhu C, et al
RILPL2 suppresses metabolic reprogramming and progression of cervical cancer by attenuating LDHA protein stability and inhibiting H3K18 lactylation.
Cell Death Dis. 2026 May 4. doi: 10.1038/s41419-026-08808.
Abstract

MARTINEZ MONTANEZ OG, Pico-Guzman FJ, Zavaleta GG, Tinoco Vazquez HR, et al
The cost-saving impact of human papillomavirus self-sampling for cervical cancer screening in women workers at the manufacturing sector in Ciudad Juarez, Chihuahua, Mexico.
PLOS Glob Public Health. 2026;6:e0006389.
Abstract

YAN Y, Guan S, Chen W, Shi J, et al
Trends, disparities, and multilevel interventions: A global review of HPV vaccination among university students.
Hum Vaccin Immunother. 2026;22:2667395.
Abstract

CHI C, Xu M, Zhang J, Zhang Y, et al
CAF-Secreted Exosomes Deliver BMP4 to Confer Radiotherapy Resistance in Cervical Cancer Through a Novel Mechanism Linking Nrf2 Activation to Cuproptosis Inhibition.
FASEB J. 2026;40:e71838.
Abstract

LIANG C, Li M, Wang H, He T, et al
Lower Limb Nonvisualization Caused by Macroarterial Thrombosis After Cervical Cancer TP Chemotherapy in Whole-body Bone Scintigraphy.
Clin Nucl Med. 2026;51:497-499.
Abstract

RAMSEYER TG, Batson B, Wu D, Matsko JL, et al
Pap testing and high-risk HPV testing for women aged 65 years and older with surgical pathology follow-up.
Cancer Cytopathol. 2026;134:e70111.
Abstract

WANG X, Zhang Y, Wang C, Huang L, et al
Efficacy and safety of first-line therapies for persistent, recurrent, or metastatic cervical cancer: a systematic review and exploratory network meta-analysis of immunotherapy.
Front Immunol. 2026;17:1789532.
Abstract

CORN E, Becht K, Adefres B, Monare B, et al
The challenges of implementing less invasive surgical management for cervical cancer in a limited-resource setting in Botswana: A case series.
Gynecol Oncol Rep. 2026;65:102089.
Abstract

ISMAIL F, Zakaria Y, Md Isa ML, Nik Hassan NF, et al
SF1, a Standardised Fraction from Clinacanthus nutans Modulates Notch1 Signalling in Cervical Cancer Stem-Like Cells.
Malays J Med Sci. 2025;32:38-50.
Abstract

BAI J, Huang J, Zhang Q, Su W, et al
Preparation of PSA-DOX/ICG-Lip and Evaluation of Its Efficacy Against Cervical Cancer.
Pharmaceutics. 2026;18:434.
Abstract

SOZEN I, Sahin G, Ulu Y, Yitiz D, et al
Cytology-Biopsy Concordance in High-Risk Human Papillomavirus-Positive Women with Abnormal Cytology Findings: Menopause-Stratified Analysis.
Medicina (Kaunas). 2026;62:631.
Abstract

BOLARINWA O, Bashir SG, Okyere J, Abdi YH, et al
Burden, Regional Trends and Risk Factors of Breast, Cervical, Uterine, and Ovarian Cancers in Sub-Saharan Africa, 1990-2023: The Global Burden of Disease 2023.
Int J Environ Res Public Health. 2026;23:419.
Abstract

THAIJIAM C, Navaitthiporn N, Rithcharung P, Piyawattanametha N, et al
Development of a Telehealth-Enabled Portable Optical Endomicroscopy System with Targeted Peptides: A Preclinical Feasibility Study for Cervical Cancer Detection.
Cancers (Basel). 2026;18:1306.
Abstract

LUCA DC, Cirimbei C, Ionescu SO, Rotaru V, et al
Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Review.
Diagnostics (Basel). 2026;16:1224.
Abstract

BRISSON M, Drolet M, Gingras G, Laprise JF, et al
Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study.
Lancet. 2026;407:1726-1737.
Abstract

CLIFFORD GM
HPV vaccine scale-up is key to curb rising cervical cancer inequalities.
Lancet. 2026;407:1662-1663.
Abstract

LIN B, Gruschow K, Burke A, Zhou X, et al
Supporting breast and cervical cancer screening follow-up: qualitative health plan interviews.
BMC Health Serv Res. 2026 May 2. doi: 10.1186/s12913-026-14641.
Abstract

THI NGOC TOAN A, Palmer MR, Phung TL, Nguyen PT, et al
Trends and disparities in cervical cancer screening prevalence in Vietnam: Evidence from the 2015 and 2021 WHO STEPS surveys.
J Cancer Policy. 2026;48:100748.
Abstract

ZHOU W, Xu Q, Qiu T, Wang J, et al
Importin-7 Facilitates Cervical Cancer Progression Through MSI2 Nuclear Import and Is Associated With MSI2-MYC-Linked Glycolytic Reprogramming.
Transl Res. 2026 Apr 29:S1931-5244(26)00087-3. doi: 10.1016/j.trsl.2026.
Abstract

SATTURWAR S, Parwani AV, Li Z
Advances in Digital Cytopathology and Artificial Intelligence Applications.
Adv Anat Pathol. 2026;33:190-200.
Abstract

QIAN D, Zhao L, Lin F, Wang L, et al
Oncolytic human adenovirus 5 (H101) modulates cell cycle progression in HPV16-positive tumors.
Biochem Biophys Res Commun. 2026;818:153747.
Abstract

GHASRI S, Johnson EE, Harris BM, Forsythe I, et al
Barriers and facilitators to using self-sampled tests for the human papillomavirus (HPV): a mixed-methods study to inform a horizon scan.
Int J Technol Assess Health Care. 2026;42:e46.
Abstract

XU MA, Pant S, DiClemente RJ
Factors affecting human papillomavirus vaccination: A review of individual, interpersonal, and structural factors affecting vaccine uptake among adolescents.
Vaccine. 2026;81:128563.
Abstract

DENG X, Zhu T, Wang Y, Hu B, et al
Reinforcement learning-based WSI diagnostic system for cervical squamous cell carcinoma and precancerous lesions.
J Transl Med. 2026;24:632.
Abstract

SHABANI V, Reci M, Veselievska Stojkovska V
Cervical Cytology and Age in HPV-Infected Women in North Macedonia: A Cross-Sectional Study.
Acta Med Acad. 2026;55:21-29.
Abstract

BENOIT M, Makki H, Almadin C, Lacaille J, et al
Colposcopy Follow-up and Findings in Women with Lower-Grade Lesions on Screening Cytology Who were Eligible for Free Human Papillomavirus Vaccination.
J Obstet Gynaecol Can. 2026;48:103267.
Abstract

LEWIS JA, Foote S, Cooper E, Butterley C, et al
Enhancing Human Papillomavirus Vaccination Uptake After Loop Electrosurgical Excision Procedure (LEEP) at Colposcopy: A Quality Improvement Study.
J Obstet Gynaecol Can. 2026;48:103266.
Abstract

RAIMUNDO GA, Batistella T, Johann Fensterseifer M, Silveira da Silva L, et al
Injection molded multidrug intravaginal rings with antimicrobial properties for prophylaxis and cancer treatment in women's health context.
Drug Dev Ind Pharm. 2026;52:853-865.
Abstract

CHEN J, Guo Y, Tang Y, Xiao R, et al
Clinical and Imaging Features of Gastric-Type Endocervical Adenocarcinoma: A Report of 9 Cases with Literature Review.
J Ultrasound Med. 2026;45:1289-1296.
Abstract

ZHANG H, Li J, Xu H, Zhang S, et al
Identifying Key Epigenetic Modification-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma and Cellular Validation.
Curr Gene Ther. 2026;26:1-13.
Abstract

LIN L, Li N, Hu X, Sun J, et al
Identification of circ_0085616 as an Upregulated and Oncogenic Circular RNA in Cervical Cancer Via the miR-503-5p-Mediated ATXN7L3 Activation.
Cancer Biother Radiopharm. 2026;41:244-256.
Abstract

MA Z, Cai Y, Zhang L, Tian C, et al
LINC00319 Promotes Cervical Cancer Progression Via Targeting miR-147a/IGF1R Pathway.
Cancer Biother Radiopharm. 2026;41:234-243.
Abstract

KWOK C, Endrawes G, Lee CF
Cervical Cancer Screening Beliefs Questionnaire: Development and Psychometric Assessment With Immigrants in Australia.
West J Nurs Res. 2026 May 15:1939459261440462. doi: 10.1177/01939459261440462.
Abstract

BAK P, Ciechacka M, Al-Jeabory M, Ziemianska JK, et al
Adaptation to neoplastic disease among women diagnosed with breast cancer and cervical cancer, taking into account the type of surgical procedure and sociodemographic factors.
Ginekol Pol. 2026;97:297-304.
Abstract

YOLANDA F, Dewi TP, Nainggolan SI, Munawar M, et al
Multi-stakeholder perspectives on cervical cancer screening implementation in Indonesia: A qualitative study of cervical screening barriers in Banda Aceh.
Narra J. 2026;6:e3022.
Abstract

WANG Y, Yue ZN, Yang H
Impact of adjuvant therapy after radical hysterectomy for early-stage cervical cancer on mortality and recurrence: a systematic review and meta-analysis.
Front Oncol. 2026;16:1743116.
Abstract

ZHOU J, Liao JH, Su LJ, Chen Y, et al
Informative HPV testing after conization and its impact on time-varying estimates: a GAMM-based cohort study.
Front Public Health. 2026;14:1808122.
Abstract

TRIPATHI T, Joshi U, Chaudhary A, Janjua D, et al
Morusin Attenuates Cancer Stemness and Modulates CSC-driven Macrophage Polarization in Cervical Cancer.
Anticancer Agents Med Chem. 2026.
Abstract

ZHAO X, Chang L, Duan W, Liu L, et al
HPV E6/E7 mRNA vs. HPV DNA in co-testing with ThinPrep cytology for cervical cancer screening: a prospective observational diagnostic accuracy study of methylation biomarkers.
J Gynecol Oncol. 2026 Apr 22. doi: 10.3802/jgo.2026.
Abstract

FODJO MT, Youmbi AK, Mayeh M, Whegang S, et al
Modeling the impact of budget limitation on the screening and treatment pathway of HPV-induced precancerous cervical lesions.
Math Biosci Eng. 2026;23:1501-1533.
Abstract

ZHAO J, Li Z, Qiu H, Wang J, et al
Gastric-Type Adenocarcinoma of the Uterine Cervix From 2013 to 2023: Clinical Characteristics and Outcomes.
J Obstet Gynaecol Res. 2026;52:e70316.
Abstract

ADEPOJU OE, Xu T, Ramirez-Pulido G, Angelocci T, et al
Individual and Co-Occurring Social Needs, and Breast and Cervical Cancer Screening Among Patients in Texas Federally Qualified Health Centers.
J Prim Care Community Health. 2026;17:21501319261448952.
Abstract

MBOUMBA BOUASSA RS, Muwonga Tukisadila J, Loemba H, Belec L, et al
Human papillomavirus viral load as promising surrogate biomarker of cervical cancer risk and clinical outcome.
Expert Rev Mol Diagn. 2026 May 14. doi: 10.1080/14737159.2026.2675388.
Abstract

WONG L, Munigala S, Banaag A, Coles C, et al
Guideline Concordant Cervical Cancer Screening Among Active-Duty Servicewomen in the U.S. Military from 2017 to 2022.
J Womens Health (Larchmt). 2026 May 14:15409996261443156.
Abstract

CHEMA TZ, Woldetsadik ES, Zingeta GT, Bedada HF, et al
Symptom palliation with QUADSHOT regimen for advanced cervical cancer patients in Tikur Anbessa Specialised Hospital: a prospective cohort study.
Ecancermedicalscience. 2026;20:2085.
Abstract

GUZELBAG B, Uzuner EG, Selcuk M, Ermin S, et al
Twelve-year trends in cervical cytology screening: a retrospective analysis of 83,148 smears from a Turkish tertiary care center.
Front Public Health. 2026;14:1818289.
Abstract

WANG Z, Zhang W, Meng X, Liang Y, et al
Test-time adaptation-driven patient-specific auto-segmentation for CBCT-guided online adaptive radiotherapy in cervical cancer.
J Appl Clin Med Phys. 2026;27:e70609.
Abstract

BRUNISSEN L, Diwan NM, Kocher EL, Suvada K, et al
Provider attitudes and organizational support for cervical cancer screening implementation across PEPFAR-supported HIV clinics in Kenya.
Implement Sci Commun. 2026 May 13. doi: 10.1186/s43058-026-00958.
Abstract

ABDELHAY EH, Elgamily KM, Badr WOE
Metaheuristic optimization of deep CNNs for multi-class diagnosis of cervical cancer and lymphoma.
Sci Rep. 2026;16:15110.
Abstract

DEL REAL-ORDONEZ S, Reynoso-Noveron N, Perez-Montiel MD, Salcedo-Hernandez RA, et al
[Sensitivity and validity of sentinel node biopsy in early-stage cervical cancer at an oncology institution].
Cir Cir. 2026 May 13. doi: 10.24875/CIRU.24000532.
Abstract

LIAN X, Qi H, Lin D, Wu Q, et al
Real-world efficacy, safety, and associated biomarkers of cadonilimab in cervical cancer: a prospective observational study.
Front Immunol. 2026;17:1723923.
Abstract

KAUL IK, Garber BL, Koch TL, Altomare AL, et al
Understanding Barriers to Cervical Cancer Screening: A Quality Improvement Project in the HIV Clinics at Dartmouth Health.
AJPM Focus. 2026;5:100488.
Abstract

TEJADA R, Baena A, Trujillo L, Rodriguez J, et al
Impact of switching from a quadrivalent to a nonavalent HPV vaccine on HPV infections and cervical cancer in Colombia: a mathematical modelling study.
Lancet Reg Health Am. 2026;58:101483.
Abstract

AGRAWAL A, Archana, Shakya P, Verma U, et al
Evaluation of Different Diagnostic Modalities for Screening and Molecular Characterization of Human Papillomavirus Causing Cervical Cancer.
J Midlife Health. 2026;17:111-116.
Abstract

XI M, Ao M, Li J, Zhang S, et al
Risk of High-Grade Cervical Intraepithelial Neoplasia Using human Papillomavirus Extended Genotyping in Chinese Women With Normal Cervical Cytology: A Population-Based Screening Cohort.
J Med Virol. 2026;98:e70968.
Abstract

MASOUD M, Shastri C, Banerjee R, Dasgupta S, et al
Genome-Wide DNA Methylation Profiling Reveals Ancestry-Associated Epigenetic Reprogramming in Cervical Intraepithelial Neoplasia.
Int J Mol Sci. 2026;27:3986.
Abstract

GREEGRAINUCH K, Kansandee W, Pientong C, Ekalaksananan T, et al
Antiviral and Anticancer Activities of Stingless Bee Propolis from Tetragonula drescheri and Tetragonula pagdeni: Toward Development of Prototype Healthcare Pharmaceuticals.
Int J Mol Sci. 2026;27:3855.
Abstract

YIN L, Lv F
Ultrasound-Clinical Machine Learning Models for Differentiating Early Cervical Cancer from Myoma: A Retrospective Exploratory Study.
J Clin Med. 2026;15:3300.
Abstract

JURCZAK M, Charzewski L, Gozlinska B, Albrycht P, et al
Artificial Intelligence-Assisted Colposcopy: Deep Learning Multi-Class Segmentation of Anatomical Structures and Pathological Findings for Cervical Cancer Screening.
Cancers (Basel). 2026;18:1485.
Abstract

TIAN D, Du M, Zheng Z, Wang W, et al
NSUN4 Suppresses Ferroptosis Through m(5)C-Dependent Stabilization of C-MYC and Activation of the PI3K/Akt Signaling Pathway in Cervical Cancer.
Cancers (Basel). 2026;18:1392.
Abstract

TAMENANG A, Vohl V, Schwartz C, Kropidlowski J, et al
Circulating microRNA Profiles as Diagnostic Tools for High-Grade Cervical Lesions and HPV Genotype Stratification.
Cells. 2026;15:849.
Abstract

PAHRIA T, Haroen H, Agustina HR, Sari CWM, et al
Women's experiences toward cervical cancer care at the initiation of care: a qualitative study closing the gap policy and implementation in Indonesia.
BMC Womens Health. 2026 May 13. doi: 10.1186/s12905-026-04493.
Abstract

KULKARNI V, Jaiswal A, Kshirsagar N, Arya M, et al
Accelerated MRI-Guided Brachytherapy in Cervical Cancer.
Clin Oncol (R Coll Radiol). 2026;55:104172.
Abstract

KANG Y, Zhuang L, Chang L, Liu J, et al
The Prognosis of Patients With Large Cell Carcinoma of the Cervix: A Retrospective Study of the SEER Database and a Chinese Multi-Center Registry.
Cancer Control. 2026;33:10732748261449853.
Abstract

LI J, Wang Y, Xu Z, Ao S, et al
Comparative analysis of cervical cancer burden trends between China and G20 countries from 1990 to 2023 with projections to 2035: A population-based observational study.
Medicine (Baltimore). 2026;105:e48640.
Abstract

LIU H, Huang F, Da H, Yin Q, et al
Absence of causal association between CD40-CD40L signaling and cervical cancer risk: A Mendelian randomization study.
Medicine (Baltimore). 2026;105:e48638.
Abstract

YU H, Liang H, Liang X, Lin H, et al
The influence of robotic-assisted systems on the surgical approach and outcomes in hysterectomy for benign and malignant diseases.
J Robot Surg. 2026;20:484.
Abstract

GARG P, Kumar P, Gupta M, Bindal P, et al
Determinants of cervical cancer screening and HPV vaccination among female medical practitioners in Punjab, India.
Sci Rep. 2026 May 11. doi: 10.1038/s41598-026-52609.
Abstract

HAN Y, Wang C, Wang X, Sun S, et al
Clinical Implementation of Dual-Isocenter MR-Guided Radiotherapy for Large-Target Cervical Cancer: A Dosimetric and Workflow Analysis.
Pract Radiat Oncol. 2026 May 9:S1879-8500(26)00144.
Abstract

XIE T, He Y, Tan M, Gao Y, et al
Caprin-1 silencing reverses YY1/HSP90alpha-mediated IDH1 stabilization to induce ferroptosis and sensitize cervical cancer to cisplatin.
Cell Signal. 2026;145:112584.
Abstract

QI L, Zhu D, Qian L, Yi B, et al
SIRT1-mediated deacetylation stabilizes cortactin to enhance glycolysis and drive cervical cancer progression.
Cell Signal. 2026 May 9:112587. doi: 10.1016/j.cellsig.2026.112587.
Abstract

DE OLIVEIRA HF, de Souza FD
Comment on: "The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer".
Clinics (Sao Paulo). 2026;81:100953.
Abstract

SIDONIE M, Elisabete G
Oncologic, pregnancy, and reproductive outcomes of fertility-sparing surgery in early-stage cervical cancer: a systematic review.
Surg Oncol. 2026;66:102439.
Abstract

HOLT HK, Ransohoff AK, Sawaya GF
Self-Collected HPV Testing for Cervical Cancer Screening-Responsible Implementation to Reduce Disparities.
JAMA Intern Med. 2026 May 11. doi: 10.1001/jamainternmed.2026.1212.
Abstract

RAHAVI H, Najafi A, Asgarian-Omran H, Aflatoonian B, et al
Dual Blockade of PD-L1 and AXL: A Novel Immunotherapeutic Approach for Ovarian and Cervical Cancer.
Iran J Allergy Asthma Immunol. 2026;25:234-250.
Abstract

SACHIT BA, Dass S, Rajan RS, Tye GJ, et al
Integrated in silico-in vitro identification of high-affinity TCR-Like antibodies targeting HPV18 E6/E7 for cervical cancer detection.
Arch Virol. 2026;171:177.
Abstract

LIN J, He H, Liu B, He T, et al
The exploration of iparomlimab and tuvonralimab combined with de-escalated chemotherapy as an innovative neoadjuvant treatment strategy for locally advanced cervical cancer: a case report from the NICE-CC trial.
Front Immunol. 2026;17:1801164.
Abstract

ZHANG Y, Xing W, Liang X, Ma Y, et al
A retrospective analysis of the prognostic value of nutritional-inflammatory markers for patients with cervical cancer.
PeerJ. 2026;14:e21273.
Abstract

SOUSA R, Fonseca-Moutinho JA, Gomes F, Loureiro F, et al
Impact of the transition to HPV-based primary screening in Portugal's organized cervical cancer screening program: A controlled interrupted time-series analysis (2014-2023).
Public Health Pract (Oxf). 2026;11:100792.
Abstract

NDAKUKAMO EK, Mahalie R, Hailonga-Van Dijk P
Health-seeking behaviour of rural women regarding cervical cancer prevention in Namibia: A qualitative study.
J Public Health Afr. 2026;17:1632.
Abstract

MiR-155-5p Accelerates the Metastasis of Cervical Cancer Cell via Targeting TP53INP1 [Retraction].
Onco Targets Ther. 2026;19:620871.
Abstract

XU S, Li Y, Yi X, Yan Z, et al
Nationwide epidemiology of HPV E6/E7 mRNA in China: genotype distribution in 11,118 women.
Front Public Health. 2026;14:1797051.
Abstract

WAN M, Zhong T, Shi W, Shen J, et al
PRDM1 Is Associated with Chemoradiotherapy-Associated Enrichment of Adaptive NK Cells in Cervical Cancer.
Comput Struct Biotechnol J. 2026;35:0092.
Abstract

WANG X, Xiong D, Cui S, Duan B, et al
Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends, 2015-2024.
Front Oncol. 2026;16:1732209.
Abstract

XIAO H, Qu A, Sun H, Zhang X, et al
Dosimetric impact of two multileaf collimator systems in simultaneous integrated boost volumetric modulated arc therapy for lymph node metastases in stage IIIC cervical cancer.
Front Oncol. 2026;16:1805020.
Abstract

LOSHNI V, Lakshmi T, Balaji R
GC?MS analysis, molecular docking, molecular dynamics simulation, and pharmacokinetic profiling of bioactive compounds from Terminalia bellirica seeds against cervical cancer targets.
In Silico Pharmacol. 2026;14:136.
Abstract

LEE KH, Jeong JH, Park CJ, Kim YS, et al
Extensive Grouped Papules on the Vulva in a Patient with Cervical Cancer.
Indian J Dermatol. 2026;71:256.
Abstract

MATSUNAGA A, Ogawa M, Kunita A, Ikeda Y, et al
Type-specific detection and quantification of circulating tumor HPV DNA by digital PCR in surgically resected cervical cancer.
J Gynecol Oncol. 2026 Apr 22. doi: 10.3802/jgo.2026.
Abstract

COMMEH ME, Husain N, Afrane CB, Apatu M, et al
Partnership Driving Impact: An Integrated Women-Centric Model to Improve Early Detection and Treatment of Cervical and Breast Cancer in Ghana and India.
Cancer Med. 2026;15:e71890.
Abstract

RIGGENBACH E, Tadic T, Han K
Uterine ultra-mover in cervical cancer radiotherapy: retroversion and the rationale for online adaptive planning.
Pract Radiat Oncol. 2026 May 8:S1879-8500(26)00137.
Abstract

BAHRUN, Melanie H, Artanti N, Anita Y, et al
Integrated In vitro, network pharmacology, and In silico analysis reveal the anti-cervical cancer properties of calcareous green algae Halimeda sp.
Comput Biol Chem. 2026;124.
Abstract

HELLSTEN C, Magnusson L, Borgfeldt C
Women's reasoning and experience in the cervical cancer screening programme when offered a self-sampling HPV test: a qualitative content analysis.
BMC Womens Health. 2026;26:239.
Abstract

PAKONEN J, Jensen A, Cruz Zorrilla M, Gutierrez R, et al
Beyond Free Screening: Structural Barriers to Follow-Up Cervical Cancer Care Among Uninsured Hispanic Women in Minnesota, 2020-2021.
Public Health Rep. 2026 May 9:333549261442167. doi: 10.1177/00333549261442167.
Abstract

HABIBA U, Ayaz M, Islam N
Machine Learning-driven Prediction of Cervical Cancer Cell Viability After Treatment With Thymoquinone, Curcumin, and 5-Fluorouracil.
Appl Biochem Biotechnol. 2026 May 9. doi: 10.1007/s12010-026-05704.
Abstract

ARNO A, Pernazza A, Leopizzi M, Benedettucci E, et al
Clinical relevance and prognostic role of PDL-1 expression in cervical cancer patients.
Arch Gynecol Obstet. 2026;313:193.
Abstract

SOYLER S, Sipahi BB, Cavmak D
Exploring barriers to women's participation in breast and cervical cancer screening programs: insights from national health surveys in Turkiye.
BMC Health Serv Res. 2026 May 7. doi: 10.1186/s12913-026-14656.
Abstract

KUMAR M, Barmon D, Baruah U, Begum D, et al
Disease laterality independently predicts survival in stage IIIB cervical cancer in a prospective cohort study from Northeast India.
Sci Rep. 2026 May 8. doi: 10.1038/s41598-026-48514.
Abstract

Corrigendum to "A Novel Network-Level Fused Self-Attention Deep Neural Network for Cervical Cancer Classification from Cervicography Images".
Technol Cancer Res Treat. 2026;25:15330338261451109.
Abstract

ZELEKE AJ, Reifferscheid L, Yunusa U, Gandhi K, et al
Population-level impact of HPV vaccination: a global systematic review of ecological, cross-sectional, and cohort studies.
Expert Rev Vaccines. 2026;25:2667734.
Abstract

LIN S, Luo Z, Li Y, Hu B, et al
Integrated spatial multi-omics delineates fatty acid degradation fuels malignant evolution at the tumour periphery in cervical squamous cell carcinoma.
EBioMedicine. 2026;127:106256.
Abstract

BENDARI A, Ahsan BU, Mohammed H, Al-Refai R, et al
Clinicopathologic Features of Six Patients With Metastatic Carcinoma to the Uterine Cervix.
Int J Surg Pathol. 2026;34:997-1006.
Abstract

PEREZ AN, Curry JL, Madewell JE, Meis JM, et al
Florid Pseudosarcomatous Polypoid Fibroplasia: An Unusual Cutaneous Manifestation of Chronic Lymphedema.
Int J Surg Pathol. 2026;34:970-975.
Abstract

SAUNDERS T, Boyd L, Machado Colling A, He J, et al
Nurse Roles Implementing the Choice for Self-Collection Cervical Screening in Rural Settings: A Qualitative Study Following National Policy Change.
J Adv Nurs. 2026;82:6543-6556.
Abstract

HALM EA, Del Vecchio NJ, Rendle KA, Tiro JA, et al
Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium.
J Gen Intern Med. 2026;41:1761-1770.
Abstract

THOMPSON EL, Griner SB, Akpan IN, Maness SB, et al
HPV Vaccination Knowledge, Attitudes, and Behaviors Among Clinic Teams in North Texas.
J Cancer Educ. 2026;41:296-301.
Abstract

MINAMITANI M, Katano A, Ohira S, Hayashi T, et al
Evaluating Behavioral Impacts of School Cancer Education Programs Several Months and Years After Implementation in Japan.
J Cancer Educ. 2026;41:270-276.
Abstract

JORGENSEN SF, Nielsen ML, Njor SH
Adherence to recommended follow-up in opportunistic versus non-opportunistic cervical screening: a registry-based cohort study from Denmark.
Scand J Public Health. 2026;54:297-306.
Abstract

TAN L, Xia Y, Teng D, Zhao D, et al
Comparative evaluation of conventional radiomics and VGG-SAM fusion strategies for MRI-based preoperative prediction of perineural invasion in cervical cancer.
Abdom Radiol (NY). 2026 May 22. doi: 10.1007/s00261-026-05559.
Abstract

VAN DER MERWE FH, Dreyer G, Visser C, Dreyer GJ, et al
Extended Genotyping as Triage of HPV Positive Screened Women in Low-and-Middle Income Countries.
J Med Virol. 2026;98:e70981.
Abstract

Retraction: "LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205".
Tumour Biol. 2026;48:14230380251408221.
Abstract

Retraction: "MicroRNA-337 inhibits cell proliferation and invasion of cervical cancer through directly targeting specificity protein 1".
Tumour Biol. 2026;48:14230380261450003.
Abstract

HIRAI R, Ohta T, Igari M, Kumazaki Y, et al
Mixed reality-guided intraoperative visual support for combined intracavitary and interstitial brachytherapy for cervical cancer.
Tech Innov Patient Support Radiat Oncol. 2026;38:100408.
Abstract

HE Q, Yin C, Mei J, Yin C, et al
Establishment of PDX/PDXO models to evaluate the antitumor efficacy and mechanism of Abemaciclib in gastric-type cervical cancer.
Histol Histopathol. 2026 May 22:25095. doi: 10.14670.
Abstract

MOHAMMED AJ, Salman SA, Chyad A, Abd Alredha RD, et al
Diagnostic Performance of Serum VEGF and M-CSF in Cervical Cancer and, Their Association with Stage.
Asian Pac J Cancer Prev. 2026;27:1883-1891.
Abstract

MADIUW D, Nivaan GV, Maelissa SR, Patty J, et al
Developing and Validating an Integrated Sinara Application as a Database for Cervical Cancer Risk in Indonesia.
Asian Pac J Cancer Prev. 2026;27:1827-1834.
Abstract

IBRAHIMOV A, Novruzova F
Clinical Significance of Atypical Squamous Cells of Undetermined Significance (ASC-US) and Atypical Squamous Cells-Cannot Exclude High-Grade Squamous Intraepithelial Lesion (ASC-H) in a Low-Income Clinical Setting: A Retrospective Analysis.
Asian Pac J Cancer Prev. 2026;27:1805-1810.
Abstract

WILOPO SA, Harisaputra RK, Hadati RS, Mustikaningtyas M, et al
Indonesian Midwives' Readiness to Upscale the Secondary Prevention of Cervical Cancer within Primary Health Clinics: A Qualitative Study of Midwives Across Three Provinces.
Asian Pac J Cancer Prev. 2026;27:1671-1677.
Abstract

CURI FSA, Campaner AB, De Sica ACAR
Comparative Analysis of Quality of Cell Collected from the Cervix: Conventional versus Liquid-Based Cytology.
Asian Pac J Cancer Prev. 2026;27:1609-1614.
Abstract

BALASUBRAMANI L, Nayak B, Singh N, Singhal S, et al
AOGIN India Policy Statement on the Use of HPV Vaccination for Cervical Cancer Elimination.
Asian Pac J Cancer Prev. 2026;27:1603-1607.
Abstract

RATTANAPITOON SK, Thanchonnang C, Rattanapitoon NK
Comment on: Introduction of the HPV Vaccine among Young Girls to Reduce the Long-Term Risk of Cervical Cancer in Eswatini.
Asian Pac J Cancer Prev. 2026;27:1551-1552.
Abstract

LIU Z, Liu G, Liu S, Wang X, et al
Methylation-based biomarkers from thin-prep cytology test samples for early detection of cervical cancer: application and clinical potential.
Clin Epigenetics. 2026 May 21. doi: 10.1186/s13148-026-02154.
Abstract

AUTORINO R, Rinaldi RM, Cusumano D, Russo L, et al
Pelvic insufficiency fractures in cervical cancer patients treated with definitive chemoradiation: impact of dosimetric and clinical factors.
Strahlenther Onkol. 2026 May 21. doi: 10.1007/s00066-026-02518.
Abstract

SCHEVENHOVEN VJC, Jansen EEL, de Kok IMCM
Corrigendum to "Determining the optimal cervical cancer screening exit strategy in the Netherlands" Preventive Medicine, 197 (2025) 108329.
Prev Med. 2026 May 21:108602. doi: 10.1016/j.ypmed.2026.108602.
Abstract

TABCHE C, Atwan Z, Al Khaldi S, Sidiropoulou Z, et al
Cervical cancer in the Arab world: knowledge gaps, health system and cultural barriers, and the path forward.
Cancer Treat Res Commun. 2026;48:101250.
Abstract

Statement of Retraction: In vivo and in vitro studies of Alloimperatorin induced autophagy in cervical cancer cells via reactive oxygen species pathway.
Bioengineered. 2026;17:2667625.
Abstract

CHEN X, Xu P, Zhang H, Su X, et al
Erratum: [Corrigendum] EGFR and ERK activation resists flavonoid quercetin-induced anticancer activities in human cervical cancer cells in vitro.
Oncol Lett. 2026;32:287.
Abstract

SOZERI A, Gokmen N, Kayali E, Cuylan ZF, et al
Differentiation of cervical cancer subtypes using machine learning models on MRI images.
Pol J Radiol. 2026;91:e195-e204.
Abstract

WEI F, Du Y, Hu H, Li W, et al
Development and internal-external validation of a nomogram for predicting postoperative 30-day malnutrition risk in cervical cancer patients: a retrospective cohort study.
Am J Cancer Res. 2026;16:1289-1311.
Abstract

CIRBAN EKREM E, Temiz M
Human Papillomavirus (HPV) Awareness, HPV-Related Concern, and Fear of Cancer as Predictors of Attitudes Toward Cervical Cancer Prevention in Women.
J Obstet Gynaecol Res. 2026;52:e70338.
Abstract

MA Y, Chu J, Li Y, Long J, et al
Paris polyphylla saponin ? induces autophagy-associated ferroptosis by regulating the BECLIN1/SLC7A11 axis in cervical cancer.
Eur J Pharmacol. 2026;1027:178969.
Abstract

CAO Q, Lin Y, Guan H, Dong C, et al
SPP1 knockdown inhibits invasion, migration and paclitaxel-induced Epithelial-Mesenchymal Transition in Cervical Cancer Cells through the TGF-beta/Akt/Snail pathway.
Sci Rep. 2026 May 20. doi: 10.1038/s41598-026-53597.
Abstract

THAY S, Vantha T, Norman J, Vanthanax C, et al
A new model for cervical cancer screening in Cambodian garment workers.
BMJ Glob Health. 2026;11:e019100.
Abstract

VERHOEVEN Y, Quatannens D, van der Heijden S, Claes J, et al
CD155 links tumor immunotype to epithelial-directed precision therapy beyond checkpoint inhibition in cervical cancer.
J Immunother Cancer. 2026;14:e014834.
Abstract

KESELAKOVA A, Nosalova N, Majirska M, Kello M, et al
2-epi-Jaspine B induces mitochondria-mediated and autophagic cell death via ceramide overload in a cervical cancer model.
Gen Physiol Biophys. 2026;45:47-62.
Abstract

XIONG J, Tuxun H, Ding J, Dong B, et al
Designable NIR-II light triggered biocompatible Au NRs for highly efficient photothermal therapy of cervical cancer.
RSC Adv. 2026;16:25705-25716.
Abstract

LIU Y, He T, Chen S, Wang S, et al
Application of a modified MSRE-qPCR method for detecting circulating cell-free DNA methylation in cervical cancer.
Front Oncol. 2026;16:1759488.
Abstract

NONNIS L, Putzu L, Vincis M, Guerriero S, et al
AI for cervical cancer screening on whole slide images: opportunities with open-source simple tools.
Pathologica. 2026;118:85-95.
Abstract

ZHOU L, Luo W, Qin R, Wang D, et al
Algorithm-driven HPV vaccine allocation paradigm for cervical cancer elimination targeting the Chinese population.
NPJ Digit Med. 2026 May 19. doi: 10.1038/s41746-026-02775.
Abstract

STRUNK J, Huppner A, Sial M, Plath M, et al
The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growth.
Commun Biol. 2026;9:678.
Abstract

ANDREASEN EK, Arum A, Pedersen H, Dahl Nielsen T, et al
Women's preference for HPV self-sampling devices: a programme-embedded, large-scale paired comparative study within the cervical cancer screening programme in the Capital Region of Denmark.
BMJ Open. 2026;16:e112643.
Abstract

KUMARI S, Wairkar S
Emerging Aptasensor Approach for Biomarkers Relevant to Cervical Cancer: A Critical Review.
Prog Biomed Eng (Bristol). 2026 May 19. doi: 10.1088/2516-1091.
Abstract

DONG C, Zhang B, Song J, Lin Y, et al
TGFA promotes the development of cervical cancer via interacting with DSG2.
Cell Cycle. 2026;25:1-14.
Abstract

GORNIAK K, Lupkowski R, Puskulluoglu M, Blecharz P, et al
Emerging immune checkpoint inhibitor strategies in cervical cancer: a scoping review of ongoing clinical trials.
Expert Rev Anticancer Ther. 2026 May 22:1-11. doi: 10.1080/14737140.2026.2677932
Abstract

VERSTRAETEN M, Stevens D
[Atoll sign: A CT finding with clinical impact].
Ned Tijdschr Geneeskd. 2026;170:D8752.
Abstract

YUAN H, Okada A, Yasunaga H
Association between metformin use and cervical cancer risk in women with diabetes in Japan: a retrospective cohort study.
Ann Clin Epidemiol. 2025;8:46-53.
Abstract

MAMINA AEH, Vilaly K, Zein EE, Memah MN, et al
[Clear cell carcinoma of the cervix in Mauritania: a case report].
Pan Afr Med J. 2026;53:32.
Abstract

ALAM BEGH MZ, Zehravi M, Sweilam SH, Shanmugarajan TS, et al
Plant-Derived Pathway Modulators: A Natural Strategy to Combat Cervical Cancer.
Curr Top Med Chem. 2026 May 12. doi: 10.2174/0115680266411142251201065848.
Abstract

WAKANA K, Akita M, Tsubata F, Kori Y, et al
Long-Term Disease-Free Survival After Systemic-First Sequential Multimodal Therapy for Advanced and Recurrent Large-Cell Neuroendocrine Carcinoma of the Uterine Cervix: A Case Report.
J Obstet Gynaecol Res. 2026;52:e70341.
Abstract

LU X, Feng Z, Han X
Cervical cancer mortality trends and inequities, 1999 to 2023: Joinpoint and spatial analyses integrated with two-sample Mendelian randomization.
Medicine (Baltimore). 2026;105:e48650.
Abstract

AZEVEDO-FERNANDES F JR, Chilundo B
Navigating cervical cancer care in Maputo: a mixed-methods analysis of socioeconomic inequities in patient pathways and health system barriers.
BMC Womens Health. 2026 May 19. doi: 10.1186/s12905-026-04550.
Abstract

GAKUNGA R, Mburu L, Ali Z, Krudy M, et al
Integrated Community-Clinic Model of Optimized Implementation Strategies to Increase Early Detection of Breast and Cervical Cancers in Kenya: Protocol for a Pragmatic Randomized Controlled Trial.
JMIR Res Protoc. 2026;15:e87850.
Abstract

LIANG X, Lu R, Wu S, Lin H, et al
Robot-Assisted Radical Trachelectomy With Sleeve Technique for Preventing Postoperative Cervical Adhesion.
Int J Med Robot. 2026;22:e70186.
Abstract

PLACKOVA K, Fialova A
The immune microenvironment of HPV-associated cancers: from viral oncogenesis to immunotherapy response.
Front Immunol. 2026;17:1813400.
Abstract

lncRNA WT1-AS Inhibits the Aggressiveness of Cervical Cancer Cell via Regulating p53 Expression via Sponging miR-330-5p [Retraction].
Cancer Manag Res. 2026;18:623061.
Abstract

LI Y, Zhang K, Wu M, Yu B, et al
Study on the diagnostic value of 3.0?T endovaginal coil magnetic resonance imaging technique for early cervical cancer.
Front Med (Lausanne). 2026;13:1805323.
Abstract

TOVAR A, Person-Rennell N, Coronado G, Madhivanan P, et al
Perceptions of HPV Self-Collection for Cervical Cancer Screening Among Mobile Health Program Attendees.
medRxiv [Preprint]. 2026 May 4:2026.05.01.26352235.
Abstract

CAI S, Wang S, Ling S, Qi M, et al
Overexpression of GJB1-13k induces mitochondrial calcium overload and triggers apoptosis and GSDME-mediated pyroptosis in cervical cancer.
Biochem Pharmacol. 2026 May 16:118073. doi: 10.1016/j.bcp.2026.118073.
Abstract

JIAO W, Liu S, Huai Q, Zhang Z, et al
EPHB2 drives EMT-linked vasculogenic mimicry and cervical cancer progression via an ERK-ETV4 transcriptional program.
J Transl Med. 2026 May 16. doi: 10.1186/s12967-026-08300.
Abstract

ONG P, Chua VH, Rebosa LMF, Tan De Guzman BM, et al
Ultrasound for image-guided brachytherapy in cervical cancer: Geometric accuracy and dosimetric evidence compared with MRI and CT.
Brachytherapy. 2026 May 16:S1538-4721(26)00038.
Abstract

MAFI S, Delpont J, Bigot A, Hantz S, et al
Comparative Evaluation of HPV PLUS ELITe MGB(R) and Allplex HPV HR Assays for High-Risk Human Papillomavirus Genotyping in Cervical Samples.
J Med Virol. 2026;98:e70954.
Abstract

XIE R, Ai Y, Bao A, Xie L, et al
MRI- and report-based multimodal model with SHAP-based explanation for preoperative prediction of deep stromal invasion in early-stage cervical cancer.
Insights Imaging. 2026;17:132.
Abstract

SMIIANOV VV, Fartushok TV, Semenyna HB, Fartushok NV, et al
Cervical pathology: Diagnosis, treatment and management of patients with Human Papillomavirus.
Wiad Lek. 2026;79:863-876.
Abstract

SPENCER JC, Montealegre JR, Calderon-Mora J, Pignone MP, et al
Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years.
JAMA Netw Open. 2026;9:e2612976.
Abstract

MENDES IBR, Cardoso AM, Freitas NS, Meschede MSC, et al
[Factors associated with failure to undergo cervical cancer screening in Brazil: a search for scientific evidence].
Cien Saude Colet. 2026;31:e19452023.
Abstract

SONI R, Suryarao P
Human Papillomavirus Vaccination in India: Paving the Way to Cervical Cancer Prevention.
Ann Afr Med. 2026 May 14. doi: 10.4103.
Abstract

PEI CZ, Song XX, Xu H, Baek KH, et al
Deubiquitinating enzymes in cervical cancer: Molecular mechanisms and therapeutic implications (Review).
Int J Oncol. 2026;69:79.
Abstract

CAO W, Huang X, Ding F, Wu J, et al
Multiplexed PfAgo-Based Digital Platform for Clinical Testing of High-Risk HPV Subtypes.
Anal Chem. 2026;98:14473-14481.
Abstract

MOUSA AAB, Thneibat FM, Al-Hamdan Z, Al-Hawarat MN, et al
Cost-effectiveness of human papillomavirus vaccination in Jordan: A modelling study.
Vaccine. 2026;83:128640.
Abstract

CAO D, Shen D, Han B, Kang N, et al
Somatic carcinomas with yolk sac tumor differentiation in the female genital tract: clinicopathological and molecular analysis of four cases with a literature review.
Ann Diagn Pathol. 2026;83:152649.
Abstract

TRANBERG M, Van Keer S, Hesselink AT, Norgaard P, et al
Evaluating DNA methylation markers and extended HPV genotyping in first-void urine for detecting high-grade cervical lesions in HPV-positive women: a cross-sectional study.
BMC Med. 2026;24:308.
Abstract

CAO F, Li N
Chemoradiotherapy-induced Th17/IL-17 signaling correlates with therapeutic tolerance and early recurrence in cervical carcinoma.
BMC Mol Cell Biol. 2026;27:29.
Abstract

GEETHA SD
Can large language models like ChatGPT and Gemini interpret cervical cytology accurately?
Ann Diagn Pathol. 2026;83:152641.
Abstract

RUFFIEUX Y, Andoh J, Haas AD, Chinogurei C, et al
Association of Immunodeficiency and HIV Viremia with Cervical Precancer and Cancer Risk among Women with HIV in South Africa.
Clin Infect Dis. 2026 Feb 14:ciag093. doi: 10.1093.
Abstract

BERNIGAUD O, Arendas K, Paulus A, Lemyre M, et al
Laparoscopic abdominal cerclage at 15 weeks of gestation after trachelectomy: a step-by-step surgical video.
Fertil Steril. 2026;125:929-931.
Abstract

ADAMOPOULOS PG, Boti MA, Athanasopoulou K, Tsiakanikas P, et al
Decoding the Transcriptional Complexity of the Human BRCA2 DNA Repair Gene Using Hybrid-seq.
Biochem Genet. 2026;64:3343-3366.
Abstract

ACAR U, Barlas F, Beyazgul B, Koruk I, et al
Health belief model-based determinants of women's participation in cervical cancer screening: a case-control study from Southeastern Turkey.
BMC Womens Health. 2026 May 30. doi: 10.1186/s12905-026-04582.
Abstract

TESHALE MM, Kebede WM, Sahilu WT, Wondimu KS, et al
Depression among women with cervical cancer: a systematic review and meta-analysis of available evidence.
BMC Psychiatry. 2026 May 29. doi: 10.1186/s12888-026-08211.
Abstract

CHEN Q, Lyu J, Li Y, Zhang L, et al
Spatial transcriptomics of cervical cancer reveals microenvironment shaped the malignant epithelial programs and ECM-associated immune niches.
Cancer Immunol Immunother. 2026 May 29. doi: 10.1007/s00262-026-04439.
Abstract

WILKINS K, David O, Oguntoyinbo JO, Zainab H, et al
Potential use of HOTAIR and MALAT1 as prognostic biomarkers for cervical cancer: An application to the NHS.
Cancer Treat Res Commun. 2026;48:101256.
Abstract

MOORTHY A, Le NA, Issac A, Willmott L, et al
Brachytherapy use in cervical cancer: a narrative review.
Gynecol Pelvic Med. 2026;9:8.
Abstract

ZHANG J, Wei W, Zhang Y, Wang D, et al
Metabolic reprogramming of cholesterol biosynthesis drives macrophage-mediated immune suppression in HPV-negative cervical adenocarcinoma.
Front Immunol. 2026;17:1808107.
Abstract

GOULIARIS M, Papalaskari A, Katsapanteras P, Zoglopitou L, et al
Cervical Cancer Brachytherapy Dose Escalation Protocol: Analysis of Early Data Treatments According to EMBRACE II Protocol.
Cureus. 2026;18:e107803.
Abstract

YAN T, Ma Q, Shi H, Qi D, et al
Disease burden of cervical cancer in China from 1990 to 2023 and prediction of future trends.
Front Oncol. 2026;16:1802330.
Abstract

VAJDA G, Loczi L, Vida B, Merkely P, et al
Systemic inflammatory ratios and their added value to cytology in cervical cancer detection: a multicenter study.
Front Med (Lausanne). 2026;13:1802477.
Abstract

MAKIN J, Elishaev E, Durbin SM, Makin RA, et al
Diagnostic Accuracy of Entropy Based Image Analysis of Cervical Precancerous Cells.
J Biophotonics. 2026;19:e70294.
Abstract

YAMAMOTO R, Asano H, Hatanaka KC, Shinomiya Y, et al
Feasibility study of photoimmunotherapy combination with ASP-1929 for vulvar, vaginal, and cervical cancer.
J Gynecol Oncol. 2026 May 21. doi: 10.3802/jgo.2026.
Abstract

HWANG JH, Kim H
Comparison of clinical outcomes between early and delayed diagnosis of cervical cancer following abnormal Pap smear results: a population-based cohort study using National Health Insurance data in South Korea.
J Gynecol Oncol. 2026 May 26. doi: 10.3802/jgo.2026.
Abstract

MA J, Wang G, Wang W, Yang H, et al
Extended-field intensity-modulated radiation therapy and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic or common iliac lymph nodes: a multicenter prospective cohort study.
J Gynecol Oncol. 2026 May 26. doi: 10.3802/jgo.2026.
Abstract

WU J, Yi J, Fang L, Lei S, et al
Urban-rural disparities in HPV prevalence and genotype distribution: a large-scale cervical cancer screening study in Xi'an, China.
BMC Infect Dis. 2026 May 28. doi: 10.1186/s12879-026-13647.
Abstract

LIU J, Jiao Y, Wang J, Cui X, et al
miR-141-5p positively regulates ACVRL1 expression to promote cervical cancer progression.
Hum Cell. 2026;39:81.
Abstract

MOORTHY S, Raj EH, Sundersingh S, Raja A, et al
Radiation-induced Osteosarcoma of the vaginal vault following cervical cancer treatment.
BMJ Case Rep. 2026;19:e269768.
Abstract

SACHIT BA, Dass S, Rajan RS, Tye GJ, et al
Development and characterization of novel T-cell receptor-like antibodies targeting human papillomavirus type 16 oncoprotein peptides for early cervical cancer detection using experimental and computational approaches.
Int J Biol Macromol. 2026 May 27:152755. doi: 10.1016/j.ijbiomac.2026.152755.
Abstract

ZHANG Y, Wu Y, Yuan J, Yang J, et al
A Longitudinal Qualitative Study on the Perioperative Symptom-Demand Journey Map of Patients with Cervical Cancer.
Int J Womens Health. 2026;18:603381.
Abstract

PATRA S, Shand H, Ghorai S
Beyond conventional therapies: immunotherapeutic strategies targeting HPV-associated cervical cancer.
Immunotherapy. 2026 May 27:1-21. doi: 10.1080/1750743X.2026.2679883.
Abstract

WANG H, Zhu Y, Zhang B, Ding H, et al
Promoting cervical cancer screening participation among Chinese women from resource-limited settings: a multicenter qualitative study.
BMC Womens Health. 2026 May 27. doi: 10.1186/s12905-026-04546.
Abstract

LYU Q, Zhao J, Chen Y, Xiong J, et al
Molecular characterization of HPV integrations in high-risk HPV-positive women and development of a prognostic signature based on integration-associated genes for cervical cancer.
Infect Agent Cancer. 2026 May 27. doi: 10.1186/s13027-026-00766.
Abstract

CHEN L, Lin W, Huang Y, Li C, et al
Spatiotemporal mapping of CD112 unveils its dichotomous role in T-cell exhaustion and ferroptosis crosstalk in cervical cancer.
Cell Death Dis. 2026 May 27. doi: 10.1038/s41419-026-08902.
Abstract

WANG J, Tu Y, Chen Y, Luo L, et al
Cumulative dose assessment in combined radiotherapy for locally advanced cervical cancer using deformable image registration framework based on BTV dose uniformity.
Brachytherapy. 2026 May 27:S1538-4721(26)00070.
Abstract

LING HJ, Zhou JL, Cao LQ, Li R, et al
TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process.
Cancer Genet. 2026;306-307:34-48.
Abstract

ZHANG C, Meng Q, Jiao H, Liu H, et al
HNRNPU K181 Lactylation Drives Cervical Cancer Growth by Upregulating PHGDH and Reprogramming Serine Metabolism.
Adv Sci (Weinh). 2026 May 27:e20222. doi: 10.1002/advs.202520222.
Abstract

XU C, Li H, Wu Y, Yao Q, et al
Investigation of the clinical value of artificial intelligence-derived prognostic signature in cervical cancer based on machine learning algorithms.
Discov Oncol. 2026 May 27. doi: 10.1007/s12672-026-05182.
Abstract

LUPKOWSKI R, Gorniak K, Lisik-Habib M, Burchardt E, et al
Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer-Data from the Polish-Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature.
Antibodies (Basel). 2026;15:42.
Abstract

FARRUKH S, Kavcic N, Canarutto G, Piazza S, et al
Rethinking residual p53 function in HPV-positive cervical cancer cells.
J Virol. 2026 May 27:e0047925. doi: 10.1128/jvi.00479.
Abstract

WEI Y, Song F, Wang W
Expression levels of serum SCC, HE4, and TSGF in cervical cancer patients and their correlation with recurrence: a retrospective study.
Front Med (Lausanne). 2026;13:1813161.
Abstract

TULIMILLI SV, Karnik M, Cockroft S, Bettadapura ADS, et al
Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.
Oncol Rev. 2026;20:1760156.
Abstract

NAKASI R, Wamozo C, Nsumba S, Rukundo B, et al
Adapting DeepLabV3+ for biopsy cervical cancer lesion segmentation.
Front Digit Health. 2026;8:1776155.
Abstract

MISAWA Y, Mizuno S, Honda S, Shinohara R, et al
Koilocytosis in LSIL Cytology Has Limited Predictive Value for CIN2+ in HPV-Positive Women: Implications for Risk-Based Cytology Triage.
Pathogens. 2026;15:537.
Abstract

BONIFACIO-VELEZ DE VILLA E, Aguilar-Luis MA, Silva-Caso W, Becerra-Goicochea L, et al
Genetic Variability and Conserved T-Cell Epitope Prediction of the HPV16 E1 Protein in Cervix Samples from Peru.
Pathogens. 2026;15:526.
Abstract

ABASI X, Liang D, Rezhake R, Tuerxun G, et al
Mechanism of Xiao-ai-fei Honey Ointment, a Traditional Uyghur Multi-Ingredient Medicinal Preparation, Against Cervical Cancer Based on Network Pharmacology and In Vitro Evaluation of Anti-Cancer Activity.
Pharmaceuticals (Basel). 2026;19:686.
Abstract

MUSHASHA MP, Modiba LM
Strategies to Raise Awareness About Screening and Vaccination for the Human Papillomavirus Among Women in Limpopo Province, South Africa.
Int J Environ Res Public Health. 2026;23:657.
Abstract

WANG L, Ouyang Y, Zhao Q, Wang T, et al
The Mechanism of Mg(2+)-Mediated Inhibition of Cervical Cancer by Inducing a Senescence-like State via the ATM/CHK2/p21 Signaling Pathway.
Int J Mol Sci. 2026;27:4397.
Abstract

PAWLIK P, Kurzawinska G, Ozarowski M, Karpinski TM, et al
Genetic Variations in the Fibronectin 1 Gene (FN1) and Risk of Female Reproductive Cancers-A Preliminary Study.
Int J Mol Sci. 2026;27:4302.
Abstract

JABLONSKA IA, Golawski M, Scieglinska D, Kacorzyk U, et al
Prognostic Value of Pretreatment Circulating Tumor HPV DNA Load in HPV-Associated Cancers: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2026;27:4263.
Abstract

SONGUR DAGLI S, Altun M
Acceptability of HPV Self-Sampling for Cervical Cancer Screening Among Previously Screened Women in Turkiye: A Cross-Sectional Study.
Healthcare (Basel). 2026;14:1312.
Abstract

GARCIA-BERNAL JR, Resendiz-Castillo LJ, Martinez-Barajas MG, Diaz-Palomera CD, et al
Differential Protumoral Mechanisms Induced by CAFs in Cervical Cancer Cells Occur Independently of 17beta-Estradiol Stimulation.
Cancers (Basel). 2026;18:1509.
Abstract

SUN C, Chu A, Liu S, Song R, et al
Prediction of myelosuppression in cervical cancer after concurrent chemoradiotherapy by CT radiomics-based model.
BMC Med Imaging. 2026 May 26. doi: 10.1186/s12880-026-02435.
Abstract

BUSAYO SE, Adewale FL, Ogundokun RO, Adewale OF, et al
Knowledge and Perception of Cervical Cancer and Pap-Smear Screening Among Antenatal Women in Ogun State, Nigeria.
Cancer Med. 2026;15:e71949.
Abstract

LIU Y, Wu R, Li C, Li R, et al
Systematic photodynamic therapy for concurrent cervical-vaginal high-grade squamous intraepithelial lesion: a series of eight cases.
Lasers Med Sci. 2026;41:102.
Abstract

ZHANG Z, Bussmann H, Vong S, Kol H, et al
A Micro-costing Study of Community-Based Primary HPV Self-Sampling and Triage Test for Cervical Cancer Screening in Rural Cambodia.
Pharmacoecon Open. 2026 May 26. doi: 10.1007/s41669-026-00659.
Abstract

SUSILADEWI IAMV, Afiyanti Y, Allenidekania A, Fitch M, et al
Perceptions and Behaviors of Healthcare Providers Regarding Sexuality in Cervical Cancer Care: A Qualitative Study.
Curr Oncol. 2026;33:253.
Abstract

ZHANG H, Chen X, Wang B, Li L, et al
Trim45 promotes the occurrence and development of cervical cancer by inhibiting the cGAS/STING signaling pathway.
Integr Biol (Camb). 2026;18:zyag009.
Abstract

BADAWY N, Alwadaany B, Safar H, Alshammaa M, et al
Knowledge and attitudes regarding cervical cancer among adult Kuwaiti women: A cross-sectional study.
Sci Rep. 2026 May 25. doi: 10.1038/s41598-026-53363.
Abstract

XIE Z, Di L, He X, Huang M, et al
DNAJC9 promotes cervical cancer cell proliferation by regulating GLI1 expression.
Acta Biochim Biophys Sin (Shanghai). 2026;58.
Abstract

ZHANG T, Zhu J, Geng L, Jin Z, et al
FABP5 confers resistance to drug-induced ROS toxicity in cervical cancer cell lines by suppressing the PPARgamma/CPT1A signaling pathway.
Discov Oncol. 2026 May 25. doi: 10.1007/s12672-026-05268.
Abstract

LEE SS, Weil CR, Boyd L, Burt LM, et al
Trends in Intensity Modulated Radiation Therapy Utilization for Definitive Treatment of Intact Cervical Cancer, 2004-2019.
Adv Radiat Oncol. 2026;11:102043.
Abstract

LI Z, Pang X, Wang Z, Wen J, et al
PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report.
Front Immunol. 2026;17:1826847.
Abstract

WESSEL L, Arians N
Postoperative proton therapy in uterine and cervical cancer: promising evidence but remaining questions.
Transl Cancer Res. 2026;15:346.
Abstract

PAN H, Bao L, Shi W, Wan J, et al
RNF112 mediates immunosuppression to inhibit the proliferation of cervical cancer by Foxm1.
Transl Cancer Res. 2026;15:317.
Abstract

GIANNECCHINI GV, Filgueiras ABT, de Andrade DAP, de Melo AC, et al
Do ethnic differences influence the response to immunotherapy in advanced cervical cancer?
Transl Cancer Res. 2026;15:350.
Abstract

CAO L, Zhang C
A novel programmed-cell-death-related prognostic risk model for cervical cancer based on mitochondrial genes.
Transl Cancer Res. 2026;15:271.
Abstract

LI P, Shao Y, Wang J, Lin R, et al
Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression.
PeerJ. 2026;14:e21255.
Abstract

CHEN H, She C, Wang Z, Huang X, et al
A ferroptosis-related lncRNAs risk score model identifies LINC02178 as a potential regulator of ferroptosis sensitivity in cervical cancer.
Front Oncol. 2026;16:1807953.
Abstract

SHINDE P, Ak A, Agarwal P, Kamalnath J, et al
Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy-results from preclinical in-silico dose comparison and quality assurance.
Br J Radiol. 2026 May 21:tqag075. doi: 10.1093.
Abstract

XUE L, Li X, Guo X, Xing H, et al
Clinical research progress and challenges of vaccine for human papillomavirus-associated cancers.
Hum Vaccin Immunother. 2026;22:2676391.
Abstract

FRUHAUF F, Fischerova D, Moro F, Kocian R, et al
Prospective comparison of diagnostic accuracy of ultrasound, PET/CT and DW-MRI for preoperative assessment of pelvic lymph nodes in cervical cancer patients: results of the CANNES trial.
Ultrasound Obstet Gynecol. 2026 May 24. doi: 10.1002/uog.70241.
Abstract

RATHOD G, Parmar P
HPV self-sampling in low-resource settings: An overlooked opportunity for cervical cancer screening.
Trop Doct. 2026 May 24:494755261454018. doi: 10.1177/00494755261454018.
Abstract

WOLDEAREGAY HG, Abebe GG, Weldemariam S, Tesfay FG, et al
Cervical cancer screening among HIV-positive women in conflict-affected and resource limited settings: the case of Tigray region, Ethiopia.
J Health Popul Nutr. 2026 May 23. doi: 10.1186/s41043-026-01331.
Abstract

LOGANATHAN T, Madhulekha S, Zayed H, C GPD, et al
Identification of common hub genes and pathways in systemic lupus erythematosus and cervical cancer using bioinformatics approach.
Adv Protein Chem Struct Biol. 2026;152:103-121.
Abstract

M TMS, S P, Selvasudha N, Sivadas S, et al
Plumbagin-PLA- chitosan nanoformulation ameliorates inflammation in cervical cancer (SiHa) cells by enhancing bioavailability and targeted drug delivery.
J Biomater Sci Polym Ed. 2026 May 23:1-26. doi: 10.1080/09205063.2026.2676164.
Abstract

GOVARTHAN PK, Agastinose Ronickom JF, Swaminathan R
Identification of Cervical Cancer Biomarkers Using Gene Co-Expression Networks and Machine Learning Methods.
Stud Health Technol Inform. 2026;336:398-402.
Abstract

TSUI J, Garcia S, Shin MB, Lui K, et al
Building capacity for equitable cervical cancer screening and follow-up in an FQHC-NCI cancer center partnership: a mixed-methods study of multilevel implementation determinants.
BMC Prim Care. 2026 May 22. doi: 10.1186/s12875-026-03387.
Abstract

AGGARWAL A, Rolland P, Leung E, Morrison J, et al
Sentinel Lymph Node Sampling in Early-Stage Cervical Cancer: A Cross-Sectional Survey.
BJOG. 2026 May 22. doi: 10.1111/1471-0528.70268.
Abstract

ABOELNASR LS, Patel J, Thomson AR, Yazbek J, et al
Concurrent uterine and pelvic angiolipoleiomyomas.
BMJ Case Rep. 2026;19:e270120.
Abstract

ILGEN O, Karatasli V
RETROPERITONEAL SENTINEL LYMPH NODE DISSECTION USING VNOTES IN EARLY-STAGE CERVICAL CANCER: A CASE REPORT.
J Minim Invasive Gynecol. 2026 May 21:S1553-4650(26)00283.
Abstract

JIA Z, Zhang J, Liu X, Liu C, et al
ISG15 drives cervical cancer progression by hyperactivating the NOD-like receptor signaling pathway.
Cancer Genet. 2026;306-307:1-6.
Abstract

VANICHBUNCHA T, Leetanaporn K, Hanprasertpong J
Impact of the diagnosis-surgery interval on survival outcomes and development of a nomogram for predicting survival in early-stage cervical cancer: a Surveillance, Epidemiology, and End Results database analysis.
J Gynecol Oncol. 2026 May 14. doi: 10.3802/jgo.2026.
Abstract

ZHANG H, Zhou H, Li M, Mutailipu T, et al
Comparison of mRNA-based and next-generation sequencing HPV assays in a population-based cervical cancer screening program in China.
J Gynecol Oncol. 2026 May 18. doi: 10.3802/jgo.2026.
Abstract

HU Y, Chen S, Cheng H, Han Y, et al
Chemotherapy plus camrelizumab for fertility preservation (NACI-F) in FIGO stage IB1 cervical cancer: a multicenter, single-arm, phase 2 trial.
J Gynecol Oncol. 2026 Apr 29. doi: 10.3802/jgo.2026.
Abstract

PAFENG J, Celaya A, Gay S, Fuentes D, et al
RADIANT: A fully configurable radiotherapy dose prediction framework.
Biomed Phys Eng Express. 2026;12.
Abstract

ZHOU Q, Du H, Gao Y, Zhang Q, et al
Baicalin induces ferroptosis in cervical squamous cell carcinoma via the NRF2/SLC7A11/GPX4 signaling axis.
Biochem Biophys Res Commun. 2026;822:153876.
Abstract

SARRIA H, Bernal G
Prevalence of human papillomavirus in the public health system of the central-northern region of Chile.
Diagn Microbiol Infect Dis. 2026;116:117451.
Abstract

LAL S, Pradhan A, Sherpa ML
"HPV 16/18 E6 DNA and mRNA expression in gross cervical lesions: A hospital based cross-sectional study from Sikkim, India".
Cancer Treat Res Commun. 2026;47:101209.
Abstract

WANG X, Xu J, Zhang H, Qu P, et al
Integrating the Silva pattern into clinical practice: a prognostic tool for tailoring surgery and adjuvant therapy in cervical adenocarcinoma.
Cancer Treat Res Commun. 2026;47:101187.
Abstract

DE WAARD J, Bhattacharya A, de Boer MT, van Hemel BM, et al
Clinical validation of a three-marker methylation panel to detect CIN3+ in vaginal self-samples in the Dutch population-based screening programme.
Clin Epigenetics. 2025;18:97.
Abstract

SMIT F, Braggion A, Cullati S, Chiolero A, et al
Cancer screening after the age of 75: Nationwide population-based trends.
J Med Screen. 2026;33:122-126.
Abstract

MUNJAL V, Schupack KM, Miller NE, Boswell CL, et al
Retrospective analysis of clinician and patient factors associated with unsatisfactory Pap tests.
J Med Screen. 2026;33:94-99.
Abstract

ANDERSSON H, Nordqvist Kleppe S, Edvardsson H, Elfstrom KM, et al
Quality indicators for cervical screening in Sweden.
J Med Screen. 2026;33:84-93.
Abstract

NAIDOO L, Nxele S, Yusuf-Saka T
Enhancing cervical cancer screening coverage in selected primary healthcare sites using Lean thinking: The CerviScreen programme.
S Afr Med J. 2026;116:e3654.
Abstract

ANGELILLO S, Miraglia Del Giudice G, Della Polla G, Angelillo IF, et al
Cervical cancer and screening: Knowledge, attitudes, and adherence among university students in Italy.
Hum Vaccin Immunother. 2026;22:2682535.
Abstract

XU M, Kang K, Zhao M, Bi S, et al
Optimizing ovarian dose sparing for young cervical cancer patients after oophoropexy: a dosimetric and radiobiological comparison of three radiotherapy techniques (IMPT, TOMO, and VMAT).
Radiat Oncol. 2026 Jun 4. doi: 10.1186/s13014-026-02862.
Abstract

ZOU Z, Zhai B
A systematic review of barriers to cervical cancer screening among Thai women based on the social ecological model: a multi-level analysis of local evidence.
Sex Health. 2026;23:SH26059.
Abstract

WENG X, Zeng C, Lv J, Huang F, et al
Exosomes derived from M2-polarized tumor-associated macrophages contribute to immune escape in cervical cancer.
Biochem Biophys Res Commun. 2026;828:154046.
Abstract

FAROOQI AA, Attar R, Gasparri ML, Berardi R, et al
Emerging landscape of oncogenic signaling pathways in cervical cancer.
Discov Oncol. 2026 Jun 4. doi: 10.1007/s12672-026-05271.
Abstract

BOTO T, Feketshane AM, Ngxola N
Evaluating knowledge and awareness of cervical cancer, human papillomavirus and human papillomavirus vaccination among women in East London, South Africa.
Afr J Prim Health Care Fam Med. 2026;18:e1-e6.
Abstract

WANG T, Zheng X, Chen B, Xiao R, et al
Exploring the celecoxib-cervical cancer relationship using in vitro, network pharmacology, and Mendelian randomization approaches.
Front Med (Lausanne). 2026;13:1777235.
Abstract

GARIN C, Daix M, Bresson L, Navarro AS, et al
Step-by-step type III total pelvic exenteration with vaginectomy and partial vulvectomy with complex pelvic reconstruction for vaginal recurrence of cervical cancer.
Gynecol Oncol Rep. 2026;65:102109.
Abstract

SELVA RAJAN R, Dass SA, Sachit BA, Tye GJ, et al
Development of a new diagnostic tool for detecting cervical cancer using a TCR-like antibody targeting the HPV 16 oncoprotein E7.
Eur Rev Med Pharmacol Sci. 2026;30:164-180.
Abstract

LIU T, Chen J, Dai B, Du D, et al
TRIM71 suppresses cervical cancer progression by inhibiting Nectin4-mediated Wnt/beta-catenin signaling.
Biol Direct. 2026 Jun 3. doi: 10.1186/s13062-026-00843.
Abstract

AKAGAWA J, Sera T, Yuasa Y
[Impact of Source Position Error in Tandem-ovoid Applicator on Dose Distribution in Cervical Cancer Brachytherapy].
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2026;82.
Abstract

MURPHY EC, Rowen TS
Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.
Obstet Gynecol Clin North Am. 2026;53:339-351.
Abstract

PAPENBURG J, Pollock K, Yansouni CP
Increasing participation in cervical cancer screening.
BMJ. 2026;393:e353462.
Abstract

LI B, Liu Y, Pan Y, Zhang Y, et al
Dnq-unet: a two-level fusion framework for few-shot domain adaptation in cervical cancer CTV segmentation.
Radiol Phys Technol. 2026 Jun 3. doi: 10.1007/s12194-026-01072.
Abstract

TANG Y, Ning L, Yang X, Li N, et al
Construction and validation of a novel prognostic risk model in cervical cancer: integrating lactylation-related genes linked to radiotherapy?associated transcriptional changes.
Discov Oncol. 2026 Jun 3. doi: 10.1007/s12672-026-05351.
Abstract

Statement of Retraction: Amygdalin Induces Apoptosis in Human Cervical Cancer Cell Line HeLa Cells.
Immunopharmacol Immunotoxicol. 2026 Jun 3:1. doi: 10.1080/08923973.2026.2675070.
Abstract

BILEK Y, Hakki Sarpun I, Koca T
Can volumetric arc therapy be an alternative to brachytherapy in advanced cervical cancer radiotherapy?
Radiat Prot Dosimetry. 2026;202:720-725.
Abstract

MANIYAR AI, Alva RC, Koushik K, Nithyanand S, et al
Enhancing brachytherapy in cervical cancer: Initial dosimetric experience and assessment of Tulip hybrid applicator - the Add-On advantage.
J Contemp Brachytherapy. 2026;18:32-39.
Abstract

MOUSSAVOU-BOUNDZANGA P, Ambounda NL, Zinsou BE, Bivigou-Mboumba B, et al
Breast and cervical cancer screening in a semi-urban African setting: evidence from Franceville, Gabon (2015-2021).
Front Oncol. 2026;16:1735802.
Abstract

WANG Y, Jin X, Zhao S, Zhang Z, et al
Trajectory changes of symptom clusters in patients with concurrent chemoradiotherapy for cervical cancer: a prospective longitudinal study.
Front Oncol. 2026;16:1808208.
Abstract

ZHANG L, Mwita CJ, Soliman GA, Mushi DF, et al
Nutritional status of patients diagnosed with cervical cancer in Tanzania.
BMC Nutr. 2026 Jun 2. doi: 10.1186/s40795-026-01323.
Abstract

BAYKEMAGN ND, Alemu GG, Tewelgne MF, Bicha AT, et al
Predicting knowledge of cervical cancer screening among reproductive-age women in sub-saharan africa using machine learning algorithms.
Sci Rep. 2026 Jun 2. doi: 10.1038/s41598-026-54976.
Abstract

BOGART LM, Whitaker L, Gwokyalya V, Beyeza-Kashesya J, et al
A Qualitative Analysis of Factors Contributing to Cervical Cancer Screening Implementation in Health Care Facilities in Uganda.
Cancer Control. 2026;33:10732748261450722.
Abstract

HUANG L, Feng W, Long W, Liu H, et al
Nobiletin attenuates self-renewal in cervical cancer cells and spheres through miR-342-3p upregulation and FOXM1 downregulation.
Mol Cell Biochem. 2026 Jun 2. doi: 10.1007/s11010-026-05572.
Abstract

NOORANI S, Tang KS, Patel A, Tran D, et al
Cancerous Arrhythmia: Metastatic Cervical Cancer to the Heart Complicated by Ventricular Tachycardia.
JACC Case Rep. 2026 Jun 2:108560. doi: 10.1016/j.jaccas.2026.108560.
Abstract

BROWN C, McNally GA
The Role of Oncology Nurses in National Breast and Cervical Cancer Screening Programs.
Clin J Oncol Nurs. 2026;30:231-235.
Abstract

MILLS D, Sridharan S, Govindarajulu G
Cervical Cancer in Australia: A Radiation Oncology Perspective on Recent Developments, Challenges and Future Directions.
J Med Imaging Radiat Oncol. 2026 Jun 2. doi: 10.1111/1754-9485.70130.
Abstract

YOSHIMURA T, Tatsuta I, Suzuki T, Tsuchino Y, et al
Feasibility and Short-Term Outcomes of an endoCUT-Based Non-Ligation Cervical Conization Strategy: A Single-Center Retrospective Study.
J Obstet Gynaecol Res. 2026;52:e70349.
Abstract

GU X, Shen T, Guo XK
Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.
Nutr Rev. 2026 Jun 2:nuag096. doi: 10.1093.
Abstract

HUA Y, Li Y, Qin H, Huo M, et al
Author's Reply: Letter to the Editor: Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.
Nutr Rev. 2026 Jun 2:nuag097. doi: 10.1093.
Abstract

ZHAO G, Al Ramadhan MM, Zhang Y
Prognostic value of lymphocyte to monocyte ratio for cervical cancer: a systematic review and meta-analysis.
PeerJ. 2026;14:e21337.
Abstract

PASSARELLA G, Vella S, Ferrario E, Provinciali N, et al
Case Report: Neurological immune-related adverse events with anti-PD-1 based immunotherapy in cervical cancer.
Front Oncol. 2026;16:1796299.
Abstract

WANG Q, Li Y, Shen L, Zhang Y, et al
Prediction of myelosuppression risk in postoperative cervical cancer patients undergoing concurrent chemoradiotherapy using machine learning models.
Front Oncol. 2026;16:1800585.
Abstract

MANGA SM, Randolph I, Ugwu L, Lee G, et al
Nurse-led visual triage against histopathology in a real-world low-resource setting cervical cancer prevention program.
Gynecol Oncol Rep. 2026;65:102105.
Abstract

SHAH S, Shah D, Shah H, Parmar J, et al
Outcomes of Pelvic Exenteration for Recurrent or Persistent Cervical Cancer: Revisiting Curative approach in the Era of Advancing Palliative Options.
Indian J Surg Oncol. 2026;17:1045-1051.
Abstract

RAJU K, Kukkamgai HM, Kamarthi PP
Evolution of Cervical Cancer Screening Techniques: A Concept of Translation Medicine.
Indian J Surg Oncol. 2026;17:1159-1170.
Abstract

KAO PY, Chen JH, Chen KH
The Role of HPV and Hormone in Cervical Precancer and Cancer: Molecular Pathophysiology and Cell Biology of Disease and Treatment.
Oncol Res. 2026;34:12.
Abstract

CHEN X, Xue Z, Zhao S, Sun L, et al
Clinical manifestations and ultrasonographic features of lobular endocervical glandular hyperplasia: a retrospective study of 135 patients.
Ann Med. 2026;58:2673627.
Abstract

FERLA S, De Gobbi V, Seracchioli R, Raimondo D, et al
Laparoscopic cervical cerclage at 10 weeks gestation in a patient with an adverse obstetric history following fertility-sparing surgery for cervical cancer.
Facts Views Vis Obgyn. 2026 Jun 1. doi: 10.52054/FVVO.2026.
Abstract

BISCHOF K, Fredriksen KM, Bjornstad M, Elstrand MB, et al
Oncological outcome and immune-checkpoint-blockade-induced toxicities in patients with cervical cancer - a Norwegian real-world cohort.
Acta Oncol. 2026;65:518-524.
Abstract

ZHENG X, Pan D, Lin J, Xiao J, et al
Analysis of Pathological Discrepancies Between Colposcopic Biopsy and Conization in Cytology-Positive Cervical Lesions.
Cancer Med. 2026;15:e72002.
Abstract

XU S, Zou Y, Wu Z, Xu Z, et al
Deep learning-based cervical cancer T-staging using MRI: multi-structure segmentation and classification.
BMC Med Imaging. 2026 May 30. doi: 10.1186/s12880-026-02449.
Abstract

MARZHOSEYNI Z, Shayestehpour M, Shaghaghi Z, Alvandi M, et al
Streptococcus-derived CpsA-CpsC fusion protein induces apoptosis in cervical cancer cells through in silico and in vitro methods.
Sci Rep. 2026 May 30. doi: 10.1038/s41598-026-55464.
Abstract

DIAZ-OBREGON D, Paco-Fernandez M, Ladera-Castaneda M, Huamani-Contreras M, et al
Implementation of HPV Self-Sampling in Cervical Cancer Screening Programs: A Bibliometric Analysis of Research Output, Global Trends, and Collaboration Networks.
Biomed Res Int. 2026;2026:e9345778.
Abstract

HAMID MR, Mohd Yunus N, Abdul Aziz AA, Azwari Annuar A, et al
Genetic polymorphisms of XRCC1 on cervical cancer susceptibility risk.
Med J Malaysia. 2026;81:356-361.
Abstract

NOVIANTI L, Calvin D, Feharsal Y, Candrani FVD, et al
Cervical cancer survival rate after abdominal vs. laparoscopic radical hysterectomy in two government hospitals in Jakarta, Indonesia.
Med J Malaysia. 2026;81:337-342.
Abstract

HAMAD RS, Doghish AS, Abdel Mageed SS, Rizk NI, et al
MicroRNAs in HPV-Associated Carcinogenesis: Potential Biomarkers in Oropharyngeal and Cervical Cancers.
IUBMB Life. 2026;78:e70117.
Abstract

ANTANO-ARIAS R, Torres-Rojas FI, Campos-Viguri GE, Arizmendi-Izazaga A, et al
miR-19a-3p as a Candidate oncomiRNA in Cervical Cancer: Insights From a Bioinformatic Analysis.
Front Biosci (Landmark Ed). 2026;31:51227.
Abstract

SUGAWARA M, Nishio H, Iwata T, Katoh Y, et al
Establishment and genomic characterization of patient-derived organoids from gastric-type cervical adenocarcinoma.
J Gynecol Oncol. 2026;37:e101.
Abstract

STEFANOS R, Gargano JW, Niccolai LM, Castilho JL, et al
Decreases in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers: HPV-IMPACT, 2008 to 2019.
Cancer Epidemiol Biomarkers Prev. 2026;35:913-920.
Abstract

KESHARWANI P, Nasir N, Wahab S, Gupta G, et al
PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment.
Cancer Sci. 2026 Mar 31. doi: 10.1111/cas.70361.
Abstract

IVERSEN L, Raja EA, Nath M, Lip G, et al
The influence of rural residency on the uptake of screening for breast, cervical, and colorectal cancers in Scotland.
J Public Health (Oxf). 2026;48:467-476.
Abstract

IRIE G, Kobayashi Y, Shikama A, Yoshino M, et al
Utility of iRECIST for evaluating treatment efficacy in patients receiving immune checkpoint inhibitors.
J Gynecol Oncol. 2026;37:e47.
Abstract

WEI S, Li X, Liu Z, Wei L, et al
Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trial.
J Gynecol Oncol. 2026;37:e46.
Abstract

NAKAZAWA M, Teramoto M, Saito T
Therapeutic efficacy of laser vaporization and conization for high-grade cervical intraepithelial neoplasia.
J Gynecol Oncol. 2026;37:e34.
Abstract

CHIKAZAWA K, Fujimori A, Imai K, Ko H, et al
Laparoscopic radical hysterectomy after the LACC trial, avoiding uterine manipulator, pre-colpotomy vaginal washing and clamping, and uterine removal using a retrieval bag: a retrospective study.
J Gynecol Oncol. 2026;37:e40.
Abstract

HARGIS A, Berg CJ, Le D
Knowledge, Attitudes, and Behaviors Regarding HPV Vaccination and Self-Sampling Among US Young Adults.
J Cancer Educ. 2026;41:588-600.
Abstract

CHENG J, Shi Y, Jiang Q, Lin C, et al
Cell-specific multi-target mechanisms of cotinine in cervical cancer oncogenesis and progression.
Discov Oncol. 2026 Jun 12. doi: 10.1007/s12672-026-05375.
Abstract

ABOAGYE ES, Abioke UB, Ogugua CE, Danquah F, et al
Knowledge and Preventive Practices Regarding Cervical Cancer Among Women in Nkoranza South Municipality, Ghana: A Cross-Sectional Study.
Cureus. 2026;18:e108654.
Abstract

CHANG CS, Na J, Seo JH, Lee YY, et al
Diagnostic performance of cervical cytology in HPV-independent cervical cancer: a comparative analysis with HPV-associated cases.
J Gynecol Oncol. 2026 Jun 1. doi: 10.3802/jgo.2026.
Abstract

YOON S, Baek HJ, Choi B, An HJ, et al
Schwannoma Mimicking Neck Nodal Metastasis on F-18 FDG PET/CT in Cervical Cancer: A Case Report with a Multimodal Approach.
Diagnostics (Basel). 2026;16:1686.
Abstract

SUBAIEA GM, Amangelsin Y, Sagatbekova K, Katamesh AA, et al
Phenformin-Induced Apoptosis: A Potential Mechanism for Cervical Cancer Cell Inhibition.
Int J Mol Sci. 2026;27:4941.
Abstract

BROCHWITZ E, Nel I, Eckardt A, Weydandt L, et al
Disseminated Tumor Cells (DTCs) in Patients with Cervical Cancer Reveal Mesenchymal Properties and Potential Therapeutic Targets-A New Perspective?
Int J Mol Sci. 2026;27:4875.
Abstract

PUTRA AD, Safika S, Fadilah F, Nuryanto KH, et al
Computational and Cytotoxicity Evaluation of Phyllanthus Urinaria-Derived Compounds as Potential Anti-Cervical Cancer Agents via HPV-16 E6 Oncoprotein Inhibition.
Int J Mol Sci. 2026;27:4780.
Abstract

SUN F, Wang Z
TMEM132A promotes cervical cancer progression via HOMER3-mediated activation of FAK/PI3K/AKT signaling pathway.
Sci Rep. 2026 Jun 11. doi: 10.1038/s41598-026-54987.
Abstract

ZHANG Y, Sun M, Li M, Zhang M, et al
Novel peptide Aurein1.2 derivative induces cytotoxicity in cervical cancer SiHa and HeLa cells by apoptosis and cell cycle arrest.
Toxicol Appl Pharmacol. 2026 Jun 11:117908. doi: 10.1016/j.taap.2026.117908.
Abstract

LIU Y, Wang S, Xia X, Zhang T, et al
Desmoglein 2 is associated with dihydroartemisinin resistance in HeLa cervical cancer cells: a potential link to the PI3K/AKT signaling pathway.
Discov Oncol. 2026 Jun 11. doi: 10.1007/s12672-026-05425.
Abstract

OZAN E, Tuncer MC, Ozdemir I
Gallic Acid Potentiates Cisplatin Response in Cervical Cancer Cells Through Coordinated Cellular and Molecular Alterations.
Biology (Basel). 2026;15:825.
Abstract

CANTIDIO FS, Costa Diniz PH, Gil G, Silva-Filho AL, et al
Bone marrow-sparing radiotherapy in women with cervical cancer treated with radiochemotherapy.
Cochrane Database Syst Rev. 2026;6:CD016258.
Abstract

OSHODIN AE, Ehikioya EE, Okobi OE, Njoku AI, et al
Diagnostic accuracy of visual inspection with acetic acid versus Papanicolaou smear in cervical cancer screening among HIV-positive women in rural Nigeria.
Afr J Reprod Health. 2026;:28-37.
Abstract

AZIZI M, Hong JS, Spitzberg J, Weissleder R, et al
Hydrogel-based multiplexed high-risk human papillomavirus DNA/RNA detection for cervical cancer screening.
Biosens Bioelectron X. 2025;26:100664.
Abstract

WASHINGTON A, Houck KF, Nelson BW, Harper DM, et al
Corrigendum to "Black US women share their experiences with follow-up after abnormal cervical cancer screening" [(2025) 100658 10].
Public Health Pract (Oxf). 2026;11:100727.
Abstract

XIA J, Sun J, Lu D
Early Screening for Cervical Squamous Cell Carcinoma and Precancerous Lesions Based on Surface-Enhanced Raman Spectroscopy Microarray Chips.
Int J Nanomedicine. 2026;21:606920.
Abstract

KUCUKCERAN H, Demirbas N, Karaoglu N, Cihan FG, et al
Evaluation of Knowledge About Human Papillomavirus and Vaccination Among Women Screened for Cervical Cancer.
Int J Health Plann Manage. 2026 Jun 11. doi: 10.1002/hpm.70094.
Abstract

DIZENDORF E, Miriyala R, Sreelakshmi KK, Tatli H, et al
Online educational program for CT-based image-guided adaptive brachytherapy in cervical cancer: The BrachyAcademy experience.
Brachytherapy. 2026 Jun 10:S1538-4721(26)00068.
Abstract

WU C, Huang L, Xu J, Liu G, et al
OGT-mediated O-GlcNAcylation of STAT1 impairs its Ser727 phosphorylation and weakens antitumor immunity of tumor-associated macrophages in cervical cancer.
Biochem Biophys Res Commun. 2026;828:154090.
Abstract

VAMSI GADE VK, Sharma J, Maity S, Bhattacharyya T, et al
Real-World Data From India on Delays and Disruptions in Cervical Cancer Care Services During the COVID-19 Pandemic.
JCO Glob Oncol. 2026;12:e2500765.
Abstract

SHI F, Xuan Y, Zhu Y, Wu S, et al
Efficacy and safety of combined immune therapy for advanced cervical cancer: a systematic review and meta-analysis.
Front Oncol. 2026;16:1772054.
Abstract

GWAYI SD, Tomoka T, Chimusa ER, Fedoriw G, et al
Burden of rare genetic variants in genes associated with cancer among Malawian cervical cancer patients.
Afr J Lab Med. 2026;15:3073.
Abstract

CHAVEZ-RIOS A, Lopez-Ruiz C, Garcia-Aguirre IA, Ocadiz-Delgado R, et al
Synergistic Interaction Between HPV-16 E7 Oncoprotein and Severe Vitamin A Deficiency in Regulating Adaptive Immunity in a Preclinical Cervical Cancer Model.
J Med Virol. 2026;98:e70992.
Abstract

GONG C, Xia X, Zhang X, Ye Y, et al
Longitudinal Study of Symptom Cluster Trajectories and Sentinel Symptoms in Patients With Cervical Cancer After Surgery and During the First Chemotherapy Cycle.
Cancer Nurs. 2026 May 28. doi: 10.1097/NCC.0000000000001596.
Abstract

ZHOU Y, Luo Y, Ge Y, Wu X, et al
Integrated multi-omics profiling of treatment-naive cervix uteri premalignant lesions and cervical squamous cell carcinoma reveals ecosystem and drivers underlying cervical cancer progression.
Cell Death Dis. 2026 Jun 9. doi: 10.1038/s41419-026-08960.
Abstract

GUI N, Pan H, Lu W, Pan G, et al
AGPAT family members act as potential predictive biomarkers and therapeutic targets in cervical cancer.
Discov Oncol. 2026 Jun 9. doi: 10.1007/s12672-026-05322.
Abstract

SERGISON JE, Alspaugh A, Janek S, Stevenson EL, et al
Scoping Review of Barriers and Facilitators of Cervical Cancer Screening in Appalachia.
Nurs Res. 2026 Jun 9. doi: 10.1097/NNR.0000000000000923.
Abstract

LIU WY, Huang HW, Ma JN, Xue L, et al
PRMT1 drives cervical cancer progression by orchestrating cell growth, migration, and angiogenesis.
Hum Mol Genet. 2026;35:ddag044.
Abstract

FAN M, Yang F, Zhang D, Dang H, et al
Demographic and Screening-to-Diagnosis Cascade Indicators for Risk Stratification in an Organized Cervical Cancer Screening Program: Evidence from 82,141 Women in Yunnan, China.
Int J Womens Health. 2026;18:602135.
Abstract

LIU L, Chen N, Zhu Q, Liu Q, et al
Effect of prophylactic HPV vaccination and timing of administration on recurrence of cervical HSIL after LEEP: A retrospective study.
Medicine (Baltimore). 2026;105:e49167.
Abstract

WU L, Chen L, Li D, Zhu Y, et al
Tisotumab vedotin versus chemotherapy in Chinese patients with recurrent or metastatic cervical cancer with disease progression on or after systemic therapy.
Chin Med J (Engl). 2026 Jun 8. doi: 10.1097/CM9.0000000000004094.
Abstract

ZHAN J, Liu D, Ye J, Peng X, et al
C3(+) cancer-associated fibroblast-derived GAS6 promotes cervical cancer metastasis via activation of AXL signaling pathway in a syngeneic orthotopic mouse model.
J Transl Med. 2026 Jun 8. doi: 10.1186/s12967-026-08392.
Abstract

YANG J, Zhou M, Gao M, Lin C, et al
Reproductive tract commensal bacterium Enterococcus faecium supernatant induces DNA damage associated stress responses and suppresses the growth of cervical cancer cells.
BMC Microbiol. 2026 Jun 8. doi: 10.1186/s12866-026-05244.
Abstract

ZHOU J, Huang Q, Yang H, Liu Q, et al
Network Pharmacology and in vitro Experimental Validation Reveal the Anticancer Mechanisms of Cichoric Acid in Cervical Cancer.
Ann Clin Lab Sci. 2026;56:182-201.
Abstract

HUO M, Zhang H, Hua Y, Qin H, et al
Multiple roles of circRNAs in cervical cancer: From fundamental carcinogenic mechanisms to clinical application prospects.
Crit Rev Oncol Hematol. 2026;225:105390.
Abstract

ZHANG R, Chavana AN, Shi Y, Zhou B, et al
Dosimetric comparison of high dose rate interstitial brachytherapy and stereotactic body radiotherapy as alternative treatment methods for advanced-stage cervical cancer.
Biomed Phys Eng Express. 2026 Jun 8. doi: 10.1088/2057-1976/ae7979.
Abstract

CHI F, Jiang X, Zhou W, Chen Z, et al
A study on the effects of intrafractional changes in bladder volume on positional accuracy and target dosimetry in online adaptive radiotherapy for cervical cancer.
Appl Radiat Isot. 2026;236:112738.
Abstract

BRUNEAU N, Balanda M, San Martin H, Roldan F, et al
HPV Trends and Genotypes in Chilean and Immigrant Women: 10-Year Surveillance Study (2014-2023).
Rev Med Chil. 2026;154:339-350.
Abstract

ALLAMEH FZ, Sabet F, Behnamfar F, Seresht LM, et al
Uterine Cervical Cancer: Diagnostic Accuracy of Clinical Staging, Magnetic Resonance Imaging, and Histopathology Findings.
Iran J Nurs Midwifery Res. 2026;31:233-237.
Abstract

CHENG Y, Li X, Yan D
Single Cell and Machine Learning-Based Analysis of Lysosome Mediated Cell Death Reveals Novel Prognostic Biomarkers and Therapeutic Targets in Cervical Cancer.
Int J Genomics. 2026;2026:8487184.
Abstract

KILIC EI, Kilic S
DeepInsight-Net: a CBAM-enhanced ResNet50 framework with focal loss for robust cervical cancer classification on multi-center datasets.
Front Med (Lausanne). 2026;13:1783634.
Abstract

ZAIDI A, Kameleen F, Saleem MS, Raza AA, et al
HPV vaccination and cervical cancer prevention in Pakistan: Why are we so far behind?
Ann Med Surg (Lond). 2026;88:3846-3847.
Abstract

ZHANG D, Meng Y, Dong X, Huang C, et al
Efficacy and safety of immune checkpoint inhibitors combined with antiangiogenic agents in advanced cervical cancer: a systematic review and meta-analysis.
Front Immunol. 2026;17:1747768.
Abstract

BAIDEN-AMISSAH REM, Tuyaerts S, Annibali D, Herreros-Pomares A, et al
Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation in the PRIMMO trial.
Front Immunol. 2026;17:1794131.
Abstract

SINGALAGA DD, Daryanto B, Purnomo AF
Success rate of Double J stent insertion in patients with advanced cervical cancer and hydronephrosis at tertiary hospital.
Arch Ital Urol Androl. 2026 Jun 5:15582. doi: 10.4081/aiua.2026.15582.
Abstract

IIJIMA K, Okamoto H, Ushijima T, Ueda Y, et al
Development of a virtual phantom for HDR cervical cancer brachytherapy: A multi-institutional tool for training, quality assurance, and variability reduction.
J Appl Clin Med Phys. 2026;27:e70620.
Abstract

DAMASCO BJ, Plete MT
Bridging knowledge and practice: strengthening cervical cancer screening uptake among rural women in low-resource settings.
Rural Remote Health. 2026;26:11298.
Abstract

BUHAY BR, Chin JD, Han RY, Wakefield MR, et al
Bridging the gap between infection and detection: Biological, clinical, and health system contributors to diagnostic delay in HPV-associated cervical cancer.
Crit Rev Oncol Hematol. 2026;225:105428.
Abstract

CHEN Y
Single-cell transcriptomics and machine learning unveil liquid-liquid phase separation-related biomarkers in HPV-positive cervical cancer.
Infect Agent Cancer. 2026 Jun 6. doi: 10.1186/s13027-026-00768.
Abstract

HUANG X, Santo T Jr
Letter to the editor on "Cervical Cancer Incidence and Mortality Trends in China: The Role of Screening".
Cancer Lett. 2026 Jun 5:218648. doi: 10.1016/j.canlet.2026.218648.
Abstract

MA S, Lin J, Deng X, Li Z, et al
Hsa_circ_0000231 activates the MAPK pathway via IGF2BP2-mediated CACNA1H mRNA stabilization to promote cervical cancer progression.
Discov Oncol. 2026 Jun 6. doi: 10.1007/s12672-026-05378.
Abstract

LIN Y, Shuang P, Tao D, Lu L, et al
Anesthetic management of a patient with malignant right ventricular tumor and pulmonary tumor embolism secondary to cervical cancer: a case report.
J Cardiothorac Surg. 2026 Jun 5. doi: 10.1186/s13019-026-04354.
Abstract

WU J, Li R, Chen H
Comparison of open and minimally invasive radical hysterectomy for cervical cancer: a systematic review and meta-analysis of survival outcomes.
BMC Surg. 2026 Jun 6. doi: 10.1186/s12893-026-03878.
Abstract

BRUCKER P, Horn S, Jansari S, Kombou M, et al
Identification of tumor-promoting functions of the Homeobox family transcription factor MSX1 in cervical cancer.
Cell Death Discov. 2026;12:270.
Abstract

ADAMS ED
Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical Trial.
J Obstet Gynecol Neonatal Nurs. 2026 Jun 5:S0884-2175(26)00148.
Abstract

HE J, Yan R, Du Y, Yang H, et al
TRPS1 inhibits cervical cancer progression by suppressing ORC6-mediated tumor stemness.
Tissue Cell. 2026;103:103655.
Abstract

RASHEED AHRS, Sekar PKC, Sreevalsan A, Veerabathiran R, et al
Oncogenic impact of PIK3CA, KRAS, and PTEN mutations in cervical cancer among South Indian women.
Adv Clin Exp Med. 2026 Jun 5. doi: 10.17219/acem/209713.
Abstract

KUMAR S, Kaul P, Kapur K, Choudhary D, et al
Cancer screening uptake and tobacco-alcohol use among women in Uttarakhand: A district-wise analysis from the 5th National Family Health Survey (NFHS-5).
Indian J Med Res. 2026;163:625-629.
Abstract

WANG R, Wang J, Ruan J, Gao C, et al
Innovative peptide-loaded hybrid membrane nanovaccine enables precise personalized immunotherapy for HPV-related cervical diseases.
Signal Transduct Target Ther. 2026;11:214.
Abstract

ADLER D, Wood N, Merriman J, Abar B, et al
Self-collection for HPV testing among emergency department patients: A prospective, interventional, single-arm, feasibility study.
Am J Emerg Med. 2026;107:33-38.
Abstract

OPALEYE OO, Esan DT
Mobile health strategies to improve HPV vaccination uptake among parents of adolescent girls: a scoping review.
Vaccine. 2026;85:128701.
Abstract

YIN L, Zhang J, Pang Y, Mou Y, et al
Blood Oxygenation Level-Dependent MRI for Predicting Lymphovascular Space Invasion in Cervical Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy: A Prospective Study.
Acad Radiol. 2026;33:2934-2945.
Abstract

TANAKA Y, Otsuka A, Goto T, Shiki Y, et al
Anatomical Highlights During Nerve-Sparing Radical Hysterectomy: A Step-by-Step Educational Video.
Ann Surg Oncol. 2026;33:6652-6653.
Abstract

TALIA KL, Soong TR, Kiyokawa T, de Brot L, et al
Assessment of lymphovascular space invasion in cervical squamous cell carcinoma using digital pathology: a reproducibility study.
Histopathology. 2026;89:154-162.
Abstract

CINTRA RC, Hsu Helmich LP, de Bastos DR, Sichero L, et al
Targeted modulation of IGFL2-AS1 reveals its translational potential in cervical adenocarcinoma.
Mol Oncol. 2026;20:1643-1660.
Abstract

ABUDERMAN AA, Mohamed MA, Rasulov F, Abdukarimova RK, et al
Antiproliferative and Apoptotic Effects of Lavandula officinalis In Vitro by Inhibiting HeLa Cancer Cell Growth and Migration.
Biotechnol Appl Biochem. 2026;73:1295-1302.
Abstract

SCAIOLI G, Vari MG, Barbera G, Durbano A, et al
Invitation strategies for improving uptake in cervical, breast, and colorectal cancer screening: a systematic review.
Eur J Cancer Prev. 2026;35:330-342.
Abstract

WU Z, Lan D, He C, Li N, et al
IGFL2-AS1 is associated with poor prognosis in cervical cancer and promotes disease progression via the miR-126-5p/MACC1 axis.
Mol Biol Rep. 2026;53:970.
Abstract

OUCHI H, Chiyoda T, Sakai K, Shiraishi Y, et al
Para-Aortic Lymph Node Metastasis Detected by Sentinel Lymph Node Biopsy in Cervical Cancer Initially Presumed to be Stage IA2: A Case Report.
J Obstet Gynaecol Res. 2026;52:e70377.
Abstract

SAJWANI N, Suchitha GP, Prasad TSK, Dagamajalu S, et al
Procaterol Enhances Cisplatin-Induced Cytotoxicity via Apoptosis, Oxidative Stress, and Cell Cycle Arrest in Breast and Cervical Cancer Cells.
OMICS. 2026 Jun 19:15578100261459475. doi: 10.1177/15578100261459475.
Abstract

VERMA N, Singh V
Blood-based Biomarkers in Cervical Cancer: The Emerging Role of Circulating Human Papillomavirus and Tumor Deoxyribonucleic Acid.
Ann Afr Med. 2026 Jun 19. doi: 10.4103.
Abstract

SHAKYA S, Paneru B, Uprety S, Acharya Y, et al
Acceptability of Self-sampling in Human Papillomavirus Deoxyribonucleic acid based Cervical Screening in Nepal: A Mixed-Methods Study.
Kathmandu Univ Med J (KUMJ). 2025;23:433-440.
Abstract

XU Z, Xu J, Gu Y, Ji Y, et al
Systematic review of self-management practices for vaginal irrigation among cervical cancer patients undergoing radiotherapy.
Front Oncol. 2026;16:1807898.
Abstract

ZHANG L, Fu H, Feng Y, Tian J, et al
Preliminary construction and validation of a prognostic prediction model for cervical cancer based on tumor mechanics-related genes.
Front Oncol. 2026;16:1841456.
Abstract

BUNDUKI GK
Beyond H uman papillomavirus (HPV): why female genital schistosomiasis must be addressed in Africa's cervical cancer prevention agenda.
Acad Pathol. 2026;13:100274.
Abstract

WEI W, Ku D, Rutherford N
Prognostic Value of Combined FDG PET and MRI Analysis of Cervical Cancer: A Systematic Review and Meta-Analysis.
J Med Radiat Sci. 2026 Jun 18. doi: 10.1002/jmrs.70103.
Abstract

LIU F, Sun W, Ding B, Yu B, et al
Association between exposure to perfluoroalkyl ether sulfonate F-53B and cervical cancer risk and its mechanisms of cervical toxicity in Chinese women.
Ecotoxicol Environ Saf. 2026;320:120373.
Abstract

STALP JL, Schneider JA, Steinkasserer L, Hachenberg J, et al
Comparing clinical decision-making between colposcopists and large language models in cervical dysplasia management: a pilot prospective multicenter study.
Arch Gynecol Obstet. 2026;313:206.
Abstract

ZUBAIDAH T
A Longitudinal Qualitative Study on the Perioperative Symptom-Demand Journey Map of Patients with Cervical Cancer [Letter].
Int J Womens Health. 2026;18:628657.
Abstract

NOV P, Wang D, Tan M, Virak V, et al
Global, regional, and national burdens of human papillomavirus-associated cervical cancer attributable to sexually acquired human papillomavirus infections among individuals aged 10-54 years from 1990 to 2021: findings from the Global Burden of Diseas
Sex Med. 2026;14:qfag045.
Abstract

OLUBAYO GT, Bakare A, Salako J, Olufayo OE, et al
Early implementation and contextual determinants of the human papillomavirus vaccine rollout and uptake in Nigeria: a mixed-methods study.
Front Public Health. 2026;14:1834756.
Abstract

KAMEPALLI S, Chavana A, Ludwig M, Flanagan M, et al
Chemoradiation after chemotherapy for metastatic cervical cancer can provide chemo-free time.
Front Oncol. 2026;16:1826017.
Abstract

THOMSON M, Tessier KM, Jones C, Lim N, et al
Prevalence of Alcohol Use Disorder and Alcohol-related Liver Disease in Women Undergoing Cervical Cancer Screening: A Missed Opportunity to Screen?
J Addict Med. 2026 Jun 19. doi: 10.1097/ADM.0000000000001705.
Abstract

TAN S, Liu X, Li B, Bao T, et al
Node-RADS in cervical cancer: a multi-reader agreement and diagnostic performance study.
Cancer Imaging. 2026 Jun 17. doi: 10.1186/s40644-026-01072.
Abstract

AYENI OA, Mmereki D, Mistry H, Achilonu O, et al
Disease characteristics, treatment, and overall survival outcomes of patients with locally advanced cervical cancer referred for radiation therapy in Johannesburg, South Africa: a 2-year retrospective study.
BMC Womens Health. 2026 Jun 17. doi: 10.1186/s12905-026-04611.
Abstract

PORTNOY A, Burger EA
HPV vaccination and early declines in cervical cancer deaths.
Lancet. 2026 Jun 17:S0140-6736(26)01024-X. doi: 10.1016/S0140-6736(26)01024.
Abstract

SASIENI P, Falcaro M
Cervical cancer mortality trends following HPV vaccination in England, 2001-24: an analysis of population-based mortality data.
Lancet. 2026 Jun 17:S0140-6736(26)00918-9. doi: 10.1016/S0140-6736(26)00918.
Abstract

FEI Y, Mao Y, Cai W, Huang L, et al
Targeting cellular senescence in cervical Cancer: a novel pathway to preserve reproductive potential.
Int Immunopharmacol. 2026;185:117005.
Abstract

ZHANG MY, Abulajiang Y, Ji C, Yang SL, et al
Epidemiology and treatment options for cervical cancer patients aged <25?Years based on SEER database and real world research.
Surg Oncol. 2026;67:102480.
Abstract

SANGER G, Damongilala LJ, Lau V, Romano R, et al
Cytotoxic Activity of Halymenia durvillaei against Cervical Cancer Cells: In Vitro and Computational Evidence.
Cell Biochem Biophys. 2026 Jun 17. doi: 10.1007/s12013-026-02099.
Abstract

SAINI V, Guo Z, Yu J, Wu D, et al
Development of a novel, urine-based high-risk human papillomavirus polymerase chain reaction test to predict cervical intraepithelial neoplasia abnormalities associated with cervical cancer.
Microbiol Spectr. 2026 Jun 17:e0379625. doi: 10.1128/spectrum.03796.
Abstract

KONG Y, Zhu L, Xiao Y
Warm autoimmune hemolytic anemia following definitive chemoradiotherapy for cervical cancer: A case report.
Oncol Lett. 2026;32:327.
Abstract

OLWAL CO, Rathore U, Makanani SK, Kaushal P, et al
Paracrine signals from HIV-1-infected immune cells reprogram cervical cancer pathways.
iScience. 2026;29:116083.
Abstract

GUO L, Song L, Liu X, Zhang B, et al
Development and validation of prognostic nomograms for patients with cervical cancer and liver metastasis: a SEER-based study.
Transl Cancer Res. 2026;15:393.
Abstract

HOU Y, Gao Y, Yan WM
A bibliometric analysis of global research in cervical cancer radiotherapy (2015-2024): trends, hotspots, and future directions.
Transl Cancer Res. 2026;15:389.
Abstract

BURANJIANG G, Xie L, Wang Y, Jin S, et al
WT1-AS acts as a tumor suppressor in cervical cancer via OSR2-mediated transcriptional activation.
Transl Cancer Res. 2026;15:386.
Abstract

WEN X, Zheng W, Zhai T, Wang Q, et al
Identifying and validating of prognostic genes associated with myeloid cell differentiation in cervical cancer: development of a risk model based on single-cell RNA sequencing combined with bulk RNA sequencing data.
Transl Cancer Res. 2026;15:390.
Abstract

LIU L, Zhang Q, Liu L, Wu Z, et al
Development and Validation of a Nomogram Integrating Body Composition and Inflammatory Markers to Predict Concurrent Chemoradiotherapy Response in Locally Advanced Cervical Cancer.
Cancer Manag Res. 2026;18:600310.
Abstract

RATHOD G, Swetha S, Nalini B
Cervical Cancer Screening in Elderly Women: Impact of Aging on Cytology and the Role of HPV Testing.
Curr Aging Sci. 2026 Jun 11. doi: 10.2174/0118746098435866260603051645.
Abstract

FUJITA T, Hyuga S, Adachi M, Onishi Y, et al
Maternal Hemodynamic Management Using the FloTrac Monitor During Ex Utero Intrapartum Treatment for a Giant Fetal Cervical Mass: A Case Report.
J Obstet Gynaecol Res. 2026;52:e70368.
Abstract

VEGA C, Medina N, Leon R, Fabelo H, et al
In-vivo detection of cervical cancer lesions using hyperspectral colposcopy.
Sci Rep. 2026 Jun 16. doi: 10.1038/s41598-026-58325.
Abstract

SASIENI P, Rix J
Vaccination is helping to eliminate cervical cancer in several countries, and continued surveillance is essential.
BMJ. 2026;393:e304038.
Abstract

ANDREE-EVARTS D, Carroll S, Osborne C, Clarke Z, et al
Case study: Innovative collaboration to connect Aboriginal women from rural New South Wales to world-class cancer treatment for cervical cancer.
J Med Imaging Radiat Sci. 2026;57:102449.
Abstract

LUMIA C, Fumagalli S, Martinelli M, Ausili D, et al
Economic incentives for cervical cancer screening: A qualitative study of healthcare professionals' perspectives.
Public Health. 2026;257:106385.
Abstract

XU M, Molina MA, Gomez-Martin C, Dekker MMHS, et al
Discovery and analytical assessment of urinary miRNA biomarkers for cervical cancer using advanced small RNA sequencing.
Transl Oncol. 2026;71:102857.
Abstract

OLUBODUN T, Luoga P, Adam J
Prevalence and determinants of cervical cancer screening among women aged 30-49 years in Nigeria: A population-based cross-sectional study.
PLOS Glob Public Health. 2026;6:e0006668.
Abstract

ZHOU J, Cai J, Zhang L, Zhu Y, et al
Effectiveness and cost-effectiveness of pembrolizumab in persistent, recurrent, or metastatic cervical cancer with PD-L1 CPS 1-10: secondary analysis of KEYNOTE-826 using innovative KMSubtraction.
Expert Rev Pharmacoecon Outcomes Res. 2026.
Abstract

TAN WM, Wang JQ, Li L, Liu XJ, et al
miR-133b induces antitumor immunity in cervical cancer through modulating CMTM6/PD-L1 axis.
Mol Genet Genomics. 2026;301:140.
Abstract

HALLIK R, Innos K, Janes J, Karro H, et al
Sociodemographic factors predicting preference for human papillomavirus self-sampling in cervical cancer screening: comparison of opt-out and opt-in strategies.
Eur J Cancer Prev. 2026 Jun 16. doi: 10.1097/CEJ.0000000000001028.
Abstract

YANG Y, He H, Lu R, Li Y, et al
Fluorescence-colorimetric dual-mode detection of cysteine in artificial urine with potential relevance to cervical cancer.
Anal Methods. 2026 Jun 10. doi: 10.1039/d6ay00473.
Abstract

FEREDE YA, Zeleke AM, Tassew WC, Abebe AD, et al
Cervical Cancer Screening Utilization and Its Associated Factors Among Women Living With HIV in Public Health Facilities of Gondar Town, Northwest Ethiopia.
J Int Assoc Provid AIDS Care. 2026;25:23259582261460521.
Abstract

CHALLGUA CH, Rodriguez DE, Goicolea I, Linander I, et al
Barriers and facilitators in access to cervical cancer secondary prevention in Cochabamba, Bolivia: a qualitative study of healthcare providers' perceptions.
BMC Prim Care. 2026;27:233.
Abstract

OMAR DI, Althobaiti S, Nabil N, Mohammed SG, et al
Human papillomavirus vaccination: knowledge, acceptance, and barriers among medical students. An Egyptian multicenter cross sectional study.
Sci Rep. 2026;16:18528.
Abstract

BIERRENBACH AL, Pungartnik PC, Goncalves Queijo R, Rego JG, et al
Early effects of HPV vaccination on high-grade cervical intraepithelial neoplasia in Brazil: Evidence from outpatient data.
Hum Vaccin Immunother. 2026;22:2684304.
Abstract

SHAN W, Shan Q, Xu X, Chen J, et al
A Machine Learning Framework for Predicting Nosocomial Escherichia coli Infections in Cervical Cancer.
Clin Lab. 2026;72.
Abstract

ZHANG T, Qian Q, Zhen Q, Zhang J, et al
Prevotella bivia promotes cervical cancer progression and modulates macrophage polarization, while Lactobacillus iners suppresses these processes: evidence from multiomics analysis.
mBio. 2026 Jun 15:e0037426. doi: 10.1128/mbio.00374.
Abstract

TAN H, Yang X
Effect of aesthetic nursing interventions on the health-related quality of life of cervical cancer patients after treatment.
Front Surg. 2026;13:1609977.
Abstract

SHINGHAL A, Sanyal S, Pradhan S, Kapoor AR, et al
Validation of IBS-GEC ESTRO-ABS Computed Tomography-Based Contouring Recommendations Using Prebrachytherapy Magnetic Resonance Imaging in Patients With Cervical Cancer Treated With Definitive Radiation Therapy.
Adv Radiat Oncol. 2026;11:102044.
Abstract

HAO F, Cheng X, He J, Song S, et al
A bibliometric analysis and visualization of trends in cervical cancer screening technologies based on dual-database analysis.
Front Oncol. 2026;16:1829800.
Abstract

SOLEHATI T, Haroen H, Hazmi HB, Putri YHS, et al
Telehealth Pathways for Cervical Cancer Prevention: A Scoping Review of Strategies to Close the Screening Gap.
Int J Womens Health. 2026;18:590474.
Abstract

YAO H, Hao Z, Zhang X, Liu S, et al
Severe immune checkpoint inhibitor-induced 3M syndrome: a case report.
Front Immunol. 2026;17:1840526.
Abstract

LI Y, Zhang J, Wu S, Liu Z, et al
The impact of gut microbiota on cervical cancer and precancerous lesions: neglected status, mechanisms, challenges, and a call to action.
Front Immunol. 2026;17:1826283.
Abstract

YAO S, Liu J, Dalisay F, Johnson BK, et al
Cervical Cancer Information Seeking in the Digital Communication Environment.
J Health Commun. 2026 Jun 15:1-11. doi: 10.1080/10810730.2026.2689090.
Abstract

FU H, Shakeel RS, Peng YB, Liu J, et al
Cinoplatin: An Efficient Platinum(IV) Prodrug Effective in Inhibiting the Growth of Cervical Cancer.
Chempluschem. 2026;91:e70191.
Abstract

BEVILACQUA F, Robba E, Berchialla P, Preti M, et al
Psychological distress and dyadic trust in Italian women awaiting colposcopy after positive cervical cancer screening: a cross-sectional study.
BMC Womens Health. 2026 Jun 15. doi: 10.1186/s12905-026-04500.
Abstract

SUN Y, Liu P, Ji M, Hao M, et al
The prognostic value of different HPV infection statuses in cervical cancer.
Sci Rep. 2026 Jun 14. doi: 10.1038/s41598-026-58010.
Abstract

LIU W, Wang XJ, Cui YM, Liu JC, et al
Clinicopathological and molecular characterization of HPV-associated cervical poorly cohesive carcinoma: a rare aggressive entity.
J Pathol Clin Res. 2026;12:e70100.
Abstract

POWELL J, Myers JB, Horns JJ, Woodle T, et al
Treatment-Related Risk of Urologic Adverse Events in Cervical Cancer Survivors.
Urology. 2026 Jun 14:S0090-4295(26)00370-5. doi: 10.1016/j.urology.2026.
Abstract

XIN R, Gong M, Guo J, Tian J, et al
Cervical cancer screening policy inequality worldwide: a systematic review of disparities in access and implementation.
J Transl Med. 2026 Jun 13. doi: 10.1186/s12967-026-08460.
Abstract

YACOUB N, Domizio ND, Ramanah R, Lepiller Q, et al
Prevalence and distribution of high-risk HPV in an organized hospital-based cervical cancer screening cohort.
J Gynecol Obstet Hum Reprod. 2026;55:103231.
Abstract

CI J, Wang C, Wang Y, Li D, et al
MICA/MICB-Mediated NKG2D Immune Escape in Cervical Cancer: Single-Cell Transcriptomic Mapping of Radionuclide Therapy Targets for Precision Radioimmunotherapy.
Cancer Biother Radiopharm. 2026 Jun 13:10849785261458459.
Abstract

SCHOLL S, Nery ED, Gestraud P, Halladjian M, et al
Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling.
Cancer Rep (Hoboken). 2026;9:e70599.
Abstract

YIN Y, Huang Y, Lin L, Cui M, et al
The role of miR-557 in modulating cervical cancer malignancy by targeting TAOK1.
Hereditas. 2026 Jun 12. doi: 10.1186/s41065-026-00695.
Abstract

HAMADA K, Umemiya M, Yamanoi K, Fukunishi T, et al
Nationwide trends in surgery selection and minimally invasive surgery for cervical cancer with preoperative T1B1/T1B2 disease in Japan.
Int J Clin Oncol. 2026 Jun 12. doi: 10.1007/s10147-026-03095.
Abstract

KANKARIA A, Shukla P, Vijayakumar M, Sachdeva A, et al
Enhancing screening, early diagnosis and treatment initiation of oral, breast and cervical cancer in selected districts of India: an implementation research protocol.
BMJ Open. 2026;16:e112428.
Abstract

MARTINEZ F, Durand C, Morel Z, Zanoune AD, et al
Organized cervical cancer screening in Brittany: follow-up at 1 year after a positive virological test with normal cytology.
J Gynecol Obstet Hum Reprod. 2026 Jun 12:103229.
Abstract

NICOLLS S, McClymont E, Lee M, Coutlee F, et al
Incidence and Prevalence of Human Papillomavirus Infection to Predict Outcomes from HPV-Based Cervical Cancer Screening in Women and People with a Cervix Living with HIV.
J Acquir Immune Defic Syndr. 2026 Jun 5. doi: 10.1097/QAI.0000000000003902.
Abstract

FUSEGI A, Nishikawa K, Kon T, Kamata M, et al
Surgical de-escalation in early-stage cervical cancer: current evidence and future perspectives.
Jpn J Clin Oncol. 2026 Jun 12:hyag092. doi: 10.1093.
Abstract

PANG H, Zhu S, Lu Q, Zheng W, et al
LAT1 Promotes Immunosuppression in Cervical Cancer by Interacting With TRIM67 to Facilitate IRF3 Ubiquitination and Degradation.
FASEB J. 2026;40:e72041.
Abstract

SERTEL E
Diagnostic Accuracy Rate of Tertiary Center Colposcopy Unit.
Anal Cell Pathol (Amst). 2026;2026:e9307280.
Abstract

PASHA T, Radhakrishna N, Buchapudi RR, Pullan SS, et al
Impact of size of ovoids with Intra-cavitary Brachytherapy on dose to point A in patients with Cancer Cervix.
Gulf J Oncolog. 2025;1:28-34.
Abstract

LATSUZBAIA A, Keer SV, Broeck DV, Weyers S, et al
Accuracy of Allplex HPV HR Detection Full Genotyping Assay on Cervical Samples Compared to Vaginal Self-Samples.
J Med Virol. 2026;98:e70982.
Abstract

GAO D, Wang X, Juan J, Bi H, et al
Prevalence and genotype distribution of cervical human papillomaviruses infection across cytology: A nationwide, cross-sectional study of over 1 million Chinese women from 2020 to 2024.
J Infect. 2026;93:106773.
Abstract

DERVEEUW S, Van Landschoot F, Willems S, Vanthomme K, et al
Navigating racialised healthcare: Intersectional experiences shaping cancer screening among Black women in Belgium.
Soc Sci Med. 2026;403:119449.
Abstract

BIZZARRI N, Schivardi G, Casarin J, Di Martino G, et al
The incidence of low volume metastases according to Silva pattern in cervical adenocarcinoma undergoing sentinel lymph node biopsy.
Eur J Surg Oncol. 2026;52:111875.
Abstract

REICH O, Regauer S
Two target cells for HPV infection at the cervix?
Virus Res. 2026;369:199754.
Abstract

GONZALEZ CANTO J, Burgos Teruel A, Burgos Isern MA
Prevalence and characteristics of HPV infection in the prevaccination and pre-screening era (2012-2022) in the Valencian Community.
Enferm Infecc Microbiol Clin (Engl Ed). 2026;44:503174.
Abstract

ZHENG S, Shao F, Shao L, Zhang L, et al
FHIT suppresses cervical squamous cell carcinoma progression by negatively regulating UBE2I-mediated SUMO modification of NOTCH1.
Cell Signal. 2026;145:112582.
Abstract

PSILOPATIS I, Vrettou K
Diagnostic Proficiency of Large Language Models in the Interpretation of Cervical Cytopathology.
Int J Gynecol Pathol. 2026;45:297-303.
Abstract

FAN L, Sowmya A, Meijering E, Yu Z, et al
Medical hierarchical image classification via dual-geometry image-text learning.
Med Image Anal. 2026;112:104120.
Abstract

LUO M, Wu J, Duan Z, Zhou D, et al
Analysis of factors affecting lesion or HPV clearance rate after photodynamic therapy of persistent cervical intraepithelial neoplasia grade 1.
Photodiagnosis Photodyn Ther. 2026;59:105491.
Abstract

QI W, Ma L, Cui S, Huang Z, et al
Evaluation of photodynamic therapy (PDT) of high-risk cervical low-grade squamous intraepithelial lesions (LSIL) - A single center experience.
Photodiagnosis Photodyn Ther. 2026;59:105490.
Abstract

HASEGAWA K, Kasuga Y, Ohnishi E, Nakabayashi K, et al
Vaginal microbiota composition in pregnant women following cervical conization and radical trachelectomy.
Sci Rep. 2026;16:18798.
Abstract

ZHANG G, Yang B
Progressive Activation of YAP1 in Human Papillomavirus-Associated Squamous Intraepithelial Lesions and Squamous Cell Carcinoma.
Lab Invest. 2026;106:106127.
Abstract

CHEN Y, Liu L, Chen Y, Wang Y, et al
Prognostic factors influencing the cure rate of 5-Aminolevulinic acid photodynamic therapy (ALA-PDT) of High-grade squamous intraepithelial lesions (HSIL): A retrospective cohort study.
Photodiagnosis Photodyn Ther. 2026;59:105463.
Abstract

BAHMAD HF, Alloush F, Jaspe G, Abulaban A, et al
PRAME Immunohistochemical Expression as a Diagnostic Tool to Distinguish Between Endocervical and Endometrial Adenocarcinomas.
Int J Gynecol Pathol. 2026;45:274-284.
Abstract

CHEN M, Li H, Wang L, Li L, et al
Evaluation of the efficacy and safety of photodynamic therapy after laser pretreatment for treating cervical high-grade intraepithlial lesions in patients of childbearing age: a non-randomized controlled prospective study.
Photodiagnosis Photodyn Ther. 2026;59:105451.
Abstract

LEVIN G, Gilbert L, Pareja R, Fumagalli D, et al
Trachelectomy in decline: national trends, outcomes, and academic output across 3 major databases.
Am J Obstet Gynecol. 2026;235:123-131.
Abstract

EERO N, Aarno L, Qiang K, Veronika F, et al
Genotype and Age Shape the Risk of Persistent High-Risk HPV Infections.
Am J Obstet Gynecol. 2026 Feb 25:S0002-9378(26)00121.
Abstract

WANG Y, Shi Q, Zhou X, Qiu L, et al
A meta-analysis of photodynamic therapy in the treatment of cervical intraepithelial neoplasia: Based on randomized controlled trials.
Photodiagnosis Photodyn Ther. 2026;59:105408.
Abstract

MORICE M, Cedric MA, Mushendwa JA, Gulamhussein MA, et al
Human Papillomavirus Vaccine Uptake and its Determinants among Parents of Adolescent Girls in Tanga city, Tanzania.
J Community Health. 2026;51:378-385.
Abstract

GERYKOVA L, Laco J, Hornychova H, Kamaradova K, et al
Utility of HoxB13 in differential diagnosis of female genital tract lesions with putative prostatic differentiation.
Virchows Arch. 2026;488:1293-1302.
Abstract

AKINCI G, Aydin R
The Effect of Women's Perceptions of Their Nurses' Communication on Their Distress and Fear of Cancer During Colposcopy: A Multicenter Study.
Cancer Nurs. 2026;49:E352-E360.
Abstract

ZHANG B, Lin Y, Xie S, Zhu X, et al
Decoding the association between platinum resistance and HPV status in cervical cancer using organoid models.
BMC Biol. 2026 Jun 26. doi: 10.1186/s12915-026-02665.
Abstract

DONG H, Zhang J, Wu L, Zhang X, et al
Human papillomavirus 18 E6-specific Affibody inhibits cervical cancer cell proliferation and induces apoptosis.
Appl Microbiol Biotechnol. 2026 Jun 26. doi: 10.1007/s00253-026-13903.
Abstract

SOMPONGNAWAKIT K, Boonyapipat S, Saeaib N
Pretreatment systemic immune-inflammatory index (SII) for a prognostic impact in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Taiwan J Obstet Gynecol. 2026;65:774-781.
Abstract

SUH-BURGMANN EJ, Hung YY, Seo T, Carlson K, et al
Home Cervical Cancer Screening Uptake in a Large Community-Based General Screening Population.
JAMA Netw Open. 2026;9:e2620343.
Abstract

CHEN S, Zhang Y, Chen D, Dang J, et al
AI-assisted Radiomic Model for Cervical Cancer Recurrence Prediction: A Multicenter Retrospective Study with Experimental Validation.
Radiol Imaging Cancer. 2026;8:e250618.
Abstract

TALPE-NUNES V, Ribeiro AL, Nunes RA, Sobrinho JS, et al
GATA3 Inhibits the Expression of Viral E6/E7 Genes, and Its Expression Is Compromised During HPV-Mediated Cervical Carcinogenesis.
J Med Virol. 2026;98:e71034.
Abstract

SUI L, Yin R
Global research trends and hotspots in human immunodeficiency virus-associated cervical cancer (1990-2025): a multi-database bibliometric analysis.
Front Immunol. 2026;17:1835957.
Abstract

RAKHAT A, Aimagambetova G
Diagnostic Accuracy of Urine and Vaginal Self-Sampling for Detection of High-Risk Human Papillomavirus: A Systematic Review and Meta-Analysis.
Viruses. 2026;18:681.
Abstract

QIAO M, Wang X, Ren C, Li Q, et al
Polymer-Based Biomaterials for Local Therapy in Cervical Cancer: A Mini-Review.
Polymers (Basel). 2026;18:1460.
Abstract

RADU EA, Anton CI, Sima CS, Streinu-Cercel A, et al
Beyond HPV in Eastern Europe: Genotype Distribution, Molecular Biomarkers, Vaginal Microbiome, and Implications for Cervical Cancer Prevention.
Life (Basel). 2026;16:1039.
Abstract

TERRINONI M, Caputo V, Palisciano M, Mascellino G, et al
Non-Coding RNAs as Emerging Biomarkers in HPV-Associated Cervical Precancer and Cancer: Molecular Mechanisms and Clinical Perspectives.
Genes (Basel). 2026;17:714.
Abstract

MOUSTAKLI E, Makrydimas S, Oikonomou ED, Nakou A, et al
The Microbiome-Mitochondria-Extracellular Vesicle Axis in HPV Persistence and Cervical Carcinogenesis.
Genes (Basel). 2026;17:655.
Abstract

SUAREZ-RICO DO, Rizo de la Torre LDC, Zermeno-Ruiz M, Balleza-Alejandri LR, et al
Bidirectional Interactions Between Cervicovaginal Microbiota and Human Papillomavirus Drive Persistence and Disease Progression.
Int J Mol Sci. 2026;27:5616.
Abstract

GACUTA E, Zajkowska M, Lawicki M, Urban J, et al
Diagnostic Potential of Selected Matrilysins and Stromelysins in the Diagnosis of Gynecological Malignancies Based on ROC Curve Analysis.
Int J Mol Sci. 2026;27:5592.
Abstract

ZHANG L, Ouyang Z, Tan J, Li W, et al
Mechanistic Study of Matrix Stiffness Promoting Lymph Node Metastasis in Cervical Cancer by Regulating NETs Formation via Piezo1.
Int J Mol Sci. 2026;27:5431.
Abstract

JELSKI W, Okrasinska S, Mroczko J, Rutkowska W, et al
MicroRNAs as Biomarkers of Cervical Cancers.
Int J Mol Sci. 2026;27:5330.
Abstract

AYAG ME, Tuncer MC, Ozdemir I
Gallic Acid Enhances Carboplatin-Induced Antitumoral Responses in Cervical Cancer Cells Through Oxidative Stress-Associated Mitochondrial and Apoptotic Mechanisms.
Biomedicines. 2026;14:1399.
Abstract

JIAO B, Wang D, Wei J, Guan S, et al
Sevoflurane-Associated Plasma Extracellular Vesicles Promote Aggressive Phenotypes in Cervical Cancer Cells with Concurrent DG Remodeling and EGFR/PKCalpha/NF-kappaB Activation.
Biomedicines. 2026;14:1333.
Abstract

LUCA DC, Cirimbei C, Ionescu SO, Rotaru V, et al
Correction: Luca et al. Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Literature Review with Narrative Synthesis. Diagnostics 2026, 16, 1224.
Diagnostics (Basel). 2026;16:1764.
Abstract

ALYAMI AS
Advanced Diffusion MRI in Cervical Cancer: A Comprehensive Review.
Diagnostics (Basel). 2026;16:1870.
Abstract

SUN L, Tunishahan A, Li X
M2 macrophage-derived exosomes promote the malignant progression and glycolysis of cervical cancer via Msi1.
Hereditas. 2026 Jun 25. doi: 10.1186/s41065-026-00703.
Abstract

ZHAO Y, Liu R, Li M, Feng M, et al
Bovine lactoferrin induces apoptosis and modulates the transcriptomic landscape of HeLa cervical cancer cells.
Biol Direct. 2026 Jun 26. doi: 10.1186/s13062-026-00859.
Abstract

GAO F, Zeng Y, Jia L, He J, et al
Transcription factor FOXA1 suppresses ferroptosis of cervical cancer cells by upregulating SLC7A11 expression.
Cell Div. 2026 Jun 25. doi: 10.1186/s13008-026-00182.
Abstract

O'LEARY K
HPV vaccination linked to dramatic reduction in cervical cancer deaths.
Nat Med. 2026 Jun 25. doi: 10.1038/d41591-026-00033.
Abstract

YANG G, Wang W, Zhang C, Liu Y, et al
Dynamic multimodal radiomic model for survival prediction in cervical cancer: a multi-cohort study.
NPJ Precis Oncol. 2026 Jun 25. doi: 10.1038/s41698-026-01545.
Abstract

CHEN L, Li C, Xu C, Cai R, et al
Unravelling the Mechanism of Compound Kushen Injection in Treating Cervical Cancer Through Ferroptosis Regulation: An Integrated Network Pharmacology and Molecular Docking Study.
IET Syst Biol. 2026;20:e70075.
Abstract

YI H, Li S, Han Y, Li Q, et al
The ESR1-MYH14 axis functions as a critical driver of cervical cancer progression and metastasis.
Transl Oncol. 2026;71:102884.
Abstract

MATSUNAGA R, Tamura J, Yamamoto K, Senuki K, et al
Evaluation of the Efficacy of Human Papillomavirus Screening Compared With Cytology Screening in Pregnant Women: Protocol for a Prospective Multicenter Trial.
JMIR Res Protoc. 2026;15:e86397.
Abstract

SAITO T, Sho K, Saida T, Sumiya T, et al
Mid-treatment MRI-based tumor volume reduction rate as a continuous prognostic factor after chemoradiation for cervical cancer: development and two-center internal-external validation.
J Radiat Res. 2026 Jun 25:rrag043. doi: 10.1093.
Abstract

HEMPEL S, Gross S, Steinkasserer L, Theis L, et al
Comparison of three different hpv self-sampling tools - a subanalysis of the prospective, randomized hannover self-collection study.
Arch Gynecol Obstet. 2026;313:210.
Abstract

THOMAS V, Devadasan JDC, John NO, Reddy JK, et al
Serum human papilloma virus detection following treatment of cervical cancer: prevalence and its correlation with recurrence.
Cancer Causes Control. 2026;37:111.
Abstract

SORBYE SW, Antonsen M, Richardsen E
Five-Year Risk of CIN3+ After CIN1 Biopsy in a Norwegian Screening Setting: Comparison of CIN1 Diagnosed in a Single Calendar Year and in Two Consecutive Calendar Years.
Pathogens. 2026;15:657.
Abstract

VILLAZANA-CALDERON B, Jimenez-Wences H, Garcia-Chavez JN, Martinez-Ramirez I, et al
HPV-16 E6 and E7 Oncoproteins Promote Cell Proliferation and Migration Through the miR-218-5p/PIK3C2A Axis.
Pathogens. 2026;15:648.
Abstract

SORBYE SW, Falang BM, Antonsen M, Richardsen E, et al
Genotype-Specific HPV mRNA Triage Improves Colposcopy Efficiency Compared with Cytology and ATHENA-Derived Triage: A Population-Based Study of HPV DNA-Positive Women.
Pathogens. 2026;15:584.
Abstract

LEE TS, Wang YC
Stage-Specific Healthcare Costs in Cervical Cancer and Cervical Intraepithelial Neoplasia: A Population-Based Analysis Informing Value-Based Oncology and Equitable Prevention.
Curr Oncol. 2026;33:329.
Abstract

ABRAHAM A, Mahajan S, Padda P, Kaur J, et al
Assessment of Total Delays and Their Associated Factors among Breast, Cervical, and Head and Neck Cancers in Northwestern India: A Cross-Sectional Study.
Asian Pac J Cancer Prev. 2026;27:2097-2105.
Abstract

BODHARE T, Bele S, Rajh B, Karthikeyan V, et al
Awareness of Cervical Cancer, Willingness, and Barriers to Cervical Cancer Screening among Women in Madurai: A Cross-Sectional Study in South India.
Asian Pac J Cancer Prev. 2026;27:2053-2060.
Abstract

TESHA NA, Jaiswal N, Ruhago G, Geue C, et al
Cost and cost-effectiveness of cervical cancer HPV DNA self-sampling: a systematic review.
BMJ Public Health. 2026;4:e004405.
Abstract

CENGIZ M, Zaim OC, Temiz BE, Grigore M, et al
Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.
Curr Opin Oncol. 2026 Jun 23. doi: 10.1097/CCO.0000000000001255.
Abstract

BELAYNEH Y, Abneh AA, Mengist A, Kassie TD, et al
Determinants of precancerous cervical lesions among women screened for cervical cancer at Debre Markos town public health facilities, Ethiopia.
Reprod Health. 2026 Jun 24. doi: 10.1186/s12978-026-02399.
Abstract

DANG S, Tang X, Li Q, Wu J, et al
Corrigendum to "Xiao-Liu Tang (XLT), a traditional Chinese medicine formula that suppresses the progression of cervical cancer by inducing apoptosis and inhibiting cell migration" [J Ethnopharmacol. (2026) 358 120966].
J Ethnopharmacol. 2026 Jun 24:122028. doi: 10.1016/j.jep.2026.122028.
Abstract

JIAN J, Xu L, Gong C, Huang Y, et al
Transformer-based magnetic resonance-to-computed tomography synthesis for radiotherapy for cervical cancer: model development and clinical evaluation.
Biomed Phys Eng Express. 2026 Jun 24. doi: 10.1088/2057-1976.
Abstract

KATARIA I, Jose S, Jebaraj P, Kumar R, et al
Living With Loss: The Caregiver Journey and Unmet Needs Across the Cervical Cancer Care Continuum in India.
JCO Glob Oncol. 2026;12:e2600031.
Abstract

OLADOYIN OO, Cuccaro P, Savas LS, Yu R, et al
Trust in Cancer Information Sources and Awareness of Human Papillomavirus as a Cause of Cervical Cancer Among US Adults.
JAMA Netw Open. 2026;9:e2620133.
Abstract

ZHENG B, Fan D, Zhou S
Less is more: patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies.
Cancer Biol Med. 2026 Jun 22:j.issn.2095-3941.2026.0139.
Abstract

BADEMCI EG, Soysal D, Gunes M, Zengin A, et al
Early colposcopy in non-16/18 high-risk human papillomavirus positivity with normal cytology.
Rev Assoc Med Bras (1992). 2026;72:e20252178.
Abstract

DONG X, Zhang J, Liu W
A turn-on fluorescent biosensor based on CdTe quantum dots for sensitive and selective detection of APE1 activity in cervical cancer cell lysates.
Anal Methods. 2026 Jun 24. doi: 10.1039/d6ay00808.
Abstract

LI J, Huang X, Abulizi G, Hasim A, et al
Exosomal Oleic Acid Promotes Lymphangiogenesis and Nodal Metastasis in Cervical Cancer via the AKT/mTOR Pathway.
J Extracell Vesicles. 2026;15:e70328.
Abstract

SHEN J, Sun S, Xu Z, Wang X, et al
A rapid semi-automated trajectory planning method for non-coplanar interstitial brachytherapy in cervical cancer using a greedy algorithm.
Radiat Oncol. 2026 Jun 23. doi: 10.1186/s13014-026-02881.
Abstract

XIE Y, Yu C, Wang M, Lin Y, et al
HMGB1 promotes radiotherapy resistance in human cervical cancer HeLa cells through regulating the AMPK/mTOR signaling.
World J Surg Oncol. 2026 Jun 23. doi: 10.1186/s12957-026-04461.
Abstract

FENG M, Yu Y, Du J, Wang H, et al
Integrative analysis identifies the intratumoral Fusobacterium nucleatum as a driver of cervical cancer malignancy.
BMC Biotechnol. 2026 Jun 23. doi: 10.1186/s12896-026-01193.
Abstract

ZHANG H, Xie L, Liu Y, Yang H, et al
Integrated bioinformatics, machine learning, and experimental validation identify a four-gene diagnostic signature for cervical cancer associated with PI3K/AKT signaling.
Sci Rep. 2026;16:19576.
Abstract

COOPER S, Wiysonge CS, Jama NA, Leon N, et al
Understanding the roots of hesitancy to unlock the game-changing impact of HPV vaccination: Insights from a global qualitative evidence synthesis.
Hum Vaccin Immunother. 2026;22:2681769.
Abstract

BAI J, Cui XL, Bo SJ, Sun L, et al
Using peripheral blood indicators and T cells subsets to evaluate the efficacy of immunotherapy for advanced and recurrent cervical cancer.
Hum Vaccin Immunother. 2026;22:2664301.
Abstract

YANG H, Zheng Q, Li X, Wang J, et al
Multi-Omics Analysis Identifies Phosphoglucomutase 2 as a Potential Target to Alleviate Chemoradiotherapy Resistance in Cervical Cancer Cells.
Onco Targets Ther. 2026;19:613657.
Abstract

ZHANG Y, Wu Y, Wang Y, Yang J, et al
Perioperative Symptom Trajectories and a Risk Prediction Model for Cervical Cancer: A Prospective Longitudinal Study.
Int J Womens Health. 2026;18:613006.
Abstract

BUZUROVIC IM, Cormack RA
A Novel Adjustable Tandem and Ring Applicator for Improved Dosimetry in Cervical Cancer HDR Brachytherapy.
Technol Cancer Res Treat. 2026;25:15330338261463597.
Abstract

GU L, Zhu B, Liu C, Wu X, et al
Genomic Determinants and an Exploratory Prognostic Model for Immunotherapy Outcomes in Recurrent or Metastatic Cervical Cancer.
Oncologist. 2026 Jun 22:oyag236. doi: 10.1093.
Abstract

ZHANG Y, Ye Y, Zhong Q, Yan Z, et al
Advances and prospects of MIL-based drug delivery systems in the diagnosis and treatment of cervical cancer.
Dalton Trans. 2026 Jun 22. doi: 10.1039/d6dt00965.
Abstract

LAMBA P
Comment on: "Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy.".
Clin Transl Radiat Oncol. 2026;59:101166.
Abstract

SITTIWONG W, Dankulchai P, Wongsuwan P, Prasartseree T, et al
Corrigendum to "Pre-Treatment and Pre-Brachytherapy MRI First-Order Radiomic Features by a Commercial Software as Survival Predictors in Radiotherapy for Cervical Cancer" [Clin. Transl. Radiat. Oncol. 53 (2025) 100965].
Clin Transl Radiat Oncol. 2026;59:101128.
Abstract

GOMES M, Li Z, Olaitan A, Gentry-Maharaj A, et al
Predictive modeling for cervical cancer: existing AI approaches and the emerging role of vaginal microbiome.
Front Netw Physiol. 2026;6:1799486.
Abstract

WANG J, Wang X, Xu J, Xu Q, et al
Cost-effectiveness of single-dose versus two-dose HPV vaccination: a Markov cohort modelling analysis of a Kenya-India LMIC composite.
Front Public Health. 2026;14:1833764.
Abstract

CHEN Y, Wen T, Wen X, Lai Z, et al
Treatment of HER2-Positive Brain Metastasis from Cervical Cancer Using Multimodal Therapy Including Pyrotinib: A Case Report.
Int J Womens Health. 2026;18:607409.
Abstract

ENEH SC, Idemili-Aronu N, Jemisenia JO, Olakunde BO, et al
Participation and Refusal in an Implementation Trial: Insights from the Accelerating Cervical Cancer Elimination through the Integration of Screen-and-Treat Services (ACCESS) Study.
Res Sq [Preprint]. 2026 Jun 11:rs.3.rs-9798338. doi: 10.21203/rs.3.rs-9798338.
Abstract

RAKHMANKULOVA A, Sakko Y, Gaipov A, Atageldiyeva K, et al
Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study.
Front Oncol. 2026;16:1820759.
Abstract

BOU ANTOUN N, Grose RP, Walker AJ, Modjtahedi H, et al
FGFR inhibitor resistance in cervical cancer: a role for integrin alpha2 and mTOR signalling.
Front Cell Dev Biol. 2026;14:1863679.
Abstract

BAI Y, Liang Y
Comparison of ThinPrep cytology and high-risk human papillomavirus testing with different triage protocols for cervical cancer screening.
Am J Transl Res. 2026;18:4314-4325.
Abstract

JERIP AR, Noni V, Senian AA, Bong ACS, et al
Mismatch Between Vaccine Targets and Endemic HPV Genotypes in Sarawak, East Malaysia: Implications for Cervical Cancer Prevention.
J Med Virol. 2026;98:e71010.
Abstract

SAKRAN W, Abdel-Hakim M, Abdel-Rashid RS
Formulation, characterization and evaluation of cytotoxic potential for febuxostat loaded chitosomes against cervical cancer cells (Hela cells).
Sci Rep. 2026;16:19198.
Abstract

ZHANG T, Yan Y, Yuan S, Yang T, et al
A novel HPV E6/E7-regulated long noncoding RNA CRL suppresses cervical intraepithelial neoplasia progression by attenuating ferroptosis.
Hum Cell. 2026;39:90.
Abstract

V P, K H, Karthikeyan S, Murugadoss H, et al
Health-related quality of life in patients with cervical cancer: a systematic review and meta-analysis of EQ?5D utility scores.
Sci Rep. 2026 Jun 20. doi: 10.1038/s41598-026-58466.
Abstract

PERKINS RB, Fontenot HB, Manassaram-Baptiste D, Scott AM, et al
The Prevention Gap: Cervical Cancer in Older Women.
Womens Health Issues. 2026 Jun 20:S1049-3867(26)00074.
Abstract

OUEDRAOGO TC, Bazie BVEJT, Simpore A, Ouattara AK, et al
Glutathione S-Transferase Mu1 polymorphisms and environmental factors in cervical cancer susceptibility: a systematic review and meta-analysis.
Cell Mol Biol (Noisy-le-grand). 2026;72:30-43.
Abstract

KULKARNI A, Wiener HW, Boitano TKL, Szychowski JM, et al
Charleson and Elixhauser Comorbidity Indices in Predicting Mortality Among Young and Old Cervical Cancer Patients.
Cancer Med. 2026;15:e71973.
Abstract

MANYANGA P, Vasavada A, Murwira S, Gondongwe L, et al
Motivations and hesitations for cervical cancer screening: considerations for scale-up of human papilloma virus (HPV) testing within HIV care in Zimbabwe.
Infect Agent Cancer. 2026 Jun 19. doi: 10.1186/s13027-026-00773.
Abstract

LEMOUPA MAKAJIO SH, Murtas M, Kenfack B, Vassilakos P, et al
Interventions involving community health workers and their effect on cervical cancer screening uptake in sub-Saharan Africa: a systematic review.
BMC Public Health. 2026 Jun 19. doi: 10.1186/s12889-026-28109.
Abstract

MAHASE E
HPV jab: cervical cancer deaths fall to zero in vaccinated young women, research shows.
BMJ. 2026;393:e100047.
Abstract

PENG L, Zhang Q, Zhang L, Dai Q, et al
Intra-nanocomposite resonance energy transfer-based electrochemiluminescence biosensor for cervical cancer microRNA assay.
Biosens Bioelectron. 2026;311:118937.
Abstract

GOSECKA M, Gosecki M, Urbaniak M, Wielgus E, et al
Unimolecular micelles as an effective carrier of poorly water-soluble nifuratel for selective in vivo anticervical cancer therapy via mucoadhesive dynamic hydrogels.
J Mater Chem B. 2026;14:7543-7557.
Abstract

CORDOVIL DC, da Silva Reis LD, Ferreira LSS, Sequeira CG, et al
High-risk oncogenic HPV genotypes in vulnerable women from the Amazon: a cross-sectional retrospective study.
Virol J. 2026;23:164.
Abstract

POULAIN F, Malassigne V, Roncarati P, Puech J, et al
Clonal origin and early lineage divergence in adenosquamous carcinoma.
Cell Rep. 2026;45:117470.
Abstract

CYRIAC J, Theel ES, Long ME, Maxson JA, et al
Human Papillomavirus Test Agreement Between Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
J Low Genit Tract Dis. 2026;30:161-168.
Abstract

ONG P, Jainar CJ, Chua VH, Cabrera SM, et al
Integrating ultrasound into cervical brachytherapy planning: A technical note with an illustrative case.
Brachytherapy. 2026;25:640-647.
Abstract

NANYONJO G, De Paepe E, Wambuzi M, Kasule S, et al
Perceived barriers and facilitators to conventional cervical screening: a qualitative study among women, primary health workers and community representatives in Uganda.
BMC Health Serv Res. 2026;26:867.
Abstract

MURDOCH S, Donaghy B, Grant A, Sheen K, et al
Exploring Autistic People's Experiences of and Attitudes Towards Cervical Screening: A Mixed-Methods Study.
Autism. 2026;30:1738-1748.
Abstract

OZDEMIR BG, Agakishiyeva L, Bilgi A, Celik C, et al
Evaluation of Clitoral Artery Doppler Parameters After Brachytherapy and Its Effects On Sexual Functions.
J Low Genit Tract Dis. 2026;30:280-284.
Abstract

OWENS H, Griner SB, Beckstead J, Kim E, et al
Predictors of Intention to Use At-Home HPV Testing: Health Belief Factors and Potential Moderation by Decision-Making Style.
Womens Health Issues. 2026;36:286-293.
Abstract

DE SEIXAS CARVALHO B, Jordao PM, de Andrade CV, da Costa ACC, et al
Swede Score can predict high-grade cervical intraepithelial neoplasia without previous cytology in colposcopies with transformation zone types 1 or 2.
BMC Womens Health. 2026;26:158.
Abstract

TYAGI P, Rivera A, Chakraborty S, Bhattacharyya T, et al
Patterns of anesthesia(AS) and analgesia(AG) practice in gynecological brachytherapy in India.
Brachytherapy. 2026;25:632-639.
Abstract

REGO RM, Vale DB, Campos CS, Vasconcelos L, et al
Age distribution of high-risk HPV infection and cervical lesions in an unvaccinated adult Brazilian population within an organized screening program.
Sci Rep. 2026;16:4453.
Abstract

RICKFORD R, Rogers M, Gunn R, Wearmouth L, et al
Facilitating engagement: Individual meaning-making and relationship-based trust in women's experiences of cervical screening.
J Health Psychol. 2026;31:3196-3209.
Abstract

SLATER T, Stevenson K, Adcock A, Clueard MA, et al
Opportunities to flip the narrative from burden to action for young women joining the National Cervical Screening Programme in Aotearoa New Zealand: a Kaupapa Maori qualitative exploration of experiences and knowledge of cervical screening for 18-30 y
J Prim Health Care. 2026;18:141-148.
Abstract

OLTIEVA MP, Alieva DA, Kizi Abdusattorova SB, Sharipova IP, et al
Epidemiology of high-risk HPV in Uzbekistan among 44,000 women - genotypes, risk profiles and screening needs in Uzbekistan.
BMC Infect Dis. 2025;25:1721.
Abstract

CHEN M, Zhang W, Wu X, Wang H, et al
Design, synthesis and verification of HPV16 and HPV18 multiple antigens peptides.
J Transl Med. 2025;24:38.
Abstract

XIE K, Hua Q, Gao L, Sun J, et al
SegMambaDP: a long-range sequential modeling mamba network for 3D dose prediction in radiotherapy.
BMC Med Imaging. 2025;25:527.
Abstract

ADDIS NA, Yigzaw KT, Ahmed OA, Yemru GM, et al
Cervical schistosomiasis masquerading as invasive carcinoma: a case report.
BMC Infect Dis. 2025;25:1654.
Abstract

SAD SA, Iftikhar L, Chamout M
Revisiting HPV vaccination post-COVID: geopolitical, sociocultural, and ethical disparities in global health.
Int J Equity Health. 2025;24:308.
Abstract

LI X, Sun B, Huang X
Trends and projections of global gynaecological cancer burden: age-period-cohort insights from Global Burden of Disease 2021.
BMC Womens Health. 2025;25:502.
Abstract

CHEN M, Wang Y, Dong B, Zhang Y, et al
Epidemiological analysis of human papillomavirus infection in senior women: a hospital-based retrospective study.
BMC Infect Dis. 2025;25:1378.
Abstract

XIAONAN L, MeiHan C, Dan H
Vaginal Microenvironment-Driven neural network model for predicting multiple HPV co-infections: a machine learning clinical decision framework.
BMC Womens Health. 2025;25:489.
Abstract

SIGVARDSSON D, MacLean A, Hoonk A, Ali T, et al
Barriers and implementation strategies for physical activity on prescription (PAP): healthcare personnel and management perspectives in Sweden-An explanatory sequential study design.
BMC Prim Care. 2025;26:302.
Abstract

JUAREZ-LEON V, Calderon-Solano D, Poterico JA, Ybaseta-Medina J, et al
Factors associated with parental acceptance of the HPV vaccine in girls from metropolitan Lima, Peru.
BMC Public Health. 2025;25:2334.
Abstract

MIYAMURA T, Mori S, Onuki M, Sekizawa A, et al
Nuclear keratin 6A upregulates human papillomavirus oncogene expression through TEAD1 interaction.
Virol J. 2025;22:202.
Abstract

HORIUCHI Y, Noguchi H, Taniguchi AY, Kazami M, et al
Xanthoangelol, a chalcone from Angelica keiskei, induces apoptosis in cervical cancer cell lines via the oxidative stress-mediated activation of caspase-8 and caspase-9.
Biochem Biophys Res Commun. 2026;830:154209.
Abstract

HERMANN KC, Peralta Chiriboga AA, Fuji KT, O'Keefe AL, et al
Perceptions, knowledge, and access to the HPV vaccine among parents and healthcare providers in South Quito, Ecuador in 2025: A qualitative study.
Glob Public Health. 2026;21:2697096.
Abstract

LIN R, Niu J, Weng S, Lin C, et al
Label-free cervical cancer detection in tissue samples using Raman spectroscopy combined with machine learning technology.
Anal Methods. 2026 Jul 3. doi: 10.1039/d6ay00509.
Abstract

PAZ-SOLDAN VA, Nussbaum L, Hidalgo C, Del Cuadro Hidalgo DL, et al
Delivering cervical cancer screening and management to women in remote communities of the Peruvian Amazon: a mixed methods analysis of a mobile point-of-care intervention.
Lancet Reg Health Am. 2026;61:101535.
Abstract

LIU Y
Application of hydrogels in 3D tumor microenvironment modeling and drug screening for cervical cancer: A review.
Bioeng Transl Med. 2026;11:e70147.
Abstract

KATANYOO K, Thavorncharoensap M, Kittisiam T
Factors Affecting Quality of Life of Thai Cervical Cancer Patients.
J Obstet Gynaecol Res. 2026;52:e70392.
Abstract

SANGONIYI OO, Dairo MD
Barriers to accessing cervical cancer prevention services among out-of-school young women in Ibadan.
BMC Womens Health. 2026 Jul 2. doi: 10.1186/s12905-026-04651.
Abstract

ABDULGHANI N, Faqih S, Alqurashi A, Baljon K, et al
Effectiveness of an educational intervention in enhancing parents' knowledge, perception, and acceptability of human papillomavirus vaccine.
BMC Public Health. 2026;26:2032.
Abstract

YADAV C, Nanda S, Sehrawat N, Yadav R, et al
Molecular and bioinformatic analysis of apoptotic tumor suppressor genes in cervical cancer.
J Appl Genet. 2026 Jul 3. doi: 10.1007/s13353-026-01093.
Abstract

YOUNG AP, Reyes R, Mgbudem C, Chen D, et al
Primary HPV Testing for Cervical Cancer Screening Among Family Medicine Educators.
J Am Board Fam Med. 2026;39:162481.
Abstract

Vaccination is helping to eliminate cervical cancer in several countries, and continued surveillance is essential.
BMJ. 2026;394:e100162.
Abstract

CUELLO MA, Gomez-Valenzuela F, Wichmann I, Olawaiye AB, et al
Global feasibility of cervical cancer elimination: a multidimensional scenario-based modelling analysis across 175 countries.
Lancet Glob Health. 2026 Jul 2:104008. doi: 10.1016/j.langlo.2026.104008.
Abstract

RAMALIBA TM, Muchengeti MM, Sithole N, Motlhale M, et al
Incidence patterns and temporal trends of breast, prostate, oesophageal and cervical cancer in rural Eastern Cape Province, South Africa 1998-2021.
Cancer Epidemiol. 2026;103:103151.
Abstract

H CHUWA A
Innovations in HPV vaccination and their role in global cervical cancer control: a review.
Ther Adv Vaccines Immunother. 2026;14:25151355261449446.
Abstract

YUAN Y, He W, Tong L, Yang Y, et al
Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report.
Front Immunol. 2026;17:1853610.
Abstract

FENG S, Huang Y, Li Z, He Z, et al
A mitochondrial regulatory network of ferroptosis defense in HPV-positive cervical cancer: therapeutic implications of the mitoSTAT3-DHODH axis.
Front Pharmacol. 2026;17:1868059.
Abstract

XU M, Lu T, Lv Q, Mo K, et al
Integrative network pharmacology, molecular dynamics simulation, and single-cell RNA sequencing strategies reveal the multi-target mechanisms of oridonin against cervical cancer.
Front Pharmacol. 2026;17:1788376.
Abstract

FILE BH, Rara MR, Nemmani RS, Chang J, et al
Sociodemographic disparities and hospice referral practice patterns among patients with recurrent cervical cancer.
Gynecol Oncol Rep. 2026;66:102151.
Abstract

JIA C, Wu Y, Gao F, Liu W, et al
Corrigendum to "The opposite role of lactate dehydrogenase a (LDHA) in cervical cancer under energy stress conditions" [Free Radic. Biol. Med. 214 (2024) 2-18].
Free Radic Biol Med. 2026 Jul 1:S0891-5849(26)00910.
Abstract

DEWI SUGANDA PUTRI MP
[Reading cervical cancer as an issue of gender justice and human rights].
Aten Primaria. 2026;58:103563.
Abstract

GEORGE J, Amoo-Mitchual S, Kernell C, Tuli S, et al
Adherence to Survivorship Care Visits in Patients With Cervical Cancer in Botswana.
JCO Glob Oncol. 2026;12:e2500352.
Abstract

KANBAS CO, Keles E, Mert EO, Ozdas CE, et al
Prognostic impact of adenomyosis in cervical cancer: insights from machine learning-driven survival analysis.
Rev Assoc Med Bras (1992). 2026;72:e20251656.
Abstract

ZHAO YH, Ruan QF, Ning JH, Zhang X, et al
Bidirectional mendelian randomization identifies plasma proteins associated with cervical cancer risk.
J Egypt Natl Canc Inst. 2026;38:40.
Abstract

RAN L, Lian Z, Tian Y, Qin L, et al
Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation.
Front Immunol. 2026;17:1850891.
Abstract

JAKIMIUK AJ, Januszewski M
Towards HPV-Based Cervical Cancer Screening in Poland: Lessons From a Landmark Trial.
Lancet Reg Health Eur. 2026;66:101752.
Abstract

ROCKWELL MS, Fendrick AM
Optimizing the Uptake and Completion of the Cervical Cancer Screening Continuum: Opportunity Knocks, Including at Home.
Cancer Epidemiol Biomarkers Prev. 2026;35:1061-1063.
Abstract

THONGSAWAD S, Rinjan N, Tharavichitkul E, Khamfongkhruea C, et al
Deep learning-based dose prediction to enhance planning efficiency in cervical brachytherapy with hybrid applicators.
Phys Med Biol. 2026;71.
Abstract

MUDRIK A
Large Language Models on European Guidelines for Cervical Cancer: Implications of Design and Clinical Applicability.
BJOG. 2026 Jun 30. doi: 10.1111/1471-0528.70299.
Abstract

AMAOUI B, Belkadi C, Dlhane M, Amrani M, et al
Performance of the cervical cancer screening program in Souss-Massa, Morocco: evidence for strategic transition toward HPV testing.
BMC Womens Health. 2026 Jul 1. doi: 10.1186/s12905-026-04644.
Abstract

SINGINI MG, Sitas F, Basu P, Kengne AP, et al
Factors associated with cervical cancer screening in the South African demographic and health survey.
Cancer Causes Control. 2026;37:113.
Abstract

SAITO M, Hasegawa T, Ohtani A, Gocho T, et al
Risk Factors for Sacral Insufficiency Fracture After Pelvic Irradiation for Cervical Cancer.
In Vivo. 2026;40:2436-2444.
Abstract

KAWAMURA Y, Yoshida K, Morita H, Nakai M, et al
Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc Analysis.
In Vivo. 2026;40:2389-2397.
Abstract

ZHANG S, Ye D, Xiu Y, Liu H, et al
Habitat heterogeneity analysis of planning CT improves the prediction of radiation proctitis in cervical cancer: A multimodal machine learning study.
Appl Radiat Isot. 2026;236:112763.
Abstract

SUNDSTROM K
Welcome reduction of US cervical cancer rates despite state differences.
J Natl Cancer Inst. 2026 Jun 30:djag107. doi: 10.1093.
Abstract

PENG P, Yin Y, Zhang B, Yao S, et al
Treatment Patterns and Decision Drivers in Chinese Patients with Locally Advanced Cervical Cancer: Results from a National Physician Survey.
Adv Ther. 2026 Jun 30. doi: 10.1007/s12325-026-03619.
Abstract

RASPAGLIESI F, Bogani G, Lanteri P
ASO Visual Abstract: Revisiting the Concept of Nerve-Sparing Radical Hysterectomy: A Proof-of-Concept Prospective Study from a Cervical Cancer Cohort.
Ann Surg Oncol. 2026 Jun 30. doi: 10.1245/s10434-026-20090.
Abstract

HIMAL I, S K, G S A
miR-4687-3p modulates cell proliferation and migration in cervical cancer cells.
Mol Biol Rep. 2026;53:1065.
Abstract

CAO D, Shi F, Huang Y, Zhang L, et al
Machine learning-assisted SERS for rapid and accurate early screening of cervical cancer.
Anal Bioanal Chem. 2026 Jun 30. doi: 10.1007/s00216-026-06619.
Abstract

DHOLLANDER N, Jaafar I, Almonte M, Rezhake R, et al
Accuracy of colposcopy to triage HPV-positive women in cervical cancer screening: a systematic review and meta-analysis.
EClinicalMedicine. 2026;96:104009.
Abstract

YANG J, Zhang Y, Wu Y, Wang Y, et al
Symptom Clusters and Quality of Life in Cervical Cancer Patients During the Perioperative Period: A Longitudinal Study.
Patient Prefer Adherence. 2026;20:589862.
Abstract

DONGRE TA, Karmarkar PJ, Gowardhan VP, Hajare S, et al
A cross-sectional analytical study assessing apoptotic index as a marker of disease progression in cervical dysplasia.
Pan Afr Med J. 2026;53:81.
Abstract

YANG Y, Zhu X, Hu D
Case Report: Metastatic right ventricular tumor and pulmonary embolism from cervical cancer post COVID-19 infection.
Front Immunol. 2026;17:1845280.
Abstract

KANG OJ, Kim Y, Nam SH, Lee SW, et al
Gastric-type Histology Independently Predicts Poor Survival in Surgically-treated Cervical Adenocarcinoma.
Anticancer Res. 2026;46:3927-3937.
Abstract

NAKAI M, Yoshida K, Morita H, Kawamura Y, et al
Association Between Brachytherapy and Acute Diarrhea During Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study.
Anticancer Res. 2026;46:3907-3917.
Abstract

NGUYEN DTN, Islam R, Qin J, Senkomago V, et al
Cervical cancer burden and elimination readiness in the US-affiliated Pacific Islands: A structured narrative review.
Cancer Epidemiol. 2026;103:103144.
Abstract

YILMAZ H, Erkal Aksoy Y
Privacy concerns, fear of pain, and health anxiety in women participating in cervical cancer screening: A cross-sectional study.
Health Care Women Int. 2026 Jun 29:1-23. doi: 10.1080/07399332.2026.2695619.
Abstract

YUAN M, Li J, Huang Y, Liang Y, et al
miR-524-5p suppresses cervical cancer progression through targeting the LRP6/Wnt/beta-catenin axis.
J Mol Histol. 2026;57:213.
Abstract

ARROYO MUHR LS, Yilmaz E, Lagheden C, Eklund C, et al
Global Performance of Human Papillomavirus Typing, Screening, and Evaluation As Assessed Using Proficiency Panels Traceable to International Standards: A Retrospective Analysis, 2008-2024.
J Med Virol. 2026;98:e71033.
Abstract

PARVATHY N, Gupta N
Cervical Cancer Screening in the Molecular Era: Integrating Cytology, Human Papillomavirus Testing, and Biomarkers.
J Cytol. 2026;43:59-62.
Abstract

WANG Y, Luo C, Li Y, Pei J, et al
Inflammatory biomarker-based prognostic model for immunotherapy outcomes in patients with recurrent or metastatic cervical cancer.
Front Oncol. 2026;16:1818240.
Abstract

CARDOSO L, Saidu R, Kuhn L
Screen-and-treat: a sustainable solution for cervical cancer elimination in low and middle income countries.
BMJ Oncol. 2026;5:e000827.
Abstract

PRIYA S, Panigrahi SK, Bansal V, Arnav A, et al
Artificial Intelligence Colposcopy Models for Cervical Cancer Screening and Diagnosis: A Systematic Review and Meta-Analysis.
J Obstet Gynaecol India. 2026;76:192-199.
Abstract

ARRIVILLAGA M, Neira D, Rivero DS, Vargas-Cardona HD, et al
CITOBOT AI for real-world cervical cancer screening using colposcopy imaging.
Front Public Health. 2026;14:1802494.
Abstract

NAKAMURA H, Mori S, Ishii Y, Takeuchi T, et al
Prevalence and genotype distribution of human papillomavirus in cervical cancer and precancer in Japan between 2012 and 2025: a retrospective single-center study.
Front Public Health. 2026;14:1857364.
Abstract

HARUN SNF, Azlan AA, Mohd Hassan NZA, Mohamad EMW, et al
Health belief model and cervical cancer screening intention among lower socioeconomic women in Malaysia: a pilot study.
Front Public Health. 2026;14:1843558.
Abstract

BEGUM T, Jacob L, L K R, M C SB, et al
A Comparative Analysis of Carboplatin- and Cisplatin-Based Concurrent Chemoradiation for Treating Locally Advanced Cervical Cancer: A Single-Center Observational Study.
Cureus. 2026;18:e109724.
Abstract

GU X, Zhang Y, Xu Z, Guan R, et al
[An auxiliary diagnosis system for cervical intraepithelial neoplasia based on colposcopic images].
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2026;43:496-503.
Abstract

KASSICK M, Pain D, Becht K, Adefres B, et al
Barriers to the use of brachytherapy for treatment of cervical cancer and prostate cancer in low- and middle-income countries.
Expert Rev Anticancer Ther. 2026 Jun 28:1-12. doi: 10.1080/14737140.2026.2684631
Abstract

YU JS, Park G, Seo H, Kim YH, et al
Biology-aligned cervical cancer screening: target-centric biomarkers and next-generation diagnostic platforms.
Biomark Res. 2026 Jun 27. doi: 10.1186/s40364-026-00964.
Abstract

KABEKKODU SP, Rodrigues AF, Hebbar P, Bhat S, et al
Identification and validation of stemness-associated hub genes in cervical cancer: a bioinformatics and experimental study.
World J Surg Oncol. 2026 Jun 27. doi: 10.1186/s12957-026-04472.
Abstract

OKOVA D, Lukwa AT, Cunnama L
Geospatial Analysis of HIV Prevalence and Cervical Cancer Screening Coverage in Sub-Saharan Africa: Opportunities and Gaps for Integrated Care.
Value Health Reg Issues. 2026 Jun 26:101670. doi: 10.1016/j.vhri.2026.101670.
Abstract

BABA SK, Jawwad T, Al Menhali A, Mirza S, et al
An innovative course-based undergraduate research experience (CURE) in HPV-associated cervical cancer: integrating molecular oncology research and scientific writing in undergraduate education.
J Microbiol Biol Educ. 2026 Jun 22:e0008526. doi: 10.1128/jmbe.00085.
Abstract

WU M, Guo Y, Yang J, Wang E, et al
LKB1 attenuates the transport activity of GLUT1 by regulating the alternative splicing of PKM1/PKM2 in cervical cancer.
J Gynecol Oncol. 2026 Jun 16. doi: 10.3802/jgo.2026.
Abstract

SAHA A, Churchill V, Rodriguez AD, Kursuncu U, et al
Large Language Models for Breast and Cervical Cancers Communication: Mixed Methods Evaluation Study Assessing Linguistic Quality, Safety, and Accessibility.
JMIR Cancer. 2026;12:e82971.
Abstract

LENCHA B, Geda B, Ahmed K, Kapps L, et al
Follow-up rescreening among women living with human immunodeficiency virus who tested positive and treated for cervical pre-cancer lesions in South Ethiopia.
Oncologist. 2026;31:oyag237.
Abstract

ALMEIDA EA, Arora M, Mehndiratta M, Agarwal R, et al
CRISPR/Cas in gynecologic cancers: A review of experimental and therapeutic applications.
Indian J Cancer. 2026;63:1-8.
Abstract

SILVA LVC, Silva KL, Rezende LC, Moreira ALA, et al
Nursing interventions for health education of incarcerated women: a systematic review.
Patient Educ Couns. 2026;150:109733.
Abstract

ABULAIZI M, Aili M, Du Z, Xiong J, et al
Bi-A@SR Nanoparticles Enable Tumor-Localized NO Release to Suppress HSP70 and Reverse Chemoresistance.
Adv Healthc Mater. 2026;15:e71321.
Abstract

GODOY-VITORINO F, Vargas-Robles D, Bolanos-Rosero B, Pagan-Zayas N, et al
Environmental fungi modulate the vaginal mycobiome and cervical disease progression in Hispanic women.
mSystems. 2026;11:e0005626.
Abstract

YUAN L, Wang H, Xu Z, Liu K, et al
Analysis of factors influencing the missed diagnosis of cervical precancerous lesions by colposcopy.
BMC Womens Health. 2026;26:333.
Abstract

ZHANG T, Zhang H, Wei Y, Wang D, et al
A repeated cross-sectional analysis of routine leucorrhea test results in women from Jianyang City, Western China (2022-2024) and exploration of the significance of health screening.
BMC Womens Health. 2026;26:322.
Abstract

SETH A, Gupta RK, Nanda S, Sonkar PK, et al
Evaluation of immunohistochemical expression of sex-determining region Y-box 2 and Antigen Kiel 67 in squamous cell carcinoma cervix and its correlation with histological and clinical parameters.
Indian J Pathol Microbiol. 2026;69:233-239.
Abstract

KESSESSA HM, Mogus AT, Woldeamanuel Y
Human papillomavirus vaccine uptake and associated factors among schoolgirls in Sululta and Chancho towns, Central Ethiopia: a cross-sectional study.
BMC Infect Dis. 2026;26:1133.
Abstract

KILAVUZ M, Genc R, Topaloglu S, Avcu E, et al
HPV vaccine: the key to a powerful shield against cancer.
BMC Public Health. 2026;26:1850.
Abstract

HUANG XX, Yao P, Wang Q, Sun PM, et al
Policy window period: analysis of HPV vaccination status among age-eligible girls in China (before national immunisation programme implementation).
BMC Womens Health. 2026;26:288.
Abstract

CANCHOLA AJ, Pruitt SL, Lin K, Boscoe FP, et al
Ethnic Enclave Residence and Breast, Cervical, and Colorectal Cancer Incidence among Asian American Adults, 2006 to 2017.
Cancer Epidemiol Biomarkers Prev. 2026;35:1139-1150.
Abstract

CHEN M, Wang X, Abudurehemu S, Li L, et al
Thermal ablation plus HPV-specific IgY vaginal gel versus watchful waiting in women with histologically confirmed CIN1 and persistent HPV: a prospective observational cohort study.
BMC Womens Health. 2026;26:299.
Abstract

GOKKAYA M, Yalcin N, Alci A, Taskum I, et al
Evaluation of ChatGPT-5-generated clinical management recommendations for HPV infection and cervical premalignant lesions: a scenario-based expert assessment study.
BMC Med Inform Decis Mak. 2026;26:197.
Abstract

MULCAHY SYMMONS S, Drury A, Darley A, Kroll T, et al
Co-designing solutions to promote awareness of cervical screening with women of low socio-economic position living in urban areas.
BMC Public Health. 2026;26:1742.
Abstract

MOHAMED HRH, Elhaggan SO, Hekal RS, Fahmy CWH, et al
Yttrium oxide nanoparticles induce potent selective cytotoxicity in HeLa cervical cance cells through ROS-mediated genomic instability and mitochondrial apoptosis.
Sci Rep. 2026;16:12239.
Abstract

BADRALDIN SQ, Alfarttoosi KH, Sameer HN, Bishoyi AK, et al
The Clinical Significance of KIFs in Cervical and Endometrial Cancer: from Mechanisms to Biomarker and Therapeutic Potential.
Reprod Sci. 2026;33:1091-1109.
Abstract

LIU H, He Y, Geng W, Huang Y, et al
The effect of estrogen and its receptors on the progression of cervical intraepithelial neoplasia in postmenopausal women through synergistic interaction with HPV.
BMC Womens Health. 2026;26:254.
Abstract

WANG S, Song Q, Ma C, Dong D, et al
Predicting the biological behavior of cervical squamous cell carcinoma: a machine learning approach using apparent transverse relaxation rate (R2* maps) radiomics nomogram.
BMC Med Imaging. 2026;26:303.
Abstract

MALING S, Ssedyabane F, Mudondo H, Kajabwangu R, et al
Depression and loss to follow-up among patients treated for premalignant cervical lesions at a tertiary hospital in Uganda: a cross-sectional study.
BMC Womens Health. 2026;26:243.
Abstract

CHERIF A, Engelbrecht K, Ovcinnikova-Hutchings O, Ntais D, et al
Age of acquisition of disease-causal human papillomavirus infection to high-grade cervical intraepithelial neoplasia (CIN2+) in England.
BMC Infect Dis. 2026;26:680.
Abstract

HABIBA U, Islam N
Synergistic anticancer effects of thymoquinone and curcumin via ROS-mediated mitochondrial apoptosis in HeLa cells.
Mol Biol Rep. 2026;53:557.
Abstract

YU M, Jiang M, Zhang X, Chen H, et al
Adenocarcinoma admixed with neuroendocrine carcinoma of the cervix: a clinicopathological diagnostic study and molecular features.
Diagn Pathol. 2026;21:46.
Abstract

UMUTESI G, Weiner BJ, Jewell T, Kapiga S, et al
A framework policy analysis of single-dose HPV vaccination adoption in East Africa: a rapid review.
BMC Health Serv Res. 2026;26:608.
Abstract

WANG M, Xu J, Xu S, Wu Y, et al
HPV status as a predictor of ovarian metastasis in cervical adenocarcinoma: implications for surgical decision-making.
BMC Womens Health. 2026;26:227.
Abstract

GHORBEL A, Zelaiti H, Saidi S, Liouane F, et al
Evaluation of HPV awareness among parents of adolescent girls in Tunisia: a cross-sectional study.
Sci Rep. 2026;16:13704.
Abstract

YAN L, Wang Z, Shen X, Yang J, et al
Time-lapsed colposcopy image-based segmentation of cervical lesion areas.
Sci Rep. 2026;16:13344.
Abstract

YORKE AA, Ignatius K, Schreiner JL, Kron T, et al
Estimating the Carbon Footprint of External Beam Radiotherapy: Should This Be a Concern for LMICs?
J Med Imaging Radiat Oncol. 2026;70:395-400.
Abstract

AXELROD ML, Zhou R, Sun L
Spatial transcriptomic landscape of invasion patterns in human papillomavirus-associated endocervical adenocarcinoma.
Sci Rep. 2026;16:13246.
Abstract

DAI W, Jiang X, Liu Y, Yu Y, et al
Integrated cross-sectional study and functional validation indicate the association of lactobacillus crispatus-derived D-lactic acid with cervical gene expression and precancerous cervical lesions.
J Transl Med. 2026;24:511.
Abstract

JIANG Z, Hua Y, Xu S, Li M, et al
Bilibili/TikTok videos as sources of HPV-related medical information: a cross-sectional content analysis.
BMC Public Health. 2026;26:1225.
Abstract

BARTHOLOMEW K, Maxwell A, Yang LPH, Aye PS, et al
Clinician and patient experiences with opportunistic offer of HPV self-testing in Aotearoa New Zealand primary care clinics: interview and survey findings.
BMC Prim Care. 2026;27:147.
Abstract

TAO H, Tong Z, Li H, Mao S, et al
Development and interpretability of an XGBoost model to predict high grade cervical intraepithelial neoplasia.
BMC Med Inform Decis Mak. 2026;26:100.
Abstract

GAO X, Liu Z, Xu Z, Liu K, et al
Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient.
Cell Oncol (Dordr). 2026;49:48.
Abstract

SADEGHI Z, Jazayeri SM, Pirkooh AA, Foroushani AR, et al
Cell cycle gene expression and microbial profiles associated with HPV related cervical neoplasia and cervical microbiome shifts.
Sci Rep. 2026;16:10310.
Abstract

ZHAO C, Cai Y
Cervical HSIL and Microinvasive Squamous Cell Carcinoma With Superficial Spread to Endometrium and/or Fallopian Tube Epithelium: Clinical and Pathological Findings in 2 Patients and Literature Review.
Int J Surg Pathol. 2026;34:1256-1264.
Abstract

MITCHELL L, Wong D, Butler T, Brotherton J, et al
Implementing HPV self-collection: a scoping review of facilitators and strategies among Indigenous women and people with a cervix.
BMC Public Health. 2026;26:1053.
Abstract

ONYENOBI E, Zhong M, Peitz J, Chawla K, et al
Identification of miRNA biomarkers and development of predictive signatures for early detection and prognosis in cervical precancer and cancer.
Hum Genomics. 2026;20:60.
Abstract

MUMUKUNDE M, Dusengumuremyi T, Polo A, Hande V, et al
A mixed-methods evaluation of a patient navigation program for breast and cervical cancers in Rwanda.
BMC Public Health. 2026;26:1027.
Abstract

KINION JH, McAllister MB, Summerton JE, Dolan BP, et al
LK-1: an investigational therapy targeting hCG-beta in metastatic breast, bladder, ovarian, and cervical cancers.
Sci Rep. 2026;16:10061.
Abstract

CHIPANTA D, Osborne C, Bohlius J, Shakarishvili A, et al
Impact of the 2013 WHO guidelines for screening and treatment of cervical pre-cancerous lesions on women's screening uptake, by HIV-status, in Eastern and Southern Africa: a regression discontinuity design analysis.
Reprod Health. 2026;23:86.
Abstract

NURMAINI S, Rachmatullah MN, Agustiansyah P, Sanif R, et al
AI-assisted diagnosis of cervical dysplasia from cervicography images.
Sci Rep. 2026;16:9920.
Abstract

RAKAB MS, Baklola M, Hafez H, Abbas SHZ, et al
Cultural and religious influences on parental knowledge of HPV infection and female vaccination in Egypt: a national cross-sectional study.
BMC Public Health. 2026;26:1109.
Abstract

MA J, Deng P, Lin B, Luo P, et al
Mapping the global research landscape on HPV vaccine hesitancy: a machine-learning based bibliometric analysis.
Virol J. 2026;23:81.
Abstract

DANESHI N, Mahmoudi M, Rezaee SA, Khoshmirsafa M, et al
Effects of nanosilymarin and conditioned medium of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells co-cultured with HeLa cells.
BMC Complement Med Ther. 2026;26:107.
Abstract

HU Y, Li D, Qiu L, Di W, et al
Occult cervical large cell neuroendocrine carcinoma masquerading as adenocarcinoma in situ during pregnancy: a case report, literature review, and SEER analysis.
BMC Pregnancy Childbirth. 2026;26:421.
Abstract

BRENNER EJ, Allison BA, Berenblum Tobi C, Kamoun C, et al
Reproductive Health in Young and Adolescent Females with Inflammatory Bowel Disease.
Curr Gastroenterol Rep. 2026;28:8.
Abstract

TASEEN S, Ayub R, Noman GEL, Yousafzai MT, et al
Leveling up immunization: a systematic review of gamification interventions to improve Human Papillomavirus (HPV) vaccine uptake.
BMC Public Health. 2026;26:911.
Abstract

FAGHIR-GANJI M, Feizabadi P, Ansari-Moghaddam A, Abdolmohammadi N, et al
HPV vaccination in Iran: expert perspectives on family dynamics and barriers.
BMC Womens Health. 2026;26:135.
Abstract

SAHIN M, Buran A, Arslanca T, Ucar YO, et al
Role of COVID-19 in the persistence of cervical high-risk human papillomavirus: a non-randomized retrospective study.
BMC Womens Health. 2026;26:117.
Abstract

WU W, Ren X, Chen Y, Du W, et al
4-Nonylphenol regulates cell proliferation and apoptosis in cervical carcinoma through the MEG3/PI3K/AKT signaling pathway.
Sci Rep. 2026;16:6067.
Abstract

LUO L, Wang L, Liu Z, Cai Y, et al
PAX1/JAM3 methylation in cervical exfoliated cells: a robust diagnostic biomarker for cervical high-grade lesions associated with vaginal dysbiosis.
BMC Womens Health. 2026;26:108.
Abstract

KAYA MB, Uzun E
Utility of SOX2 in the diagnosis of squamous intraepithelial lesions and squamous cell carcinoma of cervix uteri.
BMC Womens Health. 2026;26:101.
Abstract

OZEN S, Ozen EG, Simsek GO, Arzik AO, et al
HPV persistence and CIN2 + Detection in women with normal cytology and Non-16/18 High-Risk HPV positivity.
BMC Womens Health. 2026;26:98.
Abstract

HOJEN IB, Kristensen MK, Bertelsen VM, Tranberg M, et al
Effect of coriolus versicolor-based vaginal gel on clearance of human papillomavirus and cervical dysplasia - a scoping review.
BMC Womens Health. 2026;26:71.
Abstract

THOMPSON JH, Rivelli JS, Gautom P, Petrik AF, et al
Co-creating HPV Vaccination Messages for Rural Washington: Application of a Boot Camp Translation Approach.
Health Educ Behav. 2026;53:367-376.
Abstract

YUE C, Liu S, Wang W, Zhao Y, et al
Machine learning in early screening for high-grade cervical intraepithelial neoplasia using blood testing.
BMC Med Inform Decis Mak. 2025;26:25.
Abstract

BARTHOLOMEW K, Yang LPH, Neville C, Maxwell A, et al
Opportunistic offer of human papillomavirus (HPV) self-testing in ethnically diverse primary care clinics in Aotearoa New Zealand: an implementation study.
BMC Prim Care. 2025;27:24.
Abstract

KYEI GK, Kyei EK
Expanding HPV Vaccination in the United States Through Policy Action: A Call for Legislative Support.
Policy Polit Nurs Pract. 2026;27:165-170.
Abstract

EFFAH K, Tekpor E, Amuah JE, Goka E, et al
Expanding access to HPV screening through community health insurance schemes: lessons from a screening exercise for teachers in Ghana.
BMC Health Serv Res. 2025;26:75.
Abstract

WANG S, Zhang C, Li T, Luo P, et al
Association of Toll-like receptor signaling molecule gene polymorphisms with risk of cervical lesions in HPV-infected women.
BMC Infect Dis. 2025;25:1672.
Abstract

SHEPPARD AJ, Sutradhar R, Liu N, Kewayosh A, et al
Population-Level Outcomes for Screening Program Cancers in First Nations People in Ontario, Canada.
JAMA Netw Open. 2026;9:e2622718.
Abstract

LUO B, Lin Z, Chen J, Wang Y, et al
Real-world effectiveness of HPV vaccination against high-risk type HPV DNA positivity among adult women aged 18 - 45years in China: A matched test-negative design study.
Hum Vaccin Immunother. 2026;22:2693440.
Abstract

TRZESZCZ M, Jach R
p16/Ki-67 dual-stain immunocytochemistry in precision cervical cancer prevention: immunoprofile and clinical decision-making.
Pol J Pathol. 2026;77:195-202.
Abstract

MAO F, Campos NG, Cheung LC
Data-augmented multistate modeling for chronic disease processes using cross-sectional studies: application to HPV and cervical precancer.
Biostatistics. 2026;27:kxag022.
Abstract

MREMA A, Tarimo Q, Lidenge SJ, Shungu R, et al
Factors associated with depression among women living with HIV and cervical cancer in Tanzania: a cross-sectional study.
Ecancermedicalscience. 2026;20:2128.
Abstract

SHENG Y, Chang Y, Jiang Y, Wang S, et al
Concurrent Chemoradiotherapy Plus Immunotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: A Randomized, Single-Center, Phase II Trial of Early Tumor Regression and Pro-Inflammatory Tumor Microenvironment Remodeling.
MedComm (2020). 2026;7:e70856.
Abstract

RONSINI C, Di Nuzzo A, Cucinella G, Solazzo MC, et al
Parametrial involvement in cervical cancer is associated with systemic inflammatory indices: a retrospective observational study.
Front Med (Lausanne). 2026;13:1842260.
Abstract

AJORLOO M, Alamdary A, Samaie S, Arabi Mianroodi R, et al
Oncolytic Effects of S89K Matrix Protein of Vesicular Stomatitis Virus in Cervical Cancer.
Adv Biomed Res. 2026;15:28.
Abstract

LANYO GS, Nabe B, Tutu AO, Asore MA, et al
Determinants of cervical screening in Ghana: a systematic review.
BMJ Open. 2026;16:e111770.
Abstract

ZHANG J, Li B, He J, Shu X, et al
A retrospective study with a 5-year follow-up on the effectiveness of transcatheter arterial chemoembolization for locally advanced cervical cancer.
J Vasc Interv Radiol. 2026 Jul 9:108945. doi: 10.1016/j.jvir.2026.108945.
Abstract

LIN X, Xie L, Shao K, Jing J, et al
Unveiling the identification of the genetic features and biological characteristics shared between cervical cancer and venous thromboembolism.
Comput Biol Chem. 2026;124.
Abstract

NETHERTON TJ, Aggarwal A, Alakayleh Q, Beadle BM, et al
Artificial Intelligence-Powered Radiotherapy for Resource-Limited Settings: Advancing Cervical and Prostate Cancer Treatment Planning With the Radiation Planning Assistant.
JCO Glob Oncol. 2026;12:e2500702.
Abstract

ABADIA ACM, Trujillo Chacon LM, Willig JB, Osorio E, et al
Comparative Evaluation of the Cytotoxic Effect of Dysphania ambrosioides Extracts Against Human Breast and Cervical Cancer Cells.
Chem Biodivers. 2026;23:e71452.
Abstract

MOURA M, Bras IM, Alves C, Aguiar T, et al
Acquired Vulvar Lymphangiomatosis: A Rare Condition After Cervical Cancer Treatment.
Clin Case Rep. 2026;14:e73117.
Abstract

SHARMA AM, David S, Suresh P, Krishna SS, et al
Diverse non-vaccine high-risk HPV genotypes in rural Kerala: implications for cervical cancer prevention in an underserved population.
Infect Agent Cancer. 2026 Jul 8. doi: 10.1186/s13027-026-00778.
Abstract

GREEN BB, Mogk J, Crawford-Gallagher B, Beatty TC, et al
Impact of a Clinic- and Mail-Based Cervical Cancer Human Papillomavirus Self-Collect Screening Program.
NEJM Catal Innov Care Deliv. 2026;7:CAT250420.
Abstract

ZHU X, Xiang J, Bai J, Wang L, et al
Downregulation of miR-3074-5p slows cervical cancer progression by targeting TGFBR2 expression.
Ir J Med Sci. 2026 Jul 8. doi: 10.1007/s11845-026-04488.
Abstract

BERDICHEVSKY B A, Pavlova I V, Berdichevsky V B, Gonyaev A R, et al
[Clinical digitalization of visual manifestations of late radiation cystitis (pilot study)].
Urologiia. 2026;:24-29.
Abstract

ZHANG C, Zheng W, Wang X, Wang Z, et al
Adjunctive photodynamic therapy improves outcomes and quality of life in condyloma acuminatum after radical cervical cancer surgery.
Front Oncol. 2026;16:1848211.
Abstract

DIAZ DEL ARCO C, Aguilera Hervas M, Ramirez Mena M, Garcia Martinez R, et al
High-Risk Human Papillomavirus Prevalence and Genotype Distribution in Two Opportunistic Cervical Screening Periods in Spain: A Tertiary Hospital-Based Study.
APMIS. 2026;134:e70234.
Abstract

REMKES A, Gheit T, Martinez-Perez GZ, Fusco D, et al
Moving Beyond the Female-Only Paradigm: Arguments for Accelerating the Global Gender-Neutral Human Papillomavirus Vaccination.
Cancer Control. 2026;33:10732748261466385.
Abstract

LIU M, Zhang L, Fan Y, Han L, et al
HPV Infection Drives CXCL8(+) Neutrophil-Mediated Immune Suppression in Cervical Cancer.
Biofactors. 2026;52:e70131.
Abstract

ZABRIAN C, Vanoost A, Theret P, Mancaux A, et al
[Long-term oncological outcomes and morbidity and mortality associated with radical hysterectomy by laparoscopy versus laparotomy for early-stage cervical cancer].
Gynecol Obstet Fertil Senol. 2026 Jul 7:S2468-7189(26)00183.
Abstract

SACINTI KG, Sonmezer M
Surgical radicality and fertility preservation in early cervical cancer: An evolving paradigm.
Surg Oncol. 2026;67:102474.
Abstract

SUZUKI T, Takahashi R, Tachibana H, Oda S, et al
Patient stratification for dose scaling in cervical cancer: a model-based analysis using image-guided adaptive brachytherapy.
J Radiat Res. 2026 Jul 7:rrag047. doi: 10.1093.
Abstract

XU K, Zhang G
Diagnostic Value of SCC-Ag Combined With CYFRA 21-1 in Predicting Long-Term Lymph Node Metastasis After Cervical Cancer Surgery.
Br J Hosp Med (Lond). 2026;87:55133.
Abstract

TOMMO TCHOUAKET MC, Gabisa JE, Ngoufack Jagni Semengue E, Moko Fotso LG, et al
Interoperability of two commercial kits in detecting high oncogenic human papilloma virus and genetic diversity in Cameroon: implications for cervical cancer screening strategies in resource-limited settings.
Infect Agent Cancer. 2026;21:51.
Abstract

AHUJA R, Sharma K, Kumar Tiwari A, Uttam V, et al
Comparative clinical significance of HPV DNA, HPV E6/E7 mRNA, and p16(INK4a) in cervical cancer among Indian and USA populations: a meta-analysis and systematic review.
Sci Rep. 2026 Jul 7. doi: 10.1038/s41598-026-59440.
Abstract

RAHIM F, Atasever U
The population impact of human papillomavirus vaccination on cancer and pre-cancer outcomes: An umbrella review of meta-analyses.
Hum Vaccin Immunother. 2026;22:2699584.
Abstract

BONALA SR, Subramanian BV, Venati C, Selvamary H, et al
Improving compliance with curative radiotherapy for cervical cancer in a high-volume centre in India: a bundled workflow (AID-CARE) quality improvement project.
BMJ Open Qual. 2026;15:e003874.
Abstract

SHOGAN JC, Sukumvanich P, Boisen M, Courtney-Brooks M, et al
Ovary Sparing Intensity Modulated Radiotherapy Following Ovarian Transposition: A Single Institution Retrospective Dosimetric Analysis of Patients with Cervical Cancer Treated with External Beam Radiation Therapy After Oophoropexy.
Pract Radiat Oncol. 2026 Jul 6:S1879-8500(26)00195.
Abstract

LI Z, Li M, Tian M, Zhou M, et al
Efficacy Analysis of Paiteling in Treating Persistent High-Risk Human Papillomavirus after Cervical Cancer Surgery.
J Vis Exp. 2026;.
Abstract

JULIAN ON, Velarde I, Advani SJ, Mayadev J, et al
Past present and future of radiosensitization in cervical cancer.
Front Oncol. 2026;16:1846581.
Abstract

LIN X, Zheng J, Li Y, Wang S, et al
Oncogenic DNMT3B as a therapeutic target for cervical cancer.
Chin Med J (Engl). 2026 Jul 3. doi: 10.1097/CM9.0000000000004130.
Abstract

ANGELO C, Robinson K
Cervical Cancer Elimination Must Centre Aboriginal and Torres Strait Islander Women.
Health Promot J Austr. 2026;37:e70214.
Abstract

CHAVIS YC, Jin R, Leach DF 3rd, Walker KV, et al
Addressing barriers to care: A proposed model to predict prolonged treatment time among patients with locally advanced cervical cancer.
Brachytherapy. 2026 Jul 4:S1538-4721(26)00082.
Abstract

CUSIMANO MC, Poxon A, Gien LT, Sutradhar R, et al
Association of Surgical Approach with Oncologic Outcomes in Low-Risk Cervical Cancer.
Am J Obstet Gynecol. 2026 Jul 4:S0002-9378(26)00348.
Abstract

HU Y, Liu X, Zhang Z, Zhou J, et al
Signaling pathways in tobacco smoking-induced cervical carcinogenesis: Beyond HPV-mediated activation.
Toxicol Lett. 2026;422:113148.
Abstract

YI H, Liu Y, Yin X, Huang J, et al
Long-Term Outcomes After Cervical Cold Knife Conization or Loop Electrosurgical Excision Procedure.
JAMA Surg. 2026;161:737-744.
Abstract

LIU Y, Qu H, Zhang F, Gan S, et al
Comparative performance of L1- and E6/E7-targeted HPV genotyping assays based on a unified MeltArray platform.
Microbiol Spectr. 2026;14:e0020626.
Abstract

BEIRA SALVADOR PM, Garcia Grandal T, Iglesias Mendez R
Risk of HSIL/CIN2+ Lesions in Women with Negative Cytology and High-Risk HPV Referred to Colposcopy: Experience in a Population-Based Screening Program.
Med Clin (Barc). 2026;166:107451.
Abstract

BARTHOLOMEW K, Yang LPH, Neville C, Maxwell A, et al
An implementation study of text invitation, mailed at-home human papillomavirus (HPV) self-testing and telehealth management in Aotearoa New Zealand, with a nested randomised controlled trial that compared offering an incentive vs. no offer with a rep
BMC Public Health. 2026;26:2108.
Abstract

ESSAYAGH T, Essayagh M, Lemriss H, Mourad R, et al
Prevalence and determinants of human papillomavirus vaccine hesitancy among parents of young girls in Morocco.
Sci Rep. 2026;16:21387.
Abstract

STONYTE V, Fjeldbo CS, Langiu M, Joy-Immediato M, et al
Elevated GCN2 levels in cancer cells confer protection from mitotic stress and faster cell movement.
Cell Oncol (Dordr). 2026;49:92.
Abstract

HE M, Huang S, Wang M, Zhu T, et al
A DLEU2/E2F1 regulatory axis promotes migration and invasion phenotypes in cervical squamous cell carcinoma.
Sci Rep. 2026;16:20883.
Abstract

DIRICAN CD, Jumean S, Dhanesar G, Maroules M, et al
Cancer Prevention in Women with Sickle Cell Disease: A Scoping Review of HPV Vaccination and Cancer Screening.
J Womens Health (Larchmt). 2026;35:871-875.
Abstract

LI JJ, Yang SS, Chen KJ, Jiang LS, et al
REBACIN((R)) can remove high-risk Human Papillomavirus (HPV) persistent infection efficiently as an effective non-invasive treatment: a multicenter prospective study.
World J Surg Oncol. 2026;24:283.
Abstract

ZHOU H, Dai Y, Zhang H, Yang Y, et al
P16/Ki67 dual staining versus cytology for identifying high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) in triage management of HR-HPV-positive women: a systematic review and meta-analysis.
J Gynecol Oncol. 2026;37:e68.
Abstract

CUI M, Zhang M, Zhang J, Mao R, et al
Cervicovaginal dysbiosis and microenvironment disruption are associated with cervical carcinogenesis.
Microbiol Spectr. 2026;14:e0280424.
Abstract

PARK SM, Choi CH, Kim K, Kim H, et al
Cervical neuroendocrine carcinoma with non-neuroendocrine components has a poorer prognosis than pure neuroendocrine carcinoma.
J Gynecol Oncol. 2026;37:e80.
Abstract

QU W, Wang H, Jin N, Tang Q, et al
Comparing paclitaxel and platinum-based concurrent chemoradiotherapy with short-term adjuvant chemotherapy versus platinum-based monotherapy concurrent chemoradiotherapy in patients with postoperative gastric-type endocervical adenocarcinoma with high
J Gynecol Oncol. 2026;37:e79.
Abstract

KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening.
Am J Epidemiol. 2026 Feb 27:kwag040. doi: 10.1093.
Abstract

FANTOZZI PJ, Sonis ST, Diaz JP, Villa A, et al
Oral mucositis secondary to datopotamab deruxtecan for advanced-stage cancer managed with cryotherapy after topical steroid failure: A case series study.
J Am Dent Assoc. 2026;157:787-794.
Abstract

LIU X, Yang Y, Zhang B, Gao X, et al
Flubendazole inhibits cervical carcinoma by targeting DHODH to induce ferroptosis and mitophagy.
Biochem Pharmacol. 2025;242.
Abstract

KONG WY, St Sauver JL, Jacobson RM, MacLaughlin KL, et al
Cervical cancer screening preferences by sexual orientation among persons assigned female at birth.
BMC Womens Health. 2026 Jul 17. doi: 10.1186/s12905-026-04678.
Abstract

LIU Z, Liu W, Liu Z
Molecular mechanisms and adjuvant therapeutic potential of alpha-mangostin in cervical cancer.
Discov Oncol. 2026 Jul 17. doi: 10.1007/s12672-026-05534.
Abstract

LU TF, Shih YH, Chen YF, Fan CT, et al
Association of Hormone Therapy with Long-Term Outcomes After Chemoradiation for Locally Advanced Cervical Cancer.
Am J Obstet Gynecol. 2026 Jul 17:S0002-9378(26)00366.
Abstract

RODRIGUEZ JA, Mejia Vargas NJ, Moreno Acuna JE
Peritoneal angiosarcoma in a patient with a history of cervical cancer treated with radiotherapy: A case report.
Rev Esp Patol. 2026;59:100891.
Abstract

JIA J, Wang L, Wang F
Patient Selection and Treatment Heterogeneity in Evaluating Radiotherapy for Metastatic Cervical Cancer.
Clin Oncol (R Coll Radiol). 2026;57:104282.
Abstract

JIA J, Wang L, Wang F
Nodal Tumour Burden as a Prognostic Marker: Interpreting Volume-Based Risk Stratification in Para-Aortic Node-Positive Cervical Cancer.
Clin Oncol (R Coll Radiol). 2026;57:104283.
Abstract

MCARDLE RP, Morgan J, Itsura P, Paneru B, et al
Triangular Partnership in Oncology: The Kenya-Nepal Oncology Network Project for the Control of Breast and Cervical Cancer in Kenya and Nepal.
JCO Glob Oncol. 2026;12:e2500762.
Abstract

TOMIZAWA K, Sakamoto S, Miyasaka Y, Oike T, et al
MYC upregulation as candidate predictive biomarker for radioresistance in cervical cancer.
Jpn J Radiol. 2026 Jul 17. doi: 10.1007/s11604-026-02036.
Abstract

ABOUELELLA DK, Knettel B, Mwobobia J, Posani S, et al
Examining stigma associated with human papillomavirus (HPV) and cervical cancer screening and treatment in Africa: a scoping review.
Glob Ment Health (Camb). 2026;13:e138.
Abstract

CHEN H, Yang X, Qin Y, Xu W, et al
Efficacy and safety of immune checkpoint inhibitors combined with anti-angiogenic agents for advanced cervical cancer: A systematic review and meta-analysis.
Oncol Lett. 2026;32:387.
Abstract

BEREZA K, Kukielka A, Trojnarska D, Grabarek BO, et al
Multidimensional assessment of urinary dysfunction and quality of life after cervical cancer treatment: a multicenter study integrating urodynamics and patient-reported outcomes.
Front Oncol. 2026;16:1853725.
Abstract

IDEN M, Schmidt R, Mohammed RDAS, Dlugi TA, et al
TAOK3 inhibition constrains invasion, potentiates paclitaxel, and reprograms the tumor microenvironment toward anti-tumor immunity in cervical cancer.
bioRxiv [Preprint]. 2026 Jul 6:2026.07.04.736128.
Abstract

ZHU B, Ge Y, Wen Y, Wu Y, et al
DDOST mediates cervical cancer cell malignant progression by interacting with SMARCA4.
Am J Cancer Res. 2026;16:2377-2388.
Abstract

GUO Y, Zhang Y, Zhang S, Guo J, et al
UBE2J2-mediated ubiquitination modification of MCM6 regulates proliferation and migration of cervical cancer cells.
Am J Cancer Res. 2026;16:2355-2366.
Abstract

XU Y, Li S, Wang B, Huang J, et al
Impact of laparoscopic versus open surgery on 5-year survival in patients with stage IA2-IB1 cervical cancer: a retrospective cohort study.
Am J Cancer Res. 2026;16:2577-2611.
Abstract

ZHAO Y, Zhou H
Serum USP1 and PD-L1 levels independently predict treatment response and prognosis in cervical cancer: a retrospective cohort study.
Am J Cancer Res. 2026;16:2458-2480.
Abstract

SU L, Chen R, He T, Su X, et al
USP5 promotes glycolysis in cervical cancer by stabilizing FOXM1.
Am J Cancer Res. 2026;16:2329-2341.
Abstract

WANG J, Lin F, Chen X
Efficacy of immune checkpoint inhibitors plus chemotherapy versus chemotherapy-based control in cervical cancer: a meta-analysis.
Am J Cancer Res. 2026;16:2131-2147.
Abstract

TIAN Y, Zhang Y, Wang L, Li Z, et al
Recent progress and therapeutic strategies in the treatment of cervical neuroendocrine neoplasms (Review).
Int J Mol Med. 2026;58:259.
Abstract

GOKHAN ACIKGOZ S, Bakir A, Demir Cendek B, Beyaz H, et al
Pre-treatment MRI-derived fractal dimension as a prognostic marker in cervical cancer treated with definitive radiotherapy with or without concurrent chemotherapy.
BMC Med Imaging. 2026 Jul 16. doi: 10.1186/s12880-026-02589.
Abstract

RUBAGUMYA F, Kwizera V, Mutetiwabo I, Habimana S, et al
Feasibility of Decentralized Cervical Cancer Survivorship Care at District Hospitals in Rwanda: A Multi-Site Pilot Implementation Study.
Oncologist. 2026 Jul 16:oyag275. doi: 10.1093.
Abstract

KAMBLE S, Gurunani G, Bodhankar M
Comment on "Nano-enabled targeted transdermal therapy for pain management in cervical cancer".
J Pharm Sci. 2026 Jul 16:104421. doi: 10.1016/j.xphs.2026.104421.
Abstract

ODEI-MENSAH B, Adeyemi SA, Choonara YE
Response to the Letter Regarding "Nano-enabled Targeted Transdermal Therapy for Pain Management in Cervical Cancer".
J Pharm Sci. 2026 Jul 16:104422. doi: 10.1016/j.xphs.2026.104422.
Abstract

RAMOS AM, Bolignani CV, Gottems LBD, Costa AM, et al
Knowledge and Awareness of HPV, the HPV Vaccine, and Cervical Cancer Among Women From a Brazilian Community: A Community-Based Cross-Sectional Study.
Health Sci Rep. 2026;9:e72818.
Abstract

JAMMALAMADUGU SB, Tirelo L, Youssouf N, Umutesi G, et al
Individual-level HPV vaccination verification in Botswana: lessons learned from implementation of the HOPE II trial.
Front Public Health. 2026;14:1821335.
Abstract

OZDAS T, Donmez E, Ortabag T
Women's experiences and perspectives on a nurse navigation program for cervical cancer screening: a qualitative study.
Front Public Health. 2026;14:1883702.
Abstract

WANG Y, Gui X
Bavachinin induces oxidative stress-associated apoptosis and modulates NF-kappaB-associated inflammatory gene expression in cervical cancer cells.
Cytotechnology. 2026;78:159.
Abstract

LOXL 2 Promotes the Epithelial-Mesenchymal Transition and Malignant Progression of Cervical Cancer [Retraction].
Onco Targets Ther. 2026;19:636792.
Abstract

GROS C, Goulenok T, Timsit JF, Sacre K, et al
Risk of cancer induced by human papillomavirus in patients with immune-mediated inflammatory diseases: a nationwide matched cohort study.
RMD Open. 2026;12:e006927.
Abstract

GOULENOK T, Sierra C, Florence AM, Gonthier C, et al
Prevalence and risk factors for high-risk human papillomavirus infection in patients with immune-mediated inflammatory diseases: a prospective study.
RMD Open. 2026;12:e006955.
Abstract

LIU C, Dong C, Qu L, Jiang X, et al
Abrine inhibits cervical cancer progression by targeting UGT8.
Tissue Cell. 2026;104.
Abstract

MISHRA SK, Yeager M, Nelson CW, Zhu B, et al
Longitudinal analysis of high-risk HPV infections reveals within-host viral genome changes over time.
PLoS Pathog. 2026;22:e1014362.
Abstract

MENON SS, Gupta M, Bhardwaj A, G Chandraguthi S, et al
A prospective development and evaluation of a 2D convolutional neural network-based auto-segmentation model for cervical cancer radiotherapy.
J Egypt Natl Canc Inst. 2026;38:46.
Abstract

SERT F, Serin G, Alanyali S, Ozturk M, et al
HIF-1alpha falls short, ERCC-1 stands out: Predictive insights in locally advanced cervical cancer.
Histol Histopathol. 2026 Jul 15:25125. doi: 10.14670.
Abstract

NITTAYABOON K, Leetanaporn K, Kerdkumthong K, Mayakun J, et al
Cytotoxic Effect of Halimeda macroloba Crude Extract on Cervical Cancer Spheroid Cells via p-mTOR/mTOR, Apoptosis, and Ferroptosis Pathways.
Cancer Manag Res. 2026;18:611650.
Abstract

OOMMEN AM, Thomas V, Muliyil DE, John NO, et al
Disparities in survival after cervical cancer between tribal and rural women in Tamil Nadu, India: A retrospective cohort study.
J Family Med Prim Care. 2026;15:1762-1768.
Abstract

JEDRZEJCZYK A, Mawlichanow K, Golec-Cera A, Oplawski M, et al
Robotic Versus Open Radical Hysterectomy in Early-Stage Cervical Cancer: A Comparative Cohort Study.
J Clin Med. 2026;15:5168.
Abstract

AGUSTINA HR, Haroen H, Pahria T, Winarno GNA, et al
Family Voices in Digital Patient Navigation for Cervical Cancer Care in Indonesia.
Healthcare (Basel). 2026;14:1809.
Abstract

SIFUENTES-PADILLA JL, Granados-Lopez AJ, Campos-Lujan AM, Suarez-Castro A, et al
Naphthoquinone-Amino Acids Regulate Cellular Cancer Associated Processes, p53 and miR-34a-5p Expression in Immortal and Tumorigenic Cervical Cell Lines.
Int J Mol Sci. 2026;27:5703.
Abstract

ALBZOUR N, Lam SS
Systematic Evaluation of Vision Transformers for Automated Cervical Cancer Classification: Optimization, Statistical Validation, and Clinical Interpretability.
Cancers (Basel). 2026;18:2178.
Abstract

OBANDO-RODRIGUEZ JS, Vieira-Serna S, Peralta J, Rodriguez J, et al
Para-Aortic Lymph Node Staging and Oncologic Outcomes in Locally Advanced Cervical Cancer: A Narrative Review.
Cancers (Basel). 2026;18:2058.
Abstract

PEI K, Li D, Xi M, Zhang J, et al
Nomogram for Preoperative Prediction of Adjuvant Therapy Requirement Following Radical Surgery in Stage IB Cervical Squamous Cell Carcinoma With Tumor Size
Cancer Med. 2026;15:e72114.
Abstract

CHENG J, Li M, Li C, Ding J, et al
Global Trends and Insights in Cervical Cancer Research: A Bibliometric Analysis from 2000 to 2024.
Reprod Fertil. 2026 Jul 14:RAF-25-0174. doi: 10.1530/RAF-25-0174.
Abstract

FAROLFI A, Casadei C, Scarpi E, Paoletti E, et al
Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer.
JAMA Netw Open. 2026;9:e2623166.
Abstract

YANG H, Li X, Cai Z, Li Y, et al
Synthesis and growth inhibitory activity of sinomenine derivatives against cervical cancer SiHa cells through targeting the AKT-CyclinD1-p21/p27 pathway.
Med Chem Res. 2026 Jun 8. doi: 10.1007/s00044-026-03584.
Abstract

WAHID A, Maharaj R, Meiring M, Anand K, et al
Extracellular Vesicles as Emerging Cervical Cancer Diagnostic and Molecular Signatures of Tumor and Immune Dynamics.
ACS Biomater Sci Eng. 2026 Jul 14. doi: 10.1021/acsbiomaterials.6c00063.
Abstract

THAKUR P, Singh K, Lakhanpal V, Gupta M, et al
Comparative analysis of LDR and HDR intracavitary brachytherapy in cervical cancer: the critical role of overall treatment time - a decade of experience.
Rep Pract Oncol Radiother. 2026;31:330-340.
Abstract

NDUKWE MI, Balcarova K, Spacek J, Pohankova D, et al
Fistula occurrence after definitive chemoradiotherapy in metastatic or persistent cervical cancer: a retrospective cohort study.
Rep Pract Oncol Radiother. 2026;31:322-329.
Abstract

DOZIE UW, Favour Chisom N, Nwokorie MA, Dozie KCN, et al
Factors Affecting Pap Smear Screening Among Women of Reproductive Age in Owerri West LGA, Imo State, South-Eastern Nigeria.
J Prev Med Hyg. 2026;67:E87-E95.
Abstract

ABID A, Noor M, Maheshwari P, Saeed MH, et al
Addressing HPV Vaccine Hesitancy: A Crucial Step Toward Cervical Cancer Prevention in Pakistan.
J Prev Med Hyg. 2026;67:E7-E8.
Abstract

CHEN G, Jiang Q, Xu J, He T, et al
A senescence-based machine learning model prognosticates and personalizes therapy in cervical cancer.
Transl Cancer Res. 2026;15:490.
Abstract

HUANG S, Song Y, Zhao Y, Zhang X, et al
Ailanthone as a novel AKT1 inhibitor that induces mitochondrial apoptosis and exerts anti-tumor activity in cervical cancer.
Transl Cancer Res. 2026;15:465.
Abstract

WANG M, Xiong S, Qiu X, Hu Z, et al
Development and Validation of a Prognostic Model for Cervical Cancer Based on Chlamydia trachomatis-Associated Transcriptional Signatures.
Int J Womens Health. 2026;18:611743.
Abstract

YANG F, Zhu M, Qiu J, Chen Y, et al
PCK2 Promotes Ribosome Biogenesis in Cervical Cancer Cells via Interaction with hnRNPK.
Reprod Sci. 2026 Jul 13. doi: 10.1007/s43032-026-02143.
Abstract

NAYAK P, Chopra S, Gupta Y, Saahil W, et al
Response to letter to editor "Radiomics-based machine-learning approach to predict response at brachytherapy using pretreatment magnetic resonance imaging in locally advanced cervical cancer".
Brachytherapy. 2026 Jul 13:S1538-4721(26)00069.
Abstract

RAKHAT A, Aimagambetova G
Cervical Cancer Screening in Transition: Global Challenges and Local Realities.
Int J Womens Health. 2026;18:607741.
Abstract

ZHOU Y, Zheng X, Shao D, Cheng F, et al
Facilitators and barriers to cervical cancer screening among women living with HIV: a systematic review of qualitative studies.
Front Public Health. 2026;14:1809112.
Abstract

GUO Y, Liu Y, He Y, Zhang Y, et al
HPV viral load predicts immune exhaustion and prognosis in cervical neoplasia.
Front Immunol. 2026;17:1840435.
Abstract

WEI Q, Qu H, Yu Y, Gao S, et al
Neoadjuvant chemotherapy and immunotherapy followed by radical radiotherapy for locally advanced cervical cancer: efficacy and safety.
Front Immunol. 2026;17:1784958.
Abstract

CULCASI C, Moro F, Merenda E, Rizzi A, et al
Occult sentinel lymph node metastasis detected by intraoperative ex vivo high-frequency ultrasound in clinically early-stage cervical cancer: a case from the prospective RHINOCERUS study.
Gynecol Oncol Rep. 2026;66:102162.
Abstract

YOON JW, Kim G, Lee ES, Lee SY, et al
Cervical cancer screening and HPV vaccination among assigned female at birth transgender and gender-diverse individuals in South Korea: findings from the KITE cohort.
BMC Public Health. 2026 Jul 13. doi: 10.1186/s12889-026-28224.
Abstract

HOEGL J, Fernandes A, Hidalgo F, Escalona S, et al
Diagnostic value of routine endoscopic studies in staging locally advanced cervical cancer: a multicenter experience from a low and middle-income country.
Ecancermedicalscience. 2026;20:2139.
Abstract

KIAEE M, Entezari M, Jebali A, Hashemi M, et al
Bimetallic nano mixtures enable rapid ultrasensitive detection of high risk HPV for early cervical cancer diagnosis.
Discov Nano. 2026;21:337.
Abstract

JIANG P, Wang X, Cui S, Ren C, et al
Solution for the hot spots in adaptive radiotherapy planning for cervical cancer: a case report and review of literature.
Front Oncol. 2026;16:1862463.
Abstract

JIANG J, Gao Y, Wang M, Zhang R, et al
Metabolomic data of melittin-intervened murine cervical cancer cells based on liquid chromatography-mass spectrometry.
Data Brief. 2026;67:113051.
Abstract

HASSAN AA, Sudi LA, Mohamed MD, Abdullahi YB, et al
Persistently high cervical cancer mortality in India: Beyond screening modality alone.
Glob Epidemiol. 2026;12:100273.
Abstract

WHITE CB, McGregor LM
'...but look how many lives would have been saved if this was available then' Exploring the acceptability of future Human Papillomavirus self-sampling, and the barriers and facilitators of cervical cancer screening for those with intellectual disabili
Br J Health Psychol. 2026;31:e70092.
Abstract

POURETTE D, Cripps A, Hassine A, Opigez E, et al
Motivation, Capacity and Opportunities for Cervical Cancer Home-based Vaginal Self-sampling in Reunion Island: a Qualitative Study.
BMC Public Health. 2026 Jul 11. doi: 10.1186/s12889-026-28369.
Abstract

MOHAMMADIAN S, Seifi Alan M, Rastad H
CO(2) laser ablation versus conization for cervical intraepithelial neoplasia grade 2: a prospective cohort study.
Lasers Med Sci. 2026;41:148.
Abstract

MUKHERJEE A, Chakraborty D, Khamle AR, Sharma DD, et al
Deciphering the Anticancer Potential of Bifidobacterium longum MB BBLM15 Derived Postbiotic Metabolites in Cervical Cancer: In Vitro, In Silico, and Synergy Studies.
Probiotics Antimicrob Proteins. 2026 Jul 11. doi: 10.1007/s12602-026-11120.
Abstract

CHEN ML, Chu CY, Zhang FX, Zhang LP, et al
MiR-4327 targets TP53 to promote cervical cancer cell proliferation.
Funct Integr Genomics. 2026;26:187.
Abstract

PAN S, Wu Q, Liu H, Zhou Y, et al
ATP7A-mediated copper ion efflux reprogrammes tumour immunity and promotes cisplatin resistance in cervical cancer.
Cell Death Dis. 2026 Jul 10. doi: 10.1038/s41419-026-09082.
Abstract

GANGA VS, Esakkimuthu S, Subramaniam S
Integrative network pharmacology and genomic analysis of esculin targeting PARP1 in cervical cancer: Insights from ADME profiling, molecular docking, and biomarker discovery.
Comput Biol Chem. 2026;124.
Abstract

YBASETA-MEDINA J, Munive-Bendezu R, Flores-Hernandez N, Curotto-Palomino L, et al
Association between cervical ectropion and high-grade cervical dysplasia in women of reproductive age.
BMC Womens Health. 2026;26:352.
Abstract

WANG Y, Yao Y, Shi H, Lu W, et al
Analysis of SOX2 and SOX17 expression in cervical HPV-associated adenocarcinoma in situ: Correlation with histologic variants.
Ann Diagn Pathol. 2026;84:152674.
Abstract

ARSLAN S, Barbaud A, Bernauer J, Avoscan L, et al
Small extracellular vesicle-mediated transfer of HPV16 transcripts from Ca Ski cells increases proliferation of HPV-negative recipient cancer cells.
Cell Commun Signal. 2026;24:404.
Abstract

NAICKER N, Liebenberg L, Naidoo K, Osman F, et al
Diagnostic accuracy of the Xpert HPV assay in women starting antiretroviral treatment in South Africa.
Int J STD AIDS. 2026 Jun 14:9564624261459075. doi: 10.1177/09564624261459075.
Abstract

HOSSEIN ZADEH S, Habibnia S, Rokni M
Prevalence and genotype distribution of human papillomavirus (HPV) in an at-risk and suspected population in Iran.
BMC Infect Dis. 2026;26:1304.
Abstract

ABUDUREHEMU S, Wang X, Wang J, Liu T, et al
Cold-knife conization versus loop electrosurgical excision for cervical adenocarcinoma in situ: a retrospective cohort study.
BMC Womens Health. 2026;26:348.
Abstract

HU Z, Ma L, Huang S, Wei Y, et al
Cervi-LLM for real time colposcopy lesion detection and interpretable diagnosis.
Sci Rep. 2026;16:22207.
Abstract

YAGI A, Ikeda S, Sakakibara A, Ito Y, et al
Trends in age-standardized incidence rates of cancers of HPV-related cancer sites in Osaka, Japan: 1977-2019.
Sci Rep. 2026;16:21754.
Abstract

HULMI J, Virtanen A, Sadeluoto H, Tarkkanen J, et al
Histological outcomes and colposcopic findings in patients with persistent high-risk human papillomavirus infection without major cytological findings.
Am J Obstet Gynecol. 2026;235:356-364.
Abstract

GAYATHRI AP, Patel A, Shah L, Chaiprasit T, et al
Neuroendocrine Malignancies of the Cervix: What Radiologists Need to Know.
J Comput Assist Tomogr. 2026;50:566-576.
Abstract

PUNTONEN E, Bazzon S, Bongiovanni M, Granados R, et al
ThinPrep(R) Whole-Slide Digital Images versus Conventional Microscopy in Negative for Intraepithelial Lesion or Malignancy, Atypical Squamous Cells of Undetermined Significance, and Low-Grade Squamous Intraepithelial Lesion Cervical Lesions: European
Pathobiology. 2026;93:221-231.
Abstract

WANG Z, Zhan Y, Shi G, Ruan J, et al
Vaginoscopic Resection of Cervical Botryoid Sarcoma in a Pediatric Patient.
J Pediatr Adolesc Gynecol. 2026;39:551-552.
Abstract

SONGSIRITHAT P, Jareemit N, Warnnissorn M, Therasakvichya S, et al
Investigating Discrepancies Between Original and Review Diagnoses in Cervical Cancer and Precancerous Lesions.
J Low Genit Tract Dis. 2026 Jul 24. doi: 10.1097/LGT.0000000000000973.
Abstract

NATH A, Pant A, Thangavel G, Kunnumal A, et al
A systematic review and meta-analysis of diagnostic accuracy of urine self-sampling for human papillomavirus detection in cervical cancer screening.
J Med Screen. 2026 Jul 24:9691413261471634. doi: 10.1177/09691413261471634.
Abstract

LEE AY, Lee SH, Kim MJ, An JE, et al
Validity of HINT-8 in evaluating health-related quality of life among cervical cancer patients.
J Comp Eff Res. 2026 Jul 24:e250194. doi: 10.57264/cer-2025-0194.
Abstract

PAN F, Greuter MJ, Koot JA, Cubie H, et al
Efficient high-risk human papillomavirus screening through pooled testing: a simulation study based on real-world data in low- and middle-income countries.
J Glob Health. 2026;16:04275.
Abstract

KIBONIRE RA, Mphuthi DD, Twinomujuni M, Tumusiime A, et al
Navigating realities: Client and provider perspectives on cervical cancer screening services in rural Uganda: A convergent mixed-methods study.
Womens Health (Lond). 2026;22:17455057261471821.
Abstract

MAJDI A, Harbaj S, Agdi B, Chakir R, et al
Stereotactic Body Radiotherapy as a Salvage Treatment for Regional Lymph Node Recurrence of Cervical Cancer: Two Case Reports With Complete Metabolic Response and Literature Review.
Cureus. 2026;18:e111361.
Abstract

KIRUBA B, Sundararajan V
Synergistic Profiling of Programmed Cell Death and Immune Responses Identifies a Novel Prognostic Index for Cervical Cancer.
ACS Omega. 2026;11:41577-41596.
Abstract

WANG H, Zhao S, Lin H, Zhao S, et al
Factors influencing HPV vaccination intention and uptake behaviors among medical students based on the health belief model and vaccine hesitancy theory: a cross-sectional study.
Front Public Health. 2026;14:1894458.
Abstract

LI Z, Zhao J, Hao L, Wang J, et al
Siglec-15 Enhances Cisplatin Resistance in Cervical Cancer Cells by Promoting Mitochondrial Retrograde Signaling Through Activation of the MAPK Pathway.
DNA Cell Biol. 2026 Jul 23:10445498261470989. doi: 10.1177/10445498261470989.
Abstract

SUN X, Qian S, Ye G, Wang Q, et al
The ubiquitination of CD274 at MERCs enhances the anti-tumor immunity of cervical cancer.
Autophagy. 2026 Jul 23. doi: 10.1080/15548627.2026.2708579.
Abstract

FAN Y, Wang W, Sun Y, Guo S, et al
The Expression and Clinical Value of miR-483-5p in Cervical Cancer and Its Regulation of Cervical Cancer via TIMP2.
J Obstet Gynaecol Res. 2026;52:e70396.
Abstract

ZHAO X, Wu J, Li L, Zhang H, et al
A bioinformatics analysis of KIF transcriptomic subtyping reveals prognostic heterogeneity and differential therapeutic responses in cervical cancer.
Oncol Lett. 2026;32:398.
Abstract

LI L, Xu X, Jiang P, Wang FL, et al
Policy events, emotional fluctuations, and vaccination behavior: a longitudinal analysis of public opinion on HPV vaccines in China.
Front Public Health. 2026;14:1889894.
Abstract

KARNIK M, Anantharaju PG, Sharma A, Sukocheva O, et al
Aurora kinase B as a therapeutic target in HPV-induced cervical cancer: mechanisms and future perspectives.
Front Oncol. 2026;16:1857128.
Abstract

KANG OJ, Koh JH, Lee SW, Park JY, et al
Neoadjuvant Paclitaxel-Carboplatin Chemotherapy Followed by Cesarean Radical Hysterectomy in Pregnant Patients With Cervical Cancer: Obstetric, Neonatal, and Surgical Outcomes.
J Obstet Gynaecol Res. 2026;52:e70403.
Abstract

ONYEMA CM, Nweke AN, Oliobi CW, Chimezie-Chilaka C, et al
Determinants of Cervical Cancer Screening Uptake Among Antenatal Women in a Semi-Urban Hospital in Ebonyi State, Nigeria.
Niger Med J. 2026;66:2264-2275.
Abstract

LIU C, Wang X, Zhang N, Li J, et al
Can image-guided external beam radiotherapy boost be an alternative when intracavitary brachytherapy is unavailable for locally advanced cervical cancer? A dosimetric analysis and literature review.
J Contemp Brachytherapy. 2026;18:171-178.
Abstract

HANDE V, Rossi L, Westerveld H, Luthart L, et al
Automated planning in image-guided adaptive brachytherapy for cervical cancer: Impact analysis on patient workflows in high-volume centers.
J Contemp Brachytherapy. 2026;18:163-170.
Abstract

PAVICAR B, Kukic D, Milosavljevic A, Sovilj BK, et al
Automated EQD(2) reporting for cervical cancer high-dose-rate brachytherapy using a standalone ESAPI-based application.
J Contemp Brachytherapy. 2026;18:196-203.
Abstract

CHIANG JS, Conteh AM, Niedermayr T, Kidd E, et al
The value of pre-brachytherapy MRI in aiding applicator selection for cervical cancer procedures.
J Contemp Brachytherapy. 2026;18:142-146.
Abstract

PAN L, Zhang P, Zhang D, Wang G, et al
Mitochondrial reprogramming in cervical cancer: crosstalk with tumor immunity, HPV oncogenic signaling, and therapeutic resistance.
Front Immunol. 2026;17:1884498.
Abstract

HENES M, Mann E, Hirchenhain C, Kentner A, et al
Correction: Registry Study of the Working Group on Cervical Pathology and Colposcopy (AGCPC) on the Diagnostic Algorithm for the New Cervical Cancer Screening - Persistent HPV Infections and Squamous Cell Lesions: Evaluation of over 10000 Patients.
Geburtshilfe Frauenheilkd. 2026;86:e2.
Abstract

HE H, Cai H
Reply to Peikai Sun's Comment on "Analysis of Quality, Reliability, and Content of Cervical Cancer-Related Chinese Videos on TikTok".
J Cancer Educ. 2026 Jul 23. doi: 10.1007/s13187-026-02947.
Abstract

ZHU M, Liu X, Zhao S, Zhang X, et al
[Interpretable machine learning models for preoperative precision prediction of perineural invasion in cervical cancer to support treatment decision: a multicenter retrospective study].
Nan Fang Yi Ke Da Xue Xue Bao. 2026;46:1509-1519.
Abstract

MUSHEER A, Mannan MS, Khan MW, Bhatti A, et al
PD-1 Inhibition With Camrelizumab in Cervical Cancer: A Systematic Review and Meta-Analysis.
Am J Clin Oncol. 2026 Jul 21. doi: 10.1097/COC.0000000000001352.
Abstract

BOYD L, Nightingale C, Martinez-Gutierrez J, Machado Colling A, et al
Access to cervical screening in Australian general practices: a cross-sectional study using a 'secret shopper' approach.
Cancer Causes Control. 2026;37:129.
Abstract

BULBU R, Horasanli JE, Erdogan AC, Akkus F, et al
Self-collected versus clinician-collected human papillomavirus samples.
Rev Assoc Med Bras (1992). 2026;72:e20260122.
Abstract

AL-OMAIR OM, Alabdullatif NS
Health-related social media engagement and cervical cancer prevention: associations with HPV knowledge, vaccine awareness, and pap smear utilization among US women.
Front Public Health. 2026;14:1782691.
Abstract

RATH N, Neis K, Holleczek B
Analysis of Age, Period and Cohort Trends in Cervical In Situ and Invasive Carcinomas for Assessing the Utility of Screening Approaches-Results From the Saarland Cancer Registry.
Cancer Med. 2026;15:e72127.
Abstract

YODA RA, Huang EC
Implementation and impact of primary HPV testing in cervical cancer screening: Historical perspectives and institutional experience at a large academic medical center.
Cancer Cytopathol. 2026;134:e70129.
Abstract

DEL VALLE D, Lamo EA, Exposito AD, Amorin AG, et al
SPEACx: a screening pathway-based evaluation and audit framework of cervical cancer diagnostic routes in a population-based programme.
Arch Public Health. 2026;84:166.
Abstract

SHIN MB, Volpi CR, Szewczyk W, Hannon PA, et al
Predictors of routine HPV-based cervical cancer screening adoption in federally qualified health centers within a multi-state practice research network 2012-2022: retrospective observational study.
BMC Prim Care. 2026 Jul 21. doi: 10.1186/s12875-026-03452.
Abstract

LIAO D, Shi L, Cui Y, Li C, et al
PIN1 enhances SUMOylation of YAP1 and inhibits ferroptosis via autophagy-dependent degradation of ACSL4 in cervical cancer.
Cell Death Discov. 2026 Jul 22. doi: 10.1038/s41420-026-03257.
Abstract

WEATHERHEAD K, Nguyen C, Henry T, Harrington S, et al
Enhancing efficiency and improving turnaround time: real-world impact of the Genius Digital Diagnostics System implementation.
Am J Clin Pathol. 2026;166:aqag081.
Abstract

CHEN Y, Hong Y, Wei D, Fan L, et al
Integrative multi-omics analysis identifies FAM3D as a prognostic tumor suppressor in cervical cancer.
Funct Integr Genomics. 2026;26:198.
Abstract

EJAZ R, Chatzipanagiotou OP, Alizai Q, Sarfraz A, et al
Patient Portal Use and Cancer Screening in the United States: Individual Associations and Population Impact.
J Prim Care Community Health. 2026;17:21501319261471881.
Abstract

AZMI MB, Wasi R, Sohail A, Asif U, et al
Identification of miR-21-5p and miR-21-3p regulated hub genes and drug repurposing targets in cervical cancer: an integrative computational analysis.
Naunyn Schmiedebergs Arch Pharmacol. 2026.
Abstract

MEKONEN EG, Endalew HL, Bazezew AM, Zeleke GA, et al
Screening for hypertension, diabetes, and cervical cancer in the democratic Republic of Congo: insights from a nationally representative survey.
Sci Rep. 2026 Jul 20. doi: 10.1038/s41598-026-62712.
Abstract

HEBERT KJ
Editorial Comment: "Treatment-Related Risk of Urologic Adverse Events in Cervical Cancer Survivors".
Urology. 2026 Jul 20:S0090-4295(26)00449-8. doi: 10.1016/j.urology.2026.
Abstract

ZHANG A, Lu Y, Song J, Zhai W, et al
The value of dynamic contrast-enhanced magnetic resonance imaging (MRI) in predicting postoperative recurrence of early-stage cervical cancer.
Clin Radiol. 2026;100:107422.
Abstract

KAMANI T, Patel SK, Sharma Y, Al-Zahrani FA, et al
A rapid detection of early-stage cervical cancer using nucleus and cytoplasm-based machine learning-driven refractive index surface plasmon resonance biosensor with ZnO-ag efficient materials.
Spectrochim Acta A Mol Biomol Spectrosc. 2026;363.
Abstract

WINKELMANN MT, Bareiss A, Winkelmann JT, Hoffmann S, et al
Abbreviated T2w-only pelvic MRI for local tumor staging of cervical cancer: a pragmatic approach for time-critical and resource-limited settings.
Abdom Radiol (NY). 2026 Jul 20. doi: 10.1007/s00261-026-05691.
Abstract

ZHANG M, Lu Y, Song J, Zhang A, et al
Deep learning reconstruction versus conventional parallel imaging for sagittal T2-weighted MRI in cervical cancer: a comparison of acceleration factors.
Abdom Radiol (NY). 2026 Jul 20. doi: 10.1007/s00261-026-05685.
Abstract

PHUNG MT, Inyangetuk RS, Onar GS, Nguyen B, et al
Insights of Vietnamese American Women on Cervical Cancer Screening and HPV Self-Sampling.
J Racial Ethn Health Disparities. 2026 Jul 20. doi: 10.1007/s40615-026-03114.
Abstract

GAO J, Liu Y, Sun G
Effect of SJAMP on mTOR/p70S6K signaling pathway and invasion and migration ability of HeLa cells in cervical cancer.
Pak J Pharm Sci. 2026;39:2960-2967.
Abstract

SINGH SK, Kumar P
Synergistic U-bent geometry and bimetallic plasmonics for ultra-sensitive fibre-optic SPR biosensing of cervical cancer.
Analyst. 2026 Jul 20. doi: 10.1039/d6an00563.
Abstract

CAI L, He M, Wang L, Xie Q, et al
Prevalence and Associated Factors of Anxiety and Depression Among Family Caregivers of Patients with Cervical Cancer After Surgery: A Cross-Sectional Study.
Psychol Res Behav Manag. 2026;19:600590.
Abstract

LAHOLE BK, Tanga AT, Abdi FH, Mekuria SF, et al
Challenges of scaling up cervical cancer screening in Ethiopia: a qualitative socio-ecological study.
EClinicalMedicine. 2026;97:104057.
Abstract

GAO S, Wang K, Su X, Wu Y, et al
Limited Survival Benefit of Preoperative Conization Before Radical Surgery in Stage IB Cervical Cancer: An IPTW-Adjusted Retrospective Cohort Study.
Int J Womens Health. 2026;18:612277.
Abstract

YOO H, Kim H, Hwang JH, Suh DH, et al
Association between delayed confirmatory testing and cervical cancer detection among women with abnormal screening results.
J Gynecol Oncol. 2026 Jul 7. doi: 10.3802/jgo.2027.
Abstract

CHEN L, Chen T, Tu N, Dong L, et al
Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trial.
J Gynecol Oncol. 2026 Jul 9. doi: 10.3802/jgo.2027.
Abstract

GUO W, He R, Hu Y, Gu K, et al
Efficacy and safety of 5-aminolevulinic acid photodynamic therapy for cervical squamous intraepithelial lesion: a systematic review and meta-analysis.
Lasers Med Sci. 2026;41:154.
Abstract

GHOSH A, Bandyopadhyay A, Mukhopadhyay A
Long non-coding RNAs: a new hope for the cervical cancer staging.
Mol Biol Rep. 2026;53:1199.
Abstract

CHEN X, Zhou D, Lin Y, Lin W, et al
Cross-layer multiomic and digital pathology analysis identifies a malignant keratinization state linked to immune exclusion in cervical squamous carcinoma.
J Transl Med. 2026;24:949.
Abstract

YAMADA H, Yokoi A, Suzuki K, Yoshida K, et al
Transcriptome profiling identifies RET activation as a therapeutic target in gastric-type endocervical adenocarcinoma.
Biomed Pharmacother. 2026;201:119696.
Abstract

VILLARREAL RAMIREZ JC, Guaithero Rivas JE, Ramirez L, Pena Guillen J, et al
Morphological differentiation of hyperchromatic crowded groups (HCG) in cervical cytology. Possible clinical significance.
Rev Esp Patol. 2026;59:100883.
Abstract

CHEUNG LC, Mao F, Rydzak G, Wentzensen N, et al
Benefits and Harms of Immediate Versus Delayed Treatment of Cervical Intraepithelial Neoplasia Grade 2 : A Target Trial Emulation.
Ann Intern Med. 2026;179:980-987.
Abstract

GONZALEZ CANTO J, Amparo Burgos-Isern M, Burgos-Teruel A
Associations between high-risk human papillomavirus genotypes: evidence of HPV16 predominance as a monoinfection and its no stronger link with high-grade lesions.
Rev Esp Quimioter. 2026;39:375-379.
Abstract

SARGENT A, Rebolj M, Denton K, Mathews C, et al
HPValidate - Technical optimisation of self-collected samples for HPV testing within the NHS England cervical screening programme.
J Virol Methods. 2026;345:115423.
Abstract

BARBERA JP, Schwartz BI
Preventive Gynecologic Care for Patients With Disabilities.
Clin Obstet Gynecol. 2026;69:278-283.
Abstract

VIRARKAR M, Javadi S, Aziz A, Shah R, et al
Quantitative imaging biomarkers as prognostic indicators in squamous cell cervical carcinoma: a retrospective cohort analysis.
Abdom Radiol (NY). 2026;51:4082-4091.
Abstract

HELLNER K, Simon P, De Sutter P, Vahula KL, et al
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women w
Clin Infect Dis. 2025 Dec 17:ciaf658. doi: 10.1093.
Abstract

ANDERSSON M, Zewdie BN, Mumena C, Thulin EA, et al
Prevalence of cervical human papillomavirus infections and cytological abnormalities in asymptomatic women living with HIV in Addis Ababa, Ethiopia.
Sci Rep. 2026;16:23719.
Abstract

PANG X, Liu T, Xin J, Li W, et al
Serotonin transporter acts as a tumor suppressor in cervical cancer.
Cell Signal. 2026 Jul 31:112771. doi: 10.1016/j.cellsig.2026.112771.
Abstract

SHARMA M, Kumar D, Kumar M, Bassi P, et al
QbD-driven formulation development and evaluation of apigenin loaded chitosan-tethered in-situ cubosomal gel for the management of cervical cancer: A preclinical study.
Int J Biol Macromol. 2026 Jul 31:153834. doi: 10.1016/j.ijbiomac.2026.153834.
Abstract

SIULUTA N, Deaterly C, Villalba K, Scaglione NM, et al
Association of sexual trauma and demographic characteristics with cervical cancer screening among women with HIV.
AIDS Care. 2026 Jul 31:1-10. doi: 10.1080/09540121.2026.2706231.
Abstract

PRIYANKA B, Gurjar B, Dahiwade S, Narayan G, et al
Comparative Performance of Pap Smear and Colposcopy in Cervical Cancer Screening Among Women With Abnormal Cervical Findings in Central India: A Prospective Observational Study.
Health Sci Rep. 2026;9:e72881.
Abstract

ARROYO MUHR LS, Dillner J
Challenges and possible solutions towards reaching global cervical cancer elimination.
EClinicalMedicine. 2026;97:103890.
Abstract

KHAN NG, Adiga D, Sanjay KU, Rai PS, et al
Bisphenol A disrupts mitochondrial homeostasis and promotes metabolic alterations in cervical cancer cells.
Environ Sci Pollut Res Int. 2026 Jul 30. doi: 10.1007/s11356-026-38082.
Abstract

LIAO L, Zeng L, Zhao Y, Guo Z, et al
OTUD6A promotes de novo pyrimidine synthesis by deubiquitinating and stabilizing CAD in cervical cancer.
Oncogene. 2026 Jul 30. doi: 10.1038/s41388-026-03909.
Abstract

KOLINA AD, Oleynikova NA, Andreeva YY, Danilova NV, et al
[The effect of storage duration on the preservation of DNA and the feasibility of genetic studies in formalin-fixed paraffin-embedded tissue samples].
Arkh Patol. 2026;88:35-40.
Abstract

AHUJA S, Jainar CJE, Moufarrij S, Dee EC, et al
Global Disparities in Current Clinical Trials in Cervical Cancer.
JAMA Netw Open. 2026;9:e2626173.
Abstract

LUO D, Sharman AR, Bateson D, Smith M, et al
Gynaecologists' Views and Acceptability of Active Surveillance for Women Diagnosed With Cervical Intraepithelial Neoplasia 2: A Qualitative Study.
Aust N Z J Obstet Gynaecol. 2026;66:e70165.
Abstract

HUANG H, Li P, Zhu L, Wu Y, et al
RNA-Binding Protein RBMS3 Inhibits Cervical Cancer Progression by Enhancing HSPA6 mRNA Stability.
Front Biosci (Landmark Ed). 2026;31:51761.
Abstract

MBELWA H, Leo J, Kahesa C, Munema A, et al
BiCervi: Pap smear microscopy image dataset for cervical cancer detection and classification.
Data Brief. 2026;68:113077.
Abstract

HUANG L, Lin N, Li H, Hu Y, et al
Spatially organized macrophage-T-cell crosstalk in cervical cancer: insights from single-cell and spatial omics.
Front Immunol. 2026;17:1896004.
Abstract

CURRIER JJ, Van Houweling E, Bolten K, Wasson N, et al
Female allogeneic hematopoietic cell transplant survivors' perspectives on cervical cancer screening: a retrospective study.
Support Care Cancer. 2026;34:814.
Abstract

POLTEN R, Kutle I, Stalp JL, Hachenberg J, et al
Genomic profiling identifies actionable DNA-repair defects in a new cervical cancer model.
Sci Rep. 2026;16:23557.
Abstract

YANG H, Yang W, Tian H, Chang Y, et al
Multi-modal Stacking Machine Learning Model for Predicting Lymph Node Metastasis in Cervical Cancer.
Acad Radiol. 2026 Jul 29:S1076-6332(26)00530-1. doi: 10.1016/j.acra.2026.
Abstract

WU N, Lin F, Ji J, Pan H, et al
Retraction notice to "Mitochondrial oxidative stress related LncRNA predict cervical cancer prognosis and immunotherapy response: Molecular structure and protein interaction of ribosomal protein L34" [Int. J. Biol. Macromol. 299 (2025) 140145].
Int J Biol Macromol. 2026 Jul 29:153730. doi: 10.1016/j.ijbiomac.2026.153730.
Abstract

SCHRODER C, Qureischi M, Hecking T, Nadal J, et al
Tumoral PD-L1 Expression as a Prognostic Marker in Invasive Cervical Cancer.
Anticancer Res. 2026;46:4371-4383.
Abstract

WILSON A, Cropper A, Ma Y, Adams EJ, et al
Improving laboratory workforce efficiency using AI-assisted digital cytology within an HPV-based cervical screening programme: A model-based evaluation for the NHS Cervical Screening Programmes.
BMJ Open. 2026;16:e113298.
Abstract

MIN S, Zhu Y, Xie L, Zhang H, et al
TCTP regulates the infiltration of CXCR4+ immunosuppressive cells in cervical Cancer via the non-canonical NF-kappaB/ZEB1/CXCL12 Axis.
Cell Signal. 2026 Jul 29:112761. doi: 10.1016/j.cellsig.2026.112761.
Abstract

ZHANG P, Tong X, Chen X, Feng Y, et al
Changes in HPV vaccine hesitancy and influencing factors among female university students in China: A national repeated study.
Hum Vaccin Immunother. 2026;22:2701549.
Abstract

SWISHER EM, Davis M, Rubin-Saika M, Manhardt E, et al
Cervical Cancer Screening With Human Papillomavirus Self-Collection Testing in an Opioid Treatment Program.
JAMA Netw Open. 2026;9:e2625993.
Abstract

ZHENG X, Wang W, He C, Wang L, et al
LncRNA DNM3OS suppresses proliferation, invasion, and epithelial-mesenchymal transition in cervical cancer cells via miR-454-3p.
Mol Biol Rep. 2026;53:1300.
Abstract

SILVA ERPHD, Gubert VT, Puga MAM, Tozetti IA, et al
Cervical cancer screening in incarcerated women: deprived of freedom or deprived of health?
Rev Bras Enferm. 2026;79:e20250011.
Abstract

CHANG H, Liu X, Qin L, Wang Y, et al
An explainable machine learning approach for cervical cancer screening: decoding morphological diagnostic drivers.
Acta Clin Belg. 2026 Jul 29:1-13. doi: 10.1080/17843286.2026.2711062.
Abstract

UTAMI TW, Nuranna L, Purwoto G, Oktalia A, et al
Unveiling Optimal Cervical Cancer Screening Age Range: Study of HPV Infection Among 75,719 Women in Indonesia's Metropolitan Regions (2012 - 2022).
Asian Pac J Cancer Prev. 2026;27:2541-2548.
Abstract

KAUR SD, Dwivedi R, Nalwa A, Dwivedi P, et al
Awareness of and Barriers to Cervical Cancer Screening among Married Tribal Women in Sirohi, Rajasthan: A Community-based Study.
Asian Pac J Cancer Prev. 2026;27:2457-2465.
Abstract

CHEN Y, Xie Y, Wu J, Qu X, et al
Mucus and tumor penetrating paclitaxel micelles for potent local therapy of cervical cancer.
J Nanobiotechnology. 2026;24:700.
Abstract

OGURA J, Sato S, Koshida Y, Kasuga M, et al
HPV18-Positive Cervical Large Cell Neuroendocrine Carcinoma With Rapid Progression Despite Pembrolizumab Combined With Chemotherapy: A Case Report With Immunogenomic Insights.
J Obstet Gynaecol Res. 2026;52:e70426.
Abstract

DALABEHERA M, Chaudhari S, Kumar J, Poonia N, et al
Mechanistic advances in nanomedicine, nucleic acid therapies, and AI-driven research on cervical cancer.
J Pharm Sci. 2026 Jul 28:104442. doi: 10.1016/j.xphs.2026.104442.
Abstract

ZHANG M, Wang N, Liu X, Wang Y, et al
STING-engineered biomimetic hybrid membrane nanovaccine for enhanced immunotherapy of cervical cancer.
Colloids Surf B Biointerfaces. 2026;268.
Abstract

XIAO C, Huang C, Lin W, Tian F, et al
Improving CT-CBCT deformable image registration for cervical cancer adaptive radiotherapy using a deep learning approach.
Front Oncol. 2026;16:1855718.
Abstract

GUIMARAES JMN, Pescarini JM, Moncayo AL, Craig P, et al
Racial inequities in cervical cancer mortality and the role of the Bolsa Familia conditional cash transfer programme: results from the 100 Million Brazilian Cohort.
Lancet Reg Health Am. 2026;62:101562.
Abstract

KOLAMBKAR S, Tomar M, Arif N, Hussain S, et al
HPV vaccination in the WHO South-East Asia Region: A scoping review of uptake, implementation challenges, and pathways to acceleration.
Hum Vaccin Immunother. 2026;22:2693359.
Abstract

YILIHAMU Y, Zhang X, Zhao Z, Aili M, et al
Tumor microenvironment-activated HA@GOx/IR-820@MnO(2) nanosheets for dual-modal imaging guided phototherapy of cervical cancer.
J Mater Chem B. 2026 Jul 28. doi: 10.1039/d6tb01062.
Abstract

GONCALVES E, Fontes F, Rodrigues JR, Calisto R, et al
Second primary cancers among females with a first primary cervical, uterine and ovarian cancer: a population-based study in North Portugal.
Cancer Causes Control. 2026;37:136.
Abstract

ADEFOLALU AO
Cervical Cancer Screening in Women Living with HIV in South Africa: Addressing Health Disparities Through Integrated Prevention Strategies.
Int J Womens Health. 2026;18:613391.
Abstract

LUVIAN-MORALES J, Rueda-Escalona AA, Delgadillo-Gonzalez M, Cetina-Perez LDC, et al
Benefits of an anti-inflammatory diet compared to a low-residue diet during concurrent chemoradiation therapy for patients with locally advanced cervical cancer: a randomized clinical trial.
Front Nutr. 2026;13:1835417.
Abstract

DOU Z, Yu S, Zhang J, Wu X, et al
Establishment of prognostic nomogram in cervical cancer with hepatitis B virus infection: a retrospective study.
Front Oncol. 2026;16:1826692.
Abstract

WANG W, Li X, Jiang Y, Lu Y, et al
Non-contrast MRI Radiomics Nomogram for Predicting Recurrence and Progression-Free Survival in Cervical Cancer following Concurrent Chemoradiotherapy.
Curr Med Imaging. 2026 Jul 23. doi: 10.2174/0115734056449836260717192214.
Abstract

SORBYE SW, Falang BM, Antonsen M, Richardsen E, et al
Genotype-Specific HPV E6/E7 mRNA Triage for Risk Stratification in HPV DNA-Positive Women with ASC-US/LSIL: A Population-Based Tromso Cohort.
Pathogens. 2026;15:747.
Abstract

SAYER TG, Yilmaz G, Ozdemir F
Cisplatin and epsilon-Viniferin Synergistically Modulate Oxidative Stress in HeLa Cells: Implications for Redox Modulation in Cervical Cancer Cells.
Molecules. 2026;31:2409.
Abstract

CORTES J, Nassar N, Blasco MDR, Castano R, et al
Rapid Systematic Review-Informed Multidisciplinary Expert Consensus on the Management of HPV-Positive Women with Low-Grade Cervical Lesions and the Role of a Coriolus versicolor-Based Vaginal Treatment.
Medicina (Kaunas). 2026;62:1283.
Abstract

UCAR M, Yigit MF, Kartal SA, Yagan A, et al
Effect of a Health Belief Model Based Education Program on Women's Cervical Cancer Knowledge and HPV Vaccination Attitudes in Primary Care Settings.
Healthcare (Basel). 2026;14:2118.
Abstract

EBNER C, Ebner L, Skvortsov S, Fiegl H, et al
Early Normalization of Squamous Cell Carcinoma Antigen During Combined Chemoradiation Predicts Pathological Response and Survival in Squamous Cervical Cancer: A Retrospective Cohort Study.
Cancers (Basel). 2026;18:2225.
Abstract

DRUMOND HC, Silvestrini MMA, Dos Santos LM, Magalhaes-Gama F, et al
Elevated Circulating Extracellular Vesicles as Prognostic Biomarkers in Cervical Cancer Progression.
Biomedicines. 2026;14:1492.
Abstract

SANTOS F, Silva MS, Caramelo FA, Santana MM, et al
Cell-Free DNA Fragmentation Patterns as Biomarkers for Human Papillomavirus-Related Cancers: A Systematic Review of Methodological Diversity and Diagnostic Performance.
Int J Mol Sci. 2026;27:6372.
Abstract

SUN Q, Wang D, Zhao Q, Cui Y, et al
PET117 Deficiency Confers Ferroptosis Resistance Through ACSF2 Downregulation in Cervical Cancer.
Antioxidants (Basel). 2026;15:876.
Abstract

DE MELO NETO AB, Queiroz FR, de Souza Melo CP, Duarte BCD, et al
ATF4, ZIK1, and PNMA3 Transcriptomic Signatures Predict Chemoradiotherapy Response in Cervical Cancer.
Cancer Med. 2026;15:e72053.
Abstract

NG XR, Quek IP, Pereira MJ, Molina JA, et al
Effect of Self-Sampling HPV DNA Testing on Cervical Cancer Screening in Singapore's Primary Care: Pragmatic Randomized Controlled Trial.
Ann Fam Med. 2026;24:291-300.
Abstract

JOHANSEN ME, Ihongbe TO, McClain M
Annals Journal Club: HPV Self-Sampling vs Clinician Sampling for Cervical Cancer Screening.
Ann Fam Med. 2026;24:381.
Abstract

KATARIA B, Mukhopadhyay A, Oaknin A, O'Donnell DM, et al
Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.
Lancet Oncol. 2026;27:e379-e391.
Abstract

ALCAZAR JL, Espinosa F, de la Maza F, Opazo MP, et al
Role of three-dimensional ultrasound in the diagnosis and staging of gynecological malignancies: Focus on endometrial and cervical cancer.
Best Pract Res Clin Obstet Gynaecol. 2026;108:102758.
Abstract

JIA J, Wang L, Wang F
Considerations for the Clinical Translation of Low-Dose Computed Tomography-Based Plan-Pool Adaptive Radiotherapy in Cervical Cancer.
Clin Oncol (R Coll Radiol). 2026;57:104284.
Abstract

NAVYA VB, Muraleedharan G, Fasna PK, Kumar R, et al
A prognostic immune signaling-related lncRNA-circRNA-mRNA network model for cervical cancer using machine learning.
Biochem Biophys Res Commun. 2026;831:154337.
Abstract

QIAN L, Li Y, Zheng J, Liang T, et al
GBP6 maintains mitochondrial bioenergetics to promote immune evasion from NK cells in cervical cancer.
Cell Rep. 2026;45:117704.
Abstract

LI Z, Tang L, Wang M, Yu Q, et al
beta-Elemene Triggers Drp1-Dependent Mitochondrial Fission Through CDK1/Cyclin B1 Signaling in Cervical Cancer Cells.
J Biochem Mol Toxicol. 2026;40:e71032.
Abstract

ORTEGA-AGUIRRE MF, Olivas-Armendariz I, Silva-Espinoza JC, Hernandez-Gonzalez ME, et al
Characterization of Hydrogels of Gelatin/O-Carboxymethyl Chitosan in Ovule Form with Curcumin and Retinyl Palmitate as a Treatment for Cervical Cancer.
Gels. 2026;12:618.
Abstract

XU T, Ke J, Yue Y, Zhu Z, et al
The Efficacy of Transcutaneous Electrical Acupoint Stimulation as an Adjunct to Standard Bladder Training for Bladder Emptying After Radical Hysterectomy for Cervical Cancer: A Randomized Controlled Trial.
Curr Oncol. 2026;33:424.
Abstract

HEWAPATHIRANAGE-MAYADUNNE H, Bergeron E, Kushalnagar P
Rethinking Communication Barriers: Educational Attainment in Cervical Cancer Screening Among American Sign Language Users.
Eur J Investig Health Psychol Educ. 2026;16:97.
Abstract

KASE S, Zimmermann ML, Magi M, Baburin A, et al
Changing burden of cancers related to human papillomavirus in Estonia: a population-based registry study.
Acta Oncol. 2026;65:632-640.
Abstract

VISHNOI MG, Jain A, Akhariya R, Balaan V, et al
Dual-phase [18F]FDG PET/CT imaging in cervical carcinoma: enhanced metabolic characterization and novel prognostic indicators - a prospective study with paradigm-shifting clinical implications.
Nucl Med Rev Cent East Eur. 2026;29:e00626007.
Abstract

BARUWA OJ, Singini MG, Gwebu H, Nduka CC, et al
Accelerating cervical cancer elimination: healthcare decision-making and cervical cancer screening uptake in sub-Saharan Africa.
Prev Med Rep. 2026;69:103572.
Abstract

ABDUL KARIM SIDDIQUE F, de Zeeuw J, Koot JAR, Nakisige C, et al
Effectiveness of community-based culturally tailored cervical cancer awareness interventions among women and decision-making men in low-resource settings: A pre-post design evaluation in rural Uganda and Bangladesh.
Prev Med Rep. 2026;69:103575.
Abstract

CAI Z, Liu D, He Y, Fang Z, et al
Stichopus japonicus acidic mucopolysaccharide (SJAMP) exerts the tumor-suppressive activity in cervical cancer by targeting TFAP2A to downregulate CENPW.
Cytotechnology. 2026;78:165.
Abstract

ARIMOTO T, Kasamatsu T, Machida R, Toita T, et al
A confirmatory trial of hysterectomy with minimal parametrectomy for stage IB1 cervical cancer involving a tumor diameter of 2 cm or less: a Japan Clinical Oncology Group study (JCOG1101).
J Gynecol Oncol. 2026 Jul 13. doi: 10.3802/jgo.2027.
Abstract

YIN X, Tian X, Huang C, Xiang S, et al
Exploratory preoperative assessment of lymphovascular space invasion in cervical cancer: comparative insights from intravoxel incoherent motion and diffusion-relaxation correlation spectrum imaging.
Br J Radiol. 2026 Jul 25:tqag169. doi: 10.1093.
Abstract

ARYA K, Tiwari R, Singh V, Sukla P, et al
Assessment of Knowledge, Attitudes, and Practices Regarding Cervical Cancer and Its Vaccine Among Adolescent Girls at an Urban Health Training Center in Chhallapura, Datia, Madhya Pradesh: A Community-Based Study.
Cureus. 2026;18:e111412.
Abstract

PENG C, Liang C, Liu J, Liu Y, et al
Small RNA sequencing identifies tsRNA-05020 as a potential regulator of cervical cancer progression.
Turk J Biol. 2026;50:197-208.
Abstract

Retraction: miR-206 Inhibits Cell Proliferation, Migration, and Invasion by Targeting BAG3 in Human Cervical Cancer.
Oncol Res. 2026;34:31.
Abstract

THOBIAS AR, Patel KA, Mehta KA, Patel BM, et al
Transcriptional Scenario of Altered Glycosylation in HPV-Associated Cervical Cancer.
Indian J Clin Biochem. 2026;41:598-605.
Abstract

BAHADUR B, Choudhary S, Oswal D, Singh T, et al
Survival beyond treatment: patterns and determinants of disease-free survival in cervical cancer at a tertiary care center in India.
Front Oncol. 2026;16:1872738.
Abstract

LUO Y, Xie XH, Huang XQ, Hu HQ, et al
A prognostic signature based on methionine metabolism-related genes for cervical cancer: integrated transcriptomic and experimental validation.
PeerJ. 2026;14:e21538.
Abstract

GRILLO N, Almendra R, Correia C
Assessment of the impact of nonavalent human papillomavirus vaccine on disease clearance time in women with active infection.
Rev Bras Ginecol Obstet. 2026;48:e-rbgo17.
Abstract

SINGH K, Grover A, Dhanasekaran K
Cascade strengthening and test choice are complementary, not competing in Indian cervical cancer screening.
Glob Epidemiol. 2026;12:100277.
Abstract

DOYLE CM, Ronn MM, van Schalkwyk C, Brisson M, et al
Potential Impact of Catch-Up HPV Vaccination on HPV Prevalence and Cervical Cancer Incidence Among Women Living With HIV in South Africa: Results From Two Mathematical Models.
J Int AIDS Soc. 2026;29 Suppl 2.
Abstract

PETER O, Oborevwori E, Osagie E, Akhigbe P, et al
From Awareness to Action Study: Improving Human Papillomavirus Knowledge, Screening and Vaccine Uptake Among Mother-Adolescent Pairs in the HOMINY Study in Nigeria: A Longitudinal Study.
J Int AIDS Soc. 2026;29 Suppl 2.
Abstract

IKEDA S, Kawaguchi S, Baba K, Takahashi H, et al
Salvage tacrolimus therapy for steroid-refractory immune-related adverse event-associated sclerosing cholangitis.
Clin J Gastroenterol. 2026;19:1003-1007.
Abstract

JOPS P, Wolter A, Bavor C, Dodd R, et al
Qualitative insights into the acceptability of self-collection for cervical screening amongst under- and never-screened groups in Australia.
BMC Public Health. 2026;26:2242.
Abstract

MONTI E, Monti C, Matozzo CMM, Salmaso M, et al
The 'see-and-treat' approach in the treatment of preneoplastic cervical lesions.
Eur J Cancer Prev. 2026;35:465-472.
Abstract

DEJENE K
Navigating stigma, faith, and fear: understanding HPV vaccine acceptance among adolescent girls in rural parts of Central Ethiopia.
Cult Health Sex. 2026;28:978-989.
Abstract

ZHU G, Piao Z, Gao Y, Cong X, et al
Glycolytic reprogramming and the EMT drive cervical cancer progression via the NQO1/HIF1alpha-SIX1 axis.
iScience. 2026;29:117007.
Abstract

SUVVARI TK
Turning the Tide on Cervical Cancer in India.
Clin Med Insights Oncol. 2026;20:11795549261471277.
Abstract

ZHANG T, Fan W, Liu K, Xu H, et al
Time-dependent diffusion MRI for assessing tumor microstructure and prognostic risk factors in cervical cancer.
Abdom Radiol (NY). 2026 Aug 8. doi: 10.1007/s00261-026-05703.
Abstract

KEBEDE FB, Mare KU, Arage FG, Tiyou A, et al
Predicting lifetime cervical cancer screening among sexually active women in low- and middle-income countries using machine learning models: evidence from Demographic and Health Surveys.
AJOG Glob Rep. 2026;6:100669.
Abstract

BEJARANO-HERNANDEZ L, Chan A, Gosalia M, Moore M, et al
Expanding HPV prevention across the life course: evidence on vaccine effectiveness in adults.
Front Public Health. 2026;14:1894760.
Abstract

GUO Q, Xu C, Li J, Qi C, et al
COVID-19 vaccination rates as a proxy for health system resilience: implications of development disparities for cervical cancer control during the pandemic.
Front Med (Lausanne). 2026;13:1858206.
Abstract

HUANG H, Liu L, Cui Y, Zhou F, et al
Circular RNAs in cervical cancer: from ceRNA networks to epitranscriptomic regulation, immune modulation, and metastatic reprogramming.
Front Immunol. 2026;17:1848357.
Abstract

WANG X, Na J, Wang Y, Han B, et al
Initial clinical experience with total Mullerian compartment resection for locally advanced cervical cancer: a single-center preliminary retrospective cohort study and learning-curve analysis.
Front Oncol. 2026;16:1865445.
Abstract

ZHANG J, Chen C, Song H, Li D, et al
NTMT1 (METTL11A) promotes MYC-dependent proliferation and downstream HLA-A suppression in cervical cancer.
Front Immunol. 2026;17:1853434.
Abstract

FAUZIA RP, Rahmani AA, Putri RA, Haryuni RD, et al
Exploring the in-vitro evaluation of folic acid-modified gadolinium nanoparticles in HEK-293, HeLa, and KB cancer cells for targeted-MR-imaging agent candidate.
Sci Rep. 2026;16:24462.
Abstract

ACQUAH-HAGAN G, Boateng D, Boakye K, Idan JS, et al
Family and sexual functioning among women diagnosed with cervical cancer in Urban Ghana: A mixed-methods study.
Womens Health (Lond). 2026;22:17455057261476899.
Abstract

TANAKA S, Yamamoto Y, Yokota K, Yamamoto T, et al
Diagnostic performance of artificial intelligence models trained on scattered single-cell images is not preserved for hyperchromatic crowded cell groups in cervical cytology.
Cancer Cytopathol. 2026;134:e70140.
Abstract

FENG X, He L, Gao Y, Qiu Y, et al
Efficacy and safety of a combination of monoclonal antibodies and chemoradiotherapy for the treatment of locally advanced cervical cancer in Chinese patients: a systematic review and meta-analysis.
Int J Radiat Biol. 2026 Aug 7:1-16. doi: 10.1080/09553002.2026.2710755.
Abstract

LI BY, Fan T, Chen JY, Zhang YH, et al
Internal feasibility evaluation of SAM-Med3D for cervical cancer clinical target volume segmentation on planning computed tomography.
Radiol Phys Technol. 2026 Aug 7. doi: 10.1007/s12194-026-01092.
Abstract

LI X, Pan S, Qu P, Wu D, et al
Burden and temporal trends of cervical cancer in reproductive-age females from 1990 to 2021 and projections to 2035 in G20 countries: a systematic analysis of the Global Burden of Disease Study 2021.
J Gynecol Oncol. 2026 Jul 31. doi: 10.3802/jgo.2027.
Abstract

YOON HY, Jeon HS, Kim MJ, Kim JM, et al
Comparison of Colorimetric LAMP and PCR for High-risk HPV Detection: Implications for Cervical Cancer Screening.
J Low Genit Tract Dis. 2026 Aug 7. doi: 10.1097/LGT.0000000000000976.
Abstract

JAISWAL A, Goyal P, Kumari S, Aggarwal D, et al
Cervical cancer awareness and vaccine hesitancy with respect to HPV vaccination in urban community of Faridabad, Haryana, India.
Clin Exp Vaccine Res. 2026;15:209-215.
Abstract

ARYANPOUR M, Abolghasemi J, Moghadam SMK
Psychosocial predictors of cervical cancer screening intention among female teachers in Karaj, Iran: An integrated behavioral model.
Prev Med Rep. 2026;69:103589.
Abstract

WEI L, Menghui H, Dandan Z, Xin W, et al
HPV-driven metabolic reprogramming promotes T cell exhaustion: targeting immunometabolic barriers with natural products.
Front Immunol. 2026;17:1892919.
Abstract

PROMTHONG C, Navakanitworakul R, Obaun K, Hanprasertpong J, et al
Association between Urinary-Extracellular-Vesicle-Enriched Proteome Dynamics and Oncological Outcomes Following Concurrent Chemoradiation in Locally Advanced Cervical Cancer.
Comput Struct Biotechnol J. 2026;35:0196.
Abstract

HUANG C, Zhang W, Ma X, Li X, et al
Recurrent PIK3CA-E545K mutation promotes cervical cancer growth and invasion via AKT/mTOR signaling.
Mol Genet Genomics. 2026;301:165.
Abstract

UCOK BS, Kinay T, Kusabbi IA, Dereli ML, et al
The association of total oxidant status, total antioxidant status, and ischemia-modified albumin levels with cervical human papillomavirus infection and cervical intraepithelial neoplasia.
Rev Assoc Med Bras (1992). 2026;72:e20252260.
Abstract

BINTABARA D, Kamata CC, Mohamedi R, Konje E, et al
Regional variations and predictors of low uptake of cervical cancer screening among women aged 30-49 years in Tanzania: a geospatial and multilevel analysis of population-based survey.
Res Health Serv Reg. 2026;5:11.
Abstract

KUL KOPRULU T, Erkal Cam B
Aloe vera extract disrupts mitochondrial bioenergetics and suppresses HeLa cervical cancer cell proliferation: Transcriptomic and metabolic insights into cisplatin co-treatment.
J Bioenerg Biomembr. 2026;58:45.
Abstract

MA X, Li Y, Yi S, Chen X, et al
Time-dependent diffusion MRI for differentiating cervical cancer subtypes: impact of ROI delineation strategies on diagnostic performance.
Abdom Radiol (NY). 2026 Aug 6. doi: 10.1007/s00261-026-05721.
Abstract

KISHIMOTO Y, Sasaki M, Otsuka H, Kubo A, et al
Utility of 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in assessing treatment response after chemoradiotherapy for cervical cancer.
J Radiat Res. 2026 Aug 6:rrag060. doi: 10.1093.
Abstract

HOU H, Zhang L, Li C, Liu M, et al
Plasma HPV ctDNA as a dynamic biomarker for treatment response and prognosis in locally advanced cervical cancer: protocol for a prospective cohort study.
Front Oncol. 2026;16:1844938.
Abstract

LI Z, Duan Z, Liu R, Yu S, et al
Morphology-defined bacterial vaginosis and HPV-related cervical screening abnormalities: a two-year real-world study with histopathologic correlation.
Front Cell Infect Microbiol. 2026;16:1890650.
Abstract

QIU L, Li Y, Wang Y, Xie Y, et al
Higher pre-treatment lymphocyte-to-monocyte ratio predicts better tumor shrinkage after external beam radiotherapy in locally advanced cervical cancer.
Front Oncol. 2026;16:1917302.
Abstract

RAHAL ADAWI N, Ben Shachar I
Ethnic Disparity in Cervical Cancer Stage at Diagnosis at a Tertiary Medical Center in Northern Israel: A Retrospective Study.
Isr Med Assoc J. 2026;28:433-437.
Abstract

SHAH K, Du C, Akgul A, Alshammari FS, et al
Modelling the impact of awareness campaigns on HPV transmission dynamics: a neural network-enhanced mathematical model.
Sci Rep. 2026;16:24277.
Abstract

AWAN UA, Zafar N, Khan S
Infodemic preparedness and the 90-70-90 cervical cancer targets.
Lancet Digit Health. 2026 Aug 5:101079. doi: 10.1016/j.landig.2026.101079.
Abstract

AFTABSAVAD S, Arashkia A, Shokrgozar MA, Rahimi AA, et al
mRNA vaccines targeting HPV E6/E7: A new frontier in cervical cancer immunotherapy.
Crit Rev Oncol Hematol. 2026;226:105520.
Abstract

SOUSA R, Fonseca-Moutinho JA, Gomes F, Loureiro F, et al
Invasive Cervical Cancer Detection After Transition to Primary Human Papillomavirus Screening: Population-Based Linkage Study in Portugal.
Acta Med Port. 2026;39:438-447.
Abstract

WATSON JL
The Cancer That Could Disappear.
Clin J Oncol Nurs. 2026;30:252-253.
Abstract

QIN H, Yang N, Wang Q, Tian L, et al
Improving cervical cancer screening uptake through theory-informed education: a comprehensive systematic review and meta-analysis.
Acta Oncol. 2026;65:689-701.
Abstract

RENZAHO AMN, Challam S, Hartcher N, Smith M, et al
Co-Designing Culturally Tailored Bowel, Cervical and Breast Cancer Screening Interventions With Migrant Communities: Towards Closing the Migration-Related Cancer-Equity Gap in New South Wales, Australia.
Health Expect. 2026;29:e70805.
Abstract

CHEBAT A, Pharoun J, Rachid M, Bazzi M, et al
Prevalence and Determinants of Knowledge and Attitudes Toward Cervical Cancer Prevention, Pap Smear Uptake, and Human Papilloma Virus Vaccination Among Lebanese Women.
Womens Health Rep (New Rochelle). 2026;7:26884844261437618.
Abstract

LOU H, Zhou Y, Li D, Zhang H, et al
Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.
Cell Rep Med. 2026 Aug 4:102944. doi: 10.1016/j.xcrm.2026.102944.
Abstract

MI J, Guo W, Li L, Wang S, et al
Single-cell transcriptomics uncovers HPV-driven immune evasion and establishes a TAB2-based prognostic signature in cervical cancer.
Transl Oncol. 2026;72:102935.
Abstract

JALINK M, King WD, Booth CM, Gien LT, et al
The diagnosis to surgery interval and overall survival in patients with cervical cancer.
Cancer Epidemiol. 2026;104:103190.
Abstract

FUKUNAGA C, Hiranuma K, Hirayama T, Yoshida E, et al
Right Ventricular Metastasis From Cervical Cancer Treated With Pembrolizumab-Containing Chemotherapy: A Case Report and Literature Review.
Am J Case Rep. 2026;27:e952931.
Abstract

BEREZA K, Kukielka A, Trojnarska D, Grabarek BO, et al
Correction: Multidimensional assessment of urinary dysfunction and quality of life after cervical cancer treatment: a multicenter study integrating urodynamics and patient-reported outcomes.
Front Oncol. 2026;16:1929623.
Abstract

CAMPANHA NOVAES LA, Oliveira RD, Tegami IL, Santiago Goncalves MF, et al
Brazilian biorepository to support genome-wide association studies of colorectal, breast, and cervical cancer.
iScience. 2026;29:116758.
Abstract

HSIAO KY, Lin HL, Chen CC
Diagnostic Performance of HPV Testing Using Self-Collected Urine and Vaginal Samples for Detecting Cervical Precancer or Worse: A Meta-Analysis.
J Obstet Gynaecol Res. 2026;52:e70434.
Abstract

YIGIT E, Gultekin M, Bayatfard P, Yuce Sari S, et al
The impact of uterine position during brachytherapy on treatment outcomes and toxicity in patients with cervical cancer.
Strahlenther Onkol. 2026 Aug 3. doi: 10.1007/s00066-026-02582.
Abstract

DONG F, Chen D, Shang JF, Fang W, et al
[Diagnostic efficacy and teaching value of artificial intelligence-assisted diagnostic systems in cervical liquid-based cytology screening].
Zhonghua Bing Li Xue Za Zhi. 2026;55:744-751.
Abstract

TEBEJE TM, Metkie KA, Asgedom YS, Gebrekidan AY, et al
Magnitude of human papillomavirus vaccination uptake and its determinants among adolescent girls in Lesotho: a cross-sectional study.
BMJ Open. 2026;16:e110615.
Abstract

LYNN T, Sychareun V, Chaleunvong K, Vongxay V, et al
Integrated service delivery to improve adolescent health and human papillomavirus (HPV) vaccination in Lao PDR: a quasi-experimental mixed-methods study - study protocol.
BMJ Open. 2026;16:e098836.
Abstract

XIAO Y, Yang L, Yu X, Cheng HJ, et al
Efficacy and Safety of Camrelizumab Combined with Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: A Phase II Single-Arm Clinical Trial.
Clin Oncol (R Coll Radiol). 2026;57:104293.
Abstract

JINDAL R, R R, Ghanghas N, Gupta R, et al
Addressing HPV vaccine hesitancy and misinformation in India through public health communication strategies.
Hum Vaccin Immunother. 2026;22:2711551.
Abstract

LIU SQ, Cheng XX, He S, Xia T, et al
Corrigendum to Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis.
J Clin Invest. 2026;136:e209744.
Abstract

LIU L, Du X, Zhao Y, Chen H, et al
Cost-Related Barriers, Mental Distress, and Cervical Cancer Screening Adherence: A BRFSS 2024 Analysis.
J Prim Care Community Health. 2026;17:21501319261475712.
Abstract

ADAM J, Mukuku O, Maseb'a Mwang Sulu S, Nsambi JB, et al
Factors Associated With Cervical Cancer Awareness Among Women of Reproductive Age in the Democratic Republic of the Congo: Evidence From a Nationwide DHS Analysis.
Cancer Rep (Hoboken). 2026;9:e70633.
Abstract

DOWOU RK, Salu S, Takyiwaa JA, Aboagye RG, et al
Residency-Based Inequalities in Cervical Cancer Screening in Sub-Saharan Africa.
Trop Med Int Health. 2026 Aug 2. doi: 10.1111/tmi.70152.
Abstract

SCHLEICHER OM, Dietl AK, Behrens AS, Brueckner L, et al
Regression of high-grade squamous intraepithelial lesions in women aged 30 years or younger: a retrospective cohort study.
J Cancer Res Clin Oncol. 2026;152:152.
Abstract

MAEDA M, Kitai M, Akada M, Shimizu Y, et al
Preoperative prediction of the need for postoperative adjuvant therapy in stage IB cervical cancer using tumor size measured on magnetic resonance imaging and serum squamous cell carcinoma antigen levels.
AJOG Glob Rep. 2026;6:100671.
Abstract

SOLIMAN S, Thomas T, Barker V, Aboujaoude M, et al
Association of Increased MIEN1 Copy Number With Worse Outcomes in Lung Adenocarcinoma and Cervical Cancer.
Cureus. 2026;18:e111880.
Abstract

OLUMODEJI AM, Adefemi AK, Adedeji MO, Edun OQ, et al
RADICAL HYSTERECTOMY FOR EARLY-STAGE CERVICAL CANCER IN A LOWRESOURCE SETTING: SURGICAL OUTCOMES AND LESSONS FROM A RETROSPECTIVE CROSS-SECTIONAL STUDY.
Ann Ib Postgrad Med. 2026;24:39-45.
Abstract

CHEN Y, Wang L, Li S, Huang J, et al
Cross-scale modeling reveals a TFRC-driven immunosuppressive macrophage niche in cervical cancer.
Front Immunol. 2026;17:1872944.
Abstract

VERGALASOVA I, Jiang C, Song T, Lombe D, et al
Editorial: Optimizing radiotherapy for cervical cancer efficacy toxicity and brachytherapy integration.
Front Oncol. 2026;16:1872192.
Abstract

GONZALEZ GMN, Msadabwe S, Njala B, Sakala D, et al
Prior Cervical Cancer Screening, Social Determinants of Health, and HIV Status Among Patients at the Cancer Disease Hospital, Zambia.
Res Sq [Preprint]. 2026 Jul 22:rs.3.rs-10345811.
Abstract

BHAT S, Devi V, Kabekkodu SP
In silico analysis of driver genes in squamous cell carcinoma of the cervix: insights into their biological functions, prognosis, immune infiltration, and therapy.
World J Surg Oncol. 2026;24:324.
Abstract

ABUH SO, Barbora A, Nave V, Ben-Arie A, et al
Attenuated total reflection Fourier transform infrared spectroscopy enables determination of the extent of precancer in cervical conization biopsy.
Sci Rep. 2026;16:24132.
Abstract

DU M, Wei L, Geng M, Wang W, et al
Cervical microbial dysbiosis in single HPV16-positive HSIL.
Sci Rep. 2026;16:23893.
Abstract

MARCADET J, Ayadi S, Mal PA
When pelvic actinomycosis mimics cervical neoplasia: A diagnostic challenge.
J Gynecol Obstet Hum Reprod. 2026;55:103222.
Abstract

LI N, Hu Y, van der Zee AGJ, Schuuring E, et al
PAX1 and ZNF582 Methylation as a Triage Strategy in Cytologic and hrHPV+ Scrapings in Both Chinese and Dutch Cohorts.
Cancer Epidemiol Biomarkers Prev. 2026;35:1411-1420.
Abstract

CHENG J, Yuan H, Su M
Pleural Metastasis as the Only Presentation of Recurrent Cervical Carcinoma on 18F-FDG PET/CT.
Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006545.
Abstract

GUONA Z, Yabin S, Qian D, Yang L, et al
Mixed Large Cell Neuroendocrine Carcinoma and Adenocarcinoma of the Cervix: A Rare Entity.
Int J Surg Pathol. 2026;34:1616-1622.
Abstract

BADIGLIAN-FILHO L, Burnett A, Matak L, Ali O, et al
vNOTES sentinel nodes removal from a remaining cervix.
J Gynecol Obstet Hum Reprod. 2026;55:103189.
Abstract

DE CAMPOS MR, Carvalho LHSB, Campos AJR, Cora GR, et al
Knowledge and Perception of Human Papillomavirus in Quilombola Communities in Northeast Brazil.
Hisp Health Care Int. 2026;24:172-180.
Abstract

OZEN S
Letter to "Human Papillomavirus (HPV) Awareness, HPV-Related Concern, and Fear of Cancer as Predictors of Attitudes Toward Cervical Cancer Prevention in Women".
J Obstet Gynaecol Res. 2026;52:e70465.
Abstract

URQUHART-DUCHARME R, Dias E, Leonard R, Lu N, et al
Eliminating cervical cancer in Canada is within reach.
Can J Public Health. 2026 Aug 14. doi: 10.17269/s41997-026-01240.
Abstract

ALMSAFI T, Ribeiro R, Gilbert L, Leung SOA, et al
Late metastatic recurrence of stage IA1 cervical cancer 12 years after minimally invasive radical hysterectomy.
J Minim Invasive Gynecol. 2026 Aug 14:S1553-4650(26)00440.
Abstract

CARNEIRO FP, da Silva Rios Chen S, de Araujo Oliveira Nakashoji I, Amancio FFC, et al
Impact of HPV vaccination on cervical precancer and invasive cervical cancer twelve years after vaccine introduction in the Brazilian Public Health System.
J Infect Public Health. 2026;19:103326.
Abstract

RAQUE TL, Pointer O, Creegan M, Moody S, et al
"Don't settle": Rural cervical cancer survivors' navigation of cancer care from an intersectional framework.
Womens Health (Lond). 2026;22:17455057261478351.
Abstract

TAVARES MV, Felix MM, Batista de Carvalho AL, Santos IP, et al
Raman microspectroscopy for cervical cancer diagnosis: an ex-vivo cryopreserved tissue analysis.
Am J Cancer Res. 2026;16:2873-2884.
Abstract

JIN X, Zhang Q, Ling X, Liu Y, et al
Actin-related protein 2/3 complex subunit 1B promotes cervical cancer cell tumorigenesis in vitro and in vivo.
Am J Cancer Res. 2026;16:2955-2970.
Abstract

ZHU X, Zhou L, Li R, Shen Q, et al
Expression of Concern: AGER promotes proliferation and migration in cervical cancer.
Biosci Rep. 2026;46:BSR20171329.
Abstract

HE S, Yu G, Peng K, Liu S, et al
[Expression of Concern] MicroRNA?145?5p suppresses fascin to inhibit the invasion and migration of cervical carcinoma cells.
Mol Med Rep. 2026;34:277.
Abstract

KHALED RK, Abd-Rabou AA, Dawy M, Wahba MA, et al
Folic acid-loaded amino-functionalized MCM-41 as a drug delivery system for cervical cancer modulating apoptotic and survival signals.
Sci Rep. 2026;16:25288.
Abstract

LI T, Shi Y, Xu HJ, Zhang YB, et al
[Prevalence of cervical human papillomavirus infection among women in Honghe Hani and Yi Autonomous Prefecture, Yunnan Province, China].
Zhonghua Zhong Liu Za Zhi. 2026;48:943-953.
Abstract

ALLICOCK MA, Costa C, McKenzie AH, Loomba P, et al
Formative Work to Guide Implementation of an Evidence-Based Breast and Cervical Cancer Prevention and Early Detection Behavioral Health Program in Clinics: Qualitative Study Guided by the Consolidated Framework for Implementation Research.
JMIR Form Res. 2026;10:e89393.
Abstract

STRELOW BA, Byom E, Wangen H, Backlund J, et al
Text Messaging as a Tool to Address Language Barriers in Cervical Cancer Screening Among Spanish-Preferred Populations: A Quality Improvement Study.
Cancer Control. 2026;33:10732748261478959.
Abstract

SHASTRI S, Shastri S
Cancer Screening in India: Lessons, Limitations, and Pragmatic Solutions for the Next Decade.
JCO Glob Oncol. 2026;12:e2600018.
Abstract

ZHOU J, Liu F, Gao T, Yang Y, et al
GATA1 knockdown enhances CD8(+) T cell responses and protects against immune escape in cervical squamous cell carcinoma through FGL1 downregulation.
J Mol Histol. 2026;57:269.
Abstract

DERVISEFENDIC PELJTO M, Jahic M
Local carboxymethyl-beta-glucan and polycarbophil therapy is associated with regression of low-grade cervical cytological abnormalities: a prospective observational study.
Med Glas (Zenica). 2026;23.
Abstract

NIEBERLE LS, Dietl AK, Seibold A, Bruckner L, et al
Comparison of Ex-House and In-House Cytology for the New Cervical Cancer Screening Assessment.
Geburtshilfe Frauenheilkd. 2026;86:766-776.
Abstract

PORTILLA V, Mahaluf Recasens F, Bahamonde L
Reconstruction Using Conventional Implants in a Patient With an Acetabular Fracture Due to Cervical Cancer Metastasis: A Case Report.
Cureus. 2026;18:e112600.
Abstract

GIRBOVAN AH, Balan C, Kirsch-Mangu AT, Fischer-Fodor E, et al
Molecular Biomarkers of Radiosensitivity and Radioresistance in Cervical Cancer: A Systematic Review.
Int J Mol Sci. 2026;27:7033.
Abstract

HUANG M, Li S
Basic Clinical Bidirectional Empowerment: Synergistic Breakthrough in Molecular Mechanisms and Clinical Management of Small Cell Cervical Carcinoma.
Int J Mol Sci. 2026;27:6783.
Abstract

TOENNIESSEN-KLEIN SM, Rangno D, Sunil A, Bozko M, et al
Proteomic Analysis of TCGA Data Reveals Limited Prognostic Value of p53 but Suggests BAX as a Potential Survival Marker in Cervical Carcinoma.
Int J Mol Sci. 2026;27:6717.
Abstract

ZENG Z, Chen Y, Meng X, Sun Y, et al
Moderately Hypofractionated Online Adaptive Radiotherapy for Cervical Cancer: A Prospective Study of Feasibility, Acute Toxicity and Dosimetric Benefits.
Cancers (Basel). 2026;18:2493.
Abstract

CAO Y, Wickramage IS, Li C, Tan Y, et al
Image-Guided Adaptive Brachytherapy Using Patient-Specific 3D-Printed Templates for Complex Locally Advanced Cervical Cancer: A Real-World Implementation Study.
Cancers (Basel). 2026;18:2399.
Abstract

WATASHIGE N, Kubo-Kaneda M, Makino M, Kato M, et al
Microbiota-Derived Corisin Is Elevated in Early Cervical Neoplasia and Drives Pathogenic Cellular Programs.
Cells. 2026;15:1358.
Abstract

KABUKYE JK, Koot JAR, Beltman JJ, Nakatumba-Nabende J, et al
Frugal AI is the missing piece in cervical cancer screening.
Nat Med. 2026 Aug 12. doi: 10.1038/s41591-026-04568.
Abstract

QIU J, Xu J, Zhang J, He H, et al
Retraction notice to "Exploring the mechanism by which BXSD decoction treats cervical cancer through the combination of network pharmacology and molecular docking analysis: Molecular mechanism of AKT1 and CASP3 protein" [Int. J. Biol. Macromol. 317 (2
Int J Biol Macromol. 2026 Aug 12:153987. doi: 10.1016/j.ijbiomac.2026.153987.
Abstract

BERNARD C, Thomassin-Naggara I, Campagni L, Carcopino X, et al
Initial staging workup in cervical cancer: clinical examination, imaging, and laboratory assessment - a review from the french cervical cancer guidelines group.
J Gynecol Obstet Hum Reprod. 2026 Aug 12:103255.
Abstract

DEMIRDAG B, Ayhan RM, Keles MN, Ogec H, et al
Effect of human papillomavirus education on human papillomavirus knowledge and gynecologic cancer awareness among women aged 18-49: a randomized controlled study.
Rev Assoc Med Bras (1992). 2026;72:e20260313.
Abstract

JOMAR RT, Alves LA, Meira KC
Sexual orientation and time since last Papanicolaou test in Brazil: the 2019 National Health Survey.
Cien Saude Colet. 2026;31:e16622024.
Abstract

KAMAL S, Qin C, Wang Y, He R, et al
Exploring the molecular basis of Panax notoginseng mediated inhibition of cervical cancer through machine learning, transcriptomics analysis, network pharmacology, molecular docking, and in-silico simulation approaches.
Bioinform Adv. 2026;6:vbag164.
Abstract

DANAN ER, Woodward-Abel AB, Gowdy-Jaehnig A, Friedman JK, et al
Co-production of a conversation guide for HPV-based cervical cancer screening results communication.
Patient Educ Couns. 2026;152:109809.
Abstract

TAN B, Lin S, Wei X, Chen S, et al
Clinical Efficacy and Safety of Pembrolizumab-Based Therapy in Recurrent or Advanced Cervical Cancer: A Systematic Review and Meta-Analysis.
Onco Targets Ther. 2026;19:612659.
Abstract

DE ARAUJO RESENDE LS, Conceicao MS, Jales RM, Pereira PN, et al
Pretreatment CT-defined sarcopenia is associated with worse survival in cervical cancer.
Gynecol Oncol Rep. 2026;66:102174.
Abstract

SAMARANAYAKE S, Thiruthaneeswaran N, Turner S, Vinod S, et al
Benchmarking Cervical Cancer Care Pathways-Measuring Timelines and Identifying Factors Associated With Delay for Women Undergoing Definitive Radiotherapy in New South Wales, Australia.
Aust N Z J Obstet Gynaecol. 2026;66:e70174.
Abstract

DANTAS NMM, Graca A, Soares LC
Conization With Lymph Node Assessment in Early-Stage Cervical Cancer: A Systematic Review and Meta-Analysis.
J Obstet Gynaecol Res. 2026;52:e70411.
Abstract

KUSUMA F, Glenardi G, Winarto H, Nuranna L, et al
Effectiveness of different educational interventions on knowledge, attitude and willingness to undergo cervical cancer screening in rural Indonesia: a quasi-experimental study.
BMJ Open. 2026;16:e103814.
Abstract

INTURRISI F, Yuma S, Mchome B, Mremi A, et al
Challenging the assumption that experience- and training-related factors improve accuracy of cervical cancer screening image interpretation: Evidence from Tanzania.
PLOS Glob Public Health. 2026;6:e0007074.
Abstract

LIU C, Liu Z, Dong C, Jiang X, et al
USP1 Promotes Malignant Progression of Cervical Cancer Cells by Deubiquitinating and Stabilizing ATG13 to Enhance Autophagic Activity.
J Biochem Mol Toxicol. 2026;40:e71060.
Abstract

SENIAN AA, Noni V, Jerip AR, Bong ACS, et al
Evaluation of Sample Pooling Strategies for Point-of-Care HPV DNA Testing Using the STANDARD M10 Platform.
J Med Virol. 2026;98:e71101.
Abstract

WANG X, Song F, Lin Y, Wu A, et al
Nutritional Support Needs of Cervical Cancer Patients Undergoing Chemoradiotherapy: A Qualitative Study.
Int J Womens Health. 2026;18:609685.
Abstract

TAKEMURA H, Taki M, Okamoto H, Ikeda A, et al
Reproductive and Perinatal Outcomes After Trachelectomy: Vaginal Microbiota and Early Preterm Birth.
J Obstet Gynaecol Res. 2026;52:e70437.
Abstract

SUGITA C, Nakamura Y, Yoshimoto Y, Fujiwara S, et al
[Cervical cancer metastasis to the lumbosacral spinal root: a case report].
Rinsho Shinkeigaku. 2026 Aug 7. doi: 10.5692/clinicalneurol.cn-002272.
Abstract

ALESHIRE M, Huffines R, Tinman JS, Croghan A, et al
Acceptability of At-Home hrHPV Cervical Cancer Screening For Transmasculine Individuals: A Qualitative Descriptive Study.
West J Nurs Res. 2026 Aug 9:1939459261464522. doi: 10.1177/01939459261464522.
Abstract

DE RIDDER LA, Zusterzeel PLM, Kruse AJ
Clinician-perceived clinical accuracy and guideline alignment of ChatGPT responses to patient questions on HPV and CIN: a two-year comparative evaluation.
Int J Med Inform. 2026;220:106636.
Abstract

GYAMFI-SAMAKOME A, Nimo FA, Odoom E, Nabe B, et al
Impact of health education intervention on knowledge and attitude towards HPV vaccination in Africa: A systematic review.
Vaccine. 2026;88:128930.
Abstract

CHEN J, Li J, Wu J, Li Y, et al
The Impact of Surgery and Survival Prediction on Patients with Locally Advanced Gastric-type Endocervical Adenocarcinoma: A Population-Based Cohort Study.
Ann Surg Oncol. 2026;33:8369-8379.
Abstract

JIA Q, Liu J, Xu T, Zhao P, et al
COL6A3 drives tumor progression and predicts prognosis in cervical squamous cell carcinoma.
Pathol Res Pract. 2026;286:156612.
Abstract

UNER FO, Korukcu O
Rapid Reduction in Cancer Worry Through a Mindfulness-based Coping Programme: Evidence from a Randomised Trial with Women Awaiting Biopsy Results.
Semin Oncol Nurs. 2026;42:152284.
Abstract

YANG H, Gao X, Zhang R, Pei C, et al
Personal vs professional HPV vaccination and screening among female healthcare workers in China.
Vaccine. 2026;88:128879.
Abstract

ALAMGIR M, Randimbivololona J, Patelisio PN, Tukia O, et al
Behavioural and social drivers of HPV vaccine uptake in Tonga: a mixed-methods study using the WHO BeSD framework and Talanoa in a Pacific Island setting.
Vaccine. 2026;88:128843.
Abstract

OSEI-NTIAMOAH B, Apau-Danso PKA, Iddrisu M, Osae-Larbi J, et al
Prevalence of cervical human papillomavirus infection among women in Ghana: a systematic review and meta-analysis.
BMC Public Health. 2026;26:2325.
Abstract

ZHANG W, Li D, Liu S, Tang J, et al
CFD overexpression inhibits CESC progression and enhances TIL therapy efficacy via NOSTRIN and eNOS signaling pathway.
Sci Rep. 2026;16:25173.
Abstract

ALZAYADNEH E, Dibbern ME, Rabban J, Fadare O, et al
HER2 and FOLR1 Expression in Mesonephric and Mesonephric-Like Adenocarcinomas in the Gynecologic Tract.
Int J Gynecol Pathol. 2026;45:349-357.
Abstract

SALAZAR-HUAYNA L, Acosta U, Centeno Mediavilla MC, Serra M, et al
HPV Methylation as a Marker of Progression to High-Grade Squamous Intraepithelial Lesions (HSIL) in Patients With Negative Cytology/ASCUS and High-Risk HPV Positive.
Int J Gynecol Pathol. 2026;45:377-382.
Abstract

NIIYAMA T, Kido A, Kawabe H, Himoto Y, et al
Progressive MRI changes in lobular endocervical glandular hyperplasia suggesting malignant transformation: report of two cases with histopathologic correlation.
Abdom Radiol (NY). 2026;51:4544-4550.
Abstract

KUBAI WK, Odongo AO, Rithaa GK
Awareness, knowledge, and cervical cancer screening behaviour in an urban informal settlement: Evidence from multinomial and interaction models.
PLOS Glob Public Health. 2026;6:e0007013.
Abstract

LI Y, Wang Y, Kang Y, Luo F, et al
A Multimodal Graph Neural Network Based on MRI Radi-omics for Prognostic Prediction in Locally Advanced Cervical Squamous Cell Carcinoma.
Cancer Control. 2026;33:10732748261480328.
Abstract

ZONDI S, Mogale M, Khalongo E
Knowledge of cervical cancer screening, barriers to awareness, and the role of technological interventions in improving screening uptake: a scoping review protocol.
Front Health Serv. 2026;6:1857077.
Abstract

LIU W, Yin H, Wang B, Li Z, et al
Restriction spectrum imaging and diffusion kurtosis imaging for evaluating proliferation status in cervical cancer.
Front Med (Lausanne). 2026;13:1855242.
Abstract

ABICH K, Masrour R, Akouibaa A, Benhamou M, et al
Numerical study of the optimization of theranostic performance of (Au/SiO(2)/Au) spherical gold nanomatryoshkas for cervical cancer through structural tuning: Comparative analysis in healthy and infected tissues.
Nanomedicine. 2026 Aug 20:103010. doi: 10.1016/j.nano.2026.103010.
Abstract

YAN T, Muhebuli M, Ablise M, Mulati S, et al
Discovery of novel Quinazoline-chalcone hybrids as dual VEGFR-2/P-gp inhibitors to reverse cisplatin resistance in cervical Cancer.
Bioorg Chem. 2026;181:110411.
Abstract

FREY M, Lapp L, Swander L, Zhang RC, et al
Persistent Racial, Ethnic, and County-Level Disparities in Invasive Cervical Cancer Incidence in Wisconsin, 1998-2022.
WMJ. 2026;125:383-387.
Abstract

ZHANG Y, Abuduwufu S, Zhuo Q, Zhang J, et al
Transcription Factor ELF3 Promotes Cervical Cancer Progression via Transcriptional Upregulation of GMPS.
Mol Carcinog. 2026 Aug 20. doi: 10.1002/mc.70167.
Abstract

ZHAO Y, Wang N, Ma C, Tian S, et al
Intravoxel incoherent motion imaging with improved image quality by deep learning reconstruction for prediction of lymph-vascular space invasion in patients with cervical cancer.
Abdom Radiol (NY). 2026 Aug 20. doi: 10.1007/s00261-026-05725.
Abstract

DAWUTI R, Yao L, Wutikuer M, Liu X, et al
Combining Statistical Modeling and Machine Learning for Prognostic Feature Selection in Cervical Cancer: A Retrospective Study Based on SEER 2004 to 2015 Data.
Am J Clin Oncol. 2026 Aug 24. doi: 10.1097/COC.0000000000001364.
Abstract

JONES TE, Matsko J, Wu D, Zeng X, et al
Assessment of atypical glandular cell interpretation in Pap tests using the Hologic Genius Digital Diagnostics System.
Cancer Cytopathol. 2026;134:e70148.
Abstract

WU YL, Ho CW, Liou WS, Yin CH, et al
The Choice Between Definitive Radiotherapy and Surgery for Cervical Cancer With Different Histology in Current Clinical Practice.
Kaohsiung J Med Sci. 2026 Aug 20:e70272. doi: 10.1002/kjm2.70272.
Abstract

HE Y, Zhao Y, Ju S, Zhou P, et al
The microbiota-host metabolic axis in cervical cancer: from homeostatic disruption to mechanisms of therapy resistance.
Front Cell Infect Microbiol. 2026;16:1890330.
Abstract

DOE Y, Aboelata N, Alvarez-Nutting M, Golden D, et al
Improving Cervical Cancer Screening Participation Through Human Papillomavirus Self-Sampling: A Scoping Review of Evidence in Underserved Populations.
Womens Health Rep (New Rochelle). 2026;7:26884844261469765.
Abstract

ICHIDA K, Yamamoto K, Suzuki Y, Mitsuoka M, et al
Real-world efficacy and safety of cemiplimab in Japanese patients with recurrent or metastatic cervical cancer: A single-center retrospective cohort study.
Gynecol Oncol Rep. 2026;66:102185.
Abstract

KONG X, Zhang B, Zhang G, Xiao H, et al
Platform-specific comparison of IMRT and VMAT angular resolution for Ethos-based online adaptive radiotherapy in cervical cancer.
Front Oncol. 2026;16:1888330.
Abstract

STEINKASSERER L, Wilhelm LM, Schambach J, Schaffler H, et al
Analysis of the temporal changes in management of early-stage cervical cancer over a 10-year period in Germany: a multicenter retrospective analysis of the JAGO/NOGGO.
Front Oncol. 2026;16:1916573.
Abstract

RETRACTION: MicroRNA-374b Inhibits Cervical Cancer Cell Proliferation and Induces Apoptosis Through the p38/ERK Signaling Pathway by Binding to JAM-2.
J Cell Physiol. 2026;241:e70217.
Abstract

NUMMINEN E, Louvanto K
Host Characteristics and Genotype-Specific Risks of Human Papillomavirus in Cervical Cancer Screening (Reply to Letter-to-the-Editor).
Am J Obstet Gynecol. 2026 Aug 19:S0002-9378(26)00423.
Abstract

SINHA N
Digital health information: Validity and reliability check of Hindi YouTube videos on cervical cancer.
Indian J Cancer. 2026 Aug 18. doi: 10.4103.
Abstract

SUZUKI T, Yoshikawa N, Kamiya C, Katayama K, et al
Post-CCRT pelvic lymph node size and pathological nodal involvement in cervical cancer.
Int J Clin Oncol. 2026 Aug 19. doi: 10.1007/s10147-026-03174.
Abstract

HO HTT, Phan TT, Nguyen KT, Nguyen HH, et al
Agreement Between the CerviCARE AI Artificial-Intelligence Software and Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Women Aged Over 18 Years in Vinh Long Province, Vietnam: A Community-Based Cross-Sectional Study.
Int J Womens Health. 2026;18:637592.
Abstract

LU M, Fan Y, Guo S, Yao L, et al
Circ_0070190 suppresses the malignant progression of cervical cancer by sponging miR-587.
J Mol Histol. 2026;57:277.
Abstract

ELDIEN A, Hankins L, Neilson T, Jacobson I, et al
Rural-Urban Differences in Cervical Cancer Screening Patterns: A Cross-Sectional Analysis of the 2021 National Health Interview Survey (NHIS).
J Rural Health. 2026;42:e70210.
Abstract

YANG MQ, Huang P, Song YR, Wu YZ, et al
Exosomal hnRNPA1-delivered miR-27a-3p inhibits the radiation-induced bystander effect in cervical cancer.
Precis Radiat Oncol. 2026 Aug 17:10.1002/pro6.70084. doi: 10.1002/pro6.70084.
Abstract

DEHGHANI T, Hosseini SM, Dorazehi J, Nazari SE, et al
In vivo assessment of imoxide and diluted vitamin C's inhibitory effects on cervical cancer in mice.
Iran J Basic Med Sci. 2026;29:971-978.
Abstract

LIU H, Zhang Z, Xu J, Li J, et al
Commentary: Efficacy and safety of adding immune checkpoint inhibitors to standard chemotherapy or chemoradiotherapy for advanced or recurrent cervical cancer: a meta-analysis.
Front Immunol. 2026;17:1902016.
Abstract

IBRAHIM FM, Ibrahim AM, Dabou EAR, Elhameed SA, et al
HPV prevention awareness, vaccination willingness, and vaccine-related perceptions among middle-school girls in three Arab countries: an exploratory online survey.
Front Public Health. 2026;14:1902409.
Abstract

KOU H, Li Q, Hu X, Yue K, et al
Changes in Depressive Symptoms Following Mindfulness Training in Female Patients With Abdominal or Abdominopelvic Cancer: A Preliminary Non-Randomized Controlled Study.
Psychooncology. 2026;35:e70585.
Abstract

ZHAO G, Xu J, Liu G, Li S, et al
Construction and Validation of a Risk Prediction Model for Lower Limb Lymphedema After Cervical Cancer Surgery: A Prospective Cohort Study.
Cancer Med. 2026;15:e72194.
Abstract

KITA M, Butsuhara Y, Mizokami T, Murata H, et al
Endoscopy-assisted precise radical hysterectomy and perioperative chemotherapy for locally advanced cervical cancer: feasibility and clinical outcomes compared with radiotherapy.
Jpn J Clin Oncol. 2026 Aug 18:hyag132. doi: 10.1093.
Abstract

GAIDHANE AS, Malvika AM, Vasava M, Kevlani V, et al
Network pharmacology, molecular docking, and dynamics simulation reveal multi-target mechanisms of Mesua ferrea linn phytochemicals against cervical cancer.
Comput Biol Chem. 2026;125:109322.
Abstract

LEINO A, Numminen E, Fonagy V, Paloniemi M, et al
Improving cervical screening risk stratification through extended human papillomavirus genotyping and age-specific data.
Eur J Public Health. 2026;36:ckag139.
Abstract

WANG Q, Xu W, Feng L, Ling P, et al
Regulating the activity of cervical cancer cells through electrochemical modulation of membrane-surface redox states.
Chem Commun (Camb). 2026 Aug 17. doi: 10.1039/d6cc04339.
Abstract

DHILLON SK, Latsuzbaia A, Vandenbroeck D, Pretet JL, et al
Clinical Validation of the Sansure Human Papillomavirus DNA Diagnostic Kit for Use in Primary Cervical Cancer Screening.
J Med Virol. 2026;98:e71106.
Abstract

CUELLAR S, Lay L, Silva MRD, Martinez NS, et al
[Electrochemotherapy for the treatment of perianal carcinoma concomitant with cervical carcinoma].
Medicina (B Aires). 2026;86:1067-1071.
Abstract

PILCO J, Cabezas C, Samaniego L, Sinchiguano G, et al
A COMPARATIVE ANALYSIS OF TRENDS IN CERVICAL CANCER MORTALITY AMONG MESTIZO AND INDIGENOUS WOMEN IN ECUADOR, 2010-2024.
Georgian Med News. 2026;:90-95.
Abstract

FERNANDEZ-DEAZA G, Ortiz N, Salazar A, Parra A, et al
Participation and Follow-Up Compliance in Cervical Cancer Screening According to Delivery Strategy for HPV Self-Collection: A Community Trial in Underserved Colombian Areas.
Cancer Med. 2026;15:e72171.
Abstract

STEINBERG B, Paul R, Copeland M, Herrick C, et al
Cervical Cancer Screening Preferences in Transgender, Nonbinary, and Gender-diverse Patients.
O G Open. 2026;3:e196.
Abstract

SUN Y, Zhang J, Guo L, Zhang J, et al
BUB1 regulates cell proliferation and apoptosis in cervical cancer by AKT signaling and autophagosome-lysosome fusion via ACTN1.
iScience. 2026;29:117040.
Abstract

ZUNDONG Y, Xiaoxue L, Rodewald L, Fuzhen W, et al
Entering into life-course immunization: Process, significance, and prospects of HPV vaccine inclusion into the national immunization program of China.
Vaccine. 2026;89:129000.
Abstract

PALANDE V, Zhang T, Smith KN, Levinson K, et al
Exploration of immune correlates of viral clearance after PVX2 immunotherapy in patients with human papillomavirus type 16 infection and cervical intraepithelial neoplasia grade
J Virol. 2026;100:e0064326.
Abstract

SPURGEON ME
The cervicovaginal microbiome: an emerging determinant of HPV infection and disease.
J Virol. 2026 Jul 23:e0170625. doi: 10.1128/jvi.01706.
Abstract

TRAN PL, Hcini N, Chevallier L, Vieille P, et al
[Specificity in the management of gynecological cancers in French overseas departments].
Bull Cancer. 2026;113:1025-1037.
Abstract

JUNEJA S, Bhati BS
MedFusionNet: A hybrid transformer-based multimodal deep learning framework for chronic disease prediction in women's health.
Comput Med Imaging Graph. 2026;134:102795.
Abstract

CHEN W, Gu X, Cai L, Tang J, et al
Ultrasensitive detection of HPV-associated lower genital tract lesions using a NIR-excited luminescent assay with lanthanide-doped upconversion nanoprobes and enzymatic digestion protection.
Talanta. 2026;310:130139.
Abstract

DIELEMAN M, Vermeulen KM, Siebers AG, Wisman BA, et al
Young women with (pre)malignant cervical disease in northern Netherlands: what characterises them - A population-based cohort study.
BMC Womens Health. 2026;26:404.
Abstract

LE BONNIEC A, Woods S, McGlacken T, O'Connor M, et al
What are the views and experiences of human papillomavirus (HPV) self-sampling for cervical screening in high-income countries? A qualitative systematic review using the Theoretical Domains Framework.
BMC Public Health. 2026;26:2382.
Abstract

WEI X, Huang X, Huang Y, Yang X, et al
Co-detection of human papillomavirus and human herpesvirus in women from Yunnan, China: associations with cervical lesion severity.
BMC Infect Dis. 2026;26:1499.
Abstract

DUTTA M, Manguri C, Lalrothuama, Taye M, et al
Promoter methylation of APC, P16, and WT1 genes among high-risk HPV infected women of North-Eastern states of India.
Indian J Med Microbiol. 2026;62:101118.
Abstract

BROND M, Christensen T, Randrup TH, Tarpo CL, et al
The role of misclassification in progression of cervical intraepithelial neoplasia grade 2 during active surveillance: results from a historical cohort.
Am J Obstet Gynecol. 2026;235:584-593.
Abstract

HAM A, Harakeh Z, Kasmi S, Gidaly D, et al
Enhancing Participation in Population Based Cancer Screening: Culturally Sensitive Approaches for Underserved Women.
J Transcult Nurs. 2026;37:748-755.
Abstract

BONVICINI L, Iorio G, Ghirotto L, Auzzi N, et al
The co-creation of a document to guide the use of self-sampling for human papillomavirus screening in Italy.
J Med Screen. 2026;33:163-171.
Abstract

CULLIMORE VA, Dean T, Chu K, Brentnall A, et al
Comparison of Cervical Screening at 6- and 12-Weeks Postnatal: A Paired-Sample Feasibility Study.
BJOG. 2026;133:1857-1865.
Abstract

QI J, Nie G
Human papillomavirus 42: from a low-risk genotype to a potentially oncogenic virus.
Clin Exp Dermatol. 2026;51:1604-1610.
Abstract

KEMP E, Sim J, Chew-Graham CA, Finney AG, et al
Acceptability of, and preference for, human papillomavirus self-sampling for physically Disabled women: A cross-sectional survey.
J Med Screen. 2026;33:172-179.
Abstract

OZTURK KELES F, Korkmaz I, Dogan E, Hakverdi S, et al
Our clinical experience in pelvic magnetic resonance imaging with vaginal contrast.
Ginekol Pol. 2023;94:198-202.
Abstract

HARINATH L, Bai X, Minkowitz J, Zeng X, et al
Artificial Intelligence in Gynecologic Cytology.
Acta Cytol. 2026;70:52-71.
Abstract

KHOLOVA I
Not Enough Cells: How Insufficient Cytological Specimens Are Mirrored by Reporting Systems - Journey from the Bethesda to the WHO Reporting Systems.
Acta Cytol. 2026;70:72-83.
Abstract

EDVARDSSON H, Dillner J
Human Papillomavirus Primary Screening and Collaboration in Quality Assurance Work between Laboratories.
Acta Cytol. 2026;70:46-51.
Abstract

LONGATTO-FILHO A, Schmitt FC
Ongoing Challenges in Maintaining the Diagnostic Quality of Cervical Cytopathology: Is It Possible to Minimize Differences in Morphological Interpretations?
Acta Cytol. 2026;70:40-45.
Abstract

MARTINS TR, Witkin SS, de Oliveira RL, Gadelha JGS, et al
EVALUATION AND RECOMMENDATIONS TO MODERNIZE CERVICAL CANCER DETECTION AND PREVENTION PROGRAMS IN BRAZIL: CHALLENGES AND OPPORTUNITIES - A NARRATIVE REVIEW.
Acta Cytol. 2026 Mar 9:1-20. doi: 10.1159/000550725.
Abstract

BOHMER G, Stolte C, Vogelmann T, Schubert T, et al
Liquid-based cytology in cervical cancer screening: A systematic review and meta-analysis.
Acta Cytol. 2026 May 16:1-22. doi: 10.1159/000551747.
Abstract

KAYA FM, Ersoz S, Comba C, Demir O, et al
Comparison of Cytological and/or Histopathological Results of Patients with Single and Multiple HPV Positivity.
Acta Cytol. 2026;70:393-402.
Abstract

EBNER C, Purtscheller R, Feroz B, Rieker J, et al
Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study.
Acta Obstet Gynecol Scand. 2025 Dec 21. doi: 10.1111/aogs.70106.
Abstract

KNUDSEN AS, Randrup TH, Kesmodel US, Booth BB, et al
Negative margins and negative HPV tests after large loop excision of the transformation zone: A nationwide historical cohort study.
Acta Obstet Gynecol Scand. 2026;105:186-194.
Abstract

ERIKSEN DO, Krog L, Ostenfeld EB, Jensen PT, et al
HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression.
Acta Obstet Gynecol Scand. 2026;105:377-385.
Abstract

KALLIALA I, Milerad H, Trope AEC, Hammer A, et al
Why do the Nordic countries allow colposcopy to be a weak link in the cervical cancer screening chain?
Acta Obstet Gynecol Scand. 2026 Feb 17. doi: 10.1111/aogs.70166.
Abstract

HELLSTEN C, Forslund O, Borgfeldt C
Real-world evaluation of a population-based vaginal self-sampling program for cervical cancer prevention in Region Skane, Sweden.
Acta Obstet Gynecol Scand. 2026 Apr 8. doi: 10.1111/aogs.70206.
Abstract

ALAREF G, Petersen LK
Accuracy of human papillomavirus testing in detecting persistent or recurrent disease at follow-up after conization.
Acta Obstet Gynecol Scand. 2026;105:960-968.
Abstract

KYLLONEN S, Saloranta S, Kares S, Mustila A, et al
Introducing self-sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland.
Acta Obstet Gynecol Scand. 2026 Jun 4. doi: 10.1111/aogs.70273.
Abstract

ASSIRLIKIAN S, Mancini J, Philip CA, Canlorbe G, et al
Predictive factors for the absence of high-grade intraepithelial lesions in LLETZ specimens following a prior histological diagnosis.
Acta Obstet Gynecol Scand. 2026;105:1240-1246.
Abstract

BERTELSEN VM, Booth BB, Tranberg M, Petersen LK, et al
Assessing the clinical value of cervical biopsies in individuals with transformation zone type 3 at colposcopy: A cross-sectional study.
Acta Obstet Gynecol Scand. 2026;105:1597-1606.
Abstract

HANSEN J, Maclin BJ, Folmann B, Moller JE, et al
Women's experiences, responses, and coping strategies when testing positive for human papillomavirus in cervical cancer screening: A qualitative study.
Acta Obstet Gynecol Scand. 2026 Jul 27:10.1111/aogs.70311.
Abstract

AARNIO R, Ahuja V, Ryen L, Bergengren L, et al
Balancing diagnostic accuracy and cost in the follow-up of histological low-grade squamous intraepithelial lesions.
Acta Obstet Gynecol Scand. 2026;105:1871-1878.
Abstract

WANG M, Fan J, Mu B, Zeng Y, et al
HDAC5 stabilization by tubeimoside I suppresses cervical cancer metastasis via inhibiting H3K27ac/KPNA2 axis.
Br J Cancer. 2026 Jan 8. doi: 10.1038/s41416-025-03328.
Abstract

BOWDEN SJ, Ellis LB, Cuming T, Brogden D, et al
Multizonal intraepithelial neoplasia of the lower genital tract and anus in women: terminology for defining the disease, an introduction by the British Society for Colposcopy and Cervical Pathology (BSCCP), International Anal Neoplasia Society (IANS),
Br J Cancer. 2026;134:177-184.
Abstract

BARRAUD S, Roussel-Simonin C, Pautier P, Italiano A, et al
Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC).
Br J Cancer. 2026 May 19. doi: 10.1038/s41416-026-03438.
Abstract

ELLIS LB, Bowden SJ, Paraskevaidi M, Lyons D, et al
Methylation biomarkers in non-regressive cervical intraepithelial neoplasia grade 2 lesions: an epigenome wide association study.
Br J Cancer. 2026;135:118-126.
Abstract

LAWRENCE L
Adjuvant chemoradiation offers minimal survival improvements over radiation alone in intermediate-risk, early cervical cancer: Chemoradiation has become the standard of care for patients with locally advanced cervical cancer as well as high-risk featu
Cancer. 2026;132:e70207.
Abstract

TAMRAKAR VK, Sharma K, Singh P, Bhargava A, et al
Cervical cancer elimination in India: Repurposing diagnostics, vaccination, and accelerating policy for the 2030 target.
Cancer. 2026;132:e70292.
Abstract

BONLOKKE S, Stougaard M, Sorensen BS, Parner E, et al
Ultrasensitive next-generation sequencing-based detection of circulating human papillomavirus DNA for cervical cancer recurrence monitoring.
Cancer. 2026;132:e70282.
Abstract

HAN K
Advancing molecular residual disease detection in cervical cancer through next-generation sequencing of circulating human papillomavirus DNA.
Cancer. 2026;132:e70352.
Abstract

LAWRENCE L
HRSA recommends offering self-collection for cervical cancer screening.
Cancer. 2026;132:e70369.
Abstract

ARENA L, Alizai Q, Elemosho A, Chatzipanagiotou OP, et al
Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.
Cancer. 2026;132:e70462.
Abstract

SANDOVAL TA, Li Y, Muhammad N, Desai T, et al
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.
Cancer Res. 2026 Mar 20:OF1-OF18. doi: 10.1158/0008-5472.CAN-25-3776.
Abstract

KLOPP AH
Longitudinal Profiling of Cervical Cancers Reveals Therapy-Induced Vulnerabilities Beyond the Checkpoint.
Cancer Res. 2026;86:1540-1542.
Abstract

BAUDIN L, Zanella L, Lebeau A, Pleyers C, et al
Non-metastatic para-aortic lymph node remodeling as a predictor of outcome in locally advanced cervical cancer.
Clin Cancer Res. 2026 Mar 4. doi: 10.1158/1078-0432.CCR-25-3894.
Abstract

DE ARAUJO PONTES TH, de Souza ATB, Mendes-Aguiar CO, Silva MDPSNME, et al
Cervical Cytokine Profile in High-Grade Squamous Intraepithelial Lesions.
Cytopathology. 2026;37:523-530.
Abstract

ELEUTERIO JUNIOR J, de Souza VAA, Eleuterio RMN
Psammoma Bodies in Cervical Liquid-Based Cytology of a Kyleena User.
Cytopathology. 2026;37:564-565.
Abstract

TOYODA S, Morita K, Sado T
Metaplastic-Like and Squamous Cell Carcinoma-Like Cells in Liquid-Based Cytology Associated With Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
Cytopathology. 2026;37:560-563.
Abstract

GRANADOS R, Duarte JA, Lujan DR, Gutierrez-Pecharroman AM, et al
RNA Extended Interventional Nucleic Acid (REINA) Longitudinal Study: Decreased Risk of CIN2+/CIN3+ With Low-Grade Cytology After A Previous Negative HPV Test.
Cytopathology. 2026;37:531-537.
Abstract

QIN Y, Gao H, Liao Y, Wu K, et al
From HSIL to SCC: A Real-World Analysis of Diagnostic Upgrade Pathways and Pitfalls in Cervical Cytology.
Cytopathology. 2026;37:538-543.
Abstract

JEONG Y
Cervical Small Cell Neuroendocrine Carcinoma Initially Detected on Cytology: Diagnostic Pitfalls and Clues.
Cytopathology. 2026;37:555-559.
Abstract

TERZIOGLU HG, Aragao A, Barroeta JE
"Atypical Glandular Cells" on Cervical Cytology: Correlation Between Glandular Cell Component Volume and Histological Follow-Up.
Diagn Cytopathol. 2026;54:71-77.
Abstract

OZDEMIR CY, Marangoz B, Ozdemir N, Cicekli N, et al
Clinical Outcomes and Risk Implications of HPV 31 Infection: A 10-Year Retrospective Cohort Study.
Diagn Cytopathol. 2026;54:167-172.
Abstract

HARINATH L, Matsko J, Colaizzi A, Elishaev E, et al
Morphologic Evaluation of Hyperchromatic Crowded Groups Present in Cervical Thin Prep Cytology Tests as Identified by the Hologic Genius Digital Diagnostics System: A Descriptive Study.
Diagn Cytopathol. 2026;54:173-183.
Abstract

ZHOU S, Chen S, Xu S
Establishment of a Methodology for PAX1 and CADM1 Methylation Detection and Preliminary Assessment of Its Clinical Value for Cervical Cancer Diagnosis.
Diagn Cytopathol. 2026 Apr 16. doi: 10.1002/dc.70123.
Abstract

OLSON K, Kucher E, Rasmussen A, Selvaggi SM, et al
Unsatisfactory ThinPrep Pap Tests: An Educational Approach to Quality.
Diagn Cytopathol. 2026;54:444-448.
Abstract

YILDIZ BE, Koc N
Cytomorphologic Findings Associated With High-Risk HPV Categories in PAP Smears.
Diagn Cytopathol. 2026;54:637-643.
Abstract

KONG Y, Cao T, Pan Q, Zhao D, et al
Basaloid Squamous Cell Carcinoma of the Uterine Cervix: An Often Aggressive Subtype Frequently Underestimated by Cytology.
Diagn Cytopathol. 2026 May 14. doi: 10.1002/dc.70145.
Abstract

SCHEVENHOVEN VJC, Jansen EEL, Siebers AG, de Kok IMCM, et al
Long-term cervical cancer risk following negative hrHPV-based versus negative cytology-based screening: A population-based study.
Eur J Cancer. 2026;237:116601.
Abstract

ELLIS LB, Tighe J, Bowden SJ, Kechagias KS, et al
Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis.
Eur J Cancer. 2026;243:116823.
Abstract

MEEK JM, van Luijk IF, Gorris MAJ, Coens C, et al
Neoadjuvant chemotherapy reduces regulatory T-cells in cervical cancer.
Eur J Cancer. 2026;246:116984.
Abstract

LUO MY, Williams CYK
Application and validation of AI-driven methods to explore patient experiences of pre-cervical cancer.
Eur J Obstet Gynecol Reprod Biol. 2026;318:114953.
Abstract

CHATTERJEE R, Nobbenhuis M, Kasius J, Kaur M, et al
Robotic indocyanine green-guided sentinel lymph node mapping in early-stage cervical cancer: The fluorescent robotic indocyanine endoscopic node detection series (FRIENDS).
Eur J Obstet Gynecol Reprod Biol. 2026;318:114927.
Abstract

ANAND A, Mala YM, Tyagi S, Sharma P, et al
Knowledge, awareness and practices regarding human papillomavirus vaccine amongst secondary school girls and mothers in North India.
Eur J Obstet Gynecol Reprod Biol. 2026;318:114945.
Abstract

WU SG, Hong SS, Tang YL, Zhou J, et al
Survival trends among patients with newly diagnosed stage IVB cervical cancer before and after the approval of bevacizumab and immunotherapy.
Eur J Obstet Gynecol Reprod Biol. 2026;321:115045.
Abstract

OSAWA N, Chikazawa K, Ko H, Kuwata T, et al
Follow-up by resident physicians is associated with underuse of hormone replacement therapy after cervical cancer treatment: A retrospective study.
Eur J Obstet Gynecol Reprod Biol. 2026;323:115170.
Abstract

FLANNELLY G, Leeson S, Jariene K, Kesic V, et al
The importance of quality assurance in colposcopy in the elimination of cervical cancer: A position paper by the European Federation for Colposcopy.
Eur J Obstet Gynecol Reprod Biol. 2026;324:115238.
Abstract

LIU F, Wang L, Sun Q, Jing S, et al
Adverse events associated with immune checkpoint inhibitors in cervical cancer: A systematic review and meta-analysis of randomized controlled trials.
Eur J Obstet Gynecol Reprod Biol. 2026;324:115263.
Abstract

SHIN S, Yeo D, Kim H, Son Y, et al
Age-specific burden of cervical cancer and attributable risk factors in Asia, 1990-2023: A global burden of disease study 2023.
Eur J Obstet Gynecol Reprod Biol. 2026;326:115363.
Abstract

VERVALCKE J, Decaestecker K, Barouti K, Weyers S, et al
Genital human papillomavirus detection in self-samples from transgender men.
Eur J Obstet Gynecol Reprod Biol. 2026;325:115344.
Abstract

HANEDAN C, Nur Inal A, Koksal OK, Baydemir SK, et al
vNOTES vs laparoscopic hysterectomy following conization with positive surgical margins: Surgical outcomes and postoperative HPV results.
Eur J Obstet Gynecol Reprod Biol. 2026;325:115343.
Abstract

DAMEN JAA, Hoogendam JP, Idema DL, Lokerse ME, et al
Macroscopic prediction of cervical dysplasia at colposcopy for see-and-treat patient selection: a systematic review.
Eur J Obstet Gynecol Reprod Biol. 2026;325:115330.
Abstract

HIJONA ELOSEGUI JJ, Hijona TR, Blanco AO, Carballo Garcia AL, et al
Brushing versus curettage: Which is the best sampling mode in potmenopausal women with suspected endocervical pathology?
Eur J Obstet Gynecol Reprod Biol. 2026;325:115290.
Abstract

TANG W, Wang L, Li X, Yan X, et al
Radiation-induced acquired expression of PD-L1 and reprogramming of the tumor microenvironment in cervical cancer.
Gynecol Oncol. 2026;205:17-26.
Abstract

KIM SI, Kim JW, Kwon JS, Ferguson SE, et al
Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.
Gynecol Oncol. 2026;205:37-45.
Abstract

NISHA M, Liang YL, Bateson D, Saville M, et al
Optimising management of women with HPV (not 16/18): Findings from a national HPV screening program.
Gynecol Oncol. 2025;204:133-142.
Abstract

FAN KY, Chehade R, Wang AY, Sachdeva A, et al
Surgery versus definitive radiotherapy in the management of stage I-II small cell neuroendocrine carcinoma of the cervix: A systematic review and meta-analysis.
Gynecol Oncol. 2026;204:118-123.
Abstract

DAIX-MOREUX M, El Hajj H, Scherier S, Deandreis D, et al
Para-aortic lymphadenectomy after negative PET-CT in locally advanced cervical cancer: a continuous monocentric series of 320 cases.
Gynecol Oncol. 2026;206:99-105.
Abstract

NAUMANN RW
Commentary on: Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup Canadian Cancer Trials Group Cx.5/SHAPE tr
Gynecol Oncol. 2026;205:A1-A2.
Abstract

JAIN D, Wahidi M, Effendi J, Hoang L, et al
Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV status.
Gynecol Oncol. 2026;205:89-98.
Abstract

CUTRI-FRENCH C, Saris DH, Solorzano SS, Wang X, et al
Disparities in access to gynecologic oncology visits among elderly patients with gynecologic malignancies.
Gynecol Oncol. 2026;205:63-69.
Abstract

MOREL D, Parvu V, Andrews J, Stephenson P, et al
HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.
Gynecol Oncol. 2026;207:40-47.
Abstract

SAAB RH, Salvo G, Gonzales NR, Munsell MF, et al
Social media use is associated with higher levels of anxiety and depression in patients with neuroendocrine carcinoma of the cervix: A NeCTuR study.
Gynecol Oncol. 2023;177:95-102.
Abstract

SAAB R, Brazan A, Chisholm GB, Gonzales NR, et al
Clear cell carcinoma of cervix and vagina: A review of 63 cases in the post-DES era.
Gynecol Oncol. 2026;206:39-44.
Abstract

CHALIF J, Morton M, Gonzalez A, McLaughlin E, et al
Evaluation of immunotherapy response in the radiated field in patients with recurrent endometrial and cervical cancer.
Gynecol Oncol. 2026;208:77-84.
Abstract

OGASAWARA A, Suzuki S, Oda K, Yunokawa M, et al
Phase II study of pembrolizumab plus olaparib in recurrent cervical cancer progressing after platinum-based chemotherapy (GOTIC-025).
Gynecol Oncol. 2026;208:122-130.
Abstract

KIM JH, Hwang WY, Choi CH, Kim HS, et al
Oncologic outcomes and the impact of minimally invasive surgery in early-stage cervical cancer patients undergoing radical trachelectomy: A retrospective multicenter cohort study from the Korean Gynecologic Oncology Group Study (KGOG 1048).
Gynecol Oncol. 2026;208:113-121.
Abstract

ROTHNIE K, Tristano E, Diaz-Rodriguez M, Filippova O, et al
Expanded subtype testing for circulating tumor HPV DNA reliably detects the presence of advanced-stage cervical cancer.
Gynecol Oncol. 2026;207S:47-52.
Abstract

VAN NIEUWENHUYSEN E, Vergote I, Randall LM, Tromp J, et al
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study.
Gynecol Oncol. 2026;207S:3-13.
Abstract

BORKAR SR, Tasman JG, Bakkum-Gamez JN, Cheney MC, et al
Exploring delays in primary gynecologic and breast cancer diagnosis after emergency department presentation.
Gynecol Oncol. 2026;208:41-47.
Abstract

BRAND-WIITA S, Tsai CJ, Liu YH, Beaulieu E, et al
Cost-effectiveness of pembrolizumab as a treatment for FIGO 2014 stage III-IVA cervical cancer in the United States.
Gynecol Oncol. 2026;210:1-9.
Abstract

WOLSWINKEL JT, Bekkers AHPA, Maurits JSF, Bekkers RLM, et al
Preoperative LVSI assessment in early-stage cervical cancer: Can it reliably guide lymph node management?
Gynecol Oncol. 2026;210:106-112.
Abstract

VALSTAD H, Fauske L, Wang YY, Eyjolfsdottir B, et al
Pelvic exenteration for cervical cancer - Oncologic outcome and long-term health-related quality of life, a mixed methods study.
Gynecol Oncol. 2026;210:183-192.
Abstract

NOGUERAS GONZALEZ GM, Amboree TL, Parker S, Bulsara S, et al
Barriers to cervical cancer screening and experiences using mailed at-home HPV self-collection kits among US and foreign-born Hispanic women in a safety net health system.
Gynecol Oncol. 2026;211:238-245.
Abstract

DIXIT R, Chakrawal A, Purwar R, Pandey M, et al
Comparative performance of HPV self-sampling and conventional screening methods: A systematic review and bivariate meta-analysis.
Gynecol Oncol. 2026;210:84-94.
Abstract

JIANG A, Chen Y, Ma F, Zhang H, et al
Malignant transformation risk and management dilemmas of atypical lobular endocervical glandular hyperplasia: A retrospective cohort study comparing Peutz-Jeghers syndrome versus sporadic cases.
Gynecol Oncol. 2026;211:51-58.
Abstract

FENG P, Shi K, Zhao W, Zhang J, et al
Diagnostic value of FAM19A4/SOX1/PAX1 methylation in non-16/18 high-risk HPV cervical lesions.
Gynecol Oncol. 2026;211:37-45.
Abstract

SEO JH, Lee Y, Lim S, Chung YE, et al
Dynamics of HER2 status in recurrent cervical cancer: Highlighting the clinical value of reassessment.
Gynecol Oncol. 2026;212:125-133.
Abstract

KOCIAN R, Koehler C, Di Martino G, Klat J, et al
Quality of life outcomes after sentinel lymph node biopsy in patients with early-stage cervical cancer: Results from the prospective multicentre SENTIX study.
Gynecol Oncol. 2026;212:106-115.
Abstract

RIESE C, Yi-Tung E, Nilsson H, Salehi S, et al
Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).
Gynecol Oncol. 2026;212:152-159.
Abstract

ZHANG Z, Quddus MR, Sung CJ, Singh K, et al
Morphologic and immunohistochemical study of HPV-related cervical adenosquamous carcinoma: Reappraisal of a poorly defined entity.
Hum Pathol. 2026;170:106052.
Abstract

PALMER TJ, Kavanagh K, Cuschieri K, Cameron RL, et al
Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening.
Int J Cancer. 2025 Nov 3. doi: 10.1002/ijc.70183.
Abstract

KALJOUW S, Jansen EEL, Olthof EMG, Hontelez JAC, et al
Under which realistic circumstances is hrHPV self-sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study.
Int J Cancer. 2026;158:1361-1369.
Abstract

CUI J, Mukherjee A, Patel PG, Junkins A, et al
Sex and organ-specific risk and temporal trends of human papillomavirus-associated anogenital cancer among solid organ transplant recipients in the United States.
Int J Cancer. 2026;158:1507-1516.
Abstract

REDL E, Herzog C, Vavourakis C, Barrett J, et al
The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer.
Int J Cancer. 2026 Jan 29. doi: 10.1002/ijc.70354.
Abstract

KROON KR, Bogaards JA, Berkhof J
Cost-effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV-positive women in cervical cancer screening.
Int J Cancer. 2026 Jan 28. doi: 10.1002/ijc.70344.
Abstract

GIES S, Pohlers M, Tanzer T, Ampofo E, et al
Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner.
Int J Cancer. 2026 Jan 24. doi: 10.1002/ijc.70340.
Abstract

NOMM O, Innos K, Jasilionis D, Krumins J, et al
Educational inequalities in cervical cancer mortality in the Baltic countries and Finland in the context of organized screening: A register-based study 2000-2015.
Int J Cancer. 2026 Jan 24. doi: 10.1002/ijc.70339.
Abstract

RASMUSSEN RMW, Munk C, Kjaer SK
Is the beneficial effect of multi-cohort HPV vaccination on cervical cancer and precancerous lesions seen across all educational levels?
Int J Cancer. 2026 Feb 6. doi: 10.1002/ijc.70360.
Abstract

DE CARVALHO TM, Berkhof J, Bogaards JA
Cost-effectiveness of risk-stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage.
Int J Cancer. 2026 Feb 9. doi: 10.1002/ijc.70377.
Abstract

SNELLMAN J, Pankakoski M, Heinavaara S, Partanen VM, et al
Increased cervical cancer incidence in the target age of screening-Variation by mode of detection.
Int J Cancer. 2026 Feb 7. doi: 10.1002/ijc.70371.
Abstract

NEWTON R, Tenet V, Mugisha J, Kimono B, et al
Human papillomavirus infection and vaccination among young females in rural Uganda.
Int J Cancer. 2025 Nov 6. doi: 10.1002/ijc.70227.
Abstract

KARRBERG C, Gray P, Elfgren K, Milerad H, et al
Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative women.
Int J Cancer. 2026 Mar 9. doi: 10.1002/ijc.70415.
Abstract

LEHTINEN M, Lipsitch M, Pimenoff VN, Sundstrom K, et al
Predicting optimal impact interventions in the post-HPV vaccination world.
Int J Cancer. 2026 Jan 19. doi: 10.1002/ijc.70297.
Abstract

TSEGAYE AT, Mashele SA, Shing JZ, Mwansa-Kambafwile J, et al
Race-specific temporal trends of HPV-related cancers in South Africa: An analysis of the South African National Cancer Registry, 2011-2022.
Int J Cancer. 2025 Dec 31. doi: 10.1002/ijc.70323.
Abstract

LEI J, Falcaro M, Brentnall AR, O'Mahony JF, et al
Indicators to identify cancer screening providers with suboptimal case detection: A scoping review.
Int J Cancer. 2026;158:2339-2358.
Abstract

QUAN J, Chen Q, Lan L, Zhang B, et al
Type- and age-specific natural history of high-risk human papillomavirus infections in healthy women: A prospective cohort study in China.
Int J Cancer. 2026;158:2736-2746.
Abstract

ELFSTROM KM, Hortlund M, Ohman D, Dillner J, et al
Cancer detection using human papillomavirus self-sampling targeting long-term non-attenders in an organized cervical screening program.
Int J Cancer. 2026;158:2729-2735.
Abstract

HU Y, Liu Y, Guo W, Hong Z, et al
Efficacy and safety of 5-aminolevulinic acid-based photodynamic therapy for cervical low-grade squamous intraepithelial lesions with HPV infections.
Int J Cancer. 2025 Dec 8. doi: 10.1002/ijc.70273.
Abstract

SAVROVA A, Jakoby H, Tisler A, Innos K, et al
Nationwide Study on the Cervical Cancer Screening Pathway in Estonia.
Int J Cancer. 2026 Apr 9. doi: 10.1002/ijc.70466.
Abstract

SCHROLL JB, Bonde J, Lynge E, Waldstrom M, et al
Health care policy trial of primary human papillomavirus-based cervical screening in Denmark: Comparison of three triage algorithms.
Int J Cancer. 2026;158:3197-3207.
Abstract

ZHONG X, Jin X, Cheng Y, Chao X, et al
Clinical Utility of Cytological Methylation Assay in Cervical Cancer Screening Across Various Cervical Transformation Zones.
Int J Cancer. 2026 Jun 11. doi: 10.1002/ijc.70591.
Abstract

BHATLA N, Rol M, Singhal S, Hussain S, et al
Clinical Validation of Four Point-of-Care High-Risk HPV Assays, Including Two Reduced-Valency Assays, for Cervical Cancer Screening in Low-Resource Settings.
Int J Cancer. 2026 Jun 7. doi: 10.1002/ijc.70534.
Abstract

MENESES-LEON J, Rivera-Paredez B, Hernandez-Salazar S, Torres-Ibarra L, et al
Extended HPV typing as an efficient alternative within HPV-based screening programs.
Int J Cancer. 2026 Mar 28. doi: 10.1002/ijc.70428.
Abstract

CHOKUNONGA E, Chirenje ZM, Borok M, Makunike-Mutasa R, et al
Trends in the incidence of cancers of the breast and female genital tract in Harare, Zimbabwe 1990-2019.
Int J Cancer. 2026;159:844-852.
Abstract

ALAM MS, Smith LW, Gondara L, Cook D, et al
HPV Testing Versus Cytology for Cervical Cancer Screening Among Women 50 Years and Older: Evidence From the HPV FOCAL Randomized Controlled Trial.
Int J Cancer. 2026 Jun 27. doi: 10.1002/ijc.70616.
Abstract

BONDE J, Schroll JB, Pedersen BT, Lynge E, et al
Health Care Policy Implementation Trial of Primary Human Papillomavirus-Based Cervical Screening in Denmark.
Int J Cancer. 2026;159:1464-1476.
Abstract

PELLEGRINO RA, Shepherd BE, Pujari S, Fink V, et al
Availability of Cancer Screening Across HIV Treatment Sites in the IeDEA Consortium.
Int J Cancer. 2026 Apr 16. doi: 10.1002/ijc.70503.
Abstract

ARMAROLI P, Zappa M, Giorgi Rossi P, Carozzi FM, et al
Population-Based First Estimates of the Effect of HPV Vaccination in Three Italian Areas Covered by Organised Cervical Screening.
Int J Cancer. 2026 May 5. doi: 10.1002/ijc.70536.
Abstract

MURTAS M, Vassilakos P, Wisniak A, Hu K, et al
Resource-Adapted Triage Strategies for Women Testing HPV Positive With Self-Collected Vaginal Samples in Cameroon.
Int J Cancer. 2026 Jun 18. doi: 10.1002/ijc.70573.
Abstract

IMARENGIAYE EO, Iweka RO, Anya CJ, Nwaogwugwu JC, et al
Knowledge, acceptance, uptake barriers and missed opportunities of human papillomavirus vaccine among female adolescents in Benin City, Nigeria: A mixed method study.
Int J Gynaecol Obstet. 2026;172:373-382.
Abstract

PERALTA J, Rodriguez J, Acosta JA, Nunez M, et al
Management of invasive cervical carcinoma in three oncology centers in Latin America: A historical cohort study.
Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70371.
Abstract

KARATAS E, Salman MC, Basaran D, Akgor U, et al
Predictors of lymphocyst development following lymphadenectomy in patients with gynecologic cancer.
Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70377.
Abstract

LI M, Xu S, Yang Q, Zheng Z, et al
Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031.
Int J Gynaecol Obstet. 2025 Jul 4. doi: 10.1002/ijgo.70351.
Abstract

DUQUE CAB, Bach RB, Fleider L, Sanchez-Diaz E, et al
Colposcopists' practice patterns in Latin America: An international cross-sectional survey.
Int J Gynaecol Obstet. 2026;172:808-814.
Abstract

ZHANG H, Dai Y, Zhou H, Yang Y, et al
Application of P16/Ki-67 dual-staining for the detection of high-grade cervical lesions in the triage of patients with minor abnormal cytology: A meta-analysis.
Int J Gynaecol Obstet. 2026;172:815-827.
Abstract

MUSA MS, Swai P, Oneko O, Mmbaga B, et al
Three-year survival rate and associated factors among women with invasive cervical cancer attended at ocean road cancer institute, Tanzania.
Int J Gynaecol Obstet. 2026 Jan 22. doi: 10.1002/ijgo.70831.
Abstract

HOFFMANN S, Trif L, Kramer B, Neis F, et al
PelviSound L-Real-time intraoperative sonographic assessment of pelvic sentinel lymph nodes using a drop-in probe in endometrial and cervical cancer during minimally invasive surgery: A single-center pilot feasibility study in 20 patients.
Int J Gynaecol Obstet. 2026 Jan 29. doi: 10.1002/ijgo.70838.
Abstract

ZULFIKAROGLU E
Cervical cancer screening strategies in women 65 years and older in the human papillomavirus era: A systematic review and meta-analysis of human papillomavirus-based testing and self-sampling approaches.
Int J Gynaecol Obstet. 2026 Mar 12. doi: 10.1002/ijgo.70962.
Abstract

HO QN, Quang Le T, Pham AHT, Nguyen PN, et al
Efficacy of thermal ablation among women with cervical intraepithelial neoplasia grade 1 and high-risk human papillomavirus genotypes: The first prospective study in Vietnam.
Int J Gynaecol Obstet. 2026;173:411-421.
Abstract

LIU X, Lyu Q, Li X, He L, et al
Interaction between the level of human papillomavirus integration and human papillomavirus type on the risk of grade 3 cervical intraepithelial neoplasia or more severe in human papillomavirus integration positive women: A cross-sectional study.
Int J Gynaecol Obstet. 2026;173:187-195.
Abstract

GULHAN I, Orun H, Yanigli G, Cagiran RN, et al
Human papillomavirus positivity and cervical intraepithelial lesion in cervical biopsy and endocervical curettage in women younger than 30 years.
Int J Gynaecol Obstet. 2026;173:209-215.
Abstract

MOEIN S, Romo FAL, Fischel LB, Singh N, et al
Fluorescein colposcopy-A more specific diagnostic method for detection of high-grade cervical precancer lesions than acetic acid.
Int J Gynaecol Obstet. 2026;173:138-143.
Abstract

DOMINONI M, Rasore G, Pano MR, Gardella B, et al
"Side effects" of cervical cancer screening: How diagnosis can impact on women's emotional status. A pilot survey.
Int J Gynaecol Obstet. 2026 Apr 2. doi: 10.1002/ijgo.71005.
Abstract

TJALMA W
Letter to the Editor: Sentinel node biopsy in cervical cancer during pregnancy: The need for clarification in FIGO guidance.
Int J Gynaecol Obstet. 2026 Mar 27. doi: 10.1002/ijgo.70986.
Abstract

JIAMSET I, Nanthamongkolkul K, Kongkamsuan W, Saeaib N, et al
Neutrophil-to-lymphocyte ratio as a prognostic marker for survival outcomes in women with cervical cancer and HIV infection.
Int J Gynaecol Obstet. 2026 Apr 14. doi: 10.1002/ijgo.71016.
Abstract

ZHU A, Ma Y, Chen F, Zhou L, et al
Clinicopathologic characteristics and prognostic outcomes of surgically treated neuroendocrine cervical carcinoma: A single institution retrospective analysis.
Int J Gynaecol Obstet. 2025 Nov 27. doi: 10.1002/ijgo.70697.
Abstract

WATCHARASIN P, Sirimusika N, Atjimakul T, Rattanaburi A, et al
Diagnostic performance of human papillomavirus DNA cycle threshold values in the detection of high-grade cervical intraepithelial neoplasia.
Int J Gynaecol Obstet. 2026;173:1617-1627.
Abstract

YANG Y, Yu M, Zeng M
Distant metastasis in patients with cervical cancer: A systematic review and meta-analysis of incidence rates and common sites.
Int J Gynaecol Obstet. 2026 May 22. doi: 10.1002/ijgo.71092.
Abstract

RUSSELL JC, Amin S, Kohler RE, Kelly H, et al
Understanding barriers to cervical cancer screening in Botswana: Insights from a cross-sectional study.
Int J Gynaecol Obstet. 2026 May 26. doi: 10.1002/ijgo.71089.
Abstract

DORJI N, Dorjey Y, Tshering S, Bhujel D, et al
Status of human papillomavirus infection after loop electrosurgical excision procedure at the National Referral Hospital, Bhutan, 2022-2023: A retrospective study.
Int J Gynaecol Obstet. 2026;174:145-151.
Abstract

HASSAN UM, Hayatu A, Farouk HU, Mohammed A, et al
Readiness and affordability of utilizing human papillomavirus testing for cervical cancer screening among sexually active women in Gombe, Nigeria.
Int J Gynaecol Obstet. 2026 Jul 2. doi: 10.1002/ijgo.71155.
Abstract

ZHOU H, Zhang H, Pi R, Yang Y, et al
Head-to-head comparison of the MyGene human papillomavirus-sexually transmitted infection assay versus the Cobas 4800 human papillomavirus test for detecting high-grade cervical intraepithelial neoplasia.
Int J Gynaecol Obstet. 2026;174:824-835.
Abstract

HONG Q, Smith LW, Proctor L, Gondara L, et al
Loop electrosurgical excision procedure and perinatal outcomes post-human papillomavirus cervical screening: A longitudinal cohort study.
Int J Gynaecol Obstet. 2026;174:793-799.
Abstract

MCCLOSKEY G, Ruck C, Booth A, Mutamba B, et al
Evaluating the feasibility of using SMS to recruit women for cervical cancer screening in Rwanda: A pilot study.
Int J Gynaecol Obstet. 2026 Jul 21. doi: 10.1002/ijgo.71225.
Abstract

MOUFARRIJ S, Pareja R, Fletcher A, Wilailak S, et al
De-escalating radical surgery for select FIGO Stage I cervical cancer.
Int J Gynaecol Obstet. 2026 Jul 27. doi: 10.1002/ijgo.71230.
Abstract

LANG M, Dang L, Zhang S, Zhu L, et al
Association between Composite Dietary Antioxidant Index and cervical cancer: A population-based cross-sectional study.
Int J Gynaecol Obstet. 2026 Aug 19. doi: 10.1002/ijgo.71276.
Abstract

MATSUO K, Matsuzaki S, Roman LD
Response to "Correspondence on 'Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer' by Matsuo et al" by Hu Y and Fang Q.
Int J Gynecol Cancer. 2025 Dec 5:102840. doi: 10.1016/j.ijgc.2025.102840.
Abstract

XU Q, Han J
Correspondence on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
Int J Gynecol Cancer. 2025 Dec 5:102846. doi: 10.1016/j.ijgc.2025.102846.
Abstract

SONG Y, Ran G, Zeng R, Chen C, et al
Global burden and temporal trends of cervical cancer in women aged 60 years and older, 1990-2021: a Global Burden of Disease study.
Int J Gynecol Cancer. 2025;36:102851.
Abstract

HU Y, Fang Q
Correspondence on "Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer" by Matsuo et al.
Int J Gynecol Cancer. 2025 Nov 26:102831. doi: 10.1016/j.ijgc.2025.102831.
Abstract

WANG K, Zhai Q, Xie Y, Tian Y, et al
Sentinel node mapping with carbon nanoparticles versus lymphadenectomy in early cervical cancer.
Int J Gynecol Cancer. 2025;36:102881.
Abstract

CIANCIA M, Mascilini F, Moro F, Testa AC, et al
Response to the Correspondence by Xu et al. on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
Int J Gynecol Cancer. 2025 Dec 18:102882. doi: 10.1016/j.ijgc.2025.102882.
Abstract

WU Q, Qiu X, Peng R
Correspondence on "Role of the novel optoelectronic imaging tracing system in cervical cancer screening: preliminary outcomes of a multi-center study" by Xiao Shang et al.
Int J Gynecol Cancer. 2025 Dec 16:102873. doi: 10.1016/j.ijgc.2025.102873.
Abstract

CIBULA D, Mburu A, Planchamp F, Zapardiel I, et al
European Society of Gynaecological Oncology resource-stratified guidelines for the management of patients with cervical cancer.
Int J Gynecol Cancer. 2026;36:102747.
Abstract

LEE SS, Banson K, Koduru H, Berger AA, et al
Factors associated with treatment delay for cervical cancer patients treated with definitive chemoradiation and brachytherapy.
Int J Gynecol Cancer. 2026;36:102774.
Abstract

TORIGOE R, Dennen C, Mayadev J, Makale MT, et al
Current challenges in the assessment and management of radiotherapy-induced vaginal stenosis.
Int J Gynecol Cancer. 2026;36:102801.
Abstract

MARUCCI DA SILVA GF, Pilger TL, Candido Dos Reis FJ
Incidence of urologic co-morbidities after abdominal radical hysterectomy: a systematic review of clinical trials.
Int J Gynecol Cancer. 2026;36:102722.
Abstract

WILLIAMS G, Bindra A, Fink D, Weintraub MR, et al
Survival in human papillomavirus and non-human papillomavirus-associated invasive endocervical adenocarcinoma: outcomes in a large, integrated healthcare system.
Int J Gynecol Cancer. 2026;36:102683.
Abstract

CASARIN J, Meschini T, Schivardi G, Giudici A, et al
Determinants of adjuvant radiotherapy in early-stage cervical cancer: a retrospective analysis of the SUCCOR cohort.
Int J Gynecol Cancer. 2025;36:104448.
Abstract

LEVIN G, Leung SOA
Correspondence on "Multicenter validated machine learning model for cervical cancer based on HPV genotyping results" by Ziren Chen et al.
Int J Gynecol Cancer. 2025 Dec 23:104447. doi: 10.1016/j.ijgc.2025.104447.
Abstract

PENG R, Wu Q, Qiu X
Correspondence on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study"(1) by Mascilini et al.
Int J Gynecol Cancer. 2026 Jan 3:104459. doi: 10.1016/j.ijgc.2025.104459.
Abstract

CHU R, Wang Z, Shi S, Wu N, et al
Histology-specific prognostic models for early-stage cervical cancer based on pathologic intermediate-risk factors: a multi-center retrospective study.
Int J Gynecol Cancer. 2026;36:104465.
Abstract

CHILINDA G, Moro F, Rijken MJ, Ciancia M, et al
Ultrasound-based preoperative assessment for cervical cancer: a pragmatic staging and treatment-planning strategy adaptable to diverse resource settings.
Int J Gynecol Cancer. 2025;36:102885.
Abstract

HSU HN, Lin YH
Pembrolizumab-induced vasculitis-like dermatitis in cervical cancer.
Int J Gynecol Cancer. 2025 Dec 22:104445. doi: 10.1016/j.ijgc.2025.104445.
Abstract

HU Y, Cheng H, Chen J, Chen S, et al
Neoadjuvant chemotherapy plus cadonilimab followed by extra-fascial hysterectomy for International Federation of Gynecology and Obstetrics stage IB2 cervical cancer: a prospective, multi-center, single-arm, phase 2 trial.
Int J Gynecol Cancer. 2026 Jan 5:104457. doi: 10.1016/j.ijgc.2025.104457.
Abstract

SEO JH, Chung YE, Lim S, Kim SY, et al
Pre-diagnostic physical activity and mortality in cervical cancer: a nationwide cohort study.
Int J Gynecol Cancer. 2026 Jan 16:104477. doi: 10.1016/j.ijgc.2026.104477.
Abstract

CIANCIA M, Moro F, Mascilini F, Testa AC, et al
Response to the Correspondence by Peng et al. on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
Int J Gynecol Cancer. 2026 Jan 18:104499. doi: 10.1016/j.ijgc.2026.104499.
Abstract

YONEMORI K, Nishio S, Suzuki S, Hasegawa K, et al
Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial.
Int J Gynecol Cancer. 2025 Dec 31:104450. doi: 10.1016/j.ijgc.2025.104450.
Abstract

HEMIDA R, Barakat R, Nabil H, Hasan M, et al
Retraction notice to "Cervical cancer elimination in low-resource countries: low-cost strategy" [International Journal of Gynecological Cancer, Volume 35 Issue 9 (2025) 101828].
Int J Gynecol Cancer. 2026;36:104540.
Abstract

ELMEHRATH AO, Njala B, Sakala D, Nogueras-Gonzalez GM, et al
Demographic and social determinants of human immunodeficiency virus status among women with cervical cancer in a low-resource setting.
Int J Gynecol Cancer. 2025 Dec 26:102867. doi: 10.1016/j.ijgc.2025.102867.
Abstract

SARDINHA TG, Vale DB, Discacciati MG, Triglia RM, et al
Diagnostic performance and clinical utility of p16 immunostaining in a population-based HPV DNA screening program.
Int J Gynecol Cancer. 2026;36:104451.
Abstract

O'SHEA J, Yu K, Chang D, Khaw P, et al
Survival and patterns of failure in small cell neuroendocrine carcinoma of the cervix treated with definitive chemoradiotherapy.
Int J Gynecol Cancer. 2026;36:102874.
Abstract

KOBAYASHI M, Yao JA, Lee MW, Nakagawa S, et al
Relative survival of large cell to small cell neuroendocrine carcinoma of the uterine cervix.
Int J Gynecol Cancer. 2026;36:102852.
Abstract

SHI J, Du H
Correspondence on "Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study" by Zhou et al.
Int J Gynecol Cancer. 2026 Jan 20:104505. doi: 10.1016/j.ijgc.2026.104505.
Abstract

EBRAHIMOGHLI R, Agaei MH, Hakimi MH, Moradoghli F, et al
Temporal trends and sources of variation in late-stage cervical cancer diagnosis in low- and middle-income countries: a systematic review and meta-analysis.
Int J Gynecol Cancer. 2026 Jan 28:104479. doi: 10.1016/j.ijgc.2026.104479.
Abstract

WANG L, Wei Y, Wu Q
Correspondence on "Identifying possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer" by Matsuo et al.
Int J Gynecol Cancer. 2025;35:102710.
Abstract

ZHOU J, Cai J, Li X, Liu C, et al
Correspondence on "Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study".
Int J Gynecol Cancer. 2026 Feb 11:104551. doi: 10.1016/j.ijgc.2026.104551.
Abstract

SANTIA MC, Morante-Caicedo C, Pineros Castillo WA, Taylor A, et al
Surgical de-escalation of cervical cancer treatment in limited-resource settings.
Int J Gynecol Cancer. 2026 Mar 2:102862. doi: 10.1016/j.ijgc.2025.102862.
Abstract

VIVEROS-CARRENO D, Agusti N, Mora-Soto N, Wilke RN, et al
De-escalation in definitive surgical management for cervical cancer.
Int J Gynecol Cancer. 2025 Oct 9:102711. doi: 10.1016/j.ijgc.2025.102711.
Abstract

CAICEDO-MARTINEZ M, Arbelaez-Marino AF, Arbelaez L, Farach A, et al
Refinement in radiotherapy treatment for locally advanced cervical cancer: a historic perspective.
Int J Gynecol Cancer. 2026 Mar 2:102878. doi: 10.1016/j.ijgc.2025.102878.
Abstract

MORA-SOTO N, Viveros-Carreno D, Morante-Caicedo C, Pineros W, et al
Neoadjuvant chemotherapy in cervical cancer: a narrative review.
Int J Gynecol Cancer. 2026 Mar 2:102827. doi: 10.1016/j.ijgc.2025.102827.
Abstract

PAREJA R, Agusti N, Vieira S, Mora-Soto N, et al
Efficacy of topical treatments for high-risk human papillomavirus in preventing CIN II+ lesions: a systematic review.
Int J Gynecol Cancer. 2026;36:102729.
Abstract

LI L, You J, Yuan Y, Gu X, et al
Prophylactic extended-field radiotherapy with concurrent chemotherapy for locally advanced cervical cancer: a propensity-score matching analysis.
Int J Gynecol Cancer. 2026;36:104634.
Abstract

PAULO DOS SANTOS O, Rodrigues de Bastos D, Saddi VA, Termini L, et al
Association of NK6 homeobox 1 promoter methylation with HPV infection, histological sub-type, and patient outcomes in cervical lesions.
Int J Gynecol Cancer. 2026;36:104561.
Abstract

DONOHOE F, Cohen A, Castillo A, Dagher C, et al
Pre-operative imaging in clinical International Federation of Gynecology and Obstetrics stage IB2 or less cervical carcinoma.
Int J Gynecol Cancer. 2026;36:104562.
Abstract

KIM DY, Lee CW, Jung W, Kang HC, et al
Treatment of cervical/vaginal intra-epithelial neoplasia with high-dose-rate brachytherapy: a multi-center retrospective analysis.
Int J Gynecol Cancer. 2026;36:104466.
Abstract

SONG M, Bandoni K, Rodriguez-Rodriguez L, Nelson RA, et al
Disparities between Blacks and Whites in risk of second primary malignancies among patients with cervical cancer: analysis of Surveillance, Epidemiology, and End Results Database.
Int J Gynecol Cancer. 2026;36:104637.
Abstract

SILVA NETO ALD, Mattos JM, Scaranti M
Beyond viral detection: refining biological risk stratification in human papillomavirus-positive cervical cancer screening.
Int J Gynecol Cancer. 2026;36:104658.
Abstract

VANDECAVEYE V, Walgraeve MS, De Keyzer F, Vergote I, et al
Pre-operative assessment in International Federation of Gynaecology and Obstetrics-2009 stage IB2 to IIB cervical cancer: role of delayed gadolinium-enhanced magnetic resonance imaging after neoadjuvant chemotherapy.
Int J Gynecol Cancer. 2026;36:104650.
Abstract

CHO O, El Naqa I
Prognostic impact of pelvic bone magnetic resonance imaging features in patients with cervical cancer undergoing definitive concurrent chemoradiotherapy.
Int J Gynecol Cancer. 2026;36:104648.
Abstract

WANG XS, Pond GR, Piedimonte S, Nelson G, et al
Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study.
Int J Gynecol Cancer. 2026;36:104695.
Abstract

LIM H, Lee C, Back JW, Seol A, et al
Association of primary treatment modality and programmed death-ligand 1 expression with survival outcomes in locally advanced human papillomavirus-independent endocervical adenocarcinoma.
Int J Gynecol Cancer. 2026;36:104652.
Abstract

KOBAYASHI M, Nakagawa S, Matsuzaki S, Ouzounian AJ, et al
Treatment modality-specific survival of small cell neuroendocrine carcinoma of the uterine cervix with T1b3-2b classifications.
Int J Gynecol Cancer. 2026;36:104644.
Abstract

CHEN Z, Zeng Y, Luo L, Li J, et al
Multi-center-validated machine learning model for cervical cancer based on human papillomavirus genotyping results.
Int J Gynecol Cancer. 2025;36:102855.
Abstract

SELCUK I
Tailoring radical hysterectomy in early-stage cervical cancer: moving beyond one-size-fits-all.
Int J Gynecol Cancer. 2026;36:104726.
Abstract

TJOKROPRAWIRO BA
TeleDoIVA: expanding cervical cancer screening across Indonesia's Archipelago through smartphone-based teleconsultation.
Int J Gynecol Cancer. 2026 Apr 25:104723. doi: 10.1016/j.ijgc.2026.104723.
Abstract

TEODORICO E, Moro F, Criscione M, Culcasi C, et al
Ultrasound detection of residual cervical cancer after conization, in a retrospective monocentric analysis: the URECA study.
Int J Gynecol Cancer. 2026;36:104755.
Abstract

LEVIN G, Gilbert L, Pareja R, Leung SOA, et al
Impact of bilateral oophorectomy on survival among patients undergoing radical hysterectomy for cervical adenocarcinoma: a National Cancer Database analysis.
Int J Gynecol Cancer. 2026;36:104469.
Abstract

VERIT FF
From biological plausibility to clinical uncertainty: poly(adenosine diphosphate-ribose) polymerase-based strategies in recurrent cervical cancer.
Int J Gynecol Cancer. 2026;36:104771.
Abstract

RUBAGUMYA F, Shankar V, Kwizera V, Ndoli DA, et al
Survival outcomes of cervical cancer patients treated with external beam radiotherapy boost in Rwanda.
Int J Gynecol Cancer. 2026;36:104754.
Abstract

JOURA E, Chatzistamatiou K, Gultekin M, Sehouli J, et al
European Society of Gynaecological Oncology/European Network of Gynaecological Advocacy Groups Position on risk-based cervical cancer screening.
Int J Gynecol Cancer. 2026;36:104794.
Abstract

CARUSO G, Colombo N
ADC-opoly in endometrial and cervical cancer: expanding the board.
Int J Gynecol Cancer. 2026;36:104786.
Abstract

WOLSWINKEL JT, van Lenthe I, Maurits JSF, Aarts JWM, et al
Balancing fertility potential and oncologic and obstetric risks: a vignette study on decision-making in fertility-sparing surgery for early-stage cervical cancer.
Int J Gynecol Cancer. 2026;36:104802.
Abstract

LEJEUNE CL, Janovska N, Wakatsuki A, Novak Z, et al
Analysis of indocyanine green-guided sentinel lymph node mapping for cervical cancer during pregnancy.
Int J Gynecol Cancer. 2026;36:104810.
Abstract

NORDQVIST KLEPPE S, Almstedt P, Dillner J, Arroyo Muhr LS, et al
Design principles and core components of cervical screening registries in the human papillomavirus era: a narrative review and global framework.
Int J Gynecol Cancer. 2026;36:104751.
Abstract

DE MELLO GRAZIANO L, Leis LV, Madia RZ, Hilgert MR, et al
Rethinking adjuvant treatment intensification in early-stage cervical cancer after radical surgery.
Int J Gynecol Cancer. 2026 Jun 20:104825. doi: 10.1016/j.ijgc.2026.104825.
Abstract

RAMALHO NM, Lima Sales JTO, Carneiro VCG, Batista TP, et al
Effect of topical vaginal estrogen after radiotherapy for cervical cancer: a randomized, double-blind pilot trial.
Int J Gynecol Cancer. 2026;36:104831.
Abstract

SRAJER A, Hutchinson JM, Metcalfe A, Brenner DR, et al
Cervical cancer screening among transgender and gender diverse individuals: a systematic review and meta-analysis.
Int J Gynecol Cancer. 2026;36:104850.
Abstract

LANDMAN Y, De Sousa Smith C, Ke S, Roumeliotis M, et al
Image-guided brachytherapy for locally advanced cervical cancer: clinical outcomes and fistula risk in stage IVA disease.
Int J Gynecol Cancer. 2026;36:104848.
Abstract

MARTINS JC, Simonsen M, Salim RC, de Azevedo Focchi GR, et al
Lymphovascular space invasion in cervical cancer: beyond the binary.
Int J Gynecol Cancer. 2026 Jul 11:104864. doi: 10.1016/j.ijgc.2026.104864.
Abstract

CASARIN J, Bianchi T, Torri V, Melazzini MG, et al
Surgical volume, structural quality, and compliance with European Society of Gynaecological Oncology quality indicators in endometrial and cervical cancer: a regional cross-sectional assessment.
Int J Gynecol Cancer. 2026;36:104847.
Abstract

EL HAJJ H, Gouy S, Limkin E, Scherier S, et al
Is conization with lymph node dissection safe for International Federation of Gynecology and Obstetrics 2018 stage IB1 cervical cancer measuring 1 to 2 cm?
Int J Gynecol Cancer. 2026 Jul 15:104874. doi: 10.1016/j.ijgc.2026.104874.
Abstract

IGA K
Inconclusive, not reassuring: reporting low-risk cervical cancer surgery outcomes.
Int J Gynecol Cancer. 2026 Jul 31:104887. doi: 10.1016/j.ijgc.2026.104887.
Abstract

NAGAR A, Samanta A, Chopra S, Mittal P, et al
CT vs. MRI for image-guided brachytherapy in locally advanced cervical cancer: A Propensity Score Matched Analysis.
Int J Radiat Oncol Biol Phys. 2026 Feb 13:S0360-3016(26)00379.
Abstract

SMITH EE, Heintz JR, Chesnokova A, Taunk NK, et al
Improving treatment of radiation-induced premature ovarian insufficiency after cervical cancer: A practice quality improvement initiative.
Int J Radiat Oncol Biol Phys. 2026 Feb 14:S0360-3016(26)00389.
Abstract

BROWN MH, Pollock AE, Sun K, Marter K, et al
Comparing Acute Toxicity of Proton and Photon Radiotherapy in Newly Diagnosed Gynecologic Primaries.
Int J Radiat Oncol Biol Phys. 2025 Nov 2:S0360-3016(25)06421.
Abstract

GULSTENE S, Chuk E, Conway J, Hanuschak J, et al
Dosimetric predictors of sexual toxicity in cervical cancer patients treated with definitive chemoradiation and MRI-guided brachytherapy.
Int J Radiat Oncol Biol Phys. 2026 Mar 18:S0360-3016(26)00505.
Abstract

HOUDOU L, Bruand M, Laroze S, Annede P, et al
UNICURE-HD: A Multicentric retrospective cohort study of Single-Insertion Image-Guided HDR Brachytherapy for Locally Advanced Cervical Cancer in the context of Limited Brachytherapy access in France.
Int J Radiat Oncol Biol Phys. 2026 Apr 18:S0360-3016(26)00598.
Abstract

SAINI SK, Srivastava S, Goel A, Sharma DN, et al
Outcomes of Stage IVA Cervical Cancer Treated with Radiotherapy: A Systematic Review and Meta-Analysis.
Int J Radiat Oncol Biol Phys. 2026 Apr 23:S0360-3016(26)00571.
Abstract

MYAGMARSUREN D, Alani A, Olatunji E, Ndassi DK, et al
Radiation-Induced Vaginal Stenosis in Cervical Cancer Patients in Low- and Middle-Income Countries: A Scoping Review.
Int J Radiat Oncol Biol Phys. 2026 May 20:S0360-3016(26)00728.
Abstract

HATHOUT L, Zhang Y, Lymberis S, Sherwani Z, et al
A Systematic Review of Patient-Reported Outcomes on the Impact of Radiotherapy on Sexual Health in Gynecologic Cancer Patients.
Int J Radiat Oncol Biol Phys. 2026 Feb 18:S0360-3016(26)00398.
Abstract

GANDHI AK, Rastogi M, Khurana R, Hadi R, et al
5-Year Outcomes of Moderately Hypofractionated Whole Pelvic Radiotherapy with Concurrent Chemotherapy and Image Guided High Dose Rate Brachytherapy for Locally Advanced Cervical Carcinoma.
Int J Radiat Oncol Biol Phys. 2025 Nov 28:S0360-3016(25)06523.
Abstract

MAYADEV J, Deng W, Kim H, Xiao Y, et al
Radiation Quality and Workflow in NRG GY017: Anti PD-L1 (Atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer.
Int J Radiat Oncol Biol Phys. 2026 May 24:S0360-3016(26)00706.
Abstract

QU A, Zhuo Y, Zhu H, Sun X, et al
Nimotuzumab Plus Image-Guided Radiation Therapy for Elderly Patients with Locally Advanced Cervical Squamous Cell Carcinoma: Interim Analysis of a Prospective Multicenter Phase II Trial.
Int J Radiat Oncol Biol Phys. 2026;125:1381-1387.
Abstract

SEKAR P, Vulysteke P, Ntloedibe T, Bvochora-Nsingo M, et al
Pace of Cervical Cancer Stage Progression Prior to Radiation Therapy Initiation, an Instrumental Variable Analysis.
Int J Radiat Oncol Biol Phys. 2026 Aug 12:S0360-3016(26)04139.
Abstract

CUSCHIERI K, Latsuzbaia A, McMahon H, Giubbi C, et al
Clinical performance assessment of the Papilloplex HR-HPV assay on self-taken urine and vaginal swab samples: findings from a multicentre European study.
J Clin Pathol. 2025 Nov 7:jcp-2025-210211. doi: 10.1136/jcp-2025-210211.
Abstract

ALMAS S, Karki S, Carpenter RE, Tamrakar VK, et al
Peptide-assisted direct detection of HPV nucleic acids from liquid-based cytology samples without extraction.
J Clin Virol. 2026;182:105901.
Abstract

MAYBURY EK, Ahmad S, McKenzie ND
Worldwide Evaluation of Cervical Cancer Self-Sampling Devices.
Obstet Gynecol. 2026 Feb 26. doi: 10.1097/AOG.0000000000006179.
Abstract

VOSOONEY A, Witkop CT, Cantor AG, Nelson HD, et al
Screening for Cervical Cancer: A Recommendation From the Women's Preventive Services Initiative.
Obstet Gynecol. 2026 Apr 23. doi: 10.1097/AOG.0000000000006315.
Abstract

Screening for Cervical Cancer.
Obstet Gynecol. 2026 Apr 24. doi: 10.1097/AOG.0000000000006257.
Abstract

CLARK M, Rusley J, Graham C, Cronin B, et al
Self-Sampling for Cervical Cancer Screening in Transmasculine and Nonbinary People.
Obstet Gynecol. 2026 Apr 30. doi: 10.1097/AOG.0000000000006296.
Abstract

LUO R, Chen J, Chen Z, Wang S, et al
MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cells.
Oncol Rep. 2026;55:101.
Abstract

LEUNG RC, Liu SS, Chan KY, Tam KF, et al
[Expression of Concern] Promoter methylation of death?associated protein kinase and its role in irradiation response in cervical cancer.
Oncol Rep. 2026;55:120.
Abstract

ZHANG Y, Zou H, Deng S, Zou L, et al
Impact of WFDC2 on the biological functions of cervical cancer cells and the regulation of the ERK/NF?kappaB signaling pathway.
Oncol Rep. 2026;56:153.
Abstract

MAKISE M, Uchimura R, Shiraishi A, Kuniyasu A, et al
Stable overexpression of Nup88 enhances HeLa cell migration through independent regulation of Kif7 and Gli1.
Oncol Rep. 2026;56:165.
Abstract

AHN SH, Bhutta ZA, Na H, Lee HK, et al
Anticancer effects of tangeretin associated with reactive oxygen species generation, mitochondrial dysfunction and apoptosis in CaSki cells.
Oncol Rep. 2026;56:166.
Abstract

SPAMPINATO S, Kutluyer S, Almaz S, Schuur N, et al
Impact of primary radiotherapy on the psychosocial well-being of patients with locally advanced cervical cancer (IMPRaCC study).
Radiother Oncol. 2026 Jan 30:111405. doi: 10.1016/j.radonc.2026.111405.
Abstract

YANG XL, Zhu JW, Wang C, Zhou YC, et al
Radiation- versus surgery-based treatment for patients with resectable IIIC1 cervical adenocarcinoma.
Radiother Oncol. 2026;216:111370.
Abstract

CORBEAU A, Spampinato S, Charnalia M, Ranjan N, et al
Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial.
Radiother Oncol. 2026;218:111444.
Abstract

MACKENZIE P, Vajdic C, Delaney G, Comans T, et al
Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
Radiother Oncol. 2023;188:109862.
Abstract

ANDREADIS G, Groot W, Boer SM, Bosman PAN, et al
Interobserver variability of corresponding anatomical landmark placement in pelvic CT and MRI scans.
Radiother Oncol. 2026;218:111430.
Abstract

CHARNALIA M, Ranjan N, Spampinato S, Nout R, et al
Cumulative gastrointestinal adverse events in EMBRACE-I: comparative evaluation of CTCAE vs. MOSES methods in predicting the impact of incident vs. persistent adverse events on quality of life.
Radiother Oncol. 2026;219:111489.
Abstract

YANG XL, Li XM, Shi YG, Wei LC, et al
Induction chemotherapy prior to definitive chemoradiotherapy in locally advanced cervical cancer patients: A multi-center cohort study.
Radiother Oncol. 2026 Jun 26:111675. doi: 10.1016/j.radonc.2026.111675.
Abstract

DATTA A, Biolatti LV, Reardon M, Bigos K, et al
Hypoxia-associated gene signature for uterine cervical cancer.
Radiother Oncol. 2026 Jul 23:111703. doi: 10.1016/j.radonc.2026.111703.
Abstract

GAN S, Tang J, Qin S, Ou Q, et al
Recombinant Listeria expressing the HPV multivalent E6E7 protein has a broader spectrum of anti-tumor effects against cervical cancer.
BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15476.
Abstract

HAN X, Di R, Zhang H, Zhou B, et al
Evaluation indicators for bladder dysfunction in Chinese patients following cervical cancer surgery: a Delphi study based on nursing outcomes classification.
BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15344.
Abstract

KANG Y, Chang L, Lin H, Liu J, et al
Development and external validation of a machine learning-based prognostic model for small cell neuroendocrine cervical carcinoma: a multi-center study.
BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15338.
Abstract

WANG Y, Deng Y, Wei Y, Wang C, et al
Association of SMAD4 gene polymorphisms with human papillomavirus infection and risk of cervical cancer: a case-control study.
BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-026-15552.
Abstract

GUO W, Jian W, Zhu L, Zhang B, et al
3D transformer-based dose prediction in HDR brachytherapy for cervical cancer.
BMC Cancer. 2026 Jan 20. doi: 10.1186/s12885-026-15592.
Abstract

LIN S, Zhong J, Yuan S, Su M, et al
Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer.
BMC Cancer. 2026 Jan 30. doi: 10.1186/s12885-026-15636.
Abstract

YANG XL, He JL, Wang TJ, Ran L, et al
Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a multi-center large cohort study.
BMC Cancer. 2026 Jan 29. doi: 10.1186/s12885-026-15661.
Abstract

FEI C, Chen W, Liu J, Wang J, et al
A real-world multicenter study on opportunistic cervical cancer screening in hospital in China: comparison of TruScreen device, cytology, and HPV testing for detecting high-grade cervical lesions.
BMC Cancer. 2026 Feb 4. doi: 10.1186/s12885-026-15590.
Abstract

WANGUSI R, Ngugi E, Wafula S, Awuor P, et al
Enhancing cervical cancer screening uptake through self-sampling for HPV DNA testing: insights and results from implementing in routine HIV clinics serving women living with HIV in Nairobi, Kenya, 2021-2024.
BMC Cancer. 2026 Feb 21. doi: 10.1186/s12885-026-15771.
Abstract

ANENA S, Okello MO, Ouma RC, Olum R, et al
Uptake of cervical cancer screening services among women of reproductive age enrolled in HIV care: a facility-based cross-sectional study in rural Northern Uganda.
BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15708.
Abstract

BONNAH J, Awuah B, Williams MS
The role of healthcare providers in shared decision making for cervical cancer prevention in Ghana: A qualitative study.
BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-026-15785.
Abstract

CUI YM, Shan YM, Xiao YY, Gao Y, et al
Analysis of prognosis in early-stage cervical cancer patients post-conization treated with laparoscopic versus open radical hysterectomy.
BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15756.
Abstract

OUMA GE, Asaso Omwodo K, Itsura P, Poli PA, et al
Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary center.
BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15761.
Abstract

WU M, Jiang Z, Xian X, Lu M, et al
Transrectal ultrasound-guided optimization of needle insertion for interstitial brachytherapy in the treatment of vaginal stump recurrence of cervical cancer.
BMC Cancer. 2026 Mar 7. doi: 10.1186/s12885-026-15819.
Abstract

CHEN X, Li J, Sun Y, Ye Z, et al
LncRNA EGFR-AS1 inhibits ferroptosis to reduce radiosensitivity of cervical cancer through the m6A/IGF2BP3/APAF1 axis.
BMC Cancer. 2026 Mar 5. doi: 10.1186/s12885-026-15596.
Abstract

ABERA GB, Alemayehu M, Sori DA, Ali R, et al
Time to death and its determinants among cervical cancer patients in Tigray, Ethiopia: a retrospective follow up study.
BMC Cancer. 2026 Mar 2. doi: 10.1186/s12885-026-15712.
Abstract

CHHOKAR A, Joshi U, Keshavam CC, Gupta B, et al
Development of a novel multi-locus Flow-FISH based assay for detection of progressive cervical precancer lesions.
BMC Cancer. 2026;26:343.
Abstract

USIN SG, Olajire GA, Olumese JO, Idenyi EO, et al
Transcriptomic profiling of select genes associated with cervical cancer and its preneoplastic lesions in Nigerian patients: an in vivo and in silico study.
BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-15972.
Abstract

SORI DA, Ali R, Jibat N, Adissu W, et al
Clinicopathologic characteristics and predictors of treatment uptake among patients with cervical cancer managed at Jimma University Medical Center, Southwest Ethiopia.
BMC Cancer. 2026 Apr 14. doi: 10.1186/s12885-026-15987.
Abstract

YANG X, Xie Y, Gao C, Sun N, et al
Noninvasive prediction of lymph-vascular space invasion in cervical cancer based on ultrasomics nomogram.
BMC Cancer. 2026 Apr 13. doi: 10.1186/s12885-026-15981.
Abstract

ZHAO Y, Zhao C, Liu Y, Wang Y, et al
Prognostic prediction in primary cervical squamous cell carcinoma with serum squamous cell carcinoma antigen >/= 10 ng/mL: development and validation of a nomogram model based on inflammatory biomarkers and clinical factors.
BMC Cancer. 2026;26:479.
Abstract

NYABYENDA EC, Nkurikiyeyezu K, Sylvain MH, Absolomon G, et al
Image analysis for cervical cancer classification using deep learning techniques.
BMC Cancer. 2026 Apr 23. doi: 10.1186/s12885-026-16076.
Abstract

HUANG S, Wu S, Li Y, Lin Y, et al
The value of tertiary lymphoid structure on predicting the survival rate of advanced cervical cancer patients.
BMC Cancer. 2026 Apr 23. doi: 10.1186/s12885-026-16019.
Abstract

LIU X, Liao Y, Liu Y, Huang H, et al
Molecular markers for cervical cancer prognosis: a prognostic model using stemness-related lncRNAs and functional analysis of EMX2OS.
BMC Cancer. 2026 Apr 20. doi: 10.1186/s12885-026-16022.
Abstract

ZHOU X, Xu H, Fu Y, Nie Q, et al
Geographic and demographic patterns of cervical cancer in Africa using GLOBOCAN 2022.
BMC Cancer. 2026 Apr 18. doi: 10.1186/s12885-026-16000.
Abstract

YOU J, Wu D, Tie J, Shen J, et al
Phase I clinical trial of lobaplatin combined with image-guided volume-modulated arc radiation therapy in locally advanced cervical cancer.
BMC Cancer. 2026 May 22. doi: 10.1186/s12885-026-16089.
Abstract

PANG D, Yang H, Zhang S, Qiu W, et al
Machine learning-based radiomics analysis of PET imaging for early prediction of concurrent chemoradiotherapy response in stage II-III cervical squamous cell carcinoma.
BMC Cancer. 2026;26:620.
Abstract

DUDUYEMI BM, Mensah BNO, Addae EK, Sallah L, et al
Expression of p16 and p53 proteins in cervical cancer cases in a tertiary centre in Ghana: an immunohistochemical study.
BMC Cancer. 2026 May 27. doi: 10.1186/s12885-026-16266.
Abstract

HE Y, Yang H, Zhang C, Jiang R, et al
Identification and validation of CNTNAP2/PAX1 hypermethylation as an epigenetic biomarker panel for detection of cervical cancer and precancerous lesions in hrHPV-positive women.
BMC Cancer. 2026 May 22. doi: 10.1186/s12885-026-16208.
Abstract

ADEGBOYEGA B, Balogun O, Ogunmuyiwa J, Habeebu M, et al
Assessing predictors of brachytherapy utilization among cervical cancer patients in Nigeria: evidence from a tertiary cancer centre.
BMC Cancer. 2026 Jun 9. doi: 10.1186/s12885-026-16311.
Abstract

WU J, He W, Zhang W, Ye D, et al
EVX2 methylation assay enables risk assessment of cervical cancer in high-risk HPV-infected individuals.
BMC Cancer. 2026 Jun 8. doi: 10.1186/s12885-026-16256.
Abstract

ADEBISI TM, Oluwasola TAO, Ndikom CM, Salako BL, et al
Feasibility of the effectiveness of a psychoeducational intervention on the physical and psychosexual functioning of women being treated for cervical cancer in a tertiary hospital in Southwest, Nigeria: a quasi-experimental study.
BMC Cancer. 2026 Jun 15. doi: 10.1186/s12885-026-16288.
Abstract

CHEN Y, Li S, Huang J, Huang X, et al
Cervical pathology outcomes in the setting of completely normal colposcopic impressions.
BMC Cancer. 2025;25:1691.
Abstract

FARZANEH F, Soltani A, Dastyar F, Mohammadi M, et al
AI-Driven predictive modeling of cervical intraepithelial neoplasia severity: a comprehensive analysis with clinical adoption frameworks.
BMC Cancer. 2025;25:1521.
Abstract

WANG XC, Xu XL, Wang SY, Cheng H, et al
Nomogram based on the advanced lung cancer inflammation index and other relevant clinical factors for patients with cervical squamous cell carcinoma undergoing concurrent chemoradiotherapy.
BMC Cancer. 2025;25:1043.
Abstract

LIU Q, Liu W, Huang Y, Li Y, et al
Comparative effectiveness of radical surgery versus concurrent chemoradiotherapy in stages IB3, IIA2, or locally resectable IIICr cervical cancer: a prospective, multicenter, propensity score-matched cohort study.
BMC Cancer. 2026 Jul 1. doi: 10.1186/s12885-026-16449.
Abstract

ESMAILZADEH A, Rashki Kemmak A, Rasoulian A, Alizadeh Tabatabaei FS, et al
Artificial intelligence for cervical cancer screening and diagnosis using Pap smear images: a systematic review.
BMC Cancer. 2026 Jun 30. doi: 10.1186/s12885-026-16427.
Abstract

TROJNARSKA D, Trzeszcz M, Stukan M, Mazurec K, et al
HPV vaccination beyond primary prevention: survey of practices and attitudes of Polish obstetrician-gynecologists.
BMC Cancer. 2026 Apr 22. doi: 10.1186/s12885-026-15974.
Abstract

WANG X, Liu Y, Li Y, An Q, et al
The influence of postoperative risk factors on patient survival and lymph node metastasis in cervical squamous cell carcinoma.
BMC Cancer. 2026;26:547.
Abstract

ZHU G, Chen C, Xiang Y, Wang Y, et al
Machine learning-based prediction of long-term prognosis in cervical adenocarcinoma: a retrospective cohort study.
BMC Cancer. 2026;26:366.
Abstract

LAMY C, Laurent L, Choussy O, Pouget N, et al
SCANDARE: an institutional dynamic prospective interventional biobanking study.
BMC Cancer. 2026;26:330.
Abstract

LI X, Zhang X, Dai Y, Huang F, et al
A P4HA2 hypoxia signature derived from single cell atlas stratifies conserved subtypes with prognostic significance in cervical squamous cell carcinoma.
BMC Cancer. 2026;26:257.
Abstract

NOGUERAS-GONZALEZ GM, Inam ME, Msadabwe S, Lee KL, et al
Impact of social determinants of health on cervical cancer stage at presentation among women in Zambia: a cross-sectional single-center epidemiological study.
BMC Cancer. 2026 Jul 9. doi: 10.1186/s12885-026-16315.
Abstract

MENG H, Tan L, Chen Y, Wang D, et al
Phosphoinositide metabolism-related prognostic genes and their prognostic value in cervical cancer: an investigation based on transcriptome, single-cell analyses and verification.
BMC Cancer. 2026 Jul 9. doi: 10.1186/s12885-026-16509.
Abstract

LEMRABETT S, Elhailouch FZ, Gourinda A, Mezzoug N, et al
Awareness and acceptability of HPV vaccination among parents of young girls in northern Morocco: a mixed-methods study.
BMC Cancer. 2026 May 23. doi: 10.1186/s12885-026-16111.
Abstract

ZHANG HH, Liu M, Chen YN, Zhang MR, et al
Screening of shared molecular markers between cervical cancer and major depressive disorder and the mechanism of CRAT/CLIC4 regulating EMT in cervical cancer cells.
BMC Cancer. 2026 Jul 20. doi: 10.1186/s12885-026-16571.
Abstract

PAKDAMAN K, Shirvani AE, Pakdaman K, Nikbakht HA, et al
Systematic review and meta-analysis of lung metastases incidence in cervical cancer patients.
BMC Cancer. 2026 Jul 21. doi: 10.1186/s12885-026-16579.
Abstract

JIAHAN L, Siqi L, Keliya M, Lili H, et al
HPV genotype distribution and cervical lesions in colposcopy-referred women in Western China: a cross-sectional study.
BMC Cancer. 2026 May 26. doi: 10.1186/s12885-026-16209.
Abstract

TONG Z, Mao S, Tao H, Gan P, et al
PAX1 methylation for triage of HR-HPV-positive women: a comparative analysis with cytology and HPV16/18 genotyping.
BMC Cancer. 2026 May 25. doi: 10.1186/s12885-026-16235.
Abstract

EIDBUR A, Atjimakul T
External validation of predictive models for high-grade cervical lesions in Thai women undergoing colposcopy: a retrospective external validation study.
BMC Cancer. 2026;26:960.
Abstract

QIU L, Xie Y, Li Y, Huang J, et al
Association between serum gamma-Glutamyltransferase and the risk of cervical cancer: Evidence from the national health and nutrition examination survey.
PLoS One. 2026;21:e0339001.
Abstract

HU J, Wang Y, Liu Y, Cai Z, et al
Global burden and projections of cervical cancer attributable to unsafe sex and smoking, 1990-2034.
PLoS One. 2026;21:e0339923.
Abstract

TANIOKA M, Nagao S, Ida N, Tanaka Y, et al
Fertility-sparing surgery with neoadjuvant chemotherapy in early and locally advanced cervical cancer: A clinical protocol.
PLoS One. 2026;21:e0340963.
Abstract

WANZALA J, Anino CO
Uptake of cervical cancer screening and its associated factors among women of reproductive age in Kericho County.
PLoS One. 2026;21:e0328614.
Abstract

PROIETTI A, De Angelis E, Buccini L, Leopizzi M, et al
A pilot multimodal study of cervical cancer: Raman spectroscopy as a molecular fingerprint tool.
PLoS One. 2026;21:e0327286.
Abstract

ILIC I, Babic G, Sipetic Grujicic S, Zivanovic Macuzic I, et al
Concurrent depression and anxiety in women undergoing additional diagnostic procedures due to positive screening for cervical cancer.
PLoS One. 2026;21:e0342492.
Abstract

HADDADI M, Golestani A, Farzi Y, Rezaei N, et al
Iran is falling behind WHO cervical cancer elimination targets: HPV vaccination coverage and cervical cancer screening participation in 2021.
PLoS One. 2026;21:e0341888.
Abstract

KIM WJ, Kim YW
Association between cervical conization and pregnancy outcomes: A nationwide population-based cohort study.
PLoS One. 2026;21:e0341660.
Abstract

Retraction: Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime.
PLoS One. 2026;21:e0343674.
Abstract

ARMIJO N, Espinoza MA, Contreras-Montiel P, Vera M, et al
Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile.
PLoS One. 2026;21:e0332010.
Abstract

CUPERTINO BERGOMI L, de Souza Carvalho G, Zanetti de Albuquerque L, Goncalves Kischinhevsky D, et al
Social inequities and clinical outcomes in young women with cervical cancer: Real-world evidence.
PLoS One. 2026;21:e0343651.
Abstract

CHEN Y, Qiu W, Xiao G, Zhang R, et al
Analysis of the correlation between vaginal microbiota and high-risk human papillomavirus infection and cervical lesions.
PLoS One. 2026;21:e0343027.
Abstract

MITCHELL LE, Phillips E, Jennett CJ, Bavor C, et al
Experiences of HPV self-collection among Aboriginal and Torres Strait Islander women and people with a cervix.
PLoS One. 2026;21:e0326551.
Abstract

HASBAY E, Sahin S, Kelten Talu EC, Sanci M, et al
MRI differentiation of usual type endocervical adenocarcinoma and cervical squamous cell carcinoma.
PLoS One. 2026;21:e0343764.
Abstract

AYASS MA, Zaman N, Griko N, Pashkov V, et al
Non-invasive host transcriptome and HPV oncogene expression map the molecular landscape of HPV-driven cervical lesions.
PLoS One. 2026;21:e0339693.
Abstract

AFAYA A, Awunyo W, Udeoha MA, Kodjo MM, et al
The relational association between multiple sexual partners and HIV testing on cervical cancer screening among women of reproductive age in Ghana: A national population-based study.
PLoS One. 2026;21:e0344086.
Abstract

WU Q, Bai S, Wang P, Han L, et al
Limonin induces ferroptosis in cervical squamous cell carcinoma by activating the expression of soluble epoxide hydrolase 2 protein.
PLoS One. 2026;21:e0343495.
Abstract

DAY S, Harries J, Sawula B, Payne A, et al
Navigating cancer: Insights from patient journey mapping.
PLoS One. 2026;21:e0327113.
Abstract

YAN K, Yang G, Yan L, Wu L, et al
Global trends and forecasts of cervical cancer and a real-world safety assessment of human papillomavirus vaccines in women: A systematic analysis of the Global Burden of Disease study 2021 and the Vaccine Adverse Event Reporting System database.
PLoS One. 2026;21:e0345286.
Abstract

SHIRAKAWA S, Nagao S, Yoshio K, Mitsuhashi T, et al
Incidence of pelvic fractures after definitive radiotherapy for cervical cancer: A retrospective multicenter cohort study (The IPFAR study).
PLoS One. 2026;21:e0344384.
Abstract

EMESU G, Kiracho EE, Jatho A, Kagaayi J, et al
Equity in awareness and utilization of cervical cancer screening services among women of reproductive age in Uganda: Analysis of vertical equity using evidence from UDHS 2022.
PLoS One. 2026;21:e0335336.
Abstract

WHOP LJ, Mitchell LE, Butler TL, Wong D, et al
Screen Your Way Study Protocol: Embedding community driven models to increase cervical screening via HPV self-collection to improve cervical cancer outcomes for Aboriginal and Torres Strait Islander people.
PLoS One. 2026;21:e0336004.
Abstract

ASSEFA KT, Worku AG, Muche AA, Geremew BM, et al
Geographic inequities in human papillomavirus vaccine non-uptake and its determinants among adolescent girls in Ethiopia: Evidence from the National Immunization Survey.
PLoS One. 2026;21:e0348076.
Abstract

BITEWA MD, Yewodiaw TK, Abneh AA, Molla MG, et al
Determinants of cervical cancer screening among women aged 30 to 49 years in 20 low- and middle-income countries: A multilevel analysis.
PLoS One. 2026;21:e0347837.
Abstract

TILAHUN SW, Nega A, Wagaw L, Addissie A, et al
Shared decision-making in Cervical Cancer Care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A mixed-methods study.
PLoS One. 2026;21:e0348172.
Abstract

ESSAYAGH T, Essayagh M, Nmila K, Slibani H, et al
Prevalence and determinants of parental refusal of human papillomavirus vaccination in Morocco: A multicenter cross-sectional study.
PLoS One. 2026;21:e0348586.
Abstract

ESSAYAGH T, Essayagh M, Slibani H, El Hachimi S, et al
Challenges to human papillomavirus vaccination among young girls in Morocco: A national cross-sectional study.
PLoS One. 2026;21:e0347783.
Abstract

SALDANHA DA SILVA RL, Cardoso Mendes SR, Silva de Brito B, Pimentel de Moura B, et al
Cervical cancer: Riverside women's knowledge in the Brazilian Amazon about preventive measures.
PLoS One. 2026;21:e0347609.
Abstract

ROMLI R, Mohammed Nawi A, Abd Rahman R, Mohamad EMW, et al
Digital motivation for cervical cancer screening: A quasi-experimental trial of the SeDAR Video among middle adulthood Malaysian women.
PLoS One. 2026;21:e0347489.
Abstract

BUTTA J, Thonghoi P, Kesakul T, Thoopthong A, et al
Incremental impact of community-delivered HPV self-sampling on screening uptake within an active outreach system: A quasi-experimental implementation study in rural Thailand.
PLoS One. 2026;21:e0349531.
Abstract

YANG S, Hou Y, Wang X, Kang S, et al
Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
PLoS One. 2026;21:e0351029.
Abstract

CHEN S, Yang X, Jiang S, Lin Y, et al
Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study.
PLoS One. 2026;21:e0351539.
Abstract

EZECHUKWU C, Ayandipo EO, Osoteku D, Ibrahim R, et al
Gaps and barriers preventing sustained delivery of HPV vaccination in Kano, Kaduna, and Lagos states: An exploratory qualitative study.
PLoS One. 2026;21:e0350510.
Abstract

MUHAMMAD-OLODO AO, Asher L
Understanding factors influencing HPV vaccine uptake among caregivers in Kwara State, Nigeria: A qualitative study.
PLoS One. 2026;21:e0351659.
Abstract

NOREEN K, Noor M, Maryam S, Baig M, et al
From global to local: Developing a context-specific BeSD-HPV tool through cultural and linguistic adaptation in Pakistan.
PLoS One. 2026;21:e0350162.
Abstract

ILGAZI KILIC E, Kilic S
Multi-scale feature integration with enhanced cytomorph for high-accuracy cervical cytology classification.
PLoS One. 2026;21:e0351063.
Abstract

NEEMA UFOY MUNGU Y, Desreux J, Bianchi E, Junior BL, et al
Human papillomavirus genotypes and factors associated with major cervical smear abnormalities in a sickle cell endemic area of Kisangani, Democratic Republic of the Congo.
PLoS One. 2026;21:e0350982.
Abstract

EFFAH K, Ametefe DL, Amuah JE, Essel NOM, et al
A collaborative cervical precancer screening strategy with concurrent HPV genotyping and visual inspection using alumni of a training centre across Ghana: The Rotary 'Protect Your Pearl' initiative.
PLoS One. 2026;21:e0350573.
Abstract

SEDAGHAT SHAYEGAN G, Salehipour P, Najafi A, Modarressi MH, et al
Optimizing an ethanol-based fixative for enhanced nucleic acid preservation in cervical samples using a central composite design approach.
PLoS One. 2026;21:e0349088.
Abstract

KIM HJ, Lee HJ, Shin HY, Lee HS, et al
Understanding barriers and facilitators to cervical cancer prevention among young Korean Women: A focus group interview study.
PLoS One. 2026;21:e0353242.
Abstract

BERZA N, Zodzika J, Kivite-Urtane A, Curkste A, et al
Factors associated with women's choice for mode of cervical sampling in future cervical cancer screening.
PLoS One. 2026;21:e0353180.
Abstract

YANG S, Hou Y, Wang X, Kang S, et al
Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
PLoS One. 2026;21:e0353864.
Abstract

ZOUZOULAS D, Sofianou I, Chatzistamatiou K, Theodoulidis V, et al
Comparison of Moducare versus Wait-and-See approach for histologically proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) (MODUCIN1 TRIAL) - Study protocol.
PLoS One. 2026;21:e0353119.
Abstract

TAFESE AM, Dirbaba B, Fentie M, Zeigler-Johnson C, et al
Cervical cancer screening coverage and associated factors among women aged 25-59 in Eswatini: Insights from the 2021 Population-Based HIV Impact Assessment (PHIA).
PLoS One. 2026;21:e0354508.
Abstract

ZENEBE S, Yeheyis T, Tadesse F, Deribe B, et al
Perceived facilitators and barriers against human papillomavirus vaccine among rural parents with eligible daughters in the Alle district, Southern Ethiopia.
PLoS One. 2026;21:e0354372.
Abstract

LONG C, Wang S, Wang Y
SPP1 promotes cisplatin resistance in cervical cancer by regulating KRAS expression.
PLoS One. 2026;21:e0353621.
Abstract

JOHN A, Rasheed R, Idikula MJ
Perceptions and practices among students, parents, and teachers of the Human Papillomavirus (HPV) Vaccination: A pilot feasibility study from Rural Kerala.
PLoS One. 2026;21:e0340559.
Abstract

YANG H, Tan Y, Pang Y, Chen X, et al
Efficacy comparison of concurrent chemoradiotherapy alone versus concurrent chemoradiotherapy plus adjuvant chemotherapy in stage III Locally Advanced Cervical Cancer: A single-center, retrospective observational cohort study.
PLoS One. 2026;21:e0354207.
Abstract

RIETZ A, Kumari L, Koirala A, Pelletier S, et al
Covalent inhibitors of human papillomavirus type 16 E6 protein restore p53 function and suppress growth of HPV-driven tumors in vivo.
Proc Natl Acad Sci U S A. 2026;123:e2606213123.
Abstract

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum

;